date generated: 2020-12-06
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 393.8656285
## 5_8S_rRNA 4.2647989
## A1BG -0.4250025
## A1CF 0.9452369
## A2M -0.4893072
## A3GALT2 -0.6719394
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 2408 |
num_genes_in_profile | 18043 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 9487 |
num_profile_genes_not_in_sets | 8556 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used: GMT file of genesets: ReactomePathways.gmt
Gene sets metrics | |
---|---|
num_genesets | 2408 |
num_genesets_excluded | 960 |
num_genesets_included | 1448 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Top N= 50 gene sets
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
Xenobiotics | 20 | 1.64e-07 | -0.6760 | 0.000238 |
Plasma lipoprotein remodeling | 31 | 1.95e-06 | -0.4940 | 0.001410 |
Fatty acids | 14 | 4.06e-06 | -0.7110 | 0.001820 |
Collagen formation | 80 | 5.04e-06 | 0.2950 | 0.001820 |
Collagen biosynthesis and modifying enzymes | 58 | 7.24e-06 | 0.3410 | 0.002100 |
NR1H2 and NR1H3-mediated signaling | 48 | 3.30e-05 | -0.3460 | 0.007970 |
Phase I - Functionalization of compounds | 91 | 4.09e-05 | -0.2490 | 0.008460 |
Translation | 262 | 5.52e-05 | 0.1450 | 0.009990 |
Interferon alpha/beta signaling | 63 | 7.04e-05 | -0.2900 | 0.010700 |
Biological oxidations | 176 | 7.41e-05 | -0.1730 | 0.010700 |
Assembly of active LPL and LIPC lipase complexes | 19 | 1.16e-04 | -0.5110 | 0.015200 |
Cell death signalling via NRAGE, NRIF and NADE | 72 | 2.42e-04 | -0.2500 | 0.029200 |
Cell junction organization | 85 | 3.01e-04 | -0.2270 | 0.031400 |
Sulfur amino acid metabolism | 25 | 3.03e-04 | -0.4170 | 0.031400 |
Phenylalanine and tyrosine metabolism | 11 | 3.55e-04 | -0.6220 | 0.033600 |
Extracellular matrix organization | 274 | 3.72e-04 | 0.1250 | 0.033600 |
Cytochrome P450 - arranged by substrate type | 58 | 4.24e-04 | -0.2680 | 0.036100 |
p75 NTR receptor-mediated signalling | 92 | 4.71e-04 | -0.2110 | 0.037900 |
Plasma lipoprotein assembly, remodeling, and clearance | 68 | 5.54e-04 | -0.2420 | 0.040700 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 5.62e-04 | -0.3190 | 0.040700 |
Signal Transduction | 2386 | 7.12e-04 | -0.0429 | 0.049100 |
Synthesis of substrates in N-glycan biosythesis | 61 | 8.69e-04 | 0.2470 | 0.055200 |
Plasma lipoprotein assembly | 18 | 8.76e-04 | -0.4530 | 0.055200 |
Death Receptor Signalling | 132 | 1.02e-03 | -0.1660 | 0.061300 |
Keratan sulfate degradation | 12 | 1.08e-03 | 0.5450 | 0.061300 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 75 | 1.15e-03 | 0.2170 | 0.061300 |
GPCR downstream signalling | 829 | 1.16e-03 | -0.0667 | 0.061300 |
Miscellaneous substrates | 12 | 1.19e-03 | -0.5400 | 0.061300 |
Chylomicron remodeling | 10 | 1.25e-03 | -0.5890 | 0.061300 |
Factors involved in megakaryocyte development and platelet production | 124 | 1.27e-03 | -0.1680 | 0.061300 |
Endosomal/Vacuolar pathway | 10 | 1.37e-03 | -0.5850 | 0.063500 |
Platelet Aggregation (Plug Formation) | 37 | 1.43e-03 | -0.3030 | 0.063500 |
Formation of the beta-catenin:TCF transactivating complex | 41 | 1.45e-03 | -0.2880 | 0.063500 |
Regulation of lipid metabolism by PPARalpha | 116 | 1.58e-03 | -0.1700 | 0.067400 |
Keratan sulfate/keratin metabolism | 31 | 1.64e-03 | 0.3270 | 0.067700 |
Intrinsic Pathway of Fibrin Clot Formation | 23 | 1.77e-03 | -0.3770 | 0.068500 |
Hemostasis | 582 | 1.81e-03 | -0.0759 | 0.068500 |
Chromatin modifying enzymes | 208 | 1.90e-03 | -0.1250 | 0.068500 |
Chromatin organization | 208 | 1.90e-03 | -0.1250 | 0.068500 |
Mitochondrial translation initiation | 85 | 1.93e-03 | 0.1950 | 0.068500 |
Rho GTPase cycle | 134 | 2.01e-03 | -0.1550 | 0.068500 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 2.05e-03 | -0.4600 | 0.068500 |
Aflatoxin activation and detoxification | 18 | 2.05e-03 | -0.4200 | 0.068500 |
Formation of Fibrin Clot (Clotting Cascade) | 37 | 2.08e-03 | -0.2920 | 0.068500 |
Protein ubiquitination | 65 | 2.19e-03 | -0.2200 | 0.069700 |
Signaling by GPCR | 895 | 2.26e-03 | -0.0605 | 0.069700 |
Cytosolic tRNA aminoacylation | 23 | 2.26e-03 | 0.3680 | 0.069700 |
p130Cas linkage to MAPK signaling for integrins | 15 | 2.31e-03 | -0.4540 | 0.069700 |
NRAGE signals death through JNK | 56 | 2.38e-03 | -0.2350 | 0.070400 |
Influenza Infection | 128 | 2.53e-03 | 0.1550 | 0.072500 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
Xenobiotics | 20 | 1.64e-07 | -6.76e-01 | 0.000238 |
Plasma lipoprotein remodeling | 31 | 1.95e-06 | -4.94e-01 | 0.001410 |
Fatty acids | 14 | 4.06e-06 | -7.11e-01 | 0.001820 |
Collagen formation | 80 | 5.04e-06 | 2.95e-01 | 0.001820 |
Collagen biosynthesis and modifying enzymes | 58 | 7.24e-06 | 3.41e-01 | 0.002100 |
NR1H2 and NR1H3-mediated signaling | 48 | 3.30e-05 | -3.46e-01 | 0.007970 |
Phase I - Functionalization of compounds | 91 | 4.09e-05 | -2.49e-01 | 0.008460 |
Translation | 262 | 5.52e-05 | 1.45e-01 | 0.009990 |
Interferon alpha/beta signaling | 63 | 7.04e-05 | -2.90e-01 | 0.010700 |
Biological oxidations | 176 | 7.41e-05 | -1.73e-01 | 0.010700 |
Assembly of active LPL and LIPC lipase complexes | 19 | 1.16e-04 | -5.11e-01 | 0.015200 |
Cell death signalling via NRAGE, NRIF and NADE | 72 | 2.42e-04 | -2.50e-01 | 0.029200 |
Cell junction organization | 85 | 3.01e-04 | -2.27e-01 | 0.031400 |
Sulfur amino acid metabolism | 25 | 3.03e-04 | -4.17e-01 | 0.031400 |
Phenylalanine and tyrosine metabolism | 11 | 3.55e-04 | -6.22e-01 | 0.033600 |
Extracellular matrix organization | 274 | 3.72e-04 | 1.25e-01 | 0.033600 |
Cytochrome P450 - arranged by substrate type | 58 | 4.24e-04 | -2.68e-01 | 0.036100 |
p75 NTR receptor-mediated signalling | 92 | 4.71e-04 | -2.11e-01 | 0.037900 |
Plasma lipoprotein assembly, remodeling, and clearance | 68 | 5.54e-04 | -2.42e-01 | 0.040700 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | 39 | 5.62e-04 | -3.19e-01 | 0.040700 |
Signal Transduction | 2386 | 7.12e-04 | -4.29e-02 | 0.049100 |
Synthesis of substrates in N-glycan biosythesis | 61 | 8.69e-04 | 2.47e-01 | 0.055200 |
Plasma lipoprotein assembly | 18 | 8.76e-04 | -4.53e-01 | 0.055200 |
Death Receptor Signalling | 132 | 1.02e-03 | -1.66e-01 | 0.061300 |
Keratan sulfate degradation | 12 | 1.08e-03 | 5.45e-01 | 0.061300 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | 75 | 1.15e-03 | 2.17e-01 | 0.061300 |
GPCR downstream signalling | 829 | 1.16e-03 | -6.67e-02 | 0.061300 |
Miscellaneous substrates | 12 | 1.19e-03 | -5.40e-01 | 0.061300 |
Chylomicron remodeling | 10 | 1.25e-03 | -5.89e-01 | 0.061300 |
Factors involved in megakaryocyte development and platelet production | 124 | 1.27e-03 | -1.68e-01 | 0.061300 |
Endosomal/Vacuolar pathway | 10 | 1.37e-03 | -5.85e-01 | 0.063500 |
Platelet Aggregation (Plug Formation) | 37 | 1.43e-03 | -3.03e-01 | 0.063500 |
Formation of the beta-catenin:TCF transactivating complex | 41 | 1.45e-03 | -2.88e-01 | 0.063500 |
Regulation of lipid metabolism by PPARalpha | 116 | 1.58e-03 | -1.70e-01 | 0.067400 |
Keratan sulfate/keratin metabolism | 31 | 1.64e-03 | 3.27e-01 | 0.067700 |
Intrinsic Pathway of Fibrin Clot Formation | 23 | 1.77e-03 | -3.77e-01 | 0.068500 |
Hemostasis | 582 | 1.81e-03 | -7.59e-02 | 0.068500 |
Chromatin modifying enzymes | 208 | 1.90e-03 | -1.25e-01 | 0.068500 |
Chromatin organization | 208 | 1.90e-03 | -1.25e-01 | 0.068500 |
Mitochondrial translation initiation | 85 | 1.93e-03 | 1.95e-01 | 0.068500 |
Rho GTPase cycle | 134 | 2.01e-03 | -1.55e-01 | 0.068500 |
GRB2:SOS provides linkage to MAPK signaling for Integrins | 15 | 2.05e-03 | -4.60e-01 | 0.068500 |
Aflatoxin activation and detoxification | 18 | 2.05e-03 | -4.20e-01 | 0.068500 |
Formation of Fibrin Clot (Clotting Cascade) | 37 | 2.08e-03 | -2.92e-01 | 0.068500 |
Protein ubiquitination | 65 | 2.19e-03 | -2.20e-01 | 0.069700 |
Signaling by GPCR | 895 | 2.26e-03 | -6.05e-02 | 0.069700 |
Cytosolic tRNA aminoacylation | 23 | 2.26e-03 | 3.68e-01 | 0.069700 |
p130Cas linkage to MAPK signaling for integrins | 15 | 2.31e-03 | -4.54e-01 | 0.069700 |
NRAGE signals death through JNK | 56 | 2.38e-03 | -2.35e-01 | 0.070400 |
Influenza Infection | 128 | 2.53e-03 | 1.55e-01 | 0.072500 |
Keratan sulfate biosynthesis | 26 | 2.55e-03 | 3.42e-01 | 0.072500 |
Cell-cell junction organization | 60 | 2.73e-03 | -2.24e-01 | 0.076000 |
Gluconeogenesis | 31 | 2.99e-03 | -3.08e-01 | 0.081700 |
PPARA activates gene expression | 114 | 3.05e-03 | -1.61e-01 | 0.081700 |
Generation of second messenger molecules | 28 | 3.40e-03 | -3.20e-01 | 0.088800 |
Chylomicron assembly | 10 | 3.44e-03 | -5.34e-01 | 0.088800 |
Defects in vitamin and cofactor metabolism | 22 | 3.60e-03 | -3.59e-01 | 0.091400 |
Assembly of collagen fibrils and other multimeric structures | 50 | 3.70e-03 | 2.37e-01 | 0.092300 |
TRAF6 mediated IRF7 activation | 26 | 3.81e-03 | -3.28e-01 | 0.093400 |
SRP-dependent cotranslational protein targeting to membrane | 89 | 4.19e-03 | 1.76e-01 | 0.099600 |
Crosslinking of collagen fibrils | 10 | 4.20e-03 | 5.23e-01 | 0.099600 |
Viral mRNA Translation | 66 | 4.26e-03 | 2.03e-01 | 0.099600 |
Signaling by NOTCH1 | 69 | 4.36e-03 | -1.98e-01 | 0.100000 |
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 71 | 4.58e-03 | 1.95e-01 | 0.104000 |
Mitochondrial translation termination | 85 | 4.67e-03 | 1.78e-01 | 0.104000 |
Mitochondrial translation elongation | 85 | 4.75e-03 | 1.77e-01 | 0.104000 |
Major pathway of rRNA processing in the nucleolus and cytosol | 157 | 5.17e-03 | 1.29e-01 | 0.112000 |
rRNA processing in the nucleus and cytosol | 166 | 5.32e-03 | 1.25e-01 | 0.112000 |
Extra-nuclear estrogen signaling | 71 | 5.34e-03 | 1.91e-01 | 0.112000 |
Collagen chain trimerization | 35 | 5.86e-03 | 2.69e-01 | 0.121000 |
Selenoamino acid metabolism | 91 | 5.96e-03 | 1.67e-01 | 0.121000 |
mRNA Splicing - Major Pathway | 169 | 6.02e-03 | -1.23e-01 | 0.121000 |
Cell-extracellular matrix interactions | 16 | 6.49e-03 | -3.93e-01 | 0.129000 |
Cell-Cell communication | 117 | 7.04e-03 | -1.44e-01 | 0.136000 |
mRNA Splicing | 177 | 7.04e-03 | -1.18e-01 | 0.136000 |
RNA Polymerase III Abortive And Retractive Initiation | 37 | 7.82e-03 | -2.53e-01 | 0.147000 |
RNA Polymerase III Transcription | 37 | 7.82e-03 | -2.53e-01 | 0.147000 |
Biotin transport and metabolism | 11 | 8.67e-03 | -4.57e-01 | 0.161000 |
Intra-Golgi traffic | 42 | 9.18e-03 | 2.32e-01 | 0.166000 |
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | 16 | 9.31e-03 | -3.76e-01 | 0.166000 |
Diseases of hemostasis | 16 | 9.31e-03 | -3.76e-01 | 0.166000 |
Complement cascade | 76 | 9.57e-03 | -1.72e-01 | 0.169000 |
Mitochondrial translation | 91 | 9.99e-03 | 1.56e-01 | 0.173000 |
PKA activation in glucagon signalling | 16 | 1.00e-02 | -3.72e-01 | 0.173000 |
Tight junction interactions | 28 | 1.05e-02 | -2.80e-01 | 0.176000 |
Peptide chain elongation | 66 | 1.05e-02 | 1.82e-01 | 0.176000 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | 14 | 1.07e-02 | 3.94e-01 | 0.179000 |
Respiratory electron transport | 95 | 1.10e-02 | 1.51e-01 | 0.181000 |
Response of EIF2AK4 (GCN2) to amino acid deficiency | 78 | 1.11e-02 | 1.66e-01 | 0.181000 |
Defensins | 27 | 1.13e-02 | -2.82e-01 | 0.182000 |
Activated NOTCH1 Transmits Signal to the Nucleus | 30 | 1.15e-02 | -2.67e-01 | 0.182000 |
E3 ubiquitin ligases ubiquitinate target proteins | 46 | 1.19e-02 | -2.14e-01 | 0.188000 |
Myogenesis | 29 | 1.24e-02 | -2.68e-01 | 0.193000 |
Zinc influx into cells by the SLC39 gene family | 10 | 1.28e-02 | 4.55e-01 | 0.197000 |
Eukaryotic Translation Elongation | 70 | 1.31e-02 | 1.71e-01 | 0.200000 |
Eukaryotic Translation Termination | 70 | 1.35e-02 | 1.71e-01 | 0.202000 |
tRNA processing in the mitochondrion | 18 | 1.36e-02 | -3.36e-01 | 0.202000 |
DARPP-32 events | 23 | 1.44e-02 | -2.95e-01 | 0.213000 |
Elastic fibre formation | 38 | 1.47e-02 | 2.29e-01 | 0.214000 |
Signaling by NOTCH | 184 | 1.60e-02 | -1.03e-01 | 0.230000 |
Complex I biogenesis | 53 | 1.60e-02 | 1.91e-01 | 0.230000 |
Activation of HOX genes during differentiation | 67 | 1.68e-02 | -1.69e-01 | 0.237000 |
Activation of anterior HOX genes in hindbrain development during early embryogenesis | 67 | 1.68e-02 | -1.69e-01 | 0.237000 |
Signaling by Insulin receptor | 76 | 1.75e-02 | 1.58e-01 | 0.244000 |
tRNA Aminoacylation | 41 | 1.78e-02 | 2.14e-01 | 0.246000 |
Metabolism of lipids | 692 | 1.83e-02 | -5.28e-02 | 0.250000 |
Regulation of IFNA signaling | 24 | 1.85e-02 | -2.78e-01 | 0.250000 |
IL-6-type cytokine receptor ligand interactions | 17 | 1.89e-02 | -3.29e-01 | 0.251000 |
LDL clearance | 18 | 1.97e-02 | 3.17e-01 | 0.251000 |
Antimicrobial peptides | 58 | 1.99e-02 | -1.77e-01 | 0.251000 |
Influenza Viral RNA Transcription and Replication | 109 | 2.01e-02 | 1.29e-01 | 0.251000 |
Asparagine N-linked glycosylation | 268 | 2.01e-02 | 8.26e-02 | 0.251000 |
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. | 116 | 2.03e-02 | 1.25e-01 | 0.251000 |
Pausing and recovery of Tat-mediated HIV elongation | 32 | 2.03e-02 | -2.37e-01 | 0.251000 |
Tat-mediated HIV elongation arrest and recovery | 32 | 2.03e-02 | -2.37e-01 | 0.251000 |
Peptide ligand-binding receptors | 161 | 2.03e-02 | -1.06e-01 | 0.251000 |
Glycosaminoglycan metabolism | 117 | 2.03e-02 | 1.24e-01 | 0.251000 |
PI-3K cascade:FGFR3 | 18 | 2.05e-02 | 3.15e-01 | 0.252000 |
Developmental Biology | 905 | 2.12e-02 | -4.54e-02 | 0.258000 |
Oncogenic MAPK signaling | 77 | 2.21e-02 | -1.51e-01 | 0.267000 |
Synthesis of PC | 28 | 2.30e-02 | -2.48e-01 | 0.276000 |
FGFR3 mutant receptor activation | 12 | 2.39e-02 | 3.77e-01 | 0.282000 |
Signaling by activated point mutants of FGFR3 | 12 | 2.39e-02 | 3.77e-01 | 0.282000 |
Downstream signaling of activated FGFR3 | 25 | 2.45e-02 | 2.60e-01 | 0.286000 |
RNA Polymerase III Transcription Termination | 19 | 2.63e-02 | -2.95e-01 | 0.302000 |
Selenocysteine synthesis | 69 | 2.63e-02 | 1.55e-01 | 0.302000 |
Signaling by NTRK3 (TRKC) | 17 | 2.65e-02 | 3.11e-01 | 0.302000 |
Glyoxylate metabolism and glycine degradation | 30 | 2.69e-02 | -2.33e-01 | 0.303000 |
Formation of the cornified envelope | 39 | 2.71e-02 | -2.05e-01 | 0.303000 |
FGFR3 ligand binding and activation | 13 | 2.74e-02 | 3.53e-01 | 0.303000 |
FGFR3c ligand binding and activation | 13 | 2.74e-02 | 3.53e-01 | 0.303000 |
Sialic acid metabolism | 32 | 2.86e-02 | 2.24e-01 | 0.314000 |
Integrin signaling | 27 | 2.92e-02 | -2.42e-01 | 0.317000 |
Regulated proteolysis of p75NTR | 11 | 2.93e-02 | -3.79e-01 | 0.317000 |
SHC-mediated cascade:FGFR3 | 18 | 2.98e-02 | 2.96e-01 | 0.320000 |
Semaphorin interactions | 63 | 3.02e-02 | -1.58e-01 | 0.321000 |
PKA activation | 16 | 3.04e-02 | -3.13e-01 | 0.321000 |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 52 | 3.08e-02 | 1.73e-01 | 0.323000 |
Other interleukin signaling | 22 | 3.14e-02 | -2.65e-01 | 0.327000 |
Immune System | 1931 | 3.22e-02 | -2.98e-02 | 0.333000 |
RAF-independent MAPK1/3 activation | 23 | 3.24e-02 | -2.58e-01 | 0.333000 |
RA biosynthesis pathway | 18 | 3.26e-02 | 2.91e-01 | 0.333000 |
Signaling by BRAF and RAF fusions | 61 | 3.29e-02 | -1.58e-01 | 0.333000 |
Synthesis of IP2, IP, and Ins in the cytosol | 14 | 3.31e-02 | 3.29e-01 | 0.333000 |
Diseases of DNA repair | 10 | 3.35e-02 | 3.88e-01 | 0.334000 |
Transferrin endocytosis and recycling | 29 | 3.37e-02 | 2.28e-01 | 0.334000 |
Neurotransmitter clearance | 10 | 3.39e-02 | -3.87e-01 | 0.334000 |
Downregulation of TGF-beta receptor signaling | 25 | 3.44e-02 | 2.44e-01 | 0.337000 |
Eicosanoids | 12 | 3.55e-02 | -3.51e-01 | 0.345000 |
HIV elongation arrest and recovery | 34 | 3.65e-02 | -2.07e-01 | 0.350000 |
Pausing and recovery of HIV elongation | 34 | 3.65e-02 | -2.07e-01 | 0.350000 |
Role of second messengers in netrin-1 signaling | 10 | 3.69e-02 | 3.81e-01 | 0.351000 |
Synthesis of active ubiquitin: roles of E1 and E2 enzymes | 27 | 3.72e-02 | -2.32e-01 | 0.352000 |
Interleukin-6 family signaling | 24 | 3.75e-02 | -2.45e-01 | 0.352000 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) | 53 | 3.80e-02 | -1.65e-01 | 0.354000 |
Synthesis of PIPs at the late endosome membrane | 11 | 3.81e-02 | 3.61e-01 | 0.354000 |
Metabolism of proteins | 1819 | 3.84e-02 | 2.96e-02 | 0.354000 |
Activation of SMO | 18 | 3.94e-02 | 2.81e-01 | 0.361000 |
IGF1R signaling cascade | 51 | 4.05e-02 | 1.66e-01 | 0.366000 |
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 90 | 4.11e-02 | 1.25e-01 | 0.366000 |
Nonsense-Mediated Decay (NMD) | 90 | 4.11e-02 | 1.25e-01 | 0.366000 |
Vasopressin regulates renal water homeostasis via Aquaporins | 41 | 4.11e-02 | -1.84e-01 | 0.366000 |
Activation of gene expression by SREBF (SREBP) | 41 | 4.12e-02 | -1.84e-01 | 0.366000 |
Retinoid metabolism and transport | 39 | 4.18e-02 | -1.88e-01 | 0.368000 |
Class I peroxisomal membrane protein import | 18 | 4.21e-02 | -2.77e-01 | 0.368000 |
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | 13 | 4.21e-02 | 3.26e-01 | 0.368000 |
Dermatan sulfate biosynthesis | 11 | 4.37e-02 | 3.51e-01 | 0.375000 |
rRNA processing | 187 | 4.41e-02 | 8.54e-02 | 0.375000 |
L13a-mediated translational silencing of Ceruloplasmin expression | 85 | 4.42e-02 | 1.26e-01 | 0.375000 |
G alpha (i) signalling events | 350 | 4.51e-02 | -6.24e-02 | 0.375000 |
Recycling of bile acids and salts | 15 | 4.51e-02 | -2.99e-01 | 0.375000 |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
Signaling by NOTCH1 PEST Domain Mutants in Cancer | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
Signaling by NOTCH1 in Cancer | 54 | 4.58e-02 | -1.57e-01 | 0.375000 |
Regulation of expression of SLITs and ROBOs | 145 | 4.59e-02 | 9.61e-02 | 0.375000 |
Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 74 | 4.64e-02 | -1.34e-01 | 0.375000 |
Kinesins | 40 | 4.65e-02 | -1.82e-01 | 0.375000 |
Hedgehog 'on' state | 83 | 4.67e-02 | 1.26e-01 | 0.375000 |
GTP hydrolysis and joining of the 60S ribosomal subunit | 87 | 4.69e-02 | 1.23e-01 | 0.375000 |
DNA Damage Recognition in GG-NER | 37 | 4.71e-02 | -1.89e-01 | 0.375000 |
Transcriptional regulation by RUNX3 | 88 | 4.87e-02 | -1.22e-01 | 0.385000 |
Endosomal Sorting Complex Required For Transport (ESCRT) | 29 | 4.97e-02 | -2.11e-01 | 0.390000 |
Nucleotide Excision Repair | 106 | 4.98e-02 | -1.10e-01 | 0.390000 |
Formation of a pool of free 40S subunits | 77 | 5.09e-02 | 1.29e-01 | 0.393000 |
Aquaporin-mediated transport | 49 | 5.11e-02 | -1.61e-01 | 0.393000 |
Cap-dependent Translation Initiation | 93 | 5.13e-02 | 1.17e-01 | 0.393000 |
Eukaryotic Translation Initiation | 93 | 5.13e-02 | 1.17e-01 | 0.393000 |
Transcriptional regulation of white adipocyte differentiation | 81 | 5.16e-02 | -1.25e-01 | 0.393000 |
RHO GTPases activate PAKs | 21 | 5.20e-02 | -2.45e-01 | 0.394000 |
RMTs methylate histone arginines | 36 | 5.32e-02 | -1.86e-01 | 0.402000 |
Synthesis of Leukotrienes (LT) and Eoxins (EX) | 21 | 5.36e-02 | -2.43e-01 | 0.402000 |
FRS-mediated FGFR3 signaling | 20 | 5.43e-02 | 2.49e-01 | 0.406000 |
FOXO-mediated transcription | 64 | 5.50e-02 | -1.39e-01 | 0.409000 |
Signaling by NOTCH3 | 44 | 5.63e-02 | -1.66e-01 | 0.414000 |
Translocation of ZAP-70 to Immunological synapse | 14 | 5.66e-02 | -2.94e-01 | 0.414000 |
NS1 Mediated Effects on Host Pathways | 40 | 5.67e-02 | 1.74e-01 | 0.414000 |
Neuronal System | 375 | 5.72e-02 | -5.73e-02 | 0.416000 |
Vitamin D (calciferol) metabolism | 11 | 5.74e-02 | -3.31e-01 | 0.416000 |
Phospholipase C-mediated cascade; FGFR3 | 13 | 5.82e-02 | 3.03e-01 | 0.418000 |
Diseases of glycosylation | 134 | 5.84e-02 | 9.48e-02 | 0.418000 |
Mitotic Metaphase and Anaphase | 219 | 5.91e-02 | 7.41e-02 | 0.420000 |
Postmitotic nuclear pore complex (NPC) reformation | 26 | 5.92e-02 | 2.14e-01 | 0.420000 |
Sema4D induced cell migration and growth-cone collapse | 20 | 5.99e-02 | -2.43e-01 | 0.423000 |
Keratinization | 123 | 6.01e-02 | 9.82e-02 | 0.423000 |
Diseases associated with glycosaminoglycan metabolism | 39 | 6.08e-02 | 1.74e-01 | 0.425000 |
Notch-HLH transcription pathway | 26 | 6.18e-02 | -2.12e-01 | 0.430000 |
FOXO-mediated transcription of cell death genes | 14 | 6.22e-02 | -2.88e-01 | 0.430000 |
Transcriptional regulation of pluripotent stem cells | 29 | 6.29e-02 | -2.00e-01 | 0.430000 |
IRS-related events triggered by IGF1R | 50 | 6.30e-02 | 1.52e-01 | 0.430000 |
Pre-NOTCH Processing in Golgi | 18 | 6.31e-02 | -2.53e-01 | 0.430000 |
Metabolism | 1943 | 6.32e-02 | -2.58e-02 | 0.430000 |
Molecules associated with elastic fibres | 28 | 6.38e-02 | 2.02e-01 | 0.431000 |
Iron uptake and transport | 54 | 6.40e-02 | 1.46e-01 | 0.431000 |
Sema4D in semaphorin signaling | 24 | 6.44e-02 | -2.18e-01 | 0.431000 |
Signaling by FGFR3 in disease | 22 | 6.51e-02 | 2.27e-01 | 0.431000 |
Signaling by FGFR3 point mutants in cancer | 22 | 6.51e-02 | 2.27e-01 | 0.431000 |
Processing of Capped Intron-Containing Pre-mRNA | 228 | 6.52e-02 | -7.09e-02 | 0.431000 |
RNA Polymerase III Transcription Initiation From Type 3 Promoter | 24 | 6.57e-02 | -2.17e-01 | 0.432000 |
Regulation of beta-cell development | 39 | 6.62e-02 | -1.70e-01 | 0.434000 |
The citric acid (TCA) cycle and respiratory electron transport | 165 | 6.70e-02 | 8.27e-02 | 0.437000 |
Zinc transporters | 17 | 6.75e-02 | 2.56e-01 | 0.438000 |
Mitotic Anaphase | 218 | 6.78e-02 | 7.18e-02 | 0.438000 |
rRNA processing in the mitochondrion | 21 | 6.80e-02 | -2.30e-01 | 0.438000 |
Cobalamin (Cbl, vitamin B12) transport and metabolism | 20 | 6.96e-02 | -2.34e-01 | 0.443000 |
Mitochondrial protein import | 62 | 7.00e-02 | 1.33e-01 | 0.443000 |
ROS and RNS production in phagocytes | 34 | 7.01e-02 | 1.80e-01 | 0.443000 |
IRS-mediated signalling | 47 | 7.07e-02 | 1.52e-01 | 0.443000 |
PI3K Cascade | 43 | 7.08e-02 | 1.59e-01 | 0.443000 |
Synthesis of PIPs at the Golgi membrane | 17 | 7.09e-02 | 2.53e-01 | 0.443000 |
MAPK3 (ERK1) activation | 10 | 7.13e-02 | -3.29e-01 | 0.443000 |
Mitochondrial iron-sulfur cluster biogenesis | 11 | 7.13e-02 | 3.14e-01 | 0.443000 |
Listeria monocytogenes entry into host cells | 19 | 7.16e-02 | -2.39e-01 | 0.443000 |
Diseases of carbohydrate metabolism | 32 | 7.33e-02 | -1.83e-01 | 0.452000 |
Regulation of TP53 Activity through Acetylation | 28 | 7.36e-02 | -1.95e-01 | 0.452000 |
ERBB2 Regulates Cell Motility | 15 | 7.41e-02 | 2.66e-01 | 0.453000 |
Defects in cobalamin (B12) metabolism | 14 | 7.48e-02 | -2.75e-01 | 0.455000 |
Innate Immune System | 964 | 7.69e-02 | -3.38e-02 | 0.466000 |
PD-1 signaling | 19 | 7.89e-02 | -2.33e-01 | 0.474000 |
NOTCH4 Activation and Transmission of Signal to the Nucleus | 11 | 7.90e-02 | -3.06e-01 | 0.474000 |
cGMP effects | 15 | 7.96e-02 | -2.61e-01 | 0.476000 |
Glutathione conjugation | 30 | 8.04e-02 | -1.84e-01 | 0.478000 |
Late endosomal microautophagy | 30 | 8.06e-02 | -1.84e-01 | 0.478000 |
Diseases associated with the TLR signaling cascade | 20 | 8.28e-02 | 2.24e-01 | 0.488000 |
Diseases of Immune System | 20 | 8.28e-02 | 2.24e-01 | 0.488000 |
RIP-mediated NFkB activation via ZBP1 | 15 | 8.50e-02 | 2.57e-01 | 0.496000 |
Downstream signaling of activated FGFR2 | 30 | 8.50e-02 | 1.82e-01 | 0.496000 |
Metabolism of steroids | 133 | 8.61e-02 | -8.62e-02 | 0.497000 |
Synthesis of PIPs at the early endosome membrane | 16 | 8.61e-02 | 2.48e-01 | 0.497000 |
Class A/1 (Rhodopsin-like receptors) | 280 | 8.64e-02 | -5.96e-02 | 0.497000 |
Membrane binding and targetting of GAG proteins | 13 | 8.70e-02 | -2.74e-01 | 0.497000 |
Synthesis And Processing Of GAG, GAGPOL Polyproteins | 13 | 8.70e-02 | -2.74e-01 | 0.497000 |
Metabolism of fat-soluble vitamins | 43 | 8.71e-02 | -1.51e-01 | 0.497000 |
Metabolism of folate and pterines | 17 | 8.91e-02 | -2.38e-01 | 0.506000 |
G alpha (s) signalling events | 322 | 9.00e-02 | -5.50e-02 | 0.507000 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | 20 | 9.03e-02 | -2.19e-01 | 0.507000 |
O-linked glycosylation of mucins | 55 | 9.05e-02 | 1.32e-01 | 0.507000 |
NOTCH1 Intracellular Domain Regulates Transcription | 43 | 9.08e-02 | -1.49e-01 | 0.507000 |
L1CAM interactions | 98 | 9.19e-02 | -9.86e-02 | 0.509000 |
Tandem pore domain potassium channels | 11 | 9.32e-02 | -2.92e-01 | 0.509000 |
Degradation of cysteine and homocysteine | 11 | 9.34e-02 | -2.92e-01 | 0.509000 |
Metabolism of nucleotides | 95 | 9.35e-02 | 9.96e-02 | 0.509000 |
PI-3K cascade:FGFR2 | 23 | 9.47e-02 | 2.01e-01 | 0.509000 |
HIV Transcription Initiation | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
RNA Polymerase II HIV Promoter Escape | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
RNA Polymerase II Promoter Escape | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
RNA Polymerase II Transcription Initiation | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
RNA Polymerase II Transcription Initiation And Promoter Clearance | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 42 | 9.48e-02 | 1.49e-01 | 0.509000 |
GP1b-IX-V activation signalling | 10 | 1.02e-01 | -2.99e-01 | 0.537000 |
TNFR1-induced proapoptotic signaling | 13 | 1.03e-01 | -2.61e-01 | 0.537000 |
Paradoxical activation of RAF signaling by kinase inactive BRAF | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
Signaling by RAS mutants | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
Signaling by moderate kinase activity BRAF mutants | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
Signaling downstream of RAS mutants | 41 | 1.03e-01 | -1.47e-01 | 0.537000 |
Formation of RNA Pol II elongation complex | 59 | 1.04e-01 | -1.23e-01 | 0.537000 |
RNA Polymerase II Transcription Elongation | 59 | 1.04e-01 | -1.23e-01 | 0.537000 |
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 29 | 1.04e-01 | -1.75e-01 | 0.537000 |
Translation of structural proteins | 27 | 1.04e-01 | -1.81e-01 | 0.537000 |
Downstream signaling of activated FGFR1 | 31 | 1.04e-01 | 1.69e-01 | 0.537000 |
Negative regulation of MAPK pathway | 42 | 1.05e-01 | -1.44e-01 | 0.541000 |
Activation of the pre-replicative complex | 32 | 1.07e-01 | 1.65e-01 | 0.545000 |
Insulin receptor signalling cascade | 53 | 1.08e-01 | 1.28e-01 | 0.550000 |
PI3K events in ERBB2 signaling | 16 | 1.09e-01 | 2.32e-01 | 0.551000 |
NOTCH3 Activation and Transmission of Signal to the Nucleus | 23 | 1.09e-01 | -1.93e-01 | 0.551000 |
NOTCH2 Activation and Transmission of Signal to the Nucleus | 20 | 1.10e-01 | -2.07e-01 | 0.552000 |
Interferon Signaling | 177 | 1.10e-01 | -6.97e-02 | 0.552000 |
Glutamate binding, activation of AMPA receptors and synaptic plasticity | 30 | 1.11e-01 | -1.68e-01 | 0.553000 |
Trafficking of AMPA receptors | 30 | 1.11e-01 | -1.68e-01 | 0.553000 |
ESR-mediated signaling | 164 | 1.11e-01 | 7.21e-02 | 0.554000 |
Adenylate cyclase inhibitory pathway | 14 | 1.12e-01 | -2.45e-01 | 0.556000 |
Smooth Muscle Contraction | 33 | 1.13e-01 | -1.60e-01 | 0.556000 |
Chondroitin sulfate biosynthesis | 20 | 1.13e-01 | 2.05e-01 | 0.557000 |
Transcriptional regulation by RUNX2 | 117 | 1.13e-01 | 8.48e-02 | 0.557000 |
Signaling by NTRK2 (TRKB) | 25 | 1.15e-01 | 1.82e-01 | 0.562000 |
Reversible hydration of carbon dioxide | 12 | 1.16e-01 | -2.62e-01 | 0.562000 |
Metal ion SLC transporters | 26 | 1.16e-01 | 1.78e-01 | 0.562000 |
HATs acetylate histones | 84 | 1.16e-01 | -9.92e-02 | 0.562000 |
PI3K events in ERBB4 signaling | 10 | 1.17e-01 | 2.86e-01 | 0.562000 |
Transport of organic anions | 12 | 1.17e-01 | -2.61e-01 | 0.562000 |
Prolactin receptor signaling | 15 | 1.18e-01 | -2.33e-01 | 0.562000 |
ER Quality Control Compartment (ERQC) | 19 | 1.18e-01 | 2.07e-01 | 0.562000 |
RNA Polymerase III Transcription Initiation | 32 | 1.18e-01 | -1.60e-01 | 0.562000 |
ERK/MAPK targets | 21 | 1.19e-01 | -1.97e-01 | 0.562000 |
Formation of TC-NER Pre-Incision Complex | 50 | 1.19e-01 | -1.28e-01 | 0.562000 |
RHO GTPases Activate ROCKs | 19 | 1.19e-01 | -2.06e-01 | 0.562000 |
RHO GTPases Activate NADPH Oxidases | 23 | 1.20e-01 | 1.87e-01 | 0.565000 |
Signaling by Rho GTPases | 373 | 1.21e-01 | -4.69e-02 | 0.566000 |
PKMTs methylate histone lysines | 43 | 1.21e-01 | -1.37e-01 | 0.566000 |
Pre-NOTCH Expression and Processing | 64 | 1.23e-01 | -1.12e-01 | 0.570000 |
SHC-mediated cascade:FGFR2 | 23 | 1.23e-01 | 1.86e-01 | 0.570000 |
TGF-beta receptor signaling activates SMADs | 30 | 1.25e-01 | 1.62e-01 | 0.578000 |
Hyaluronan metabolism | 17 | 1.26e-01 | 2.14e-01 | 0.581000 |
Striated Muscle Contraction | 34 | 1.26e-01 | -1.51e-01 | 0.581000 |
Nucleobase catabolism | 36 | 1.27e-01 | 1.47e-01 | 0.581000 |
Common Pathway of Fibrin Clot Formation | 20 | 1.28e-01 | -1.97e-01 | 0.583000 |
Chemokine receptors bind chemokines | 42 | 1.28e-01 | -1.36e-01 | 0.583000 |
DNA Replication Pre-Initiation | 82 | 1.29e-01 | 9.71e-02 | 0.583000 |
Global Genome Nucleotide Excision Repair (GG-NER) | 82 | 1.29e-01 | -9.70e-02 | 0.583000 |
Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 22 | 1.30e-01 | -1.87e-01 | 0.585000 |
Base-Excision Repair, AP Site Formation | 27 | 1.30e-01 | 1.68e-01 | 0.585000 |
Regulation of gene expression by Hypoxia-inducible Factor | 11 | 1.31e-01 | -2.63e-01 | 0.585000 |
Metabolism of cofactors | 18 | 1.31e-01 | 2.05e-01 | 0.585000 |
Deposition of new CENPA-containing nucleosomes at the centromere | 35 | 1.32e-01 | 1.47e-01 | 0.585000 |
Nucleosome assembly | 35 | 1.32e-01 | 1.47e-01 | 0.585000 |
Regulation of Complement cascade | 68 | 1.32e-01 | -1.06e-01 | 0.586000 |
Insulin receptor recycling | 25 | 1.33e-01 | 1.73e-01 | 0.589000 |
Signal transduction by L1 | 21 | 1.34e-01 | -1.89e-01 | 0.590000 |
Budding and maturation of HIV virion | 25 | 1.35e-01 | -1.73e-01 | 0.590000 |
RUNX2 regulates osteoblast differentiation | 24 | 1.35e-01 | 1.76e-01 | 0.590000 |
Cleavage of the damaged pyrimidine | 25 | 1.36e-01 | 1.72e-01 | 0.590000 |
Depyrimidination | 25 | 1.36e-01 | 1.72e-01 | 0.590000 |
Recognition and association of DNA glycosylase with site containing an affected pyrimidine | 25 | 1.36e-01 | 1.72e-01 | 0.590000 |
mRNA decay by 5' to 3' exoribonuclease | 15 | 1.38e-01 | -2.21e-01 | 0.593000 |
Interleukin-2 signaling | 12 | 1.38e-01 | -2.47e-01 | 0.593000 |
tRNA processing in the nucleus | 57 | 1.38e-01 | 1.13e-01 | 0.593000 |
Phase 4 - resting membrane potential | 18 | 1.41e-01 | -2.01e-01 | 0.593000 |
Adenylate cyclase activating pathway | 10 | 1.43e-01 | -2.68e-01 | 0.593000 |
Assembly Of The HIV Virion | 15 | 1.43e-01 | -2.19e-01 | 0.593000 |
Regulation of gene expression in beta cells | 21 | 1.43e-01 | -1.85e-01 | 0.593000 |
Uptake and actions of bacterial toxins | 26 | 1.43e-01 | -1.66e-01 | 0.593000 |
Resolution of D-loop Structures through Holliday Junction Intermediates | 32 | 1.43e-01 | 1.50e-01 | 0.593000 |
FGFR2 ligand binding and activation | 19 | 1.44e-01 | 1.94e-01 | 0.593000 |
ECM proteoglycans | 53 | 1.44e-01 | 1.16e-01 | 0.593000 |
FGFR1c ligand binding and activation | 11 | 1.45e-01 | 2.54e-01 | 0.593000 |
Signaling by activated point mutants of FGFR1 | 11 | 1.45e-01 | 2.54e-01 | 0.593000 |
Dual incision in TC-NER | 61 | 1.45e-01 | -1.08e-01 | 0.593000 |
FGFRL1 modulation of FGFR1 signaling | 13 | 1.45e-01 | 2.33e-01 | 0.593000 |
Activated point mutants of FGFR2 | 17 | 1.45e-01 | 2.04e-01 | 0.593000 |
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | 12 | 1.45e-01 | -2.43e-01 | 0.593000 |
alpha-linolenic acid (ALA) metabolism | 12 | 1.45e-01 | -2.43e-01 | 0.593000 |
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | 46 | 1.45e-01 | -1.24e-01 | 0.593000 |
Regulation of IFNG signaling | 14 | 1.46e-01 | 2.25e-01 | 0.593000 |
Pexophagy | 10 | 1.46e-01 | -2.66e-01 | 0.593000 |
Transmission across Chemical Synapses | 241 | 1.46e-01 | -5.44e-02 | 0.593000 |
Repression of WNT target genes | 14 | 1.46e-01 | -2.24e-01 | 0.593000 |
Signaling by ERBB2 in Cancer | 24 | 1.47e-01 | 1.71e-01 | 0.593000 |
Signaling by RAF1 mutants | 38 | 1.48e-01 | -1.36e-01 | 0.594000 |
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | 37 | 1.48e-01 | -1.37e-01 | 0.594000 |
Selective autophagy | 56 | 1.48e-01 | -1.12e-01 | 0.594000 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination | 26 | 1.49e-01 | -1.64e-01 | 0.595000 |
Peroxisomal protein import | 60 | 1.51e-01 | -1.07e-01 | 0.602000 |
Adherens junctions interactions | 31 | 1.53e-01 | -1.48e-01 | 0.607000 |
Regulation of TP53 Activity through Phosphorylation | 84 | 1.54e-01 | 9.00e-02 | 0.608000 |
Killing mechanisms | 12 | 1.54e-01 | 2.38e-01 | 0.608000 |
WNT5:FZD7-mediated leishmania damping | 12 | 1.54e-01 | 2.38e-01 | 0.608000 |
Formation of the ternary complex, and subsequently, the 43S complex | 44 | 1.55e-01 | 1.24e-01 | 0.611000 |
Muscle contraction | 177 | 1.56e-01 | -6.18e-02 | 0.613000 |
Dual Incision in GG-NER | 39 | 1.57e-01 | -1.31e-01 | 0.615000 |
PKA-mediated phosphorylation of CREB | 18 | 1.59e-01 | -1.92e-01 | 0.620000 |
O-linked glycosylation | 102 | 1.59e-01 | 8.07e-02 | 0.620000 |
Fc epsilon receptor (FCERI) signaling | 153 | 1.61e-01 | 6.57e-02 | 0.626000 |
Chaperone Mediated Autophagy | 18 | 1.63e-01 | -1.90e-01 | 0.629000 |
FCERI mediated MAPK activation | 56 | 1.63e-01 | 1.08e-01 | 0.631000 |
Nuclear Events (kinase and transcription factor activation) | 60 | 1.67e-01 | -1.03e-01 | 0.642000 |
BMAL1:CLOCK,NPAS2 activates circadian gene expression | 27 | 1.68e-01 | -1.53e-01 | 0.643000 |
Ribosomal scanning and start codon recognition | 50 | 1.68e-01 | 1.13e-01 | 0.643000 |
PRC2 methylates histones and DNA | 23 | 1.71e-01 | -1.65e-01 | 0.649000 |
Metabolism of vitamins and cofactors | 179 | 1.71e-01 | -5.94e-02 | 0.649000 |
ZBP1(DAI) mediated induction of type I IFNs | 19 | 1.71e-01 | 1.81e-01 | 0.649000 |
Establishment of Sister Chromatid Cohesion | 11 | 1.72e-01 | 2.38e-01 | 0.649000 |
Signaling by TGFB family members | 96 | 1.72e-01 | 8.06e-02 | 0.649000 |
Regulation of TLR by endogenous ligand | 15 | 1.73e-01 | -2.03e-01 | 0.649000 |
COPII-mediated vesicle transport | 61 | 1.73e-01 | -1.01e-01 | 0.649000 |
G alpha (12/13) signalling events | 76 | 1.73e-01 | -9.03e-02 | 0.649000 |
Mucopolysaccharidoses | 11 | 1.74e-01 | -2.37e-01 | 0.649000 |
Interactions of Rev with host cellular proteins | 36 | 1.74e-01 | 1.31e-01 | 0.649000 |
FRS-mediated FGFR2 signaling | 25 | 1.74e-01 | 1.57e-01 | 0.649000 |
DAG and IP3 signaling | 38 | 1.75e-01 | -1.27e-01 | 0.649000 |
Initial triggering of complement | 45 | 1.75e-01 | -1.17e-01 | 0.649000 |
Effects of PIP2 hydrolysis | 27 | 1.76e-01 | -1.50e-01 | 0.649000 |
Activated NTRK2 signals through FRS2 and FRS3 | 11 | 1.76e-01 | 2.36e-01 | 0.649000 |
Signaling by Leptin | 11 | 1.77e-01 | -2.35e-01 | 0.649000 |
M Phase | 347 | 1.78e-01 | 4.22e-02 | 0.650000 |
Separation of Sister Chromatids | 166 | 1.78e-01 | 6.06e-02 | 0.650000 |
AKT phosphorylates targets in the cytosol | 14 | 1.78e-01 | -2.08e-01 | 0.650000 |
EML4 and NUDC in mitotic spindle formation | 95 | 1.79e-01 | 7.99e-02 | 0.650000 |
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | 12 | 1.79e-01 | -2.24e-01 | 0.651000 |
G beta:gamma signalling through BTK | 17 | 1.80e-01 | 1.88e-01 | 0.651000 |
Receptor Mediated Mitophagy | 11 | 1.80e-01 | -2.33e-01 | 0.651000 |
N-glycan antennae elongation in the medial/trans-Golgi | 23 | 1.82e-01 | 1.61e-01 | 0.655000 |
Assembly of the pre-replicative complex | 66 | 1.83e-01 | 9.49e-02 | 0.655000 |
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS) | 13 | 1.83e-01 | 2.13e-01 | 0.655000 |
G1/S Transition | 127 | 1.85e-01 | 6.81e-02 | 0.663000 |
Epigenetic regulation of gene expression | 94 | 1.87e-01 | -7.89e-02 | 0.665000 |
SHC1 events in ERBB2 signaling | 22 | 1.87e-01 | 1.62e-01 | 0.666000 |
Integration of energy metabolism | 102 | 1.88e-01 | -7.56e-02 | 0.666000 |
Transport of the SLBP Dependant Mature mRNA | 35 | 1.89e-01 | 1.28e-01 | 0.667000 |
Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 14 | 1.89e-01 | -2.03e-01 | 0.667000 |
Transport of the SLBP independent Mature mRNA | 34 | 1.89e-01 | 1.30e-01 | 0.667000 |
Folding of actin by CCT/TriC | 10 | 1.90e-01 | -2.39e-01 | 0.667000 |
Mitophagy | 26 | 1.90e-01 | -1.48e-01 | 0.667000 |
Activation of the AP-1 family of transcription factors | 10 | 1.92e-01 | 2.38e-01 | 0.671000 |
Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 23 | 1.92e-01 | 1.57e-01 | 0.671000 |
Carnitine metabolism | 11 | 1.93e-01 | -2.27e-01 | 0.671000 |
MECP2 regulates neuronal receptors and channels | 16 | 1.93e-01 | 1.88e-01 | 0.671000 |
TP53 Regulates Transcription of DNA Repair Genes | 61 | 1.94e-01 | -9.63e-02 | 0.671000 |
Syndecan interactions | 19 | 1.96e-01 | 1.72e-01 | 0.674000 |
Translation initiation complex formation | 49 | 1.96e-01 | 1.07e-01 | 0.674000 |
Resolution of D-Loop Structures | 33 | 1.96e-01 | 1.30e-01 | 0.674000 |
Glucagon signaling in metabolic regulation | 30 | 1.96e-01 | -1.36e-01 | 0.674000 |
G-protein mediated events | 51 | 1.98e-01 | -1.04e-01 | 0.677000 |
FGFR2c ligand binding and activation | 13 | 1.98e-01 | 2.06e-01 | 0.677000 |
Downstream signaling of activated FGFR4 | 26 | 2.00e-01 | 1.45e-01 | 0.682000 |
Sphingolipid de novo biosynthesis | 43 | 2.01e-01 | -1.13e-01 | 0.683000 |
HuR (ELAVL1) binds and stabilizes mRNA | 10 | 2.02e-01 | -2.33e-01 | 0.683000 |
NOTCH3 Intracellular Domain Regulates Transcription | 22 | 2.03e-01 | -1.57e-01 | 0.683000 |
Nuclear import of Rev protein | 33 | 2.04e-01 | 1.28e-01 | 0.683000 |
SHC1 events in ERBB4 signaling | 14 | 2.04e-01 | 1.96e-01 | 0.683000 |
Cell Cycle, Mitotic | 485 | 2.04e-01 | 3.38e-02 | 0.683000 |
Interleukin-10 signaling | 38 | 2.04e-01 | -1.19e-01 | 0.683000 |
Phase II - Conjugation of compounds | 79 | 2.04e-01 | -8.26e-02 | 0.683000 |
Diseases of signal transduction by growth factor receptors and second messengers | 367 | 2.06e-01 | -3.85e-02 | 0.685000 |
Cell Cycle Checkpoints | 252 | 2.06e-01 | 4.63e-02 | 0.685000 |
Post-chaperonin tubulin folding pathway | 18 | 2.06e-01 | 1.72e-01 | 0.685000 |
Signaling by ERBB2 | 47 | 2.07e-01 | 1.06e-01 | 0.687000 |
Asymmetric localization of PCP proteins | 62 | 2.08e-01 | 9.25e-02 | 0.688000 |
The role of Nef in HIV-1 replication and disease pathogenesis | 27 | 2.11e-01 | -1.39e-01 | 0.693000 |
Cristae formation | 27 | 2.11e-01 | 1.39e-01 | 0.693000 |
Nitric oxide stimulates guanylate cyclase | 19 | 2.12e-01 | -1.66e-01 | 0.695000 |
Costimulation by the CD28 family | 65 | 2.13e-01 | -8.93e-02 | 0.695000 |
N-Glycan antennae elongation | 14 | 2.13e-01 | 1.92e-01 | 0.695000 |
Resolution of Sister Chromatid Cohesion | 103 | 2.14e-01 | 7.09e-02 | 0.695000 |
Collagen degradation | 37 | 2.14e-01 | 1.18e-01 | 0.695000 |
Calnexin/calreticulin cycle | 24 | 2.14e-01 | 1.46e-01 | 0.695000 |
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 24 | 2.15e-01 | -1.46e-01 | 0.695000 |
PI-3K cascade:FGFR1 | 21 | 2.16e-01 | 1.56e-01 | 0.695000 |
Nephrin family interactions | 21 | 2.17e-01 | 1.56e-01 | 0.695000 |
Beta defensins | 18 | 2.17e-01 | -1.68e-01 | 0.695000 |
CaM pathway | 32 | 2.18e-01 | -1.26e-01 | 0.695000 |
Calmodulin induced events | 32 | 2.18e-01 | -1.26e-01 | 0.695000 |
Transport of Mature mRNA derived from an Intron-Containing Transcript | 72 | 2.19e-01 | 8.38e-02 | 0.695000 |
Recognition of DNA damage by PCNA-containing replication complex | 28 | 2.19e-01 | -1.34e-01 | 0.695000 |
PCP/CE pathway | 90 | 2.20e-01 | 7.48e-02 | 0.695000 |
Interactions of Vpr with host cellular proteins | 34 | 2.20e-01 | 1.21e-01 | 0.695000 |
SLC transporter disorders | 96 | 2.21e-01 | 7.23e-02 | 0.695000 |
Disorders of transmembrane transporters | 171 | 2.22e-01 | 5.42e-02 | 0.695000 |
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 91 | 2.23e-01 | 7.39e-02 | 0.695000 |
Amplification of signal from the kinetochores | 91 | 2.23e-01 | 7.39e-02 | 0.695000 |
Signaling by FGFR in disease | 60 | 2.23e-01 | 9.10e-02 | 0.695000 |
Formation of HIV-1 elongation complex containing HIV-1 Tat | 44 | 2.23e-01 | -1.06e-01 | 0.695000 |
HIV Transcription Elongation | 44 | 2.23e-01 | -1.06e-01 | 0.695000 |
Tat-mediated elongation of the HIV-1 transcript | 44 | 2.23e-01 | -1.06e-01 | 0.695000 |
Vitamin B5 (pantothenate) metabolism | 15 | 2.24e-01 | 1.81e-01 | 0.695000 |
ABC-family proteins mediated transport | 98 | 2.24e-01 | 7.11e-02 | 0.695000 |
Signaling by ERBB2 KD Mutants | 23 | 2.24e-01 | 1.46e-01 | 0.695000 |
Adrenaline,noradrenaline inhibits insulin secretion | 27 | 2.25e-01 | 1.35e-01 | 0.695000 |
Rev-mediated nuclear export of HIV RNA | 34 | 2.25e-01 | 1.20e-01 | 0.695000 |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 30 | 2.28e-01 | 1.27e-01 | 0.699000 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 68 | 2.28e-01 | -8.45e-02 | 0.699000 |
RHO GTPases activate CIT | 19 | 2.28e-01 | -1.60e-01 | 0.699000 |
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | 14 | 2.28e-01 | -1.86e-01 | 0.699000 |
NRIF signals cell death from the nucleus | 15 | 2.29e-01 | -1.80e-01 | 0.699000 |
TICAM1, RIP1-mediated IKK complex recruitment | 16 | 2.30e-01 | 1.73e-01 | 0.702000 |
GRB2 events in ERBB2 signaling | 16 | 2.31e-01 | 1.73e-01 | 0.702000 |
FGFR1 mutant receptor activation | 30 | 2.32e-01 | 1.26e-01 | 0.702000 |
O-glycosylation of TSR domain-containing proteins | 37 | 2.32e-01 | 1.14e-01 | 0.702000 |
PERK regulates gene expression | 31 | 2.32e-01 | 1.24e-01 | 0.702000 |
Signaling by FGFR3 | 38 | 2.33e-01 | 1.12e-01 | 0.702000 |
Circadian Clock | 68 | 2.33e-01 | -8.36e-02 | 0.702000 |
DNA Damage Bypass | 44 | 2.34e-01 | -1.04e-01 | 0.702000 |
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | 26 | 2.35e-01 | 1.35e-01 | 0.702000 |
p75NTR signals via NF-kB | 14 | 2.35e-01 | -1.83e-01 | 0.702000 |
Signaling by TGF-beta Receptor Complex | 69 | 2.36e-01 | 8.25e-02 | 0.704000 |
Phospholipase C-mediated cascade; FGFR2 | 18 | 2.37e-01 | 1.61e-01 | 0.704000 |
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 17 | 2.38e-01 | 1.65e-01 | 0.704000 |
Other semaphorin interactions | 19 | 2.38e-01 | -1.56e-01 | 0.704000 |
Activation of BH3-only proteins | 27 | 2.39e-01 | -1.31e-01 | 0.704000 |
Metabolism of water-soluble vitamins and cofactors | 119 | 2.39e-01 | -6.25e-02 | 0.704000 |
FGFR2 mutant receptor activation | 31 | 2.40e-01 | 1.22e-01 | 0.704000 |
Potential therapeutics for SARS | 76 | 2.40e-01 | -7.80e-02 | 0.704000 |
KSRP (KHSRP) binds and destabilizes mRNA | 17 | 2.40e-01 | 1.65e-01 | 0.704000 |
PI-3K cascade:FGFR4 | 19 | 2.41e-01 | 1.56e-01 | 0.704000 |
SUMOylation of chromatin organization proteins | 56 | 2.41e-01 | 9.06e-02 | 0.704000 |
Translesion synthesis by REV1 | 15 | 2.41e-01 | -1.75e-01 | 0.704000 |
CDT1 association with the CDC6:ORC:origin complex | 57 | 2.43e-01 | 8.95e-02 | 0.707000 |
Signaling by NOTCH2 | 29 | 2.44e-01 | -1.25e-01 | 0.710000 |
Maturation of nucleoprotein | 10 | 2.45e-01 | -2.12e-01 | 0.711000 |
DCC mediated attractive signaling | 14 | 2.48e-01 | -1.78e-01 | 0.717000 |
Interleukin-1 family signaling | 131 | 2.48e-01 | 5.84e-02 | 0.717000 |
Nuclear signaling by ERBB4 | 30 | 2.49e-01 | -1.22e-01 | 0.717000 |
Signaling by FGFR2 in disease | 41 | 2.49e-01 | 1.04e-01 | 0.717000 |
Aspartate and asparagine metabolism | 10 | 2.49e-01 | 2.10e-01 | 0.717000 |
WNT5A-dependent internalization of FZD4 | 15 | 2.50e-01 | 1.71e-01 | 0.718000 |
Translesion Synthesis by POLH | 16 | 2.52e-01 | -1.65e-01 | 0.721000 |
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 17 | 2.53e-01 | 1.60e-01 | 0.721000 |
GPCR ligand binding | 396 | 2.53e-01 | -3.35e-02 | 0.721000 |
Synthesis of very long-chain fatty acyl-CoAs | 24 | 2.58e-01 | -1.34e-01 | 0.722000 |
Passive transport by Aquaporins | 12 | 2.58e-01 | -1.89e-01 | 0.722000 |
Chondroitin sulfate/dermatan sulfate metabolism | 49 | 2.58e-01 | 9.34e-02 | 0.722000 |
Regulation of RUNX2 expression and activity | 71 | 2.58e-01 | 7.76e-02 | 0.722000 |
Metabolic disorders of biological oxidation enzymes | 32 | 2.59e-01 | 1.15e-01 | 0.722000 |
Signaling by high-kinase activity BRAF mutants | 34 | 2.59e-01 | -1.12e-01 | 0.722000 |
Acetylcholine binding and downstream events | 13 | 2.61e-01 | -1.80e-01 | 0.722000 |
Postsynaptic nicotinic acetylcholine receptors | 13 | 2.61e-01 | -1.80e-01 | 0.722000 |
Dectin-2 family | 21 | 2.61e-01 | 1.42e-01 | 0.722000 |
Mitotic Spindle Checkpoint | 107 | 2.62e-01 | 6.28e-02 | 0.722000 |
ERKs are inactivated | 12 | 2.62e-01 | -1.87e-01 | 0.722000 |
RUNX1 regulates transcription of genes involved in differentiation of HSCs | 78 | 2.63e-01 | 7.33e-02 | 0.722000 |
Interleukin-3, Interleukin-5 and GM-CSF signaling | 44 | 2.64e-01 | -9.74e-02 | 0.722000 |
Condensation of Prometaphase Chromosomes | 10 | 2.64e-01 | -2.04e-01 | 0.722000 |
Cross-presentation of soluble exogenous antigens (endosomes) | 49 | 2.65e-01 | 9.21e-02 | 0.722000 |
ERBB2 Activates PTK6 Signaling | 13 | 2.65e-01 | 1.79e-01 | 0.722000 |
N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 33 | 2.65e-01 | 1.12e-01 | 0.722000 |
Glycerophospholipid biosynthesis | 124 | 2.66e-01 | -5.79e-02 | 0.722000 |
Disorders of Developmental Biology | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
Disorders of Nervous System Development | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
Loss of function of MECP2 in Rett syndrome | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
Pervasive developmental disorders | 13 | 2.66e-01 | -1.78e-01 | 0.722000 |
Nuclear Envelope (NE) Reassembly | 64 | 2.66e-01 | 8.04e-02 | 0.722000 |
YAP1- and WWTR1 (TAZ)-stimulated gene expression | 14 | 2.67e-01 | -1.72e-01 | 0.722000 |
SUMOylation of transcription cofactors | 43 | 2.67e-01 | -9.78e-02 | 0.722000 |
RAB geranylgeranylation | 60 | 2.67e-01 | 8.28e-02 | 0.722000 |
G1/S-Specific Transcription | 29 | 2.68e-01 | 1.19e-01 | 0.722000 |
PLC beta mediated events | 50 | 2.68e-01 | -9.07e-02 | 0.722000 |
Frs2-mediated activation | 12 | 2.68e-01 | -1.85e-01 | 0.722000 |
Regulation of HSF1-mediated heat shock response | 76 | 2.69e-01 | 7.34e-02 | 0.722000 |
CD28 dependent Vav1 pathway | 12 | 2.69e-01 | -1.84e-01 | 0.722000 |
SHC-mediated cascade:FGFR1 | 21 | 2.69e-01 | 1.39e-01 | 0.722000 |
Transcriptional activation of mitochondrial biogenesis | 52 | 2.70e-01 | -8.84e-02 | 0.723000 |
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | 50 | 2.71e-01 | 9.00e-02 | 0.723000 |
Intra-Golgi and retrograde Golgi-to-ER traffic | 176 | 2.72e-01 | 4.81e-02 | 0.723000 |
InlB-mediated entry of Listeria monocytogenes into host cell | 14 | 2.72e-01 | -1.69e-01 | 0.723000 |
Biosynthesis of DHA-derived SPMs | 15 | 2.73e-01 | 1.64e-01 | 0.723000 |
Ovarian tumor domain proteases | 35 | 2.73e-01 | -1.07e-01 | 0.723000 |
SUMOylation of ubiquitinylation proteins | 38 | 2.74e-01 | 1.03e-01 | 0.723000 |
Orc1 removal from chromatin | 69 | 2.74e-01 | 7.62e-02 | 0.723000 |
SARS-CoV-1 Infection | 47 | 2.75e-01 | -9.21e-02 | 0.725000 |
Removal of aminoterminal propeptides from gamma-carboxylated proteins | 10 | 2.75e-01 | -1.99e-01 | 0.725000 |
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | 120 | 2.77e-01 | -5.74e-02 | 0.729000 |
MASTL Facilitates Mitotic Progression | 10 | 2.79e-01 | -1.98e-01 | 0.730000 |
Activation of ATR in response to replication stress | 36 | 2.80e-01 | 1.04e-01 | 0.730000 |
Metabolism of polyamines | 58 | 2.80e-01 | 8.21e-02 | 0.730000 |
RUNX2 regulates bone development | 30 | 2.80e-01 | 1.14e-01 | 0.730000 |
G-protein activation | 27 | 2.80e-01 | 1.20e-01 | 0.730000 |
Olfactory Signaling Pathway | 197 | 2.81e-01 | -4.45e-02 | 0.731000 |
Transport of inorganic cations/anions and amino acids/oligopeptides | 105 | 2.82e-01 | 6.08e-02 | 0.731000 |
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 10 | 2.83e-01 | 1.96e-01 | 0.733000 |
G2/M Checkpoints | 134 | 2.84e-01 | 5.37e-02 | 0.734000 |
Trafficking of GluR2-containing AMPA receptors | 17 | 2.85e-01 | -1.50e-01 | 0.736000 |
Regulation of FZD by ubiquitination | 19 | 2.86e-01 | 1.42e-01 | 0.736000 |
Signaling by the B Cell Receptor (BCR) | 131 | 2.88e-01 | 5.38e-02 | 0.740000 |
RORA activates gene expression | 18 | 2.88e-01 | -1.45e-01 | 0.740000 |
Hyaluronan uptake and degradation | 12 | 2.90e-01 | 1.76e-01 | 0.741000 |
Pre-NOTCH Transcription and Translation | 48 | 2.92e-01 | -8.79e-02 | 0.741000 |
Signaling by FGFR1 in disease | 37 | 2.92e-01 | 1.00e-01 | 0.741000 |
Formation of HIV elongation complex in the absence of HIV Tat | 46 | 2.93e-01 | -8.97e-02 | 0.741000 |
Erythrocytes take up carbon dioxide and release oxygen | 11 | 2.93e-01 | -1.83e-01 | 0.741000 |
O2/CO2 exchange in erythrocytes | 11 | 2.93e-01 | -1.83e-01 | 0.741000 |
Spry regulation of FGF signaling | 14 | 2.93e-01 | -1.62e-01 | 0.741000 |
HS-GAG degradation | 20 | 2.93e-01 | -1.36e-01 | 0.741000 |
NIK-->noncanonical NF-kB signaling | 57 | 2.93e-01 | 8.05e-02 | 0.741000 |
NEP/NS2 Interacts with the Cellular Export Machinery | 31 | 2.94e-01 | 1.09e-01 | 0.742000 |
Switching of origins to a post-replicative state | 88 | 2.95e-01 | 6.46e-02 | 0.742000 |
Presynaptic nicotinic acetylcholine receptors | 11 | 2.95e-01 | -1.82e-01 | 0.742000 |
Fatty acyl-CoA biosynthesis | 35 | 2.98e-01 | -1.02e-01 | 0.747000 |
Defective GALNT12 causes colorectal cancer 1 (CRCS1) | 12 | 2.98e-01 | 1.73e-01 | 0.747000 |
HSF1-dependent transactivation | 30 | 3.00e-01 | -1.09e-01 | 0.750000 |
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | 35 | 3.01e-01 | -1.01e-01 | 0.751000 |
SHC-mediated cascade:FGFR4 | 19 | 3.02e-01 | 1.37e-01 | 0.751000 |
Dopamine Neurotransmitter Release Cycle | 23 | 3.02e-01 | 1.24e-01 | 0.751000 |
p75NTR recruits signalling complexes | 12 | 3.03e-01 | -1.72e-01 | 0.752000 |
Homologous DNA Pairing and Strand Exchange | 41 | 3.03e-01 | 9.29e-02 | 0.752000 |
Transcriptional regulation by RUNX1 | 188 | 3.04e-01 | -4.35e-02 | 0.753000 |
Regulation of MECP2 expression and activity | 30 | 3.05e-01 | -1.08e-01 | 0.754000 |
Defective B3GALTL causes Peters-plus syndrome (PpS) | 36 | 3.08e-01 | 9.83e-02 | 0.758000 |
Biosynthesis of specialized proresolving mediators (SPMs) | 17 | 3.08e-01 | 1.43e-01 | 0.758000 |
Phosphorylation of CD3 and TCR zeta chains | 18 | 3.09e-01 | -1.39e-01 | 0.758000 |
Depolymerisation of the Nuclear Lamina | 15 | 3.09e-01 | 1.52e-01 | 0.758000 |
RAS processing | 19 | 3.10e-01 | 1.34e-01 | 0.759000 |
Gap-filling DNA repair synthesis and ligation in TC-NER | 60 | 3.10e-01 | -7.57e-02 | 0.759000 |
Translesion synthesis by POLK | 16 | 3.13e-01 | -1.46e-01 | 0.763000 |
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | 11 | 3.13e-01 | 1.76e-01 | 0.763000 |
CDC6 association with the ORC:origin complex | 11 | 3.14e-01 | 1.75e-01 | 0.765000 |
Interleukin-6 signaling | 11 | 3.16e-01 | -1.75e-01 | 0.767000 |
FCERI mediated NF-kB activation | 100 | 3.17e-01 | 5.80e-02 | 0.767000 |
EPHA-mediated growth cone collapse | 15 | 3.17e-01 | -1.49e-01 | 0.767000 |
Downstream signal transduction | 29 | 3.18e-01 | -1.07e-01 | 0.767000 |
Neurotransmitter receptors and postsynaptic signal transmission | 176 | 3.18e-01 | -4.37e-02 | 0.767000 |
Signaling by FGFR1 | 47 | 3.19e-01 | 8.41e-02 | 0.768000 |
tRNA modification in the nucleus and cytosol | 42 | 3.21e-01 | 8.85e-02 | 0.771000 |
Interaction between L1 and Ankyrins | 29 | 3.22e-01 | -1.06e-01 | 0.771000 |
Post-translational protein phosphorylation | 104 | 3.22e-01 | -5.63e-02 | 0.771000 |
Gap junction assembly | 17 | 3.23e-01 | -1.39e-01 | 0.772000 |
Interleukin-37 signaling | 20 | 3.24e-01 | 1.27e-01 | 0.774000 |
TNFR1-induced NFkappaB signaling pathway | 26 | 3.26e-01 | -1.11e-01 | 0.777000 |
Amino acids regulate mTORC1 | 50 | 3.27e-01 | 8.02e-02 | 0.777000 |
TICAM1-dependent activation of IRF3/IRF7 | 10 | 3.27e-01 | 1.79e-01 | 0.777000 |
Synthesis of IP3 and IP4 in the cytosol | 26 | 3.29e-01 | -1.11e-01 | 0.777000 |
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | 31 | 3.29e-01 | 1.01e-01 | 0.777000 |
Regulation of Glucokinase by Glucokinase Regulatory Protein | 31 | 3.29e-01 | 1.01e-01 | 0.777000 |
Degradation of the extracellular matrix | 104 | 3.29e-01 | 5.54e-02 | 0.777000 |
S Phase | 158 | 3.30e-01 | 4.49e-02 | 0.777000 |
SHC1 events in EGFR signaling | 14 | 3.30e-01 | 1.50e-01 | 0.777000 |
Unfolded Protein Response (UPR) | 91 | 3.30e-01 | 5.91e-02 | 0.777000 |
SUMOylation of intracellular receptors | 30 | 3.31e-01 | -1.03e-01 | 0.777000 |
Diseases associated with N-glycosylation of proteins | 16 | 3.33e-01 | 1.40e-01 | 0.778000 |
Nervous system development | 514 | 3.34e-01 | -2.50e-02 | 0.778000 |
Signaling by FGFR | 79 | 3.34e-01 | 6.29e-02 | 0.778000 |
Anti-inflammatory response favouring Leishmania parasite infection | 174 | 3.34e-01 | -4.25e-02 | 0.778000 |
Leishmania parasite growth and survival | 174 | 3.34e-01 | -4.25e-02 | 0.778000 |
Presynaptic phase of homologous DNA pairing and strand exchange | 38 | 3.35e-01 | 9.05e-02 | 0.778000 |
Glucose metabolism | 87 | 3.35e-01 | -5.98e-02 | 0.778000 |
Amine ligand-binding receptors | 36 | 3.36e-01 | 9.26e-02 | 0.779000 |
Chromosome Maintenance | 98 | 3.39e-01 | 5.59e-02 | 0.784000 |
Fanconi Anemia Pathway | 35 | 3.40e-01 | -9.32e-02 | 0.784000 |
Signaling by PDGFR in disease | 19 | 3.40e-01 | -1.26e-01 | 0.784000 |
FGFR1 ligand binding and activation | 15 | 3.43e-01 | 1.41e-01 | 0.790000 |
Transport of bile salts and organic acids, metal ions and amine compounds | 80 | 3.46e-01 | 6.10e-02 | 0.794000 |
Inflammasomes | 20 | 3.49e-01 | 1.21e-01 | 0.798000 |
RAF activation | 32 | 3.49e-01 | -9.57e-02 | 0.798000 |
Constitutive Signaling by Aberrant PI3K in Cancer | 74 | 3.50e-01 | 6.28e-02 | 0.798000 |
Non-integrin membrane-ECM interactions | 41 | 3.52e-01 | 8.41e-02 | 0.798000 |
Regulation of commissural axon pathfinding by SLIT and ROBO | 10 | 3.52e-01 | 1.70e-01 | 0.798000 |
Cellular hexose transport | 19 | 3.52e-01 | -1.23e-01 | 0.798000 |
Role of LAT2/NTAL/LAB on calcium mobilization | 40 | 3.52e-01 | 8.50e-02 | 0.798000 |
CS/DS degradation | 14 | 3.53e-01 | 1.43e-01 | 0.798000 |
ADORA2B mediated anti-inflammatory cytokines production | 114 | 3.53e-01 | -5.04e-02 | 0.798000 |
Classical antibody-mediated complement activation | 32 | 3.53e-01 | 9.49e-02 | 0.798000 |
FRS-mediated FGFR1 signaling | 23 | 3.53e-01 | 1.12e-01 | 0.798000 |
Nuclear Envelope Breakdown | 50 | 3.54e-01 | 7.57e-02 | 0.799000 |
DSCAM interactions | 11 | 3.57e-01 | 1.61e-01 | 0.799000 |
Synthesis of PIPs at the plasma membrane | 51 | 3.57e-01 | -7.46e-02 | 0.799000 |
Opioid Signalling | 86 | 3.57e-01 | -5.75e-02 | 0.799000 |
Metabolism of non-coding RNA | 51 | 3.58e-01 | 7.44e-02 | 0.799000 |
snRNP Assembly | 51 | 3.58e-01 | 7.44e-02 | 0.799000 |
ADP signalling through P2Y purinoceptor 1 | 23 | 3.58e-01 | 1.11e-01 | 0.799000 |
Cytokine Signaling in Immune system | 801 | 3.59e-01 | -1.91e-02 | 0.799000 |
Pyrimidine salvage | 10 | 3.60e-01 | -1.67e-01 | 0.799000 |
Activation of NF-kappaB in B cells | 63 | 3.60e-01 | 6.67e-02 | 0.799000 |
RHO GTPases Activate Formins | 118 | 3.61e-01 | 4.88e-02 | 0.799000 |
Signaling by BMP | 26 | 3.61e-01 | 1.04e-01 | 0.799000 |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 12 | 3.61e-01 | -1.52e-01 | 0.799000 |
Free fatty acids regulate insulin secretion | 10 | 3.63e-01 | -1.66e-01 | 0.799000 |
Acyl chain remodelling of PI | 16 | 3.63e-01 | 1.31e-01 | 0.799000 |
Autodegradation of the E3 ubiquitin ligase COP1 | 48 | 3.64e-01 | 7.57e-02 | 0.799000 |
The NLRP3 inflammasome | 15 | 3.64e-01 | 1.35e-01 | 0.799000 |
Cholesterol biosynthesis | 22 | 3.65e-01 | 1.12e-01 | 0.799000 |
ATF6 (ATF6-alpha) activates chaperones | 12 | 3.65e-01 | -1.51e-01 | 0.799000 |
Platelet activation, signaling and aggregation | 252 | 3.65e-01 | -3.32e-02 | 0.799000 |
Vpu mediated degradation of CD4 | 50 | 3.66e-01 | 7.40e-02 | 0.799000 |
Regulation of Apoptosis | 51 | 3.66e-01 | 7.32e-02 | 0.799000 |
Cell Cycle | 608 | 3.66e-01 | 2.15e-02 | 0.799000 |
Heparan sulfate/heparin (HS-GAG) metabolism | 51 | 3.67e-01 | -7.30e-02 | 0.799000 |
SARS-CoV Infections | 138 | 3.68e-01 | -4.45e-02 | 0.799000 |
Endogenous sterols | 24 | 3.70e-01 | 1.06e-01 | 0.802000 |
HDACs deacetylate histones | 39 | 3.70e-01 | -8.30e-02 | 0.802000 |
Laminin interactions | 23 | 3.72e-01 | -1.08e-01 | 0.805000 |
Nuclear Receptor transcription pathway | 53 | 3.73e-01 | -7.08e-02 | 0.805000 |
CDK-mediated phosphorylation and removal of Cdc6 | 70 | 3.74e-01 | 6.15e-02 | 0.805000 |
Caspase-mediated cleavage of cytoskeletal proteins | 12 | 3.74e-01 | 1.48e-01 | 0.805000 |
Signaling by FGFR3 fusions in cancer | 10 | 3.74e-01 | 1.62e-01 | 0.805000 |
IRE1alpha activates chaperones | 50 | 3.75e-01 | 7.25e-02 | 0.807000 |
Neurexins and neuroligins | 54 | 3.76e-01 | 6.96e-02 | 0.808000 |
PINK1-PRKN Mediated Mitophagy | 19 | 3.79e-01 | -1.17e-01 | 0.811000 |
SLC-mediated transmembrane transport | 240 | 3.86e-01 | 3.25e-02 | 0.824000 |
Export of Viral Ribonucleoproteins from Nucleus | 32 | 3.87e-01 | 8.84e-02 | 0.824000 |
FGFR4 ligand binding and activation | 13 | 3.88e-01 | 1.38e-01 | 0.824000 |
Tryptophan catabolism | 14 | 3.88e-01 | -1.33e-01 | 0.824000 |
TCF dependent signaling in response to WNT | 177 | 3.89e-01 | -3.76e-02 | 0.824000 |
Negative regulators of DDX58/IFIH1 signaling | 31 | 3.89e-01 | -8.94e-02 | 0.824000 |
Pentose phosphate pathway | 14 | 3.90e-01 | 1.33e-01 | 0.824000 |
Signaling by Retinoic Acid | 39 | 3.90e-01 | 7.96e-02 | 0.824000 |
Signaling by NTRK1 (TRKA) | 113 | 3.91e-01 | -4.68e-02 | 0.824000 |
Cyclin A:Cdk2-associated events at S phase entry | 83 | 3.91e-01 | 5.45e-02 | 0.824000 |
HDR through Homologous Recombination (HRR) | 63 | 3.91e-01 | 6.25e-02 | 0.824000 |
Acyl chain remodelling of PG | 17 | 3.92e-01 | 1.20e-01 | 0.824000 |
Processing of DNA double-strand break ends | 66 | 3.92e-01 | 6.09e-02 | 0.824000 |
Clathrin-mediated endocytosis | 139 | 3.94e-01 | -4.19e-02 | 0.827000 |
PI Metabolism | 80 | 3.95e-01 | 5.51e-02 | 0.827000 |
FRS-mediated FGFR4 signaling | 21 | 3.96e-01 | 1.07e-01 | 0.828000 |
Interconversion of nucleotide di- and triphosphates | 28 | 3.98e-01 | 9.24e-02 | 0.831000 |
Regulation of TNFR1 signaling | 34 | 3.99e-01 | -8.36e-02 | 0.831000 |
Binding and Uptake of Ligands by Scavenger Receptors | 63 | 3.99e-01 | 6.14e-02 | 0.831000 |
Ion transport by P-type ATPases | 52 | 4.00e-01 | -6.75e-02 | 0.831000 |
Cellular responses to stress | 475 | 4.00e-01 | 2.26e-02 | 0.831000 |
Ca-dependent events | 34 | 4.01e-01 | -8.33e-02 | 0.831000 |
XBP1(S) activates chaperone genes | 48 | 4.03e-01 | 6.98e-02 | 0.834000 |
Meiotic recombination | 37 | 4.03e-01 | 7.95e-02 | 0.834000 |
IKK complex recruitment mediated by RIP1 | 18 | 4.04e-01 | 1.14e-01 | 0.834000 |
Ub-specific processing proteases | 160 | 4.06e-01 | -3.81e-02 | 0.837000 |
Transport of Ribonucleoproteins into the Host Nucleus | 31 | 4.08e-01 | 8.58e-02 | 0.837000 |
SUMOylation of DNA damage response and repair proteins | 73 | 4.09e-01 | 5.59e-02 | 0.837000 |
SCF-beta-TrCP mediated degradation of Emi1 | 53 | 4.10e-01 | 6.55e-02 | 0.837000 |
Autophagy | 122 | 4.11e-01 | -4.31e-02 | 0.837000 |
Gap-filling DNA repair synthesis and ligation in GG-NER | 23 | 4.11e-01 | -9.90e-02 | 0.837000 |
Ephrin signaling | 19 | 4.11e-01 | -1.09e-01 | 0.837000 |
Signaling by ERBB2 TMD/JMD mutants | 20 | 4.12e-01 | 1.06e-01 | 0.837000 |
The canonical retinoid cycle in rods (twilight vision) | 23 | 4.12e-01 | 9.88e-02 | 0.837000 |
The phototransduction cascade | 31 | 4.13e-01 | 8.50e-02 | 0.837000 |
Downstream signaling events of B Cell Receptor (BCR) | 76 | 4.13e-01 | 5.43e-02 | 0.837000 |
Intrinsic Pathway for Apoptosis | 46 | 4.14e-01 | -6.96e-02 | 0.837000 |
Signaling by VEGF | 100 | 4.15e-01 | -4.72e-02 | 0.837000 |
WNT ligand biogenesis and trafficking | 25 | 4.15e-01 | -9.42e-02 | 0.837000 |
Regulation of PTEN gene transcription | 58 | 4.16e-01 | -6.18e-02 | 0.837000 |
Constitutive Signaling by AKT1 E17K in Cancer | 25 | 4.16e-01 | -9.41e-02 | 0.837000 |
FCGR3A-mediated IL10 synthesis | 64 | 4.16e-01 | -5.88e-02 | 0.837000 |
CD28 dependent PI3K/Akt signaling | 22 | 4.16e-01 | 1.00e-01 | 0.837000 |
Translesion synthesis by POLI | 16 | 4.16e-01 | -1.17e-01 | 0.837000 |
Energy dependent regulation of mTOR by LKB1-AMPK | 28 | 4.17e-01 | 8.86e-02 | 0.838000 |
SUMOylation of SUMOylation proteins | 34 | 4.19e-01 | 8.00e-02 | 0.841000 |
Apoptotic cleavage of cell adhesion proteins | 11 | 4.21e-01 | -1.40e-01 | 0.841000 |
Constitutive Signaling by NOTCH1 HD Domain Mutants | 14 | 4.21e-01 | -1.24e-01 | 0.841000 |
Signaling by NOTCH1 HD Domain Mutants in Cancer | 14 | 4.21e-01 | -1.24e-01 | 0.841000 |
Suppression of phagosomal maturation | 12 | 4.22e-01 | -1.34e-01 | 0.841000 |
PCNA-Dependent Long Patch Base Excision Repair | 20 | 4.23e-01 | -1.03e-01 | 0.841000 |
Cargo recognition for clathrin-mediated endocytosis | 102 | 4.24e-01 | -4.59e-02 | 0.841000 |
DNA methylation | 15 | 4.24e-01 | -1.19e-01 | 0.841000 |
Uptake and function of anthrax toxins | 10 | 4.25e-01 | -1.46e-01 | 0.841000 |
Autodegradation of Cdh1 by Cdh1:APC/C | 61 | 4.25e-01 | 5.91e-02 | 0.841000 |
DNA Replication | 123 | 4.26e-01 | 4.16e-02 | 0.841000 |
Glutamate and glutamine metabolism | 13 | 4.26e-01 | 1.27e-01 | 0.841000 |
Vpr-mediated nuclear import of PICs | 32 | 4.26e-01 | 8.12e-02 | 0.841000 |
Negative regulation of MET activity | 20 | 4.27e-01 | -1.03e-01 | 0.841000 |
Recycling pathway of L1 | 27 | 4.27e-01 | -8.83e-02 | 0.841000 |
NF-kB is activated and signals survival | 11 | 4.29e-01 | -1.38e-01 | 0.843000 |
Antigen processing-Cross presentation | 93 | 4.30e-01 | 4.74e-02 | 0.843000 |
Downregulation of ERBB2 signaling | 26 | 4.32e-01 | 8.90e-02 | 0.847000 |
Dectin-1 mediated noncanonical NF-kB signaling | 60 | 4.35e-01 | 5.83e-02 | 0.847000 |
Insulin processing | 27 | 4.35e-01 | -8.68e-02 | 0.847000 |
Nucleobase biosynthesis | 13 | 4.35e-01 | 1.25e-01 | 0.847000 |
Metalloprotease DUBs | 18 | 4.36e-01 | 1.06e-01 | 0.847000 |
MET activates PTK2 signaling | 18 | 4.37e-01 | -1.06e-01 | 0.847000 |
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | 49 | 4.37e-01 | 6.41e-02 | 0.847000 |
p53-Independent DNA Damage Response | 49 | 4.37e-01 | 6.41e-02 | 0.847000 |
p53-Independent G1/S DNA damage checkpoint | 49 | 4.37e-01 | 6.41e-02 | 0.847000 |
Cell surface interactions at the vascular wall | 153 | 4.39e-01 | -3.63e-02 | 0.847000 |
Defective CFTR causes cystic fibrosis | 59 | 4.40e-01 | 5.82e-02 | 0.847000 |
Metabolism of amino acids and derivatives | 337 | 4.41e-01 | -2.45e-02 | 0.847000 |
NGF-stimulated transcription | 39 | 4.41e-01 | -7.13e-02 | 0.847000 |
HSF1 activation | 24 | 4.42e-01 | -9.07e-02 | 0.847000 |
Cellular responses to external stimuli | 481 | 4.42e-01 | 2.05e-02 | 0.847000 |
RUNX3 regulates NOTCH signaling | 12 | 4.42e-01 | -1.28e-01 | 0.847000 |
Cyclin A/B1/B2 associated events during G2/M transition | 23 | 4.42e-01 | 9.26e-02 | 0.847000 |
FOXO-mediated transcription of cell cycle genes | 16 | 4.44e-01 | -1.11e-01 | 0.847000 |
Deubiquitination | 232 | 4.45e-01 | -2.91e-02 | 0.847000 |
MET receptor recycling | 10 | 4.46e-01 | 1.39e-01 | 0.847000 |
CLEC7A (Dectin-1) signaling | 95 | 4.46e-01 | 4.52e-02 | 0.847000 |
RNA Polymerase I Promoter Escape | 38 | 4.47e-01 | 7.14e-02 | 0.847000 |
Nicotinate metabolism | 31 | 4.47e-01 | 7.89e-02 | 0.847000 |
RNA Polymerase III Transcription Initiation From Type 1 Promoter | 24 | 4.48e-01 | -8.95e-02 | 0.847000 |
Deadenylation-dependent mRNA decay | 51 | 4.48e-01 | -6.14e-02 | 0.847000 |
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | 11 | 4.48e-01 | -1.32e-01 | 0.847000 |
Prolonged ERK activation events | 14 | 4.49e-01 | -1.17e-01 | 0.847000 |
Cargo concentration in the ER | 29 | 4.49e-01 | -8.12e-02 | 0.847000 |
Pyrimidine catabolism | 12 | 4.50e-01 | -1.26e-01 | 0.847000 |
RNA Polymerase I Transcription Termination | 28 | 4.50e-01 | 8.25e-02 | 0.847000 |
Regulation of ornithine decarboxylase (ODC) | 50 | 4.51e-01 | 6.17e-02 | 0.847000 |
SUMOylation of DNA replication proteins | 44 | 4.51e-01 | 6.57e-02 | 0.847000 |
Platelet Adhesion to exposed collagen | 13 | 4.51e-01 | -1.21e-01 | 0.847000 |
MAPK targets/ Nuclear events mediated by MAP kinases | 30 | 4.53e-01 | -7.92e-02 | 0.847000 |
Heme biosynthesis | 13 | 4.53e-01 | 1.20e-01 | 0.847000 |
Axon guidance | 491 | 4.53e-01 | -1.98e-02 | 0.847000 |
C-type lectin receptors (CLRs) | 128 | 4.54e-01 | 3.84e-02 | 0.847000 |
Scavenging by Class A Receptors | 17 | 4.54e-01 | 1.05e-01 | 0.847000 |
Potassium Channels | 98 | 4.55e-01 | -4.37e-02 | 0.847000 |
Regulation of TP53 Activity through Association with Co-factors | 13 | 4.57e-01 | -1.19e-01 | 0.848000 |
Transcriptional Regulation by VENTX | 36 | 4.58e-01 | -7.15e-02 | 0.848000 |
Regulation of activated PAK-2p34 by proteasome mediated degradation | 48 | 4.58e-01 | 6.20e-02 | 0.848000 |
Cyclin E associated events during G1/S transition | 81 | 4.58e-01 | 4.77e-02 | 0.848000 |
Stabilization of p53 | 52 | 4.58e-01 | 5.95e-02 | 0.848000 |
Regulation of PTEN stability and activity | 67 | 4.59e-01 | 5.24e-02 | 0.848000 |
GAB1 signalosome | 17 | 4.59e-01 | 1.04e-01 | 0.848000 |
Creatine metabolism | 10 | 4.60e-01 | -1.35e-01 | 0.849000 |
Rap1 signalling | 14 | 4.61e-01 | -1.14e-01 | 0.849000 |
Synthesis of bile acids and bile salts via 27-hydroxycholesterol | 11 | 4.61e-01 | 1.28e-01 | 0.849000 |
Cellular Senescence | 136 | 4.62e-01 | -3.65e-02 | 0.849000 |
STING mediated induction of host immune responses | 16 | 4.63e-01 | -1.06e-01 | 0.849000 |
TRAF3-dependent IRF activation pathway | 12 | 4.65e-01 | -1.22e-01 | 0.851000 |
Elevation of cytosolic Ca2+ levels | 16 | 4.66e-01 | 1.05e-01 | 0.851000 |
Signaling by Hedgehog | 132 | 4.66e-01 | 3.67e-02 | 0.851000 |
G beta:gamma signalling through PLC beta | 19 | 4.66e-01 | 9.65e-02 | 0.851000 |
Synthesis of PA | 37 | 4.67e-01 | 6.91e-02 | 0.851000 |
Gene expression (Transcription) | 1222 | 4.68e-01 | -1.24e-02 | 0.851000 |
Regulation of RUNX1 Expression and Activity | 23 | 4.68e-01 | -8.75e-02 | 0.851000 |
GABA synthesis, release, reuptake and degradation | 19 | 4.68e-01 | -9.61e-02 | 0.851000 |
mRNA Capping | 27 | 4.71e-01 | 8.02e-02 | 0.854000 |
Pregnenolone biosynthesis | 11 | 4.71e-01 | 1.26e-01 | 0.854000 |
HCMV Infection | 89 | 4.74e-01 | -4.39e-02 | 0.858000 |
TCR signaling | 108 | 4.75e-01 | -3.98e-02 | 0.859000 |
MAP kinase activation | 60 | 4.77e-01 | -5.31e-02 | 0.860000 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | 13 | 4.77e-01 | 1.14e-01 | 0.860000 |
Class B/2 (Secretin family receptors) | 85 | 4.77e-01 | 4.46e-02 | 0.860000 |
Activation of BAD and translocation to mitochondria | 15 | 4.80e-01 | -1.05e-01 | 0.861000 |
Regulation of pyruvate dehydrogenase (PDH) complex | 16 | 4.80e-01 | -1.02e-01 | 0.861000 |
Interleukin-20 family signaling | 23 | 4.81e-01 | -8.50e-02 | 0.861000 |
Josephin domain DUBs | 10 | 4.81e-01 | 1.29e-01 | 0.861000 |
HDR through Single Strand Annealing (SSA) | 37 | 4.82e-01 | 6.68e-02 | 0.861000 |
ADP signalling through P2Y purinoceptor 12 | 21 | 4.82e-01 | 8.85e-02 | 0.861000 |
Negative regulation of FGFR3 signaling | 27 | 4.83e-01 | 7.79e-02 | 0.861000 |
Signaling by FGFR2 | 67 | 4.84e-01 | 4.95e-02 | 0.861000 |
TRP channels | 25 | 4.85e-01 | 8.08e-02 | 0.861000 |
Resolution of Abasic Sites (AP sites) | 37 | 4.87e-01 | 6.61e-02 | 0.861000 |
Interleukin receptor SHC signaling | 27 | 4.87e-01 | -7.73e-02 | 0.861000 |
Regulation of actin dynamics for phagocytic cup formation | 85 | 4.87e-01 | -4.36e-02 | 0.861000 |
MyD88 cascade initiated on plasma membrane | 76 | 4.87e-01 | -4.61e-02 | 0.861000 |
Toll Like Receptor 10 (TLR10) Cascade | 76 | 4.87e-01 | -4.61e-02 | 0.861000 |
Toll Like Receptor 5 (TLR5) Cascade | 76 | 4.87e-01 | -4.61e-02 | 0.861000 |
Signal amplification | 31 | 4.90e-01 | 7.16e-02 | 0.864000 |
Platelet sensitization by LDL | 16 | 4.91e-01 | 9.95e-02 | 0.864000 |
Defective B3GALT6 causes EDSP2 and SEMDJL1 | 19 | 4.91e-01 | 9.13e-02 | 0.864000 |
Inactivation, recovery and regulation of the phototransduction cascade | 30 | 4.91e-01 | 7.27e-02 | 0.864000 |
G alpha (z) signalling events | 47 | 4.94e-01 | -5.76e-02 | 0.868000 |
COPI-dependent Golgi-to-ER retrograde traffic | 78 | 4.95e-01 | -4.48e-02 | 0.868000 |
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD | 54 | 4.97e-01 | 5.35e-02 | 0.869000 |
Mitotic Prometaphase | 182 | 4.98e-01 | 2.92e-02 | 0.869000 |
Signaling by ROBO receptors | 190 | 4.98e-01 | 2.86e-02 | 0.869000 |
Transcription of E2F targets under negative control by DREAM complex | 19 | 4.98e-01 | 8.98e-02 | 0.869000 |
Degradation of DVL | 55 | 4.98e-01 | 5.28e-02 | 0.869000 |
Arachidonic acid metabolism | 53 | 5.02e-01 | 5.34e-02 | 0.874000 |
RNA Polymerase III Transcription Initiation From Type 2 Promoter | 23 | 5.02e-01 | -8.08e-02 | 0.874000 |
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | 56 | 5.03e-01 | 5.17e-02 | 0.874000 |
Phospholipase C-mediated cascade: FGFR1 | 16 | 5.04e-01 | 9.66e-02 | 0.874000 |
DNA Double-Strand Break Repair | 131 | 5.04e-01 | 3.38e-02 | 0.874000 |
Glucagon-type ligand receptors | 30 | 5.05e-01 | 7.03e-02 | 0.875000 |
Trafficking and processing of endosomal TLR | 12 | 5.06e-01 | 1.11e-01 | 0.876000 |
Activation of kainate receptors upon glutamate binding | 29 | 5.08e-01 | 7.11e-02 | 0.876000 |
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 14 | 5.08e-01 | 1.02e-01 | 0.876000 |
Signaling by ERBB4 | 55 | 5.08e-01 | -5.16e-02 | 0.876000 |
SCF(Skp2)-mediated degradation of p27/p21 | 58 | 5.09e-01 | 5.02e-02 | 0.876000 |
Signaling by ERBB2 ECD mutants | 14 | 5.13e-01 | 1.01e-01 | 0.879000 |
Regulation of RAS by GAPs | 66 | 5.13e-01 | 4.66e-02 | 0.879000 |
Toll Like Receptor 7/8 (TLR7/8) Cascade | 81 | 5.13e-01 | -4.21e-02 | 0.879000 |
Interferon gamma signaling | 77 | 5.14e-01 | -4.30e-02 | 0.879000 |
Response of EIF2AK1 (HRI) to heme deficiency | 15 | 5.14e-01 | 9.72e-02 | 0.879000 |
Gastrin-CREB signalling pathway via PKC and MAPK | 17 | 5.15e-01 | 9.13e-02 | 0.879000 |
Purine catabolism | 18 | 5.15e-01 | 8.87e-02 | 0.879000 |
Interleukin-15 signaling | 14 | 5.17e-01 | -1.00e-01 | 0.880000 |
Scavenging of heme from plasma | 38 | 5.17e-01 | 6.07e-02 | 0.880000 |
Centrosome maturation | 79 | 5.18e-01 | -4.21e-02 | 0.880000 |
Recruitment of mitotic centrosome proteins and complexes | 79 | 5.18e-01 | -4.21e-02 | 0.880000 |
CREB1 phosphorylation through the activation of Adenylate Cyclase | 11 | 5.20e-01 | -1.12e-01 | 0.883000 |
Adaptive Immune System | 688 | 5.21e-01 | -1.44e-02 | 0.883000 |
Host Interactions of HIV factors | 124 | 5.22e-01 | 3.33e-02 | 0.883000 |
Heme degradation | 13 | 5.23e-01 | -1.02e-01 | 0.883000 |
Sema3A PAK dependent Axon repulsion | 15 | 5.23e-01 | -9.53e-02 | 0.883000 |
Phase 2 - plateau phase | 14 | 5.26e-01 | 9.79e-02 | 0.888000 |
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | 19 | 5.27e-01 | 8.38e-02 | 0.889000 |
Formation of tubulin folding intermediates by CCT/TriC | 21 | 5.28e-01 | -7.95e-02 | 0.889000 |
RNA Polymerase III Chain Elongation | 14 | 5.29e-01 | -9.72e-02 | 0.889000 |
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC) | 12 | 5.30e-01 | 1.05e-01 | 0.890000 |
APC/C:Cdc20 mediated degradation of Cyclin B | 22 | 5.30e-01 | -7.73e-02 | 0.890000 |
G beta:gamma signalling through PI3Kgamma | 24 | 5.32e-01 | 7.37e-02 | 0.892000 |
Synthesis of PE | 13 | 5.34e-01 | 9.97e-02 | 0.892000 |
Synthesis of DNA | 116 | 5.34e-01 | 3.35e-02 | 0.892000 |
Triglyceride catabolism | 23 | 5.36e-01 | -7.46e-02 | 0.892000 |
Leishmania infection | 254 | 5.36e-01 | -2.26e-02 | 0.892000 |
G alpha (q) signalling events | 199 | 5.36e-01 | -2.55e-02 | 0.892000 |
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | 12 | 5.37e-01 | -1.03e-01 | 0.892000 |
Regulation of innate immune responses to cytosolic DNA | 13 | 5.37e-01 | 9.90e-02 | 0.892000 |
Purine ribonucleoside monophosphate biosynthesis | 10 | 5.38e-01 | 1.13e-01 | 0.892000 |
Cargo trafficking to the periciliary membrane | 49 | 5.38e-01 | 5.09e-02 | 0.892000 |
VEGFR2 mediated vascular permeability | 26 | 5.39e-01 | -6.96e-02 | 0.893000 |
Removal of the Flap Intermediate | 13 | 5.43e-01 | 9.75e-02 | 0.898000 |
Fertilization | 20 | 5.44e-01 | -7.83e-02 | 0.898000 |
Regulation of PLK1 Activity at G2/M Transition | 83 | 5.45e-01 | -3.85e-02 | 0.898000 |
Base Excision Repair | 54 | 5.45e-01 | 4.76e-02 | 0.898000 |
CLEC7A (Dectin-1) induces NFAT activation | 11 | 5.45e-01 | -1.05e-01 | 0.898000 |
RNA polymerase II transcribes snRNA genes | 68 | 5.46e-01 | -4.23e-02 | 0.899000 |
Gene Silencing by RNA | 85 | 5.47e-01 | 3.78e-02 | 0.899000 |
Interleukin-2 family signaling | 42 | 5.47e-01 | -5.37e-02 | 0.899000 |
GRB2 events in EGFR signaling | 13 | 5.48e-01 | 9.62e-02 | 0.899000 |
Synthesis of bile acids and bile salts via 24-hydroxycholesterol | 10 | 5.49e-01 | 1.09e-01 | 0.899000 |
DNA Repair | 281 | 5.49e-01 | -2.08e-02 | 0.899000 |
Processive synthesis on the lagging strand | 14 | 5.53e-01 | 9.15e-02 | 0.902000 |
RNA Polymerase II Transcription | 1089 | 5.54e-01 | -1.07e-02 | 0.902000 |
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | 49 | 5.54e-01 | 4.88e-02 | 0.902000 |
Telomere C-strand synthesis initiation | 13 | 5.54e-01 | 9.47e-02 | 0.902000 |
Mitotic Prophase | 89 | 5.55e-01 | 3.62e-02 | 0.902000 |
Response to elevated platelet cytosolic Ca2+ | 128 | 5.55e-01 | -3.02e-02 | 0.902000 |
Cellular response to hypoxia | 73 | 5.56e-01 | -3.99e-02 | 0.902000 |
Translocation of SLC2A4 (GLUT4) to the plasma membrane | 50 | 5.57e-01 | -4.81e-02 | 0.902000 |
Phosphorylation of the APC/C | 19 | 5.57e-01 | -7.78e-02 | 0.902000 |
Intracellular signaling by second messengers | 306 | 5.59e-01 | -1.95e-02 | 0.903000 |
EPH-Ephrin signaling | 90 | 5.60e-01 | -3.56e-02 | 0.903000 |
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | 11 | 5.61e-01 | -1.01e-01 | 0.903000 |
rRNA modification in the nucleus and cytosol | 57 | 5.62e-01 | 4.45e-02 | 0.903000 |
Metabolism of porphyrins | 24 | 5.62e-01 | -6.84e-02 | 0.903000 |
HS-GAG biosynthesis | 28 | 5.62e-01 | -6.33e-02 | 0.903000 |
Purine salvage | 13 | 5.63e-01 | 9.28e-02 | 0.903000 |
CD22 mediated BCR regulation | 31 | 5.63e-01 | 6.01e-02 | 0.903000 |
Hh mutants abrogate ligand secretion | 57 | 5.63e-01 | 4.43e-02 | 0.903000 |
Transcriptional regulation of granulopoiesis | 40 | 5.64e-01 | -5.27e-02 | 0.904000 |
Abortive elongation of HIV-1 transcript in the absence of Tat | 21 | 5.65e-01 | -7.25e-02 | 0.904000 |
Metabolism of nitric oxide: NOS3 activation and regulation | 14 | 5.67e-01 | -8.85e-02 | 0.904000 |
Nuclear Pore Complex (NPC) Disassembly | 34 | 5.67e-01 | 5.68e-02 | 0.904000 |
Antigen processing: Ubiquitination & Proteasome degradation | 290 | 5.67e-01 | -1.96e-02 | 0.904000 |
Tie2 Signaling | 18 | 5.68e-01 | 7.78e-02 | 0.904000 |
Beta-catenin phosphorylation cascade | 16 | 5.71e-01 | 8.19e-02 | 0.907000 |
Ubiquitin-dependent degradation of Cyclin D | 50 | 5.71e-01 | 4.63e-02 | 0.907000 |
Phospholipase C-mediated cascade; FGFR4 | 14 | 5.72e-01 | 8.73e-02 | 0.907000 |
EGFR downregulation | 30 | 5.73e-01 | -5.94e-02 | 0.907000 |
Glycosphingolipid metabolism | 41 | 5.73e-01 | 5.09e-02 | 0.907000 |
Hedgehog ligand biogenesis | 62 | 5.73e-01 | 4.14e-02 | 0.907000 |
Golgi-to-ER retrograde transport | 111 | 5.74e-01 | -3.09e-02 | 0.907000 |
MyD88 dependent cascade initiated on endosome | 80 | 5.76e-01 | -3.62e-02 | 0.908000 |
Apoptotic factor-mediated response | 14 | 5.76e-01 | 8.63e-02 | 0.908000 |
Signaling by EGFR | 49 | 5.76e-01 | -4.62e-02 | 0.908000 |
Disassembly of the destruction complex and recruitment of AXIN to the membrane | 30 | 5.77e-01 | 5.89e-02 | 0.908000 |
Fcgamma receptor (FCGR) dependent phagocytosis | 110 | 5.77e-01 | -3.08e-02 | 0.908000 |
Rab regulation of trafficking | 117 | 5.79e-01 | 2.97e-02 | 0.908000 |
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 17 | 5.79e-01 | -7.78e-02 | 0.908000 |
Response of Mtb to phagocytosis | 22 | 5.79e-01 | -6.83e-02 | 0.908000 |
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | 17 | 5.80e-01 | 7.74e-02 | 0.908000 |
Transcription of the HIV genome | 68 | 5.81e-01 | 3.87e-02 | 0.908000 |
Lysine catabolism | 12 | 5.81e-01 | -9.20e-02 | 0.908000 |
TNFs bind their physiological receptors | 27 | 5.82e-01 | -6.12e-02 | 0.908000 |
CD209 (DC-SIGN) signaling | 19 | 5.84e-01 | -7.26e-02 | 0.908000 |
Membrane Trafficking | 579 | 5.84e-01 | -1.34e-02 | 0.908000 |
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 98 | 5.84e-01 | 3.20e-02 | 0.908000 |
Fatty acid metabolism | 164 | 5.86e-01 | -2.47e-02 | 0.908000 |
Cyclin D associated events in G1 | 43 | 5.86e-01 | -4.80e-02 | 0.908000 |
G1 Phase | 43 | 5.86e-01 | -4.80e-02 | 0.908000 |
DAP12 signaling | 29 | 5.86e-01 | 5.84e-02 | 0.908000 |
Negative regulation of TCF-dependent signaling by WNT ligand antagonists | 15 | 5.88e-01 | -8.09e-02 | 0.908000 |
Interleukin-27 signaling | 11 | 5.89e-01 | -9.41e-02 | 0.908000 |
VEGFR2 mediated cell proliferation | 19 | 5.90e-01 | 7.15e-02 | 0.908000 |
Mitotic G1 phase and G1/S transition | 143 | 5.92e-01 | 2.60e-02 | 0.908000 |
Thromboxane signalling through TP receptor | 22 | 5.93e-01 | 6.59e-02 | 0.908000 |
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 11 | 5.94e-01 | 9.29e-02 | 0.908000 |
Nicotinamide salvaging | 19 | 5.94e-01 | 7.07e-02 | 0.908000 |
EPH-ephrin mediated repulsion of cells | 48 | 5.94e-01 | 4.44e-02 | 0.908000 |
RHO GTPases activate IQGAPs | 11 | 5.95e-01 | -9.26e-02 | 0.908000 |
NoRC negatively regulates rRNA expression | 54 | 5.95e-01 | 4.18e-02 | 0.908000 |
tRNA processing | 118 | 5.95e-01 | 2.83e-02 | 0.908000 |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | 17 | 5.96e-01 | 7.44e-02 | 0.908000 |
Meiotic synapsis | 41 | 5.96e-01 | -4.79e-02 | 0.908000 |
Glycogen storage diseases | 14 | 5.97e-01 | -8.17e-02 | 0.908000 |
Toll-like Receptor Cascades | 138 | 5.98e-01 | -2.60e-02 | 0.908000 |
Metabolism of carbohydrates | 275 | 5.98e-01 | 1.85e-02 | 0.908000 |
Presynaptic function of Kainate receptors | 20 | 6.00e-01 | 6.78e-02 | 0.908000 |
Interleukin-17 signaling | 68 | 6.00e-01 | -3.68e-02 | 0.908000 |
Caspase activation via Death Receptors in the presence of ligand | 11 | 6.01e-01 | 9.11e-02 | 0.908000 |
Regulation of APC/C activators between G1/S and early anaphase | 78 | 6.01e-01 | 3.43e-02 | 0.908000 |
Activation of GABAB receptors | 42 | 6.01e-01 | -4.66e-02 | 0.908000 |
GABA B receptor activation | 42 | 6.01e-01 | -4.66e-02 | 0.908000 |
Transcriptional regulation by small RNAs | 54 | 6.01e-01 | 4.11e-02 | 0.908000 |
Long-term potentiation | 22 | 6.02e-01 | -6.42e-02 | 0.908000 |
Sphingolipid metabolism | 84 | 6.02e-01 | -3.29e-02 | 0.908000 |
HDMs demethylate histones | 21 | 6.06e-01 | -6.50e-02 | 0.913000 |
Signaling by cytosolic FGFR1 fusion mutants | 17 | 6.06e-01 | 7.22e-02 | 0.913000 |
Mitotic Telophase/Cytokinesis | 13 | 6.10e-01 | -8.17e-02 | 0.913000 |
Degradation of GLI2 by the proteasome | 56 | 6.12e-01 | 3.92e-02 | 0.913000 |
ATF4 activates genes in response to endoplasmic reticulum stress | 26 | 6.12e-01 | 5.74e-02 | 0.913000 |
VLDLR internalisation and degradation | 12 | 6.13e-01 | -8.44e-02 | 0.913000 |
Senescence-Associated Secretory Phenotype (SASP) | 56 | 6.13e-01 | -3.90e-02 | 0.913000 |
Triglyceride metabolism | 36 | 6.14e-01 | -4.86e-02 | 0.913000 |
HSP90 chaperone cycle for steroid hormone receptors (SHR) | 35 | 6.14e-01 | -4.92e-02 | 0.913000 |
NOTCH4 Intracellular Domain Regulates Transcription | 18 | 6.15e-01 | -6.86e-02 | 0.913000 |
Cytochrome c-mediated apoptotic response | 11 | 6.17e-01 | -8.72e-02 | 0.913000 |
Viral Messenger RNA Synthesis | 41 | 6.17e-01 | 4.52e-02 | 0.913000 |
p53-Dependent G1 DNA Damage Response | 61 | 6.18e-01 | 3.70e-02 | 0.913000 |
p53-Dependent G1/S DNA damage checkpoint | 61 | 6.18e-01 | 3.70e-02 | 0.913000 |
Signaling by WNT | 271 | 6.18e-01 | -1.76e-02 | 0.913000 |
Signaling by PDGF | 50 | 6.19e-01 | -4.07e-02 | 0.913000 |
IRAK4 deficiency (TLR2/4) | 10 | 6.20e-01 | 9.07e-02 | 0.913000 |
Regulation of RUNX3 expression and activity | 52 | 6.20e-01 | 3.98e-02 | 0.913000 |
Serotonin Neurotransmitter Release Cycle | 18 | 6.20e-01 | 6.75e-02 | 0.913000 |
MAP2K and MAPK activation | 38 | 6.21e-01 | -4.64e-02 | 0.913000 |
Caspase activation via extrinsic apoptotic signalling pathway | 21 | 6.22e-01 | 6.21e-02 | 0.913000 |
mTORC1-mediated signalling | 22 | 6.22e-01 | -6.06e-02 | 0.913000 |
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 40 | 6.23e-01 | -4.49e-02 | 0.913000 |
Platelet degranulation | 123 | 6.25e-01 | -2.55e-02 | 0.913000 |
Signaling by NOTCH4 | 78 | 6.26e-01 | -3.19e-02 | 0.913000 |
Recruitment of NuMA to mitotic centrosomes | 78 | 6.27e-01 | -3.19e-02 | 0.913000 |
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 53 | 6.27e-01 | 3.86e-02 | 0.913000 |
Metabolism of steroid hormones | 27 | 6.28e-01 | -5.39e-02 | 0.913000 |
Downstream TCR signaling | 88 | 6.28e-01 | -2.99e-02 | 0.913000 |
Activation of G protein gated Potassium channels | 28 | 6.28e-01 | 5.29e-02 | 0.913000 |
G protein gated Potassium channels | 28 | 6.28e-01 | 5.29e-02 | 0.913000 |
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | 28 | 6.28e-01 | 5.29e-02 | 0.913000 |
G1/S DNA Damage Checkpoints | 62 | 6.28e-01 | 3.55e-02 | 0.913000 |
Negative epigenetic regulation of rRNA expression | 57 | 6.30e-01 | 3.69e-02 | 0.913000 |
Regulation of TP53 Activity through Methylation | 16 | 6.31e-01 | 6.94e-02 | 0.913000 |
Golgi Associated Vesicle Biogenesis | 54 | 6.32e-01 | -3.77e-02 | 0.913000 |
Cleavage of the damaged purine | 20 | 6.32e-01 | 6.19e-02 | 0.913000 |
Depurination | 20 | 6.32e-01 | 6.19e-02 | 0.913000 |
Recognition and association of DNA glycosylase with site containing an affected purine | 20 | 6.32e-01 | 6.19e-02 | 0.913000 |
Mitochondrial tRNA aminoacylation | 20 | 6.32e-01 | 6.18e-02 | 0.913000 |
Transport of Mature Transcript to Cytoplasm | 80 | 6.33e-01 | 3.09e-02 | 0.913000 |
Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 13 | 6.33e-01 | -7.64e-02 | 0.913000 |
Defective EXT2 causes exostoses 2 | 13 | 6.33e-01 | -7.64e-02 | 0.913000 |
Signaling by EGFR in Cancer | 23 | 6.33e-01 | 5.75e-02 | 0.913000 |
SUMOylation of DNA methylation proteins | 16 | 6.36e-01 | -6.83e-02 | 0.916000 |
Post-translational protein modification | 1276 | 6.37e-01 | 7.92e-03 | 0.916000 |
Diseases associated with O-glycosylation of proteins | 62 | 6.38e-01 | 3.45e-02 | 0.917000 |
Diseases associated with glycosylation precursor biosynthesis | 18 | 6.38e-01 | 6.40e-02 | 0.917000 |
DNA Double Strand Break Response | 46 | 6.39e-01 | 4.00e-02 | 0.917000 |
Beta-catenin independent WNT signaling | 142 | 6.40e-01 | 2.28e-02 | 0.917000 |
Digestion | 16 | 6.41e-01 | 6.73e-02 | 0.917000 |
IRF3-mediated induction of type I IFN | 13 | 6.41e-01 | -7.46e-02 | 0.917000 |
MHC class II antigen presentation | 94 | 6.42e-01 | -2.77e-02 | 0.918000 |
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 79 | 6.44e-01 | -3.01e-02 | 0.919000 |
Association of TriC/CCT with target proteins during biosynthesis | 38 | 6.44e-01 | -4.33e-02 | 0.919000 |
Homology Directed Repair | 104 | 6.45e-01 | 2.61e-02 | 0.919000 |
Early Phase of HIV Life Cycle | 13 | 6.46e-01 | 7.36e-02 | 0.919000 |
Miscellaneous transport and binding events | 23 | 6.46e-01 | -5.53e-02 | 0.919000 |
Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 12 | 6.46e-01 | 7.65e-02 | 0.919000 |
ABC transporter disorders | 75 | 6.47e-01 | 3.06e-02 | 0.919000 |
Post-translational modification: synthesis of GPI-anchored proteins | 84 | 6.49e-01 | 2.87e-02 | 0.920000 |
DNA Damage/Telomere Stress Induced Senescence | 41 | 6.49e-01 | -4.10e-02 | 0.920000 |
GPVI-mediated activation cascade | 32 | 6.51e-01 | 4.62e-02 | 0.921000 |
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | 129 | 6.53e-01 | -2.30e-02 | 0.923000 |
Condensation of Prophase Chromosomes | 24 | 6.53e-01 | -5.30e-02 | 0.923000 |
SUMOylation of RNA binding proteins | 45 | 6.55e-01 | 3.85e-02 | 0.925000 |
MTOR signalling | 38 | 6.57e-01 | -4.17e-02 | 0.925000 |
Cohesin Loading onto Chromatin | 10 | 6.57e-01 | -8.11e-02 | 0.925000 |
Methylation | 14 | 6.57e-01 | -6.85e-02 | 0.925000 |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 13 | 6.60e-01 | 7.06e-02 | 0.925000 |
Loss of Nlp from mitotic centrosomes | 67 | 6.60e-01 | -3.11e-02 | 0.925000 |
Loss of proteins required for interphase microtubule organization from the centrosome | 67 | 6.60e-01 | -3.11e-02 | 0.925000 |
Cellular response to heat stress | 92 | 6.61e-01 | 2.65e-02 | 0.926000 |
RHO GTPases activate PKNs | 44 | 6.63e-01 | -3.80e-02 | 0.927000 |
ER to Golgi Anterograde Transport | 126 | 6.64e-01 | -2.24e-02 | 0.927000 |
Signaling by NODAL | 17 | 6.64e-01 | -6.09e-02 | 0.927000 |
E2F mediated regulation of DNA replication | 21 | 6.64e-01 | 5.48e-02 | 0.927000 |
GLI3 is processed to GLI3R by the proteasome | 57 | 6.65e-01 | 3.32e-02 | 0.927000 |
Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 24 | 6.67e-01 | -5.07e-02 | 0.928000 |
Gap junction trafficking and regulation | 27 | 6.68e-01 | -4.77e-02 | 0.928000 |
Interleukin-7 signaling | 23 | 6.68e-01 | 5.16e-02 | 0.928000 |
Constitutive Signaling by EGFRvIII | 14 | 6.69e-01 | 6.59e-02 | 0.928000 |
Signaling by EGFRvIII in Cancer | 14 | 6.69e-01 | 6.59e-02 | 0.928000 |
Metabolism of Angiotensinogen to Angiotensins | 18 | 6.70e-01 | -5.81e-02 | 0.928000 |
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | 19 | 6.70e-01 | -5.64e-02 | 0.928000 |
Neurodegenerative Diseases | 19 | 6.70e-01 | -5.64e-02 | 0.928000 |
Prostacyclin signalling through prostacyclin receptor | 18 | 6.71e-01 | 5.78e-02 | 0.928000 |
Generic Transcription Pathway | 973 | 6.72e-01 | -8.07e-03 | 0.928000 |
Transcriptional Regulation by TP53 | 341 | 6.72e-01 | -1.33e-02 | 0.928000 |
Eicosanoid ligand-binding receptors | 13 | 6.73e-01 | -6.77e-02 | 0.928000 |
Signaling by NTRKs | 132 | 6.75e-01 | 2.12e-02 | 0.930000 |
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 42 | 6.76e-01 | 3.73e-02 | 0.930000 |
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | 30 | 6.79e-01 | 4.37e-02 | 0.930000 |
Acetylcholine Neurotransmitter Release Cycle | 17 | 6.79e-01 | 5.81e-02 | 0.930000 |
Processing of Intronless Pre-mRNAs | 18 | 6.79e-01 | -5.64e-02 | 0.930000 |
Sodium/Calcium exchangers | 11 | 6.80e-01 | 7.18e-02 | 0.930000 |
Degradation of beta-catenin by the destruction complex | 82 | 6.80e-01 | 2.64e-02 | 0.930000 |
activated TAK1 mediates p38 MAPK activation | 18 | 6.80e-01 | 5.61e-02 | 0.930000 |
CD28 co-stimulation | 33 | 6.80e-01 | -4.15e-02 | 0.930000 |
MET promotes cell motility | 29 | 6.81e-01 | -4.41e-02 | 0.930000 |
Peptide hormone metabolism | 84 | 6.82e-01 | -2.59e-02 | 0.930000 |
APC/C-mediated degradation of cell cycle proteins | 85 | 6.83e-01 | 2.56e-02 | 0.930000 |
Regulation of mitotic cell cycle | 85 | 6.83e-01 | 2.56e-02 | 0.930000 |
Amino acid transport across the plasma membrane | 32 | 6.84e-01 | 4.16e-02 | 0.930000 |
Bile acid and bile salt metabolism | 37 | 6.84e-01 | -3.87e-02 | 0.930000 |
Signaling by FGFR4 | 38 | 6.85e-01 | 3.81e-02 | 0.930000 |
Signaling by PDGFRA extracellular domain mutants | 12 | 6.86e-01 | 6.75e-02 | 0.930000 |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 12 | 6.86e-01 | 6.75e-02 | 0.930000 |
Vif-mediated degradation of APOBEC3G | 51 | 6.87e-01 | 3.26e-02 | 0.931000 |
Synaptic adhesion-like molecules | 21 | 6.88e-01 | -5.06e-02 | 0.931000 |
Toll Like Receptor 9 (TLR9) Cascade | 84 | 6.89e-01 | -2.53e-02 | 0.931000 |
Interleukin-12 family signaling | 49 | 6.89e-01 | 3.31e-02 | 0.931000 |
Surfactant metabolism | 24 | 6.90e-01 | -4.70e-02 | 0.931000 |
Glycolysis | 68 | 6.91e-01 | -2.79e-02 | 0.932000 |
SUMOylation of transcription factors | 17 | 6.92e-01 | -5.55e-02 | 0.932000 |
Attenuation phase | 21 | 6.94e-01 | -4.96e-02 | 0.934000 |
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases | 14 | 6.96e-01 | -6.02e-02 | 0.936000 |
Glutathione synthesis and recycling | 12 | 6.99e-01 | 6.46e-02 | 0.938000 |
Glycogen synthesis | 14 | 6.99e-01 | 5.98e-02 | 0.938000 |
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 16 | 7.01e-01 | 5.55e-02 | 0.939000 |
Inwardly rectifying K+ channels | 33 | 7.03e-01 | 3.83e-02 | 0.940000 |
Defective B4GALT7 causes EDS, progeroid type | 19 | 7.03e-01 | 5.04e-02 | 0.940000 |
Peroxisomal lipid metabolism | 27 | 7.04e-01 | -4.22e-02 | 0.940000 |
Signal attenuation | 10 | 7.06e-01 | -6.88e-02 | 0.940000 |
FLT3 Signaling | 282 | 7.07e-01 | 1.30e-02 | 0.940000 |
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 28 | 7.07e-01 | -4.10e-02 | 0.940000 |
NCAM1 interactions | 31 | 7.07e-01 | 3.90e-02 | 0.940000 |
Post NMDA receptor activation events | 59 | 7.08e-01 | -2.82e-02 | 0.940000 |
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 102 | 7.08e-01 | 2.15e-02 | 0.940000 |
RAF/MAP kinase cascade | 268 | 7.08e-01 | 1.33e-02 | 0.940000 |
RHO GTPases activate KTN1 | 10 | 7.08e-01 | -6.83e-02 | 0.940000 |
Protein localization | 156 | 7.09e-01 | -1.73e-02 | 0.940000 |
UCH proteinases | 85 | 7.11e-01 | 2.33e-02 | 0.941000 |
TBC/RABGAPs | 44 | 7.12e-01 | 3.22e-02 | 0.941000 |
Calcitonin-like ligand receptors | 10 | 7.13e-01 | 6.71e-02 | 0.941000 |
Signaling by KIT in disease | 20 | 7.13e-01 | -4.75e-02 | 0.941000 |
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | 20 | 7.13e-01 | -4.75e-02 | 0.941000 |
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 12 | 7.13e-01 | 6.12e-02 | 0.941000 |
Nucleotide-like (purinergic) receptors | 15 | 7.16e-01 | -5.43e-02 | 0.941000 |
Alpha-protein kinase 1 signaling pathway | 10 | 7.17e-01 | -6.63e-02 | 0.941000 |
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | 71 | 7.17e-01 | 2.49e-02 | 0.941000 |
Negative regulation of the PI3K/AKT network | 109 | 7.17e-01 | 2.01e-02 | 0.941000 |
Nucleotide salvage | 22 | 7.18e-01 | -4.45e-02 | 0.941000 |
Signal regulatory protein family interactions | 12 | 7.18e-01 | -6.02e-02 | 0.941000 |
Phase 0 - rapid depolarisation | 30 | 7.19e-01 | 3.79e-02 | 0.941000 |
ER-Phagosome pathway | 80 | 7.20e-01 | 2.32e-02 | 0.941000 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | 19 | 7.21e-01 | 4.73e-02 | 0.941000 |
Negative regulation of NOTCH4 signaling | 52 | 7.21e-01 | 2.86e-02 | 0.941000 |
Reduction of cytosolic Ca++ levels | 12 | 7.23e-01 | -5.90e-02 | 0.941000 |
Class I MHC mediated antigen processing & presentation | 345 | 7.24e-01 | -1.11e-02 | 0.941000 |
VEGFA-VEGFR2 Pathway | 91 | 7.25e-01 | -2.13e-02 | 0.941000 |
Protein folding | 94 | 7.26e-01 | 2.09e-02 | 0.941000 |
Retrograde neurotrophin signalling | 14 | 7.27e-01 | 5.38e-02 | 0.941000 |
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 11 | 7.28e-01 | -6.06e-02 | 0.941000 |
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 27 | 7.29e-01 | 3.86e-02 | 0.941000 |
MET activates RAS signaling | 11 | 7.29e-01 | -6.04e-02 | 0.941000 |
Lewis blood group biosynthesis | 14 | 7.29e-01 | 5.34e-02 | 0.941000 |
Organic anion transporters | 10 | 7.30e-01 | -6.31e-02 | 0.941000 |
Telomere C-strand (Lagging Strand) Synthesis | 33 | 7.30e-01 | 3.47e-02 | 0.941000 |
Assembly and cell surface presentation of NMDA receptors | 23 | 7.31e-01 | 4.15e-02 | 0.941000 |
PI3K/AKT Signaling in Cancer | 100 | 7.31e-01 | 1.99e-02 | 0.941000 |
Interleukin-35 Signalling | 11 | 7.32e-01 | -5.97e-02 | 0.941000 |
Initiation of Nuclear Envelope (NE) Reformation | 16 | 7.34e-01 | -4.90e-02 | 0.941000 |
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 17 | 7.35e-01 | 4.75e-02 | 0.941000 |
Signaling by Ligand-Responsive EGFR Variants in Cancer | 17 | 7.35e-01 | 4.75e-02 | 0.941000 |
Transcriptional Regulation by E2F6 | 32 | 7.35e-01 | 3.46e-02 | 0.941000 |
HIV Infection | 220 | 7.36e-01 | 1.32e-02 | 0.941000 |
Cytosolic iron-sulfur cluster assembly | 13 | 7.37e-01 | 5.38e-02 | 0.941000 |
Beta-oxidation of very long chain fatty acids | 10 | 7.37e-01 | 6.13e-02 | 0.941000 |
B-WICH complex positively regulates rRNA expression | 39 | 7.38e-01 | 3.10e-02 | 0.941000 |
Regulation of PTEN mRNA translation | 21 | 7.38e-01 | 4.22e-02 | 0.941000 |
RHO GTPases Activate WASPs and WAVEs | 35 | 7.40e-01 | -3.24e-02 | 0.941000 |
Lysosphingolipid and LPA receptors | 14 | 7.40e-01 | 5.11e-02 | 0.941000 |
HCMV Early Events | 67 | 7.40e-01 | 2.34e-02 | 0.941000 |
TNF signaling | 43 | 7.41e-01 | -2.91e-02 | 0.941000 |
CRMPs in Sema3A signaling | 16 | 7.43e-01 | -4.74e-02 | 0.941000 |
Norepinephrine Neurotransmitter Release Cycle | 18 | 7.43e-01 | 4.47e-02 | 0.941000 |
Degradation of AXIN | 52 | 7.43e-01 | 2.63e-02 | 0.941000 |
RAB GEFs exchange GTP for GDP on RABs | 85 | 7.43e-01 | 2.06e-02 | 0.941000 |
Glutamate Neurotransmitter Release Cycle | 24 | 7.43e-01 | 3.87e-02 | 0.941000 |
TNFR2 non-canonical NF-kB pathway | 96 | 7.43e-01 | 1.94e-02 | 0.941000 |
Downregulation of ERBB2:ERBB3 signaling | 12 | 7.44e-01 | -5.45e-02 | 0.941000 |
Integrin cell surface interactions | 60 | 7.44e-01 | -2.44e-02 | 0.941000 |
Erythropoietin activates RAS | 14 | 7.45e-01 | 5.03e-02 | 0.941000 |
Ion channel transport | 170 | 7.45e-01 | 1.45e-02 | 0.941000 |
Neutrophil degranulation | 449 | 7.45e-01 | -8.96e-03 | 0.941000 |
Signaling by Activin | 13 | 7.46e-01 | 5.19e-02 | 0.941000 |
RNA Polymerase II Pre-transcription Events | 79 | 7.46e-01 | -2.11e-02 | 0.941000 |
Negative regulation of FGFR2 signaling | 32 | 7.47e-01 | 3.30e-02 | 0.941000 |
Thrombin signalling through proteinase activated receptors (PARs) | 30 | 7.48e-01 | 3.39e-02 | 0.942000 |
Platelet calcium homeostasis | 28 | 7.50e-01 | 3.48e-02 | 0.942000 |
Digestion and absorption | 21 | 7.51e-01 | -4.00e-02 | 0.942000 |
MAPK6/MAPK4 signaling | 86 | 7.51e-01 | -1.98e-02 | 0.942000 |
Signaling by Hippo | 20 | 7.55e-01 | -4.04e-02 | 0.942000 |
RNA Polymerase II Transcription Termination | 63 | 7.55e-01 | 2.28e-02 | 0.942000 |
Termination of translesion DNA synthesis | 30 | 7.55e-01 | -3.29e-02 | 0.942000 |
Signaling by Receptor Tyrosine Kinases | 468 | 7.55e-01 | 8.43e-03 | 0.942000 |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 39 | 7.56e-01 | -2.88e-02 | 0.942000 |
Ras activation upon Ca2+ influx through NMDA receptor | 19 | 7.56e-01 | 4.12e-02 | 0.942000 |
RNA Pol II CTD phosphorylation and interaction with CE | 25 | 7.56e-01 | 3.59e-02 | 0.942000 |
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | 25 | 7.56e-01 | 3.59e-02 | 0.942000 |
RET signaling | 39 | 7.57e-01 | -2.86e-02 | 0.942000 |
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 17 | 7.58e-01 | -4.32e-02 | 0.942000 |
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 17 | 7.58e-01 | -4.32e-02 | 0.942000 |
Protein methylation | 14 | 7.58e-01 | 4.76e-02 | 0.942000 |
Disease | 1436 | 7.59e-01 | -4.86e-03 | 0.943000 |
Degradation of GLI1 by the proteasome | 57 | 7.60e-01 | 2.34e-02 | 0.943000 |
Creation of C4 and C2 activators | 38 | 7.62e-01 | -2.84e-02 | 0.944000 |
Regulation of localization of FOXO transcription factors | 11 | 7.62e-01 | -5.27e-02 | 0.944000 |
Vesicle-mediated transport | 640 | 7.63e-01 | -7.01e-03 | 0.944000 |
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 11 | 7.63e-01 | 5.25e-02 | 0.944000 |
Apoptosis induced DNA fragmentation | 12 | 7.65e-01 | -4.98e-02 | 0.945000 |
Inhibition of DNA recombination at telomere | 29 | 7.65e-01 | -3.20e-02 | 0.945000 |
Toll Like Receptor 4 (TLR4) Cascade | 114 | 7.68e-01 | -1.60e-02 | 0.948000 |
VxPx cargo-targeting to cilium | 21 | 7.70e-01 | -3.69e-02 | 0.948000 |
TP53 Regulates Transcription of Caspase Activators and Caspases | 10 | 7.70e-01 | 5.33e-02 | 0.948000 |
HCMV Late Events | 61 | 7.70e-01 | -2.16e-02 | 0.948000 |
Positive epigenetic regulation of rRNA expression | 52 | 7.72e-01 | -2.32e-02 | 0.949000 |
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 64 | 7.73e-01 | -2.08e-02 | 0.950000 |
Prefoldin mediated transfer of substrate to CCT/TriC | 25 | 7.78e-01 | -3.25e-02 | 0.955000 |
Bicarbonate transporters | 10 | 7.83e-01 | 5.04e-02 | 0.959000 |
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 22 | 7.83e-01 | -3.39e-02 | 0.959000 |
Defective B3GAT3 causes JDSSDHD | 19 | 7.85e-01 | 3.61e-02 | 0.959000 |
GABA receptor activation | 58 | 7.85e-01 | -2.07e-02 | 0.959000 |
Branched-chain amino acid catabolism | 21 | 7.86e-01 | -3.43e-02 | 0.959000 |
Processive synthesis on the C-strand of the telomere | 18 | 7.86e-01 | 3.70e-02 | 0.959000 |
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | 10 | 7.86e-01 | -4.96e-02 | 0.959000 |
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 13 | 7.89e-01 | -4.28e-02 | 0.960000 |
Activation of NMDA receptors and postsynaptic events | 71 | 7.89e-01 | -1.83e-02 | 0.960000 |
Interleukin-12 signaling | 39 | 7.91e-01 | 2.46e-02 | 0.960000 |
Unwinding of DNA | 12 | 7.91e-01 | -4.41e-02 | 0.960000 |
RIPK1-mediated regulated necrosis | 24 | 7.92e-01 | 3.11e-02 | 0.960000 |
Regulated Necrosis | 24 | 7.92e-01 | 3.11e-02 | 0.960000 |
Regulation of necroptotic cell death | 24 | 7.92e-01 | 3.11e-02 | 0.960000 |
mitochondrial fatty acid beta-oxidation of saturated fatty acids | 10 | 7.94e-01 | 4.76e-02 | 0.962000 |
Sealing of the nuclear envelope (NE) by ESCRT-III | 24 | 7.95e-01 | 3.06e-02 | 0.963000 |
Protein-protein interactions at synapses | 84 | 7.96e-01 | 1.63e-02 | 0.963000 |
Ca2+ pathway | 60 | 7.97e-01 | -1.92e-02 | 0.963000 |
Toll Like Receptor 3 (TLR3) Cascade | 85 | 8.00e-01 | -1.59e-02 | 0.966000 |
Physiological factors | 12 | 8.01e-01 | 4.20e-02 | 0.966000 |
Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 70 | 8.04e-01 | 1.72e-02 | 0.969000 |
eNOS activation | 10 | 8.04e-01 | 4.53e-02 | 0.969000 |
Programmed Cell Death | 172 | 8.05e-01 | 1.09e-02 | 0.969000 |
Aberrant regulation of mitotic cell cycle due to RB1 defects | 35 | 8.08e-01 | -2.38e-02 | 0.970000 |
Diseases of mitotic cell cycle | 35 | 8.08e-01 | -2.38e-02 | 0.970000 |
Phospholipid metabolism | 203 | 8.12e-01 | -9.71e-03 | 0.970000 |
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | 45 | 8.12e-01 | 2.05e-02 | 0.970000 |
TP53 Regulates Transcription of Cell Cycle Genes | 47 | 8.13e-01 | 2.00e-02 | 0.970000 |
Signaling by Non-Receptor Tyrosine Kinases | 53 | 8.14e-01 | 1.87e-02 | 0.970000 |
Signaling by PTK6 | 53 | 8.14e-01 | 1.87e-02 | 0.970000 |
Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 15 | 8.14e-01 | -3.50e-02 | 0.970000 |
Processing of SMDT1 | 14 | 8.16e-01 | 3.60e-02 | 0.970000 |
Acyl chain remodelling of PC | 26 | 8.16e-01 | -2.64e-02 | 0.970000 |
Inositol phosphate metabolism | 47 | 8.17e-01 | 1.96e-02 | 0.970000 |
Transport of Mature mRNAs Derived from Intronless Transcripts | 41 | 8.17e-01 | 2.09e-02 | 0.970000 |
Urea cycle | 10 | 8.17e-01 | -4.22e-02 | 0.970000 |
PIWI-interacting RNA (piRNA) biogenesis | 26 | 8.18e-01 | 2.61e-02 | 0.970000 |
Deadenylation of mRNA | 20 | 8.19e-01 | 2.96e-02 | 0.970000 |
Antiviral mechanism by IFN-stimulated genes | 77 | 8.19e-01 | 1.51e-02 | 0.970000 |
Mitochondrial biogenesis | 86 | 8.19e-01 | -1.42e-02 | 0.970000 |
Voltage gated Potassium channels | 41 | 8.20e-01 | 2.06e-02 | 0.970000 |
RNA Polymerase I Promoter Opening | 13 | 8.21e-01 | 3.63e-02 | 0.970000 |
Mitochondrial calcium ion transport | 21 | 8.21e-01 | -2.86e-02 | 0.970000 |
The role of GTSE1 in G2/M progression after G2 checkpoint | 55 | 8.22e-01 | -1.75e-02 | 0.970000 |
Gamma-carboxylation of protein precursors | 10 | 8.22e-01 | -4.10e-02 | 0.970000 |
Regulation of insulin secretion | 74 | 8.23e-01 | -1.50e-02 | 0.970000 |
Negative regulation of NMDA receptor-mediated neuronal transmission | 20 | 8.23e-01 | 2.88e-02 | 0.970000 |
Deactivation of the beta-catenin transactivating complex | 39 | 8.24e-01 | -2.06e-02 | 0.970000 |
APC/C:Cdc20 mediated degradation of mitotic proteins | 73 | 8.28e-01 | 1.47e-02 | 0.970000 |
Glycogen breakdown (glycogenolysis) | 14 | 8.29e-01 | -3.34e-02 | 0.970000 |
APC/C:Cdc20 mediated degradation of Securin | 65 | 8.29e-01 | 1.55e-02 | 0.970000 |
NOTCH2 intracellular domain regulates transcription | 10 | 8.29e-01 | 3.95e-02 | 0.970000 |
RNA Polymerase I Transcription Initiation | 44 | 8.29e-01 | -1.88e-02 | 0.970000 |
Transport of Mature mRNA Derived from an Intronless Transcript | 40 | 8.30e-01 | 1.96e-02 | 0.970000 |
Diseases associated with visual transduction | 13 | 8.31e-01 | 3.43e-02 | 0.970000 |
Diseases of the neuronal system | 13 | 8.31e-01 | 3.43e-02 | 0.970000 |
Retinoid cycle disease events | 13 | 8.31e-01 | 3.43e-02 | 0.970000 |
FCGR3A-mediated phagocytosis | 84 | 8.31e-01 | -1.35e-02 | 0.970000 |
Leishmania phagocytosis | 84 | 8.31e-01 | -1.35e-02 | 0.970000 |
Parasite infection | 84 | 8.31e-01 | -1.35e-02 | 0.970000 |
CTLA4 inhibitory signaling | 21 | 8.31e-01 | -2.68e-02 | 0.970000 |
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 31 | 8.33e-01 | -2.19e-02 | 0.970000 |
ISG15 antiviral mechanism | 69 | 8.33e-01 | 1.47e-02 | 0.970000 |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | 22 | 8.33e-01 | 2.59e-02 | 0.970000 |
Extension of Telomeres | 50 | 8.35e-01 | 1.71e-02 | 0.971000 |
Removal of the Flap Intermediate from the C-strand | 16 | 8.37e-01 | 2.98e-02 | 0.972000 |
Neurotransmitter release cycle | 51 | 8.37e-01 | -1.66e-02 | 0.972000 |
Negative regulation of FGFR4 signaling | 28 | 8.40e-01 | -2.21e-02 | 0.973000 |
BBSome-mediated cargo-targeting to cilium | 22 | 8.40e-01 | 2.49e-02 | 0.973000 |
Aggrephagy | 20 | 8.41e-01 | -2.60e-02 | 0.973000 |
Cytosolic sensors of pathogen-associated DNA | 55 | 8.41e-01 | -1.57e-02 | 0.973000 |
Dissolution of Fibrin Clot | 11 | 8.42e-01 | 3.48e-02 | 0.973000 |
Late Phase of HIV Life Cycle | 130 | 8.44e-01 | 1.00e-02 | 0.974000 |
Signaling by Nuclear Receptors | 235 | 8.44e-01 | -7.48e-03 | 0.974000 |
A tetrasaccharide linker sequence is required for GAG synthesis | 25 | 8.44e-01 | -2.27e-02 | 0.974000 |
MAPK family signaling cascades | 312 | 8.47e-01 | -6.38e-03 | 0.975000 |
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | 16 | 8.47e-01 | -2.78e-02 | 0.975000 |
Role of phospholipids in phagocytosis | 52 | 8.49e-01 | 1.52e-02 | 0.975000 |
Chaperonin-mediated protein folding | 88 | 8.49e-01 | -1.17e-02 | 0.975000 |
AURKA Activation by TPX2 | 70 | 8.50e-01 | -1.31e-02 | 0.975000 |
Visual phototransduction | 92 | 8.51e-01 | 1.13e-02 | 0.975000 |
Transport of small molecules | 687 | 8.53e-01 | -4.17e-03 | 0.975000 |
HIV Life Cycle | 142 | 8.54e-01 | 8.97e-03 | 0.975000 |
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | 10 | 8.54e-01 | 3.36e-02 | 0.975000 |
Pyruvate metabolism and Citric Acid (TCA) cycle | 53 | 8.54e-01 | -1.46e-02 | 0.975000 |
PTEN Regulation | 146 | 8.54e-01 | 8.81e-03 | 0.975000 |
Macroautophagy | 108 | 8.55e-01 | -1.02e-02 | 0.975000 |
DNA strand elongation | 31 | 8.55e-01 | -1.90e-02 | 0.975000 |
Activation of the phototransduction cascade | 10 | 8.55e-01 | 3.33e-02 | 0.975000 |
P2Y receptors | 11 | 8.56e-01 | 3.17e-02 | 0.975000 |
Basigin interactions | 25 | 8.56e-01 | -2.09e-02 | 0.975000 |
Infection with Mycobacterium tuberculosis | 26 | 8.57e-01 | -2.04e-02 | 0.975000 |
Mitotic G2-G2/M phases | 178 | 8.58e-01 | 7.80e-03 | 0.975000 |
Signaling by Interleukins | 413 | 8.58e-01 | -5.14e-03 | 0.975000 |
Polymerase switching on the C-strand of the telomere | 25 | 8.61e-01 | 2.02e-02 | 0.977000 |
Signalling to RAS | 19 | 8.62e-01 | 2.31e-02 | 0.977000 |
Apoptotic execution phase | 51 | 8.62e-01 | -1.41e-02 | 0.977000 |
mRNA decay by 3' to 5' exoribonuclease | 16 | 8.62e-01 | -2.50e-02 | 0.977000 |
mRNA 3'-end processing | 55 | 8.63e-01 | 1.34e-02 | 0.977000 |
Mitochondrial Fatty Acid Beta-Oxidation | 36 | 8.64e-01 | 1.65e-02 | 0.977000 |
Reproduction | 87 | 8.64e-01 | -1.06e-02 | 0.977000 |
Presynaptic depolarization and calcium channel opening | 12 | 8.67e-01 | 2.80e-02 | 0.977000 |
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 19 | 8.68e-01 | 2.20e-02 | 0.977000 |
Metabolism of amine-derived hormones | 17 | 8.68e-01 | -2.32e-02 | 0.977000 |
Regulation of TP53 Activity | 149 | 8.69e-01 | -7.85e-03 | 0.977000 |
Caspase activation via Dependence Receptors in the absence of ligand | 10 | 8.69e-01 | 3.02e-02 | 0.977000 |
FCERI mediated Ca+2 mobilization | 55 | 8.70e-01 | 1.28e-02 | 0.977000 |
MAPK1/MAPK3 signaling | 274 | 8.72e-01 | 5.67e-03 | 0.977000 |
Processing and activation of SUMO | 10 | 8.72e-01 | 2.94e-02 | 0.977000 |
Netrin-1 signaling | 49 | 8.73e-01 | -1.32e-02 | 0.977000 |
Mismatch Repair | 14 | 8.74e-01 | 2.44e-02 | 0.977000 |
SARS-CoV-2 Infection | 64 | 8.74e-01 | -1.14e-02 | 0.977000 |
Stimuli-sensing channels | 97 | 8.75e-01 | 9.26e-03 | 0.977000 |
MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
Toll Like Receptor 2 (TLR2) Cascade | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
Toll Like Receptor TLR1:TLR2 Cascade | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
Toll Like Receptor TLR6:TLR2 Cascade | 86 | 8.75e-01 | -9.83e-03 | 0.977000 |
Aberrant regulation of mitotic exit in cancer due to RB1 defects | 19 | 8.75e-01 | -2.08e-02 | 0.977000 |
trans-Golgi Network Vesicle Budding | 70 | 8.78e-01 | -1.06e-02 | 0.979000 |
Regulation of TP53 Expression and Degradation | 34 | 8.79e-01 | 1.51e-02 | 0.979000 |
ABC transporters in lipid homeostasis | 17 | 8.80e-01 | 2.12e-02 | 0.979000 |
NOD1/2 Signaling Pathway | 30 | 8.82e-01 | 1.57e-02 | 0.979000 |
Infectious disease | 757 | 8.83e-01 | -3.16e-03 | 0.979000 |
Transcriptional Regulation by MECP2 | 57 | 8.83e-01 | 1.13e-02 | 0.979000 |
Inactivation of APC/C via direct inhibition of the APC/C complex | 20 | 8.84e-01 | -1.88e-02 | 0.979000 |
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | 20 | 8.84e-01 | -1.88e-02 | 0.979000 |
Interleukin-4 and Interleukin-13 signaling | 102 | 8.84e-01 | -8.33e-03 | 0.979000 |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 10 | 8.85e-01 | 2.64e-02 | 0.979000 |
Activation of RAC1 | 13 | 8.87e-01 | -2.27e-02 | 0.979000 |
Termination of O-glycan biosynthesis | 19 | 8.88e-01 | 1.87e-02 | 0.979000 |
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | 16 | 8.88e-01 | 2.03e-02 | 0.979000 |
NCAM signaling for neurite out-growth | 52 | 8.88e-01 | 1.12e-02 | 0.979000 |
Organelle biogenesis and maintenance | 265 | 8.89e-01 | -4.97e-03 | 0.979000 |
Receptor-type tyrosine-protein phosphatases | 19 | 8.90e-01 | 1.83e-02 | 0.979000 |
Amyloid fiber formation | 56 | 8.90e-01 | -1.07e-02 | 0.979000 |
Meiosis | 67 | 8.91e-01 | 9.71e-03 | 0.979000 |
Incretin synthesis, secretion, and inactivation | 22 | 8.91e-01 | 1.68e-02 | 0.979000 |
Regulation of TP53 Degradation | 33 | 8.92e-01 | -1.36e-02 | 0.979000 |
MyD88-independent TLR4 cascade | 87 | 8.92e-01 | -8.39e-03 | 0.979000 |
TRIF(TICAM1)-mediated TLR4 signaling | 87 | 8.92e-01 | -8.39e-03 | 0.979000 |
Leading Strand Synthesis | 13 | 8.93e-01 | 2.14e-02 | 0.979000 |
Polymerase switching | 13 | 8.93e-01 | 2.14e-02 | 0.979000 |
DAP12 interactions | 38 | 8.96e-01 | 1.23e-02 | 0.980000 |
RHO GTPase Effectors | 249 | 8.97e-01 | 4.77e-03 | 0.981000 |
G-protein beta:gamma signalling | 31 | 8.99e-01 | -1.32e-02 | 0.982000 |
Regulation of signaling by NODAL | 10 | 9.00e-01 | -2.29e-02 | 0.982000 |
COPI-mediated anterograde transport | 77 | 9.01e-01 | 8.23e-03 | 0.982000 |
Activation of Ca-permeable Kainate Receptor | 10 | 9.01e-01 | 2.27e-02 | 0.982000 |
Ionotropic activity of kainate receptors | 10 | 9.01e-01 | 2.27e-02 | 0.982000 |
G2/M DNA damage checkpoint | 64 | 9.02e-01 | 8.92e-03 | 0.982000 |
Nonhomologous End-Joining (NHEJ) | 40 | 9.05e-01 | 1.09e-02 | 0.985000 |
Pyruvate metabolism | 29 | 9.07e-01 | 1.25e-02 | 0.986000 |
Formation of Incision Complex in GG-NER | 42 | 9.09e-01 | -1.02e-02 | 0.986000 |
Ion homeostasis | 47 | 9.09e-01 | -9.63e-03 | 0.986000 |
Retrograde transport at the Trans-Golgi-Network | 46 | 9.09e-01 | -9.71e-03 | 0.986000 |
MicroRNA (miRNA) biogenesis | 24 | 9.10e-01 | -1.33e-02 | 0.986000 |
Gamma carboxylation, hypusine formation and arylsulfatase activation | 37 | 9.12e-01 | 1.06e-02 | 0.987000 |
Apoptosis | 162 | 9.12e-01 | 5.03e-03 | 0.987000 |
Processing of Capped Intronless Pre-mRNA | 26 | 9.13e-01 | -1.24e-02 | 0.987000 |
LGI-ADAM interactions | 14 | 9.15e-01 | -1.65e-02 | 0.988000 |
Glycogen metabolism | 25 | 9.16e-01 | -1.21e-02 | 0.988000 |
Telomere Maintenance | 73 | 9.17e-01 | -7.06e-03 | 0.988000 |
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 13 | 9.17e-01 | -1.66e-02 | 0.988000 |
Translation of Replicase and Assembly of the Replication Transcription Complex | 12 | 9.18e-01 | 1.71e-02 | 0.988000 |
Class C/3 (Metabotropic glutamate/pheromone receptors) | 31 | 9.19e-01 | -1.05e-02 | 0.988000 |
Intraflagellar transport | 38 | 9.20e-01 | -9.42e-03 | 0.988000 |
Activation of Matrix Metalloproteinases | 30 | 9.21e-01 | 1.05e-02 | 0.988000 |
MET activates RAP1 and RAC1 | 11 | 9.21e-01 | -1.72e-02 | 0.988000 |
Transport of vitamins, nucleosides, and related molecules | 42 | 9.23e-01 | 8.64e-03 | 0.988000 |
TP53 Regulates Transcription of Cell Death Genes | 34 | 9.24e-01 | 9.47e-03 | 0.988000 |
HDR through MMEJ (alt-NHEJ) | 10 | 9.24e-01 | -1.73e-02 | 0.988000 |
Regulation of mRNA stability by proteins that bind AU-rich elements | 86 | 9.25e-01 | -5.89e-03 | 0.988000 |
Negative regulation of FGFR1 signaling | 30 | 9.26e-01 | -9.86e-03 | 0.988000 |
Oxidative Stress Induced Senescence | 69 | 9.26e-01 | 6.51e-03 | 0.988000 |
Transport to the Golgi and subsequent modification | 154 | 9.30e-01 | 4.13e-03 | 0.988000 |
Neddylation | 226 | 9.30e-01 | -3.37e-03 | 0.988000 |
G2/M Transition | 176 | 9.31e-01 | 3.81e-03 | 0.988000 |
SIRT1 negatively regulates rRNA expression | 18 | 9.32e-01 | 1.16e-02 | 0.988000 |
Regulation of KIT signaling | 16 | 9.33e-01 | -1.22e-02 | 0.988000 |
Misspliced GSK3beta mutants stabilize beta-catenin | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
S33 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
S37 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
S45 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
T41 mutants of beta-catenin aren't phosphorylated | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex | 14 | 9.33e-01 | 1.30e-02 | 0.988000 |
Detoxification of Reactive Oxygen Species | 33 | 9.33e-01 | 8.46e-03 | 0.988000 |
Signaling by Erythropoietin | 25 | 9.33e-01 | 9.69e-03 | 0.988000 |
Gap junction trafficking | 25 | 9.34e-01 | 9.62e-03 | 0.988000 |
AUF1 (hnRNP D0) binds and destabilizes mRNA | 52 | 9.36e-01 | -6.45e-03 | 0.989000 |
Organic cation/anion/zwitterion transport | 12 | 9.36e-01 | 1.33e-02 | 0.989000 |
Diseases of programmed cell death | 25 | 9.38e-01 | 9.03e-03 | 0.990000 |
p38MAPK events | 13 | 9.39e-01 | 1.22e-02 | 0.991000 |
TRAF6 mediated NF-kB activation | 19 | 9.40e-01 | -9.94e-03 | 0.991000 |
Interleukin-1 signaling | 95 | 9.40e-01 | 4.44e-03 | 0.991000 |
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 74 | 9.44e-01 | 4.76e-03 | 0.992000 |
Anchoring of the basal body to the plasma membrane | 94 | 9.44e-01 | 4.19e-03 | 0.992000 |
Hedgehog 'off' state | 96 | 9.44e-01 | -4.12e-03 | 0.992000 |
TP53 Regulates Metabolic Genes | 83 | 9.45e-01 | 4.36e-03 | 0.992000 |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | 23 | 9.46e-01 | 8.22e-03 | 0.992000 |
Synthesis, secretion, and deacylation of Ghrelin | 18 | 9.46e-01 | 9.28e-03 | 0.992000 |
G beta:gamma signalling through CDC42 | 19 | 9.49e-01 | -8.41e-03 | 0.995000 |
Activation of the TFAP2 (AP-2) family of transcription factors | 11 | 9.51e-01 | 1.07e-02 | 0.996000 |
Growth hormone receptor signaling | 24 | 9.52e-01 | -7.11e-03 | 0.997000 |
MAP3K8 (TPL2)-dependent MAPK1/3 activation | 15 | 9.52e-01 | 8.89e-03 | 0.997000 |
SUMO E3 ligases SUMOylate target proteins | 158 | 9.54e-01 | -2.69e-03 | 0.997000 |
Unblocking of NMDA receptors, glutamate binding and activation | 20 | 9.56e-01 | 7.15e-03 | 0.999000 |
Signaling by FGFR4 in disease | 11 | 9.57e-01 | -9.44e-03 | 0.999000 |
Metabolism of RNA | 632 | 9.57e-01 | -1.25e-03 | 0.999000 |
Telomere Extension By Telomerase | 23 | 9.58e-01 | 6.35e-03 | 0.999000 |
Cardiac conduction | 116 | 9.59e-01 | -2.77e-03 | 0.999000 |
Acyl chain remodelling of PE | 26 | 9.60e-01 | 5.64e-03 | 0.999000 |
Platelet homeostasis | 81 | 9.61e-01 | 3.18e-03 | 0.999000 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex | 12 | 9.61e-01 | 8.11e-03 | 0.999000 |
FCGR activation | 39 | 9.62e-01 | -4.41e-03 | 0.999000 |
Apoptotic cleavage of cellular proteins | 38 | 9.63e-01 | -4.35e-03 | 0.999000 |
Citric acid cycle (TCA cycle) | 22 | 9.64e-01 | -5.48e-03 | 0.999000 |
Formation of ATP by chemiosmotic coupling | 15 | 9.65e-01 | -6.64e-03 | 0.999000 |
Formation of the Early Elongation Complex | 31 | 9.68e-01 | 4.16e-03 | 0.999000 |
Formation of the HIV-1 Early Elongation Complex | 31 | 9.68e-01 | 4.16e-03 | 0.999000 |
Polo-like kinase mediated events | 15 | 9.70e-01 | -5.56e-03 | 0.999000 |
Synthesis of bile acids and bile salts | 29 | 9.71e-01 | -3.91e-03 | 0.999000 |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | 71 | 9.71e-01 | -2.45e-03 | 0.999000 |
RNA Polymerase I Promoter Clearance | 56 | 9.72e-01 | 2.69e-03 | 0.999000 |
RNA Polymerase I Transcription | 56 | 9.72e-01 | 2.69e-03 | 0.999000 |
Plasma lipoprotein clearance | 32 | 9.72e-01 | -3.54e-03 | 0.999000 |
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | 13 | 9.72e-01 | 5.53e-03 | 0.999000 |
Lysosome Vesicle Biogenesis | 34 | 9.73e-01 | 3.40e-03 | 0.999000 |
SUMOylation | 164 | 9.73e-01 | 1.51e-03 | 0.999000 |
Cytosolic sulfonation of small molecules | 23 | 9.74e-01 | -3.90e-03 | 0.999000 |
Oncogene Induced Senescence | 30 | 9.74e-01 | -3.40e-03 | 0.999000 |
Signalling to ERKs | 33 | 9.77e-01 | 2.96e-03 | 0.999000 |
Signaling by MET | 66 | 9.79e-01 | -1.86e-03 | 0.999000 |
PECAM1 interactions | 11 | 9.80e-01 | 4.46e-03 | 0.999000 |
APC-Cdc20 mediated degradation of Nek2A | 24 | 9.80e-01 | 2.99e-03 | 0.999000 |
Lagging Strand Synthesis | 19 | 9.81e-01 | -3.10e-03 | 0.999000 |
Estrogen-dependent gene expression | 96 | 9.83e-01 | -1.28e-03 | 0.999000 |
Signaling by FGFR2 IIIa TM | 17 | 9.83e-01 | 3.02e-03 | 0.999000 |
COPI-independent Golgi-to-ER retrograde traffic | 33 | 9.84e-01 | 1.98e-03 | 0.999000 |
Triglyceride biosynthesis | 13 | 9.88e-01 | -2.38e-03 | 0.999000 |
Signaling by SCF-KIT | 42 | 9.88e-01 | -1.32e-03 | 0.999000 |
Packaging Of Telomere Ends | 16 | 9.88e-01 | -2.12e-03 | 0.999000 |
Regulation of signaling by CBL | 18 | 9.89e-01 | -1.82e-03 | 0.999000 |
AMER1 mutants destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
APC truncation mutants have impaired AXIN binding | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
AXIN missense mutants destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
AXIN mutants destabilize the destruction complex, activating WNT signaling | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
Truncations of AMER1 destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
truncated APC mutants destabilize the destruction complex | 13 | 9.90e-01 | -1.95e-03 | 0.999000 |
SUMOylation of immune response proteins | 10 | 9.91e-01 | 2.07e-03 | 0.999000 |
Cell recruitment (pro-inflammatory response) | 23 | 9.91e-01 | -1.30e-03 | 0.999000 |
Purinergic signaling in leishmaniasis infection | 23 | 9.91e-01 | -1.30e-03 | 0.999000 |
Cilium Assembly | 179 | 9.92e-01 | -4.51e-04 | 0.999000 |
PIP3 activates AKT signaling | 269 | 9.92e-01 | -3.58e-04 | 0.999000 |
Na+/Cl- dependent neurotransmitter transporters | 18 | 9.92e-01 | -1.34e-03 | 0.999000 |
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 19 | 9.93e-01 | 1.18e-03 | 0.999000 |
Acyl chain remodelling of PS | 21 | 9.93e-01 | 1.04e-03 | 0.999000 |
Signaling by WNT in cancer | 33 | 9.94e-01 | -8.16e-04 | 0.999000 |
FGFR2 alternative splicing | 23 | 9.94e-01 | -8.73e-04 | 0.999000 |
ATF6 (ATF6-alpha) activates chaperone genes | 10 | 9.95e-01 | 1.22e-03 | 0.999000 |
EPHB-mediated forward signaling | 33 | 9.96e-01 | 5.38e-04 | 0.999000 |
Blood group systems biosynthesis | 18 | 9.96e-01 | -7.06e-04 | 0.999000 |
Carboxyterminal post-translational modifications of tubulin | 33 | 9.96e-01 | 4.66e-04 | 0.999000 |
G0 and Early G1 | 27 | 9.97e-01 | 4.56e-04 | 0.999000 |
Golgi Cisternae Pericentriolar Stack Reorganization | 12 | 9.97e-01 | -6.75e-04 | 0.999000 |
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 13 | 9.97e-01 | 5.80e-04 | 0.999000 |
Synthesis of glycosylphosphatidylinositol (GPI) | 17 | 9.98e-01 | 3.52e-04 | 0.999000 |
Diseases of metabolism | 230 | 9.99e-01 | -7.18e-05 | 0.999000 |
mRNA Splicing - Minor Pathway | 48 | 1.00e+00 | -3.13e-05 | 1.000000 |
Xenobiotics
1408 | |
---|---|
set | Xenobiotics |
setSize | 20 |
pANOVA | 1.64e-07 |
s.dist | -0.676 |
p.adjustANOVA | 0.000238 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
AHRR | -8688.0 |
CYP2F1 | -8491.0 |
CYP2C18 | -7923.5 |
CYP1A2 | -6798.0 |
CYP2W1 | -3941.0 |
CYP2S1 | -1638.0 |
CYP2J2 | -235.0 |
CYP1A1 | 359.0 |
ARNT2 | 1509.0 |
AHR | 2943.5 |
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
AHRR | -8688.0 |
CYP2F1 | -8491.0 |
CYP2C18 | -7923.5 |
CYP1A2 | -6798.0 |
CYP2W1 | -3941.0 |
CYP2S1 | -1638.0 |
CYP2J2 | -235.0 |
CYP1A1 | 359.0 |
ARNT2 | 1509.0 |
AHR | 2943.5 |
Plasma lipoprotein remodeling
884 | |
---|---|
set | Plasma lipoprotein remodeling |
setSize | 31 |
pANOVA | 1.95e-06 |
s.dist | -0.494 |
p.adjustANOVA | 0.00141 |
Top enriched genes
GeneID | Gene Rank |
---|---|
APOC3 | -8904.0 |
CIDEC | -8897.0 |
ABCG1 | -8866.0 |
APOE | -8836.0 |
MBTPS2 | -8761.0 |
APOA5 | -8466.0 |
MBTPS1 | -7804.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
APOF | -7268.0 |
CREB3L3 | -7263.0 |
LCAT | -6772.0 |
APOA4 | -6758.0 |
ANGPTL3 | -6400.0 |
FURIN | -6399.0 |
ANGPTL4 | -6243.0 |
LIPC | -5932.0 |
LMF2 | -5317.0 |
LIPG | -5216.0 |
FGF21 | -5116.0 |
GeneID | Gene Rank |
---|---|
APOC3 | -8904.0 |
CIDEC | -8897.0 |
ABCG1 | -8866.0 |
APOE | -8836.0 |
MBTPS2 | -8761.0 |
APOA5 | -8466.0 |
MBTPS1 | -7804.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
APOF | -7268.0 |
CREB3L3 | -7263.0 |
LCAT | -6772.0 |
APOA4 | -6758.0 |
ANGPTL3 | -6400.0 |
FURIN | -6399.0 |
ANGPTL4 | -6243.0 |
LIPC | -5932.0 |
LMF2 | -5317.0 |
LIPG | -5216.0 |
FGF21 | -5116.0 |
ANGPTL8 | -4094.0 |
LPA | -3826.0 |
GPIHBP1 | -3404.0 |
LPL | -2467.0 |
PLTP | -2003.0 |
APOA1 | -547.0 |
APOB | 573.0 |
PCSK5 | 3308.0 |
PCSK6 | 4262.0 |
LMF1 | 4677.0 |
ALB | 7970.0 |
Fatty acids
414 | |
---|---|
set | Fatty acids |
setSize | 14 |
pANOVA | 4.06e-06 |
s.dist | -0.711 |
p.adjustANOVA | 0.00182 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP2A7 | -9057.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2F1 | -8491.0 |
CYP4F2 | -8108.0 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4F12 | -7728.5 |
CYP4B1 | -6651.0 |
CYP4F3 | -4081.0 |
CYP2J2 | -235.0 |
CYP4F22 | 4080.0 |
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP2A7 | -9057.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2F1 | -8491.0 |
CYP4F2 | -8108.0 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4F12 | -7728.5 |
CYP4B1 | -6651.0 |
CYP4F3 | -4081.0 |
CYP2J2 | -235.0 |
CYP4F22 | 4080.0 |
Collagen formation
212 | |
---|---|
set | Collagen formation |
setSize | 80 |
pANOVA | 5.04e-06 |
s.dist | 0.295 |
p.adjustANOVA | 0.00182 |
Top enriched genes
GeneID | Gene Rank |
---|---|
COL1A2 | 8941 |
LOX | 8924 |
LAMC2 | 8913 |
COL17A1 | 8726 |
COL11A2 | 8584 |
COL13A1 | 8432 |
P4HA3 | 8415 |
COL16A1 | 8364 |
LOXL2 | 8342 |
PCOLCE | 8334 |
P4HA2 | 8315 |
SERPINH1 | 8239 |
ADAMTS2 | 8086 |
COL8A2 | 8066 |
COL1A1 | 7952 |
COL9A1 | 7923 |
MMP3 | 7551 |
MMP9 | 7518 |
COL12A1 | 7478 |
ADAMTS3 | 7408 |
GeneID | Gene Rank |
---|---|
COL1A2 | 8941 |
LOX | 8924 |
LAMC2 | 8913 |
COL17A1 | 8726 |
COL11A2 | 8584 |
COL13A1 | 8432 |
P4HA3 | 8415 |
COL16A1 | 8364 |
LOXL2 | 8342 |
PCOLCE | 8334 |
P4HA2 | 8315 |
SERPINH1 | 8239 |
ADAMTS2 | 8086 |
COL8A2 | 8066 |
COL1A1 | 7952 |
COL9A1 | 7923 |
MMP3 | 7551 |
MMP9 | 7518 |
COL12A1 | 7478 |
ADAMTS3 | 7408 |
BMP1 | 7235 |
COL5A1 | 7233 |
COL8A1 | 7168 |
COL2A1 | 7114 |
LOXL1 | 7085 |
PCOLCE2 | 6917 |
PPIB | 6887 |
COL11A1 | 6757 |
LAMB3 | 6421 |
TLL2 | 6245 |
LOXL4 | 6012 |
P3H2 | 5928 |
DST | 5910 |
P4HA1 | 5544 |
COL14A1 | 5203 |
ADAMTS14 | 4789 |
COL6A2 | 4759 |
PLOD3 | 4609 |
TLL1 | 4083 |
MMP20 | 3915 |
COL3A1 | 3907 |
P3H3 | 3882 |
COL26A1 | 3774 |
COL6A1 | 3749 |
COL4A6 | 3630 |
COL23A1 | 3188 |
COL5A2 | 3064 |
CRTAP | 2918 |
MMP7 | 2736 |
CTSS | 2396 |
P3H1 | 2050 |
CD151 | 1741 |
COL27A1 | 951 |
PLOD1 | 638 |
COL19A1 | 452 |
COL4A3 | 385 |
MMP13 | -756 |
COL5A3 | -869 |
COLGALT1 | -898 |
CTSB | -1337 |
LOXL3 | -2045 |
P4HB | -2423 |
COL28A1 | -2995 |
COL4A5 | -3059 |
COL6A6 | -3769 |
COL4A1 | -4472 |
CTSV | -4546 |
COL4A2 | -4819 |
COL18A1 | -5131 |
COL6A5 | -5779 |
ITGA6 | -5895 |
COL15A1 | -6154 |
LAMA3 | -6177 |
ITGB4 | -6853 |
PXDN | -7676 |
COL9A2 | -7743 |
COLGALT2 | -7793 |
PLOD2 | -7959 |
COL25A1 | -8293 |
PLEC | -9079 |
Collagen biosynthesis and modifying enzymes
209 | |
---|---|
set | Collagen biosynthesis and modifying enzymes |
setSize | 58 |
pANOVA | 7.24e-06 |
s.dist | 0.341 |
p.adjustANOVA | 0.0021 |
Top enriched genes
GeneID | Gene Rank |
---|---|
COL1A2 | 8941 |
COL17A1 | 8726 |
COL11A2 | 8584 |
COL13A1 | 8432 |
P4HA3 | 8415 |
COL16A1 | 8364 |
PCOLCE | 8334 |
P4HA2 | 8315 |
SERPINH1 | 8239 |
ADAMTS2 | 8086 |
COL8A2 | 8066 |
COL1A1 | 7952 |
COL9A1 | 7923 |
COL12A1 | 7478 |
ADAMTS3 | 7408 |
BMP1 | 7235 |
COL5A1 | 7233 |
COL8A1 | 7168 |
COL2A1 | 7114 |
PCOLCE2 | 6917 |
GeneID | Gene Rank |
---|---|
COL1A2 | 8941 |
COL17A1 | 8726 |
COL11A2 | 8584 |
COL13A1 | 8432 |
P4HA3 | 8415 |
COL16A1 | 8364 |
PCOLCE | 8334 |
P4HA2 | 8315 |
SERPINH1 | 8239 |
ADAMTS2 | 8086 |
COL8A2 | 8066 |
COL1A1 | 7952 |
COL9A1 | 7923 |
COL12A1 | 7478 |
ADAMTS3 | 7408 |
BMP1 | 7235 |
COL5A1 | 7233 |
COL8A1 | 7168 |
COL2A1 | 7114 |
PCOLCE2 | 6917 |
PPIB | 6887 |
COL11A1 | 6757 |
TLL2 | 6245 |
P3H2 | 5928 |
P4HA1 | 5544 |
COL14A1 | 5203 |
ADAMTS14 | 4789 |
COL6A2 | 4759 |
PLOD3 | 4609 |
TLL1 | 4083 |
COL3A1 | 3907 |
P3H3 | 3882 |
COL26A1 | 3774 |
COL6A1 | 3749 |
COL4A6 | 3630 |
COL23A1 | 3188 |
COL5A2 | 3064 |
CRTAP | 2918 |
P3H1 | 2050 |
COL27A1 | 951 |
PLOD1 | 638 |
COL19A1 | 452 |
COL4A3 | 385 |
COL5A3 | -869 |
COLGALT1 | -898 |
P4HB | -2423 |
COL28A1 | -2995 |
COL4A5 | -3059 |
COL6A6 | -3769 |
COL4A1 | -4472 |
COL4A2 | -4819 |
COL18A1 | -5131 |
COL6A5 | -5779 |
COL15A1 | -6154 |
COL9A2 | -7743 |
COLGALT2 | -7793 |
PLOD2 | -7959 |
COL25A1 | -8293 |
NR1H2 and NR1H3-mediated signaling
751 | |
---|---|
set | NR1H2 and NR1H3-mediated signaling |
setSize | 48 |
pANOVA | 3.3e-05 |
s.dist | -0.346 |
p.adjustANOVA | 0.00797 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PLIN1 | -9007.0 |
APOC1 | -8963.0 |
ABCG1 | -8866.0 |
APOE | -8836.0 |
PCK1 | -8806.0 |
TNRC6B | -8577.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
AGO4 | -8424.0 |
NCOR1 | -8129.0 |
RXRB | -7956.0 |
FASN | -7594.0 |
APOC2 | -7531.5 |
NR1H3 | -7384.0 |
NCOA1 | -6733.0 |
ANGPTL3 | -6400.0 |
EEPD1 | -6385.0 |
ABCA1 | -6097.0 |
AGO1 | -5804.0 |
GPS2 | -5694.0 |
GeneID | Gene Rank |
---|---|
PLIN1 | -9007.0 |
APOC1 | -8963.0 |
ABCG1 | -8866.0 |
APOE | -8836.0 |
PCK1 | -8806.0 |
TNRC6B | -8577.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
AGO4 | -8424.0 |
NCOR1 | -8129.0 |
RXRB | -7956.0 |
FASN | -7594.0 |
APOC2 | -7531.5 |
NR1H3 | -7384.0 |
NCOA1 | -6733.0 |
ANGPTL3 | -6400.0 |
EEPD1 | -6385.0 |
ABCA1 | -6097.0 |
AGO1 | -5804.0 |
GPS2 | -5694.0 |
TNRC6C | -5527.0 |
MIR144 | -5518.0 |
AGO2 | -5246.0 |
RXRA | -5221.0 |
TBL1XR1 | -5183.0 |
MYLIP | -5032.0 |
NR1H2 | -4967.0 |
SREBF1 | -4592.0 |
APOD | -4213.0 |
KDM1B | -3115.0 |
SCD | -2989.0 |
KDM3A | -2751.0 |
ABCG5 | -2445.0 |
FABP6 | -2049.0 |
PLTP | -2003.0 |
APOC4 | -1990.0 |
MIR33A | -1119.0 |
EP300 | 1591.0 |
TBL1X | 1601.5 |
HDAC3 | 5550.0 |
MIR26A1 | 5951.0 |
MOV10 | 6056.0 |
ABCG8 | 6224.0 |
MIR26A2 | 6542.0 |
AGO3 | 7448.0 |
TNRC6A | 7675.0 |
NRIP1 | 8401.0 |
KDM1A | 8614.0 |
Phase I - Functionalization of compounds
870 | |
---|---|
set | Phase I - Functionalization of compounds |
setSize | 91 |
pANOVA | 4.09e-05 |
s.dist | -0.249 |
p.adjustANOVA | 0.00846 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CES2 | -9059.0 |
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
CYB5B | -8813.0 |
CES1 | -8705.0 |
AHRR | -8688.0 |
CYP2F1 | -8491.0 |
CYP46A1 | -8248.0 |
CYP4F2 | -8108.0 |
CYP2C18 | -7923.5 |
ALDH2 | -7822.5 |
GeneID | Gene Rank |
---|---|
CES2 | -9059.0 |
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
CYB5B | -8813.0 |
CES1 | -8705.0 |
AHRR | -8688.0 |
CYP2F1 | -8491.0 |
CYP46A1 | -8248.0 |
CYP4F2 | -8108.0 |
CYP2C18 | -7923.5 |
ALDH2 | -7822.5 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4F12 | -7728.5 |
ACSS1 | -7584.0 |
FMO2 | -7251.0 |
CMBL | -7011.0 |
FMO3 | -6965.0 |
CYP1A2 | -6798.0 |
NCOA1 | -6733.0 |
CYP4B1 | -6651.0 |
MAOA | -6052.0 |
AIP | -5975.0 |
POR | -5945.0 |
CYP26B1 | -5722.0 |
SMOX | -5524.0 |
RXRA | -5221.0 |
NCOA2 | -5184.0 |
CYB5R3 | -5151.0 |
ALDH1B1 | -4681.0 |
CYP24A1 | -4478.0 |
CYP4F3 | -4081.0 |
CYP2W1 | -3941.0 |
ALDH1A1 | -3766.0 |
CYP27B1 | -3689.0 |
MAOB | -3229.0 |
HSP90AB1 | -3151.0 |
EPHX1 | -2961.0 |
CYP4V2 | -2726.0 |
ADH7 | -2536.0 |
ACSS2 | -2133.0 |
PAOX | -1652.5 |
CYP2S1 | -1638.0 |
CBR3 | -1562.5 |
CYP2R1 | -1234.0 |
CYP2J2 | -235.0 |
CYP1A1 | 359.0 |
AADAC | 480.0 |
AOC3 | 784.0 |
CYP51A1 | 1117.0 |
CYP27A1 | 1302.0 |
CYP8B1 | 1456.0 |
AOC1 | 1466.0 |
ARNT2 | 1509.0 |
CYP19A1 | 1797.0 |
CYP21A2 | 2301.0 |
CYP2U1 | 2375.0 |
ADH5 | 2725.0 |
AHR | 2943.5 |
CYP7A1 | 3065.0 |
POMC | 3261.0 |
CYP4F22 | 4080.0 |
MTARC2 | 4279.0 |
PTGES3 | 4369.0 |
FDX2 | 4488.5 |
FDX1 | 4538.0 |
NR1H4 | 4600.0 |
BPHL | 4818.0 |
ALDH3A1 | 4826.0 |
PTGS1 | 4865.0 |
CYP7B1 | 4950.0 |
MTARC1 | 5152.5 |
FMO1 | 5603.0 |
TBXAS1 | 5711.0 |
CYP26A1 | 5725.0 |
CYP39A1 | 6053.0 |
CYP11A1 | 6250.0 |
NQO2 | 6527.0 |
CYP26C1 | 7324.0 |
CYP1B1 | 8673.0 |
PTGIS | 8898.0 |
Translation
1345 | |
---|---|
set | Translation |
setSize | 262 |
pANOVA | 5.52e-05 |
s.dist | 0.145 |
p.adjustANOVA | 0.00999 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL13A | 8957 |
RPL3 | 8943 |
MRPS14 | 8926 |
RPS15A | 8920 |
RPL29 | 8919 |
RPS16 | 8907 |
RPL6 | 8889 |
MRPS24 | 8562 |
MRPL1 | 8558 |
MRPS28 | 8557 |
MRPS18B | 8556 |
MRPL36 | 8464 |
SSR2 | 8391 |
TRAM1 | 8349 |
PTCD3 | 8263 |
NARS1 | 8198 |
EIF3E | 8145 |
MARS2 | 8097 |
PPA2 | 8059 |
RPL37 | 8039 |
GeneID | Gene Rank |
---|---|
RPL13A | 8957.0 |
RPL3 | 8943.0 |
MRPS14 | 8926.0 |
RPS15A | 8920.0 |
RPL29 | 8919.0 |
RPS16 | 8907.0 |
RPL6 | 8889.0 |
MRPS24 | 8562.0 |
MRPL1 | 8558.0 |
MRPS28 | 8557.0 |
MRPS18B | 8556.0 |
MRPL36 | 8464.0 |
SSR2 | 8391.0 |
TRAM1 | 8349.0 |
PTCD3 | 8263.0 |
NARS1 | 8198.0 |
EIF3E | 8145.0 |
MARS2 | 8097.0 |
PPA2 | 8059.0 |
RPL37 | 8039.0 |
SRP9 | 7935.0 |
NARS2 | 7888.0 |
DAP3 | 7885.0 |
EIF2B1 | 7876.0 |
EPRS1 | 7828.0 |
TARS1 | 7731.0 |
GARS1 | 7641.0 |
MRPS35 | 7617.0 |
CHCHD1 | 7563.0 |
HARS2 | 7559.0 |
PARS2 | 7528.0 |
RPL30 | 7370.0 |
RPS27A | 7369.0 |
IARS1 | 7272.0 |
PPA1 | 7256.0 |
MRPL2 | 7250.0 |
RPL7A | 7100.0 |
RPS23 | 7033.0 |
MRPL17 | 7018.0 |
SEC61A1 | 6972.0 |
MRPL14 | 6867.0 |
WARS1 | 6861.0 |
HARS1 | 6860.0 |
EIF4A2 | 6640.0 |
RPS18 | 6557.0 |
RPLP2 | 6538.0 |
RPL10L | 6517.0 |
EARS2 | 6509.0 |
RPS15 | 6242.0 |
RPS5 | 6228.0 |
AIMP1 | 6191.0 |
MRPL24 | 6176.0 |
MRPL42 | 6072.0 |
EEF1E1 | 5978.5 |
RPL22 | 5939.0 |
MRPL45 | 5839.0 |
MRPS2 | 5800.0 |
RPS14 | 5784.0 |
RPL31 | 5673.0 |
MRPL50 | 5621.0 |
SRP72 | 5465.0 |
SSR4 | 5408.0 |
MRPL40 | 5368.0 |
RPN2 | 5298.0 |
RPS26 | 5195.0 |
EIF2S1 | 5177.0 |
MRPL22 | 5146.0 |
MTIF3 | 5074.0 |
MRPL46 | 4943.0 |
GSPT1 | 4905.0 |
RPL9 | 4882.0 |
CARS1 | 4806.0 |
RPS3A | 4794.0 |
EEF1A1 | 4762.0 |
MRPL20 | 4603.0 |
MRPL47 | 4579.0 |
MRPS33 | 4506.0 |
RPL19 | 4494.0 |
MRPL12 | 4269.0 |
MRPS9 | 4258.0 |
MARS1 | 4257.0 |
RPL5 | 4255.0 |
RPS21 | 4017.0 |
DARS1 | 3988.0 |
GADD45GIP1 | 3958.0 |
MRPS6 | 3955.0 |
MRPL44 | 3931.0 |
MRPL3 | 3905.0 |
EEF1B2 | 3903.0 |
SSR3 | 3879.0 |
EIF2S2 | 3845.0 |
MRPL11 | 3798.0 |
MRPL13 | 3789.0 |
RPS13 | 3688.0 |
MRPL35 | 3604.0 |
EIF5 | 3580.0 |
EIF1AX | 3548.0 |
MRPL32 | 3475.0 |
RPS8 | 3383.0 |
MRPL18 | 3358.0 |
MRPL10 | 3267.0 |
MRPL33 | 3221.0 |
MRPL43 | 3190.0 |
RPS28 | 3175.0 |
AIMP2 | 3169.0 |
RPL7 | 3151.0 |
EIF2B3 | 3068.0 |
SEC61B | 3048.0 |
RARS2 | 3043.0 |
SRP19 | 2991.0 |
RPL27 | 2912.0 |
RPL18 | 2790.0 |
LARS2 | 2718.0 |
EIF2B2 | 2716.0 |
RPS3 | 2715.0 |
GSPT2 | 2691.0 |
MRPL52 | 2647.0 |
MRPS18C | 2564.0 |
RPS4X | 2555.0 |
MRPS16 | 2548.0 |
MRPL19 | 2510.0 |
RPS11 | 2321.0 |
EIF3J | 2169.0 |
EIF4A1 | 2154.0 |
DDOST | 2136.0 |
MRPL27 | 2126.0 |
RPS19 | 2111.0 |
RPL37A | 2071.0 |
FARSA | 1906.0 |
SEC11A | 1883.0 |
MRPS23 | 1674.0 |
APEH | 1541.0 |
SPCS2 | 1359.0 |
RPL36 | 1297.0 |
EIF3C | 1287.5 |
EIF3B | 1269.0 |
MTIF2 | 1252.0 |
MRPL21 | 1230.0 |
MRPL15 | 1187.0 |
YARS1 | 1102.0 |
FARS2 | 980.0 |
SPCS3 | 834.0 |
GFM2 | 816.0 |
LARS1 | 795.0 |
MRPL55 | 741.0 |
RPL10A | 667.0 |
KARS1 | 648.0 |
MRPL53 | 586.0 |
MRPL49 | 582.0 |
SRPRA | 471.0 |
MRPL54 | 450.0 |
MRPL39 | 395.0 |
MRPS31 | 362.0 |
RPL11 | 231.0 |
RPL21 | 231.0 |
EIF2S3 | 137.5 |
MRPS30 | 45.0 |
EIF4E | 41.0 |
ETF1 | -32.0 |
MRPS34 | -44.0 |
MRPS5 | -53.0 |
TUFM | -107.0 |
MRPS7 | -161.0 |
SRP54 | -175.0 |
SEC11C | -221.0 |
RPS25 | -242.0 |
MRPS15 | -371.0 |
EIF2B4 | -372.0 |
RARS1 | -424.0 |
MRPS12 | -431.0 |
EEF1G | -647.0 |
RPLP1 | -660.0 |
MRPS11 | -799.0 |
EIF3M | -835.0 |
SRPRB | -853.0 |
EEF1A2 | -854.0 |
MRPS26 | -888.0 |
YARS2 | -1090.0 |
MRPL48 | -1212.0 |
MRPS22 | -1452.0 |
MRPL9 | -1492.0 |
RPSA | -1493.0 |
FARSB | -1497.0 |
RPS2 | -1703.0 |
MRPS18A | -1837.0 |
RPS17 | -1958.0 |
RPS10 | -1984.5 |
RPL23 | -2023.0 |
RPL18A | -2151.0 |
RPS7 | -2157.0 |
UBA52 | -2166.0 |
MRPL16 | -2312.0 |
RPN1 | -2344.0 |
EIF4H | -2444.0 |
MRPS10 | -2682.0 |
MRPS27 | -2810.0 |
SEC61G | -2848.0 |
EEF1D | -2901.0 |
MRPL58 | -3023.0 |
RPS27L | -3093.0 |
RPL35 | -3206.0 |
IARS2 | -3217.0 |
RPL24 | -3268.0 |
MRPS25 | -3279.0 |
RPL28 | -3293.0 |
EIF3L | -3353.0 |
EIF3F | -3615.0 |
MTFMT | -3773.0 |
EIF5B | -3801.0 |
MRPL28 | -3922.0 |
SPCS1 | -3937.0 |
EIF3D | -4062.0 |
SRP68 | -4122.0 |
MRPL38 | -4142.0 |
RPL8 | -4167.0 |
OXA1L | -4251.0 |
EEF2 | -4255.0 |
MRPL34 | -4385.0 |
MRPL41 | -4451.0 |
MRPL30 | -4489.5 |
TRMT112 | -4639.0 |
EIF3A | -4675.0 |
MRPL4 | -4800.0 |
DARS2 | -4831.0 |
N6AMT1 | -4864.0 |
MRRF | -4989.0 |
TSFM | -5028.0 |
VARS1 | -5052.0 |
AARS1 | -5067.0 |
EIF3G | -5370.0 |
SEC61A2 | -5387.0 |
EIF3H | -5607.0 |
SARS1 | -5612.0 |
GFM1 | -5626.0 |
RPL38 | -5629.0 |
ERAL1 | -5635.0 |
SRP14 | -5681.0 |
EIF2B5 | -5686.0 |
RPS6 | -5720.0 |
SARS2 | -5926.5 |
MRPS21 | -6064.0 |
RPL15 | -6128.0 |
TARS2 | -6151.0 |
MTRF1L | -6305.0 |
MRPS36 | -6427.0 |
AARS2 | -6494.0 |
EIF4EBP1 | -6644.0 |
RPL23A | -6843.0 |
MRPL51 | -6884.0 |
WARS2 | -7035.0 |
RPL3L | -7058.0 |
RPL13 | -7209.0 |
MRPL37 | -7284.0 |
VARS2 | -7367.0 |
SSR1 | -7497.0 |
RPS9 | -7535.0 |
MRPS17 | -7874.5 |
EIF3K | -8130.0 |
CARS2 | -8624.0 |
FAU | -8625.0 |
EIF4G1 | -8658.0 |
RPL35A | -8900.0 |
Interferon alpha/beta signaling
586 | |
---|---|
set | Interferon alpha/beta signaling |
setSize | 63 |
pANOVA | 7.04e-05 |
s.dist | -0.29 |
p.adjustANOVA | 0.0107 |
Top enriched genes
GeneID | Gene Rank |
---|---|
OAS1 | -9078.0 |
IP6K2 | -8814.0 |
IRF5 | -8770.0 |
OAS3 | -8197.0 |
HLA-A | -8118.5 |
HLA-B | -8118.5 |
HLA-C | -8118.5 |
HLA-E | -8118.5 |
HLA-F | -8118.5 |
HLA-G | -8118.5 |
MX1 | -7569.0 |
IFNAR1 | -7388.0 |
IFIT3 | -7329.0 |
RSAD2 | -7050.0 |
USP18 | -6844.5 |
STAT2 | -6464.0 |
IRF6 | -5882.0 |
IFITM1 | -5649.0 |
IFITM2 | -5649.0 |
IFITM3 | -5649.0 |
GeneID | Gene Rank |
---|---|
OAS1 | -9078.0 |
IP6K2 | -8814.0 |
IRF5 | -8770.0 |
OAS3 | -8197.0 |
HLA-A | -8118.5 |
HLA-B | -8118.5 |
HLA-C | -8118.5 |
HLA-E | -8118.5 |
HLA-F | -8118.5 |
HLA-G | -8118.5 |
MX1 | -7569.0 |
IFNAR1 | -7388.0 |
IFIT3 | -7329.0 |
RSAD2 | -7050.0 |
USP18 | -6844.5 |
STAT2 | -6464.0 |
IRF6 | -5882.0 |
IFITM1 | -5649.0 |
IFITM2 | -5649.0 |
IFITM3 | -5649.0 |
JAK1 | -5621.0 |
IFNA1 | -5355.0 |
IFNA10 | -5355.0 |
IFNA14 | -5355.0 |
IFNA16 | -5355.0 |
IFNA17 | -5355.0 |
IFNA2 | -5355.0 |
IFNA21 | -5355.0 |
IFNA4 | -5355.0 |
IFNA5 | -5355.0 |
IFNA6 | -5355.0 |
IFNA7 | -5355.0 |
IFNA8 | -5355.0 |
ISG20 | -5075.0 |
IRF1 | -4752.0 |
IRF7 | -4727.0 |
BST2 | -4688.0 |
IRF9 | -4680.0 |
ADAR | -4323.0 |
GBP2 | -3613.0 |
IRF3 | -3543.0 |
IFIT2 | -3196.0 |
IFNAR2 | -3030.0 |
TYK2 | -2663.0 |
IRF8 | -2275.0 |
OASL | -2132.0 |
ISG15 | 1321.0 |
EGR1 | 3598.0 |
PTPN11 | 3701.0 |
IFI35 | 3793.0 |
SOCS3 | 3999.0 |
PTPN6 | 4670.0 |
ABCE1 | 4834.0 |
IRF2 | 5903.0 |
IRF4 | 6589.0 |
PTPN1 | 6830.0 |
SOCS1 | 6890.0 |
OAS2 | 7501.0 |
XAF1 | 7601.0 |
RNASEL | 7612.0 |
PSMB8 | 7643.0 |
STAT1 | 8658.0 |
SAMHD1 | 8677.0 |
Biological oxidations
119 | |
---|---|
set | Biological oxidations |
setSize | 176 |
pANOVA | 7.41e-05 |
s.dist | -0.173 |
p.adjustANOVA | 0.0107 |
Top enriched genes
GeneID | Gene Rank |
---|---|
UGT1A1 | -9062.0 |
CES2 | -9059.0 |
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
SULT2A1 | -9051.0 |
GSTM2 | -9046.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
SULT1C2 | -8909.0 |
CYB5B | -8813.0 |
MAT1A | -8783.0 |
GSTA5 | -8728.0 |
CES1 | -8705.0 |
GeneID | Gene Rank |
---|---|
UGT1A1 | -9062.0 |
CES2 | -9059.0 |
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
SULT2A1 | -9051.0 |
GSTM2 | -9046.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
SULT1C2 | -8909.0 |
CYB5B | -8813.0 |
MAT1A | -8783.0 |
GSTA5 | -8728.0 |
CES1 | -8705.0 |
GSTZ1 | -8695.0 |
AHRR | -8688.0 |
GSTT2 | -8637.5 |
GSTT2B | -8637.5 |
UGT2A3 | -8632.0 |
CYP2F1 | -8491.0 |
SULT1E1 | -8483.5 |
DPEP1 | -8348.0 |
CYP46A1 | -8248.0 |
MGST1 | -8188.0 |
CYP4F2 | -8108.0 |
GSTM1 | -8025.0 |
GGT6 | -7974.0 |
CYP2C18 | -7923.5 |
ALDH2 | -7822.5 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4F12 | -7728.5 |
SLC35B3 | -7717.0 |
AKR7L | -7680.0 |
ACSS1 | -7584.0 |
MTRR | -7315.0 |
FMO2 | -7251.0 |
AKR7A3 | -7174.0 |
GSTP1 | -7158.0 |
ABHD14B | -7139.0 |
CMBL | -7011.0 |
FMO3 | -6965.0 |
CYP1A2 | -6798.0 |
NCOA1 | -6733.0 |
CYP4B1 | -6651.0 |
ACSM5 | -6562.0 |
COMT | -6362.0 |
MAOA | -6052.0 |
ACSM4 | -6045.0 |
AIP | -5975.0 |
POR | -5945.0 |
GGT5 | -5861.0 |
CYP26B1 | -5722.0 |
SMOX | -5524.0 |
RXRA | -5221.0 |
NCOA2 | -5184.0 |
CYB5R3 | -5151.0 |
GSTM3 | -5144.0 |
MTR | -5111.0 |
DPEP2 | -4879.0 |
N6AMT1 | -4864.0 |
SLC26A1 | -4701.0 |
ALDH1B1 | -4681.0 |
TRMT112 | -4639.0 |
CYP24A1 | -4478.0 |
CYP4F3 | -4081.0 |
CYP2W1 | -3941.0 |
SLC26A2 | -3919.0 |
ALDH1A1 | -3766.0 |
CYP27B1 | -3689.0 |
AHCY | -3314.0 |
GGT7 | -3254.0 |
PODXL2 | -3241.0 |
MAOB | -3229.0 |
GSTK1 | -3187.0 |
CHAC1 | -3179.0 |
HSP90AB1 | -3151.0 |
EPHX1 | -2961.0 |
SLC35D1 | -2880.0 |
CYP4V2 | -2726.0 |
ADH7 | -2536.0 |
ESD | -2500.0 |
SULT1A3 | -2333.5 |
SULT1A4 | -2333.5 |
ACSS2 | -2133.0 |
AS3MT | -1670.0 |
PAOX | -1652.5 |
CYP2S1 | -1638.0 |
CBR3 | -1562.5 |
GSS | -1324.0 |
CYP2R1 | -1234.0 |
AKR1A1 | -841.0 |
GSTO2 | -624.0 |
UGT3A2 | -338.5 |
CYP2J2 | -235.0 |
GGCT | -62.5 |
BPNT1 | 105.0 |
ACY1 | 106.5 |
CYP1A1 | 359.0 |
AADAC | 480.0 |
GGT1 | 592.0 |
SULT1A1 | 746.0 |
SULT1A2 | 746.0 |
AOC3 | 784.0 |
GCLC | 786.0 |
CYP51A1 | 1117.0 |
SULT6B1 | 1206.0 |
CYP27A1 | 1302.0 |
CYP8B1 | 1456.0 |
AOC1 | 1466.0 |
ARNT2 | 1509.0 |
CYP19A1 | 1797.0 |
CYP21A2 | 2301.0 |
MGST2 | 2307.0 |
CYP2U1 | 2375.0 |
HPGDS | 2411.0 |
TPST2 | 2499.0 |
ADH5 | 2725.0 |
AHR | 2943.5 |
CYP7A1 | 3065.0 |
ACY3 | 3112.0 |
POMC | 3261.0 |
GSTM4 | 3592.0 |
NAT1 | 3626.5 |
NAT2 | 3626.5 |
CYP4F22 | 4080.0 |
SULT1B1 | 4254.0 |
MTARC2 | 4279.0 |
PAPSS1 | 4326.0 |
PTGES3 | 4369.0 |
FDX2 | 4488.5 |
FDX1 | 4538.0 |
NR1H4 | 4600.0 |
SULT4A1 | 4631.0 |
MGST3 | 4742.0 |
BPHL | 4818.0 |
ALDH3A1 | 4826.0 |
PTGS1 | 4865.0 |
CYP7B1 | 4950.0 |
MTARC1 | 5152.5 |
PAPSS2 | 5409.0 |
FMO1 | 5603.0 |
SLC35B2 | 5607.0 |
TBXAS1 | 5711.0 |
CYP26A1 | 5725.0 |
CNDP2 | 6042.0 |
CYP39A1 | 6053.0 |
UGP2 | 6062.0 |
UGDH | 6178.0 |
CYP11A1 | 6250.0 |
CHAC2 | 6274.0 |
NQO2 | 6527.0 |
ACSM1 | 6711.0 |
GLYAT | 6865.0 |
MAT2A | 6915.0 |
GCLM | 6937.0 |
DPEP3 | 7176.0 |
OPLAH | 7290.0 |
CYP26C1 | 7324.0 |
NNMT | 7566.0 |
TPMT | 8205.0 |
MAT2B | 8229.0 |
GSTO1 | 8455.0 |
SULT2B1 | 8608.0 |
CYP1B1 | 8673.0 |
BPNT2 | 8715.0 |
TPST1 | 8787.0 |
ABHD10 | 8844.0 |
PTGIS | 8898.0 |
Assembly of active LPL and LIPC lipase complexes
96 | |
---|---|
set | Assembly of active LPL and LIPC lipase complexes |
setSize | 19 |
pANOVA | 0.000116 |
s.dist | -0.511 |
p.adjustANOVA | 0.0152 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CIDEC | -8897.0 |
MBTPS2 | -8761.0 |
APOA5 | -8466.0 |
MBTPS1 | -7804.0 |
APOC2 | -7531.5 |
CREB3L3 | -7263.0 |
APOA4 | -6758.0 |
ANGPTL3 | -6400.0 |
FURIN | -6399.0 |
ANGPTL4 | -6243.0 |
LIPC | -5932.0 |
LMF2 | -5317.0 |
FGF21 | -5116.0 |
ANGPTL8 | -4094.0 |
GPIHBP1 | -3404.0 |
LPL | -2467.0 |
PCSK5 | 3308.0 |
PCSK6 | 4262.0 |
LMF1 | 4677.0 |
GeneID | Gene Rank |
---|---|
CIDEC | -8897.0 |
MBTPS2 | -8761.0 |
APOA5 | -8466.0 |
MBTPS1 | -7804.0 |
APOC2 | -7531.5 |
CREB3L3 | -7263.0 |
APOA4 | -6758.0 |
ANGPTL3 | -6400.0 |
FURIN | -6399.0 |
ANGPTL4 | -6243.0 |
LIPC | -5932.0 |
LMF2 | -5317.0 |
FGF21 | -5116.0 |
ANGPTL8 | -4094.0 |
GPIHBP1 | -3404.0 |
LPL | -2467.0 |
PCSK5 | 3308.0 |
PCSK6 | 4262.0 |
LMF1 | 4677.0 |
Cell death signalling via NRAGE, NRIF and NADE
169 | |
---|---|
set | Cell death signalling via NRAGE, NRIF and NADE |
setSize | 72 |
pANOVA | 0.000242 |
s.dist | -0.25 |
p.adjustANOVA | 0.0292 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834 |
ARHGEF1 | -8718 |
OBSCN | -8574 |
ARHGEF7 | -8534 |
PLEKHG5 | -8454 |
ITSN1 | -8377 |
MAGED1 | -8312 |
ARHGEF11 | -8287 |
NCSTN | -8213 |
NGFR | -8192 |
ARHGEF40 | -7699 |
MCF2 | -7686 |
ARHGEF16 | -7667 |
ABR | -7655 |
MCF2L | -7517 |
ARHGEF5 | -7293 |
PLEKHG2 | -7206 |
VAV3 | -7088 |
ARHGEF17 | -6885 |
ARHGEF10L | -6624 |
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834.0 |
ARHGEF1 | -8718.0 |
OBSCN | -8574.0 |
ARHGEF7 | -8534.0 |
PLEKHG5 | -8454.0 |
ITSN1 | -8377.0 |
MAGED1 | -8312.0 |
ARHGEF11 | -8287.0 |
NCSTN | -8213.0 |
NGFR | -8192.0 |
ARHGEF40 | -7699.0 |
MCF2 | -7686.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
MCF2L | -7517.0 |
ARHGEF5 | -7293.0 |
PLEKHG2 | -7206.0 |
VAV3 | -7088.0 |
ARHGEF17 | -6885.0 |
ARHGEF10L | -6624.0 |
UBC | -6432.0 |
APH1B | -6387.0 |
TRIO | -6348.0 |
BCL2L11 | -6346.0 |
FGD4 | -6196.0 |
FGD1 | -5982.0 |
YWHAE | -5754.0 |
ARHGEF19 | -5545.0 |
SQSTM1 | -5320.0 |
ARHGEF6 | -5311.0 |
CASP2 | -5200.0 |
AKAP13 | -5190.0 |
NET1 | -4984.0 |
NGEF | -4851.0 |
ARHGEF38 | -4562.0 |
CASP3 | -4363.0 |
BEX3 | -3892.0 |
PSEN1 | -3548.0 |
PREX1 | -3045.0 |
SOS1 | -2808.0 |
ARHGEF18 | -2547.5 |
TRAF6 | -2185.0 |
AATF | -2176.0 |
PSEN2 | -2171.5 |
UBA52 | -2166.0 |
PSENEN | -1907.0 |
ARHGEF39 | -1272.0 |
ARHGEF10 | -775.0 |
ARHGEF15 | -470.0 |
ARHGEF33 | -451.0 |
KALRN | -177.0 |
BAD | 928.0 |
APH1A | 1110.0 |
VAV1 | 1912.0 |
RAC1 | 2240.0 |
NGF | 2470.0 |
FGD2 | 4170.0 |
ITGB3BP | 4443.0 |
TIAM2 | 4841.0 |
RASGRF2 | 5220.0 |
GNA13 | 5282.0 |
VAV2 | 5813.0 |
MAPK8 | 5956.0 |
ARHGEF12 | 6104.0 |
FGD3 | 6255.0 |
TIAM1 | 6942.0 |
ECT2 | 7350.0 |
RPS27A | 7369.0 |
ARHGEF3 | 7632.0 |
SOS2 | 7658.0 |
ARHGEF2 | 7980.0 |
ARHGEF26 | 8302.0 |
Cell junction organization
170 | |
---|---|
set | Cell junction organization |
setSize | 85 |
pANOVA | 0.000301 |
s.dist | -0.227 |
p.adjustANOVA | 0.0314 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PLEC | -9079.0 |
PXN | -9019.0 |
CLDN10 | -8984.0 |
CLDN2 | -8877.0 |
SDK2 | -8789.0 |
FERMT2 | -8675.0 |
CDH4 | -8642.0 |
PARVB | -8581.0 |
NECTIN2 | -8501.0 |
FBLIM1 | -8331.0 |
JUP | -8056.0 |
CDH5 | -8036.0 |
FLNC | -8034.0 |
CLDN7 | -7969.5 |
CLDN14 | -7884.0 |
PARD3 | -7779.0 |
VASP | -7621.0 |
ANG | -7566.0 |
CDH13 | -7131.0 |
CLDN9 | -7005.0 |
GeneID | Gene Rank |
---|---|
PLEC | -9079.0 |
PXN | -9019.0 |
CLDN10 | -8984.0 |
CLDN2 | -8877.0 |
SDK2 | -8789.0 |
FERMT2 | -8675.0 |
CDH4 | -8642.0 |
PARVB | -8581.0 |
NECTIN2 | -8501.0 |
FBLIM1 | -8331.0 |
JUP | -8056.0 |
CDH5 | -8036.0 |
FLNC | -8034.0 |
CLDN7 | -7969.5 |
CLDN14 | -7884.0 |
PARD3 | -7779.0 |
VASP | -7621.0 |
ANG | -7566.0 |
CDH13 | -7131.0 |
CLDN9 | -7005.0 |
ITGB4 | -6853.0 |
CDH9 | -6602.0 |
TESK1 | -6401.0 |
PATJ | -6367.0 |
PARD6G | -6344.0 |
CLDN1 | -6211.0 |
LAMA3 | -6177.0 |
CLDN4 | -6023.0 |
CTNND1 | -6002.0 |
LIMS1 | -5950.0 |
ITGA6 | -5895.0 |
NECTIN1 | -5893.0 |
CLDN3 | -5590.0 |
PARD6B | -5450.0 |
ARHGEF6 | -5311.0 |
CRB3 | -5128.0 |
CLDN23 | -5078.0 |
CDH15 | -4795.0 |
CDH17 | -4741.0 |
CTNNA1 | -4715.0 |
CDH1 | -4511.0 |
CDH12 | -4207.0 |
F11R | -3912.0 |
LIMS2 | -3484.0 |
CDH10 | -3034.0 |
AFDN | -2352.0 |
CLDN19 | -2269.0 |
CLDN8 | -2194.0 |
PRKCI | -2165.0 |
NECTIN4 | -2014.0 |
CLDN16 | -1562.5 |
CDH8 | -850.0 |
CLDN18 | -282.0 |
CADM2 | 70.0 |
CLDN11 | 725.0 |
CDH3 | 1031.0 |
ACTN1 | 1114.0 |
CD151 | 1741.0 |
CTNNB1 | 1809.0 |
ILK | 1817.0 |
PVR | 2238.0 |
CDH24 | 2287.0 |
CDH18 | 2439.0 |
ITGB1 | 2469.0 |
RSU1 | 2530.0 |
FLNA | 2688.0 |
PARVA | 3142.0 |
CLDN20 | 3374.0 |
CLDN15 | 3865.0 |
MPP5 | 3925.0 |
CDH11 | 4613.0 |
CLDN5 | 4896.0 |
CDH6 | 5171.0 |
CDH2 | 5589.0 |
DST | 5910.0 |
CLDN12 | 5952.0 |
CLDN6 | 6032.0 |
PARD6A | 6114.0 |
CDH7 | 6360.0 |
LAMB3 | 6421.0 |
NECTIN3 | 6461.0 |
CADM3 | 7556.0 |
CADM1 | 8716.0 |
COL17A1 | 8726.0 |
LAMC2 | 8913.0 |
Sulfur amino acid metabolism
1231 | |
---|---|
set | Sulfur amino acid metabolism |
setSize | 25 |
pANOVA | 0.000303 |
s.dist | -0.417 |
p.adjustANOVA | 0.0314 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MAT1A | -8783.0 |
CDO1 | -8662.0 |
CBS | -8643.5 |
CBSL | -8643.5 |
CSAD | -8554.0 |
BHMT | -8229.0 |
APIP | -8053.0 |
BHMT2 | -8052.0 |
MTRR | -7315.0 |
MPST | -6695.0 |
MRI1 | -5775.0 |
CTH | -5465.0 |
MTR | -5111.0 |
TST | -3834.0 |
SUOX | -3648.0 |
AHCY | -3314.0 |
ADI1 | -3222.0 |
TXN2 | -1312.0 |
ENOPH1 | -504.0 |
SLC25A10 | 1159.5 |
GeneID | Gene Rank |
---|---|
MAT1A | -8783.0 |
CDO1 | -8662.0 |
CBS | -8643.5 |
CBSL | -8643.5 |
CSAD | -8554.0 |
BHMT | -8229.0 |
APIP | -8053.0 |
BHMT2 | -8052.0 |
MTRR | -7315.0 |
MPST | -6695.0 |
MRI1 | -5775.0 |
CTH | -5465.0 |
MTR | -5111.0 |
TST | -3834.0 |
SUOX | -3648.0 |
AHCY | -3314.0 |
ADI1 | -3222.0 |
TXN2 | -1312.0 |
ENOPH1 | -504.0 |
SLC25A10 | 1159.5 |
GOT2 | 2252.0 |
TSTD1 | 2351.0 |
ETHE1 | 2775.0 |
MTAP | 4294.5 |
GOT1 | 5480.0 |
Phenylalanine and tyrosine metabolism
872 | |
---|---|
set | Phenylalanine and tyrosine metabolism |
setSize | 11 |
pANOVA | 0.000355 |
s.dist | -0.622 |
p.adjustANOVA | 0.0336 |
Top enriched genes
GeneID | Gene Rank |
---|---|
IL4I1 | -8943.0 |
GSTZ1 | -8695.0 |
PAH | -8599.0 |
HPD | -8142.0 |
HGD | -7311.0 |
FAH | -6438.0 |
QDPR | -5654.0 |
PCBD1 | -5138.0 |
ASRGL1 | -4963.0 |
TAT | -1127.0 |
KYAT1 | 2675.5 |
GeneID | Gene Rank |
---|---|
IL4I1 | -8943.0 |
GSTZ1 | -8695.0 |
PAH | -8599.0 |
HPD | -8142.0 |
HGD | -7311.0 |
FAH | -6438.0 |
QDPR | -5654.0 |
PCBD1 | -5138.0 |
ASRGL1 | -4963.0 |
TAT | -1127.0 |
KYAT1 | 2675.5 |
Extracellular matrix organization
382 | |
---|---|
set | Extracellular matrix organization |
setSize | 274 |
pANOVA | 0.000372 |
s.dist | 0.125 |
p.adjustANOVA | 0.0336 |
Top enriched genes
GeneID | Gene Rank |
---|---|
COL1A2 | 8941 |
LOX | 8924 |
LAMC2 | 8913 |
COMP | 8906 |
DDR1 | 8892 |
TGFB2 | 8828 |
VCAM1 | 8798 |
EFEMP2 | 8730 |
COL17A1 | 8726 |
THBS1 | 8627 |
COL11A2 | 8584 |
NRXN1 | 8487 |
COL13A1 | 8432 |
GDF5 | 8430 |
P4HA3 | 8415 |
LAMA2 | 8370 |
COL16A1 | 8364 |
LOXL2 | 8342 |
PCOLCE | 8334 |
NCAN | 8319 |
GeneID | Gene Rank |
---|---|
COL1A2 | 8941.0 |
LOX | 8924.0 |
LAMC2 | 8913.0 |
COMP | 8906.0 |
DDR1 | 8892.0 |
TGFB2 | 8828.0 |
VCAM1 | 8798.0 |
EFEMP2 | 8730.0 |
COL17A1 | 8726.0 |
THBS1 | 8627.0 |
COL11A2 | 8584.0 |
NRXN1 | 8487.0 |
COL13A1 | 8432.0 |
GDF5 | 8430.0 |
P4HA3 | 8415.0 |
LAMA2 | 8370.0 |
COL16A1 | 8364.0 |
LOXL2 | 8342.0 |
PCOLCE | 8334.0 |
NCAN | 8319.0 |
P4HA2 | 8315.0 |
SERPINH1 | 8239.0 |
ASPN | 8232.0 |
HTRA1 | 8144.0 |
TRAPPC4 | 8123.0 |
ADAMTS2 | 8086.0 |
COL8A2 | 8066.0 |
ITGA2 | 8050.0 |
COL1A1 | 7952.0 |
CAST | 7947.0 |
CD47 | 7939.0 |
COL9A1 | 7923.0 |
IBSP | 7884.0 |
PHYKPL | 7845.0 |
VCAN | 7807.0 |
DCN | 7802.0 |
FMOD | 7779.0 |
ITGA9 | 7572.0 |
MMP3 | 7551.0 |
MMP2 | 7540.0 |
MMP9 | 7518.0 |
TNC | 7516.0 |
MATN4 | 7494.0 |
COL12A1 | 7478.0 |
DMD | 7463.0 |
MFAP5 | 7417.0 |
ADAMTS3 | 7408.0 |
OPTC | 7380.0 |
SDC1 | 7316.0 |
BMP1 | 7235.0 |
COL5A1 | 7233.0 |
MMP16 | 7188.0 |
COL8A1 | 7168.0 |
COL2A1 | 7114.0 |
LOXL1 | 7085.0 |
FBLN5 | 7064.0 |
ACAN | 7037.0 |
PCOLCE2 | 6917.0 |
FN1 | 6913.0 |
PPIB | 6887.0 |
CTSK | 6859.0 |
COL11A1 | 6757.0 |
TIMP2 | 6680.0 |
LTBP1 | 6514.0 |
CASK | 6499.0 |
SDC2 | 6449.0 |
BSG | 6428.0 |
LAMB3 | 6421.0 |
CMA1 | 6414.0 |
ADAM9 | 6383.0 |
CAPN8 | 6351.0 |
BMP2 | 6309.0 |
CD44 | 6282.0 |
ADAMTS8 | 6254.0 |
TLL2 | 6245.0 |
LTBP2 | 6149.0 |
DDR2 | 6135.0 |
SPARC | 6116.0 |
ITGA11 | 6092.0 |
LOXL4 | 6012.0 |
TNN | 5931.0 |
P3H2 | 5928.0 |
DST | 5910.0 |
FBN1 | 5838.0 |
BGN | 5787.0 |
HAPLN1 | 5604.0 |
P4HA1 | 5544.0 |
COL14A1 | 5203.0 |
MFAP2 | 5009.0 |
FBN2 | 5007.0 |
ADAM19 | 4993.0 |
CAPN6 | 4958.0 |
MFAP4 | 4885.0 |
ADAMTS14 | 4789.0 |
COL6A2 | 4759.0 |
LAMA1 | 4727.0 |
PLOD3 | 4609.0 |
NTN4 | 4587.0 |
ICAM4 | 4394.0 |
MATN3 | 4328.0 |
BMP4 | 4187.0 |
ITGA7 | 4112.0 |
TLL1 | 4083.0 |
MMP20 | 3915.0 |
COL3A1 | 3907.0 |
P3H3 | 3882.0 |
ICAM5 | 3799.0 |
COL26A1 | 3774.0 |
ADAMTS9 | 3756.0 |
COL6A1 | 3749.0 |
ADAMTS5 | 3692.0 |
COL4A6 | 3630.0 |
ADAMTS16 | 3486.0 |
CTRB1 | 3316.5 |
CTRB2 | 3316.5 |
COL23A1 | 3188.0 |
ADAMTS1 | 3176.0 |
COL5A2 | 3064.0 |
ICAM1 | 3053.0 |
MMP14 | 2974.0 |
CRTAP | 2918.0 |
FGF2 | 2815.0 |
BMP7 | 2742.0 |
MMP7 | 2736.0 |
PTPRS | 2729.0 |
CTSD | 2669.5 |
ITGB1 | 2469.0 |
CTSS | 2396.0 |
ITGA10 | 2327.0 |
ITGAV | 2243.0 |
MADCAM1 | 2232.0 |
P3H1 | 2050.0 |
MMP1 | 2049.0 |
CD151 | 1741.0 |
ELN | 1616.0 |
ADAMTS18 | 1599.0 |
KLK2 | 1449.5 |
CAPN1 | 1166.0 |
ACTN1 | 1114.0 |
ADAM12 | 1062.0 |
COL27A1 | 951.0 |
LUM | 941.0 |
CAPN9 | 896.0 |
CAPN11 | 818.0 |
TGFB3 | 801.0 |
MMP17 | 768.0 |
FBLN2 | 754.0 |
PLOD1 | 638.0 |
LTBP3 | 636.0 |
NID1 | 625.0 |
DSPP | 575.0 |
COL19A1 | 452.0 |
COL4A3 | 385.0 |
CTSG | 231.0 |
LAMB1 | 139.0 |
CAPN7 | 118.0 |
BMP10 | 36.0 |
CAPN13 | 4.0 |
PRSS1 | -190.0 |
PRSS2 | -190.0 |
MMP12 | -309.0 |
ITGB2 | -462.0 |
ELANE | -671.0 |
MMP13 | -756.0 |
LRP4 | -808.0 |
COL5A3 | -869.0 |
COLGALT1 | -898.0 |
MATN1 | -987.0 |
AGRN | -1136.0 |
KLK7 | -1148.0 |
TGFB1 | -1162.0 |
DMP1 | -1207.0 |
TIMP1 | -1254.0 |
CTSB | -1337.0 |
ITGB8 | -1484.0 |
MMP19 | -1645.0 |
FBLN1 | -1728.0 |
ITGAL | -1761.0 |
PRKCA | -1808.0 |
CAPN15 | -1858.0 |
JAM2 | -1946.0 |
SCUBE1 | -1981.0 |
SDC3 | -2040.0 |
LOXL3 | -2045.0 |
ADAM17 | -2112.0 |
LAMA4 | -2168.0 |
ITGA8 | -2280.0 |
P4HB | -2423.0 |
ADAM8 | -2497.0 |
EFEMP1 | -2671.0 |
ICAM2 | -2737.0 |
LTBP4 | -2926.0 |
SDC4 | -2987.0 |
COL28A1 | -2995.0 |
COL4A5 | -3059.0 |
ITGA1 | -3067.0 |
JAM3 | -3140.0 |
CAPN5 | -3167.0 |
CAPN2 | -3290.0 |
SERPINE1 | -3327.0 |
ITGB3 | -3380.5 |
LAMC1 | -3476.0 |
PSEN1 | -3548.0 |
HSPG2 | -3764.0 |
COL6A6 | -3769.0 |
A2M | -3884.0 |
F11R | -3912.0 |
SCUBE3 | -4132.0 |
CAPN10 | -4166.0 |
ITGB6 | -4238.0 |
ITGA4 | -4297.0 |
CASP3 | -4363.0 |
CEACAM1 | -4406.5 |
CEACAM6 | -4406.5 |
CEACAM8 | -4406.5 |
COL4A1 | -4472.0 |
CAPN12 | -4477.0 |
CDH1 | -4511.0 |
CTSV | -4546.0 |
COL4A2 | -4819.0 |
PDGFB | -4881.0 |
MMP24 | -4965.0 |
SPOCK3 | -5006.0 |
ADAMTS4 | -5074.0 |
MFAP3 | -5088.0 |
COL18A1 | -5131.0 |
LAMC3 | -5168.0 |
LAMA5 | -5206.0 |
ITGAX | -5237.0 |
ITGAE | -5312.0 |
ADAM10 | -5402.0 |
KDR | -5733.0 |
COL6A5 | -5779.0 |
MUSK | -5811.0 |
ITGA6 | -5895.0 |
KLKB1 | -6048.0 |
COL15A1 | -6154.0 |
LAMA3 | -6177.0 |
MMP15 | -6347.0 |
FURIN | -6399.0 |
ITGA3 | -6852.0 |
ITGB4 | -6853.0 |
ADAM15 | -6936.0 |
TMPRSS6 | -6939.0 |
MMP11 | -7212.0 |
ITGA2B | -7222.0 |
PDGFA | -7301.0 |
TNR | -7305.0 |
CAPNS1 | -7620.0 |
SPP1 | -7652.0 |
PXDN | -7676.0 |
LAMB2 | -7709.0 |
COL9A2 | -7743.0 |
ITGA5 | -7756.0 |
BCAN | -7782.0 |
COLGALT2 | -7793.0 |
MMP8 | -7832.0 |
ITGB7 | -7863.0 |
PLOD2 | -7959.0 |
DAG1 | -7964.0 |
FGG | -8035.0 |
NCSTN | -8213.0 |
NID2 | -8273.0 |
COL25A1 | -8293.0 |
CAPN3 | -8435.0 |
FGA | -8696.0 |
TTR | -8839.0 |
VTN | -8869.5 |
NCAM1 | -8937.0 |
SH3PXD2A | -8986.0 |
PLG | -9005.0 |
ITGAM | -9020.0 |
FGB | -9053.0 |
PLEC | -9079.0 |
Cytochrome P450 - arranged by substrate type
239 | |
---|---|
set | Cytochrome P450 - arranged by substrate type |
setSize | 58 |
pANOVA | 0.000424 |
s.dist | -0.268 |
p.adjustANOVA | 0.0361 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
AHRR | -8688.0 |
CYP2F1 | -8491.0 |
CYP46A1 | -8248.0 |
CYP4F2 | -8108.0 |
CYP2C18 | -7923.5 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4F12 | -7728.5 |
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP2A6 | -9057.0 |
CYP2A7 | -9057.0 |
CYP4F8 | -9040.0 |
CYP2D6 | -9035.5 |
CYP2E1 | -8999.0 |
CYP3A4 | -8991.0 |
CYP3A43 | -8991.0 |
CYP3A5 | -8991.0 |
CYP3A7 | -8991.0 |
ARNT | -8977.0 |
AHRR | -8688.0 |
CYP2F1 | -8491.0 |
CYP46A1 | -8248.0 |
CYP4F2 | -8108.0 |
CYP2C18 | -7923.5 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4F12 | -7728.5 |
CYP1A2 | -6798.0 |
NCOA1 | -6733.0 |
CYP4B1 | -6651.0 |
POR | -5945.0 |
CYP26B1 | -5722.0 |
RXRA | -5221.0 |
NCOA2 | -5184.0 |
CYP24A1 | -4478.0 |
CYP4F3 | -4081.0 |
CYP2W1 | -3941.0 |
CYP27B1 | -3689.0 |
CYP4V2 | -2726.0 |
CYP2S1 | -1638.0 |
CYP2R1 | -1234.0 |
CYP2J2 | -235.0 |
CYP1A1 | 359.0 |
CYP51A1 | 1117.0 |
CYP27A1 | 1302.0 |
CYP8B1 | 1456.0 |
ARNT2 | 1509.0 |
CYP19A1 | 1797.0 |
CYP21A2 | 2301.0 |
CYP2U1 | 2375.0 |
AHR | 2943.5 |
CYP7A1 | 3065.0 |
POMC | 3261.0 |
CYP4F22 | 4080.0 |
FDX2 | 4488.5 |
FDX1 | 4538.0 |
NR1H4 | 4600.0 |
CYP7B1 | 4950.0 |
TBXAS1 | 5711.0 |
CYP26A1 | 5725.0 |
CYP39A1 | 6053.0 |
CYP11A1 | 6250.0 |
CYP26C1 | 7324.0 |
CYP1B1 | 8673.0 |
PTGIS | 8898.0 |
p75 NTR receptor-mediated signalling
1433 | |
---|---|
set | p75 NTR receptor-mediated signalling |
setSize | 92 |
pANOVA | 0.000471 |
s.dist | -0.211 |
p.adjustANOVA | 0.0379 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834 |
ARHGEF1 | -8718 |
OBSCN | -8574 |
ARHGEF7 | -8534 |
PLEKHG5 | -8454 |
ITSN1 | -8377 |
MAGED1 | -8312 |
ARHGEF11 | -8287 |
RTN4 | -8274 |
NCSTN | -8213 |
NGFR | -8192 |
ARHGEF40 | -7699 |
MCF2 | -7686 |
ARHGEF16 | -7667 |
ABR | -7655 |
MCF2L | -7517 |
ARHGEF5 | -7293 |
PLEKHG2 | -7206 |
VAV3 | -7088 |
ARHGEF17 | -6885 |
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834.0 |
ARHGEF1 | -8718.0 |
OBSCN | -8574.0 |
ARHGEF7 | -8534.0 |
PLEKHG5 | -8454.0 |
ITSN1 | -8377.0 |
MAGED1 | -8312.0 |
ARHGEF11 | -8287.0 |
RTN4 | -8274.0 |
NCSTN | -8213.0 |
NGFR | -8192.0 |
ARHGEF40 | -7699.0 |
MCF2 | -7686.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
MCF2L | -7517.0 |
ARHGEF5 | -7293.0 |
PLEKHG2 | -7206.0 |
VAV3 | -7088.0 |
ARHGEF17 | -6885.0 |
ARHGEF10L | -6624.0 |
UBC | -6432.0 |
APH1B | -6387.0 |
TRIO | -6348.0 |
BCL2L11 | -6346.0 |
FGD4 | -6196.0 |
FGD1 | -5982.0 |
MAG | -5858.0 |
YWHAE | -5754.0 |
ARHGEF19 | -5545.0 |
SQSTM1 | -5320.0 |
ARHGEF6 | -5311.0 |
CASP2 | -5200.0 |
AKAP13 | -5190.0 |
NET1 | -4984.0 |
NGEF | -4851.0 |
ARHGEF38 | -4562.0 |
CASP3 | -4363.0 |
RIPK2 | -4098.0 |
BEX3 | -3892.0 |
PRDM4 | -3727.0 |
PSEN1 | -3548.0 |
MYD88 | -3411.0 |
PREX1 | -3045.0 |
SOS1 | -2808.0 |
ARHGDIA | -2696.0 |
NFKB1 | -2579.0 |
ARHGEF18 | -2547.5 |
LINGO1 | -2353.0 |
TRAF6 | -2185.0 |
AATF | -2176.0 |
PSEN2 | -2171.5 |
UBA52 | -2166.0 |
PRKCI | -2165.0 |
ADAM17 | -2112.0 |
RELA | -2108.0 |
PSENEN | -1907.0 |
OMG | -1376.0 |
ARHGEF39 | -1272.0 |
ARHGEF10 | -775.0 |
RHOA | -640.0 |
ARHGEF15 | -470.0 |
ARHGEF33 | -451.0 |
KALRN | -177.0 |
IRAK1 | 791.0 |
BAD | 928.0 |
SORCS3 | 985.0 |
APH1A | 1110.0 |
VAV1 | 1912.0 |
RAC1 | 2240.0 |
NGF | 2470.0 |
HDAC2 | 3553.0 |
IKBKB | 4039.0 |
FGD2 | 4170.0 |
ITGB3BP | 4443.0 |
TIAM2 | 4841.0 |
RASGRF2 | 5220.0 |
GNA13 | 5282.0 |
HDAC3 | 5550.0 |
SMPD2 | 5759.0 |
VAV2 | 5813.0 |
MAPK8 | 5956.0 |
ARHGEF12 | 6104.0 |
FGD3 | 6255.0 |
TIAM1 | 6942.0 |
HDAC1 | 7175.0 |
ECT2 | 7350.0 |
RPS27A | 7369.0 |
ARHGEF3 | 7632.0 |
SOS2 | 7658.0 |
ARHGEF2 | 7980.0 |
ARHGEF26 | 8302.0 |
Plasma lipoprotein assembly, remodeling, and clearance
882 | |
---|---|
set | Plasma lipoprotein assembly, remodeling, and clearance |
setSize | 68 |
pANOVA | 0.000554 |
s.dist | -0.242 |
p.adjustANOVA | 0.0407 |
Top enriched genes
GeneID | Gene Rank |
---|---|
APOC1 | -8963.0 |
APOC3 | -8904.0 |
CIDEC | -8897.0 |
ABCG1 | -8866.0 |
SCARB1 | -8857.0 |
APOE | -8836.0 |
MBTPS2 | -8761.0 |
APOA5 | -8466.0 |
CUBN | -8462.0 |
LSR | -8207.0 |
MTTP | -8003.0 |
MBTPS1 | -7804.0 |
PRKACA | -7713.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
NR1H3 | -7384.0 |
APOF | -7268.0 |
CREB3L3 | -7263.0 |
LCAT | -6772.0 |
APOA4 | -6758.0 |
GeneID | Gene Rank |
---|---|
APOC1 | -8963.0 |
APOC3 | -8904.0 |
CIDEC | -8897.0 |
ABCG1 | -8866.0 |
SCARB1 | -8857.0 |
APOE | -8836.0 |
MBTPS2 | -8761.0 |
APOA5 | -8466.0 |
CUBN | -8462.0 |
LSR | -8207.0 |
MTTP | -8003.0 |
MBTPS1 | -7804.0 |
PRKACA | -7713.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
NR1H3 | -7384.0 |
APOF | -7268.0 |
CREB3L3 | -7263.0 |
LCAT | -6772.0 |
APOA4 | -6758.0 |
PRKACB | -6707.0 |
ANGPTL3 | -6400.0 |
FURIN | -6399.0 |
ANGPTL4 | -6243.0 |
PCSK9 | -6169.0 |
ABCA1 | -6097.0 |
LIPC | -5932.0 |
AP2A1 | -5700.0 |
LMF2 | -5317.0 |
LIPG | -5216.0 |
FGF21 | -5116.0 |
MYLIP | -5032.0 |
NR1H2 | -4967.0 |
VLDLR | -4329.0 |
ANGPTL8 | -4094.0 |
A2M | -3884.0 |
LPA | -3826.0 |
GPIHBP1 | -3404.0 |
LPL | -2467.0 |
P4HB | -2423.0 |
PLTP | -2003.0 |
APOC4 | -1990.0 |
AMN | -1681.0 |
AP2S1 | -1453.0 |
APOA1 | -547.0 |
LDLRAP1 | 515.0 |
APOB | 573.0 |
SAR1B | 1055.0 |
AP2M1 | 1347.0 |
ZDHHC8 | 2324.0 |
LDLR | 2957.0 |
PCSK5 | 3308.0 |
PCSK6 | 4262.0 |
AP2B1 | 4289.0 |
CLTC | 4525.0 |
LMF1 | 4677.0 |
NPC2 | 5620.0 |
AP2A2 | 6431.0 |
HDLBP | 6636.0 |
APOBR | 6980.0 |
SOAT1 | 7007.0 |
NPC1 | 7043.0 |
LIPA | 7213.0 |
BMP1 | 7235.0 |
SOAT2 | 7523.0 |
ALB | 7970.0 |
NCEH1 | 8324.0 |
CLTA | 8586.0 |
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
752 | |
---|---|
set | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux |
setSize | 39 |
pANOVA | 0.000562 |
s.dist | -0.319 |
p.adjustANOVA | 0.0407 |
Top enriched genes
GeneID | Gene Rank |
---|---|
APOC1 | -8963.0 |
ABCG1 | -8866.0 |
APOE | -8836.0 |
TNRC6B | -8577.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
AGO4 | -8424.0 |
NCOR1 | -8129.0 |
RXRB | -7956.0 |
APOC2 | -7531.5 |
NR1H3 | -7384.0 |
NCOA1 | -6733.0 |
EEPD1 | -6385.0 |
ABCA1 | -6097.0 |
AGO1 | -5804.0 |
GPS2 | -5694.0 |
TNRC6C | -5527.0 |
MIR144 | -5518.0 |
AGO2 | -5246.0 |
RXRA | -5221.0 |
GeneID | Gene Rank |
---|---|
APOC1 | -8963.0 |
ABCG1 | -8866.0 |
APOE | -8836.0 |
TNRC6B | -8577.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
AGO4 | -8424.0 |
NCOR1 | -8129.0 |
RXRB | -7956.0 |
APOC2 | -7531.5 |
NR1H3 | -7384.0 |
NCOA1 | -6733.0 |
EEPD1 | -6385.0 |
ABCA1 | -6097.0 |
AGO1 | -5804.0 |
GPS2 | -5694.0 |
TNRC6C | -5527.0 |
MIR144 | -5518.0 |
AGO2 | -5246.0 |
RXRA | -5221.0 |
TBL1XR1 | -5183.0 |
NR1H2 | -4967.0 |
APOD | -4213.0 |
KDM1B | -3115.0 |
KDM3A | -2751.0 |
ABCG5 | -2445.0 |
PLTP | -2003.0 |
APOC4 | -1990.0 |
MIR33A | -1119.0 |
EP300 | 1591.0 |
TBL1X | 1601.5 |
HDAC3 | 5550.0 |
MIR26A1 | 5951.0 |
MOV10 | 6056.0 |
ABCG8 | 6224.0 |
MIR26A2 | 6542.0 |
AGO3 | 7448.0 |
TNRC6A | 7675.0 |
KDM1A | 8614.0 |
Signal Transduction
1139 | |
---|---|
set | Signal Transduction |
setSize | 2386 |
pANOVA | 0.000712 |
s.dist | -0.0429 |
p.adjustANOVA | 0.0491 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GABBR1 | -9063 |
C5 | -9060 |
FGB | -9053 |
RDH16 | -9052 |
KNG1 | -9050 |
TAS1R2 | -9042 |
PAK1 | -9034 |
CRHR2 | -9033 |
STARD8 | -9030 |
MXD4 | -9029 |
PXN | -9019 |
TLE1 | -9016 |
SAG | -9009 |
PLIN1 | -9007 |
PLG | -9005 |
EDNRA | -8998 |
IGF2 | -8965 |
APOC1 | -8963 |
GFAP | -8957 |
PDE4D | -8956 |
GeneID | Gene Rank |
---|---|
GABBR1 | -9063.0 |
C5 | -9060.0 |
FGB | -9053.0 |
RDH16 | -9052.0 |
KNG1 | -9050.0 |
TAS1R2 | -9042.0 |
PAK1 | -9034.0 |
CRHR2 | -9033.0 |
STARD8 | -9030.0 |
MXD4 | -9029.0 |
PXN | -9019.0 |
TLE1 | -9016.0 |
SAG | -9009.0 |
PLIN1 | -9007.0 |
PLG | -9005.0 |
EDNRA | -8998.0 |
IGF2 | -8965.0 |
APOC1 | -8963.0 |
GFAP | -8957.0 |
PDE4D | -8956.0 |
MYO9B | -8944.0 |
SRGAP2 | -8939.0 |
NCAM1 | -8937.0 |
PTGER3 | -8925.0 |
CDKN1A | -8923.0 |
PDE2A | -8915.0 |
AKR1B10 | -8911.0 |
APOC3 | -8904.0 |
CAMK2B | -8898.0 |
CENPP | -8891.0 |
FOXO4 | -8887.0 |
MEF2A | -8883.0 |
PRKAR2B | -8880.0 |
NTRK1 | -8876.0 |
MYH14 | -8868.0 |
ABCG1 | -8866.0 |
PDE11A | -8842.0 |
TTR | -8839.0 |
PDGFRB | -8838.0 |
APOE | -8836.0 |
ARHGEF37 | -8834.0 |
NDC80 | -8832.0 |
IL2RB | -8825.0 |
DNM2 | -8817.0 |
ARHGAP17 | -8816.0 |
NRG1 | -8815.0 |
PCK1 | -8806.0 |
PLPPR3 | -8805.0 |
PSME3 | -8804.0 |
CHD8 | -8792.0 |
CSNK2B | -8791.0 |
HPN | -8779.0 |
CCL28 | -8774.0 |
RGS17 | -8772.0 |
RRH | -8768.0 |
WNT4 | -8755.0 |
PDGFC | -8753.0 |
TAS1R3 | -8751.0 |
DGKE | -8747.0 |
NR4A1 | -8745.0 |
SGO2 | -8734.0 |
NTSR1 | -8726.0 |
CYFIP1 | -8724.0 |
ARHGEF1 | -8718.0 |
LIMK1 | -8717.0 |
INSR | -8709.0 |
IKZF1 | -8704.0 |
FGA | -8696.0 |
ZNF217 | -8689.0 |
P2RY14 | -8673.0 |
ADORA1 | -8671.0 |
NEDD4L | -8665.0 |
EIF4G1 | -8658.0 |
REST | -8650.0 |
RPS6KA1 | -8610.0 |
CXCR1 | -8608.0 |
GNAS | -8601.0 |
FOSB | -8589.0 |
PBX1 | -8578.0 |
TNRC6B | -8577.0 |
RGS14 | -8576.0 |
OBSCN | -8574.0 |
PPP2R5C | -8572.0 |
PSMD11 | -8559.0 |
OPHN1 | -8557.0 |
GSK3B | -8548.0 |
ARHGEF7 | -8534.0 |
RARA | -8531.0 |
RGS5 | -8529.0 |
RGS20 | -8516.0 |
GRK6 | -8511.0 |
NCOR2 | -8506.0 |
PPARG | -8498.0 |
NUMB | -8494.0 |
CCL11 | -8487.0 |
GMIP | -8479.0 |
PPP3CC | -8476.0 |
CDC37 | -8475.0 |
SPRED3 | -8474.0 |
KDM4A | -8470.5 |
RGS6 | -8457.0 |
PLEKHG5 | -8454.0 |
CSNK1G2 | -8450.0 |
CDC42 | -8440.0 |
USP2 | -8432.0 |
PDE1B | -8427.0 |
AGO4 | -8424.0 |
POLR2E | -8423.0 |
ATP6V0D1 | -8410.0 |
ETV4 | -8397.0 |
PLB1 | -8395.0 |
PSMB10 | -8393.0 |
PLPPR1 | -8390.0 |
ITSN1 | -8377.0 |
PLCB4 | -8376.0 |
LIN7B | -8366.0 |
RBFOX2 | -8362.0 |
PTK2 | -8355.0 |
CXCR6 | -8347.0 |
MRTFA | -8345.0 |
TSC2 | -8340.0 |
GRB10 | -8326.0 |
CXCR3 | -8323.0 |
ARAP2 | -8318.0 |
TRH | -8317.0 |
MAGED1 | -8312.0 |
CHRM3 | -8311.0 |
ATF1 | -8305.0 |
HNRNPH1 | -8301.0 |
SH2D2A | -8300.0 |
STAT6 | -8298.0 |
CHN2 | -8291.5 |
ARHGEF11 | -8287.0 |
RTN4 | -8274.0 |
USP4 | -8272.0 |
WASF2 | -8271.0 |
VIPR1 | -8263.0 |
IFT88 | -8255.0 |
RNF41 | -8243.0 |
AMOT | -8241.0 |
MADD | -8225.0 |
NCSTN | -8213.0 |
GALR2 | -8209.0 |
BAIAP2 | -8193.0 |
NGFR | -8192.0 |
DEPDC7 | -8183.0 |
RBP4 | -8178.0 |
KMT2D | -8177.0 |
DGKZ | -8155.0 |
TEC | -8139.0 |
GPSM3 | -8134.0 |
MYC | -8133.0 |
NCOR1 | -8129.0 |
NUP43 | -8128.0 |
PRKAR2A | -8106.0 |
EVL | -8105.0 |
TCF12 | -8098.0 |
PIK3AP1 | -8096.0 |
SRC | -8095.0 |
TAX1BP3 | -8093.0 |
CHD4 | -8089.5 |
VIP | -8083.0 |
ACVR1C | -8082.0 |
CDK1 | -8079.0 |
WIPF2 | -8075.0 |
GLP2R | -8069.0 |
UBE2D3 | -8068.0 |
JUP | -8056.0 |
NPY | -8050.0 |
LPAR5 | -8048.0 |
ATP6V0A2 | -8039.0 |
CDH5 | -8036.0 |
FGG | -8035.0 |
H2BC1 | -8026.0 |
NUP85 | -8017.0 |
HDAC5 | -8016.0 |
NPY1R | -8014.0 |
ARHGAP20 | -8012.0 |
NR3C1 | -8004.0 |
XK | -7994.0 |
PDE4C | -7992.5 |
ADRB3 | -7987.5 |
STAT5B | -7980.0 |
QRFPR | -7977.0 |
PLCB3 | -7957.0 |
RXRB | -7956.0 |
ASH2L | -7949.0 |
LEPR | -7925.0 |
NEDD4 | -7922.0 |
ARC | -7921.0 |
ARHGAP6 | -7915.0 |
DUSP10 | -7908.0 |
RUVBL1 | -7902.0 |
CCNT1 | -7896.0 |
NPFFR1 | -7883.0 |
OR52W1 | -7878.0 |
DAGLB | -7867.0 |
NTS | -7866.0 |
PSMB9 | -7864.0 |
AGT | -7862.0 |
PTPRA | -7844.0 |
DKK4 | -7836.0 |
RGS2 | -7801.0 |
PARD3 | -7779.0 |
ZDHHC9 | -7778.0 |
EDN3 | -7773.0 |
SYNGAP1 | -7758.0 |
COL9A2 | -7743.0 |
HDAC9 | -7742.0 |
DUSP4 | -7719.0 |
PRKACA | -7713.0 |
LAMB2 | -7709.0 |
GFRA2 | -7703.0 |
GPR27 | -7702.0 |
ARHGEF40 | -7699.0 |
CYFIP2 | -7693.0 |
BMPR1B | -7692.0 |
MCF2 | -7686.0 |
TACC3 | -7685.0 |
RBPJ | -7670.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
SPP1 | -7652.0 |
RTP2 | -7650.0 |
GNAI1 | -7649.0 |
WAS | -7636.0 |
CDK5R1 | -7635.0 |
CSF2RB | -7632.0 |
RXFP2 | -7630.0 |
RFNG | -7625.0 |
BCAR1 | -7614.0 |
RPGRIP1L | -7611.0 |
PDE1C | -7601.0 |
FASN | -7594.0 |
POU2F1 | -7582.0 |
MGLL | -7581.0 |
RHPN1 | -7579.0 |
GREM2 | -7567.0 |
S100A8 | -7563.0 |
AKT1S1 | -7553.0 |
DGKB | -7547.0 |
PTGER4 | -7545.0 |
ADORA2B | -7537.0 |
RASA4 | -7533.5 |
APOC2 | -7531.5 |
AXIN2 | -7523.0 |
ATF2 | -7522.0 |
MCF2L | -7517.0 |
CNTN1 | -7515.0 |
SCRIB | -7509.0 |
SMARCA4 | -7503.0 |
ABHD12 | -7496.0 |
PORCN | -7494.0 |
CDC20 | -7493.0 |
PHLPP1 | -7491.0 |
ADRA2B | -7489.0 |
IHH | -7487.0 |
PELP1 | -7485.0 |
STRADA | -7482.0 |
SPC24 | -7479.0 |
DAB2IP | -7464.0 |
CCDC88C | -7459.0 |
CASP9 | -7456.0 |
RING1 | -7450.0 |
PTK2B | -7442.0 |
RAC2 | -7433.0 |
CHD1 | -7428.0 |
PAK3 | -7424.0 |
BUB3 | -7420.0 |
NFATC1 | -7417.0 |
MDM2 | -7403.0 |
APOA2 | -7400.0 |
LEO1 | -7393.0 |
NR1H3 | -7384.0 |
IFT52 | -7374.0 |
STAT3 | -7372.0 |
GRK3 | -7362.0 |
LAMTOR5 | -7358.0 |
RASGRP2 | -7350.0 |
TNFAIP3 | -7318.0 |
GNG4 | -7316.0 |
DGKG | -7310.0 |
SPTBN2 | -7304.0 |
PDGFA | -7301.0 |
PIP4K2A | -7295.0 |
ARHGEF5 | -7293.0 |
PTPN3 | -7286.0 |
VWF | -7285.0 |
CSNK1E | -7277.5 |
DLG4 | -7276.0 |
TRIB1 | -7257.0 |
VEGFD | -7250.0 |
CNR1 | -7245.0 |
ITGA2B | -7222.0 |
ARHGAP12 | -7221.0 |
SRMS | -7215.0 |
PLEKHG2 | -7206.0 |
ARHGAP8 | -7192.5 |
WNT10A | -7189.0 |
CHRM5 | -7183.0 |
LIMK2 | -7173.0 |
PARP1 | -7161.0 |
GPC4 | -7160.0 |
HDAC6 | -7154.0 |
PRKCE | -7128.0 |
NEURL1 | -7123.0 |
GNAL | -7120.0 |
S1PR1 | -7115.0 |
GATAD2B | -7106.0 |
KIF2C | -7103.0 |
PIK3R2 | -7098.5 |
VAV3 | -7088.0 |
EPAS1 | -7087.0 |
RTP3 | -7086.0 |
STRAP | -7077.0 |
ABL1 | -7066.0 |
TNKS2 | -7057.0 |
LEF1 | -7053.0 |
RGS8 | -7040.0 |
MFNG | -7025.0 |
CCR9 | -7000.0 |
CSF2RA | -6994.0 |
PHC1 | -6987.0 |
DUSP7 | -6984.0 |
GNA14 | -6980.0 |
RBP1 | -6975.0 |
AVPR2 | -6968.0 |
GRAP2 | -6960.0 |
ARHGAP35 | -6956.0 |
NUDC | -6950.0 |
CDK9 | -6949.0 |
POLR2L | -6941.0 |
SMAD4 | -6937.0 |
PPARD | -6930.0 |
PLXND1 | -6922.0 |
SPTB | -6905.0 |
CD28 | -6902.0 |
ATN1 | -6896.0 |
KLC3 | -6887.0 |
ARHGEF17 | -6885.0 |
ADCY6 | -6882.0 |
PTGER2 | -6876.0 |
KL | -6866.0 |
ITGA3 | -6852.0 |
OR51E1 | -6846.0 |
RASGRP3 | -6839.0 |
AAMP | -6822.0 |
CNKSR1 | -6817.0 |
PGF | -6799.0 |
GPR39 | -6779.0 |
CNR2 | -6771.0 |
ADCY4 | -6759.0 |
APOA4 | -6758.0 |
ARRB2 | -6754.0 |
ECE1 | -6749.0 |
NCOA1 | -6733.0 |
MYH9 | -6722.0 |
NOG | -6719.0 |
CCL19 | -6713.0 |
MAP2K5 | -6709.0 |
PRKACB | -6707.0 |
ICMT | -6702.0 |
WWP1 | -6699.0 |
LYL1 | -6681.0 |
AMOTL1 | -6677.0 |
PSAP | -6675.0 |
TAOK1 | -6649.0 |
EIF4EBP1 | -6644.0 |
ARHGEF10L | -6624.0 |
GPAM | -6619.0 |
IL3RA | -6604.0 |
HSD17B6 | -6589.0 |
S1PR4 | -6587.0 |
EZH2 | -6564.0 |
TMED2 | -6563.0 |
PLK1 | -6555.0 |
OTUD7B | -6540.0 |
KIF5A | -6521.0 |
RASGEF1A | -6517.0 |
HIF1A | -6513.0 |
RAPGEF3 | -6504.0 |
TSHR | -6499.0 |
HTR7 | -6482.0 |
RASAL1 | -6479.0 |
RASAL2 | -6477.0 |
CXCR5 | -6476.0 |
RALGDS | -6468.5 |
SGK1 | -6445.0 |
FGF10 | -6441.0 |
PMF1 | -6435.0 |
ADCY2 | -6434.0 |
UBC | -6432.0 |
RBBP7 | -6428.0 |
ESRP2 | -6418.0 |
ANGPTL3 | -6400.0 |
FURIN | -6399.0 |
CENPM | -6395.0 |
APH1B | -6387.0 |
EEPD1 | -6385.0 |
SYK | -6379.0 |
WLS | -6377.0 |
TRIO | -6348.0 |
BCL2L11 | -6346.0 |
LRRC7 | -6336.0 |
PRKAB1 | -6325.0 |
TCF4 | -6313.0 |
SSTR1 | -6304.0 |
C3 | -6303.0 |
USP21 | -6295.0 |
CHRM4 | -6286.0 |
CLASP1 | -6270.0 |
GPR132 | -6259.0 |
PPP2CA | -6258.0 |
CER1 | -6253.0 |
PIK3R6 | -6249.0 |
CSNK2A2 | -6247.0 |
MYO9A | -6231.0 |
RHOH | -6217.0 |
REEP6 | -6204.0 |
PPP2R5A | -6197.0 |
FGD4 | -6196.0 |
TCF7 | -6192.0 |
TAC3 | -6187.0 |
WNT6 | -6186.0 |
LAMA3 | -6177.0 |
MAP2K2 | -6140.5 |
TAB1 | -6122.0 |
KAT2A | -6099.0 |
ABCA1 | -6097.0 |
RDH8 | -6074.0 |
RAMP2 | -6073.0 |
YWHAH | -6072.0 |
FZD3 | -6063.0 |
BRAP | -6050.0 |
TACR1 | -6047.0 |
ITPR3 | -6046.0 |
PTGDR2 | -6038.0 |
OR52I1 | -6033.5 |
OR52I2 | -6033.5 |
GATAD2A | -6019.0 |
IRAK4 | -6013.0 |
CTNND1 | -6002.0 |
STAM | -6001.0 |
PCP2 | -6000.0 |
ST3GAL3 | -5996.0 |
PDK4 | -5994.0 |
PSMB2 | -5987.0 |
SNAI1 | -5985.0 |
FGD1 | -5982.0 |
SYVN1 | -5980.0 |
BCL9L | -5979.0 |
DYNC1I2 | -5974.0 |
TACR3 | -5973.0 |
DOCK7 | -5972.0 |
OR6S1 | -5969.0 |
USF1 | -5967.0 |
PDK2 | -5965.0 |
LFNG | -5964.0 |
AKT2 | -5958.0 |
ACTR3 | -5956.0 |
CD80 | -5911.0 |
IFT122 | -5901.0 |
CIT | -5900.0 |
GNG12 | -5884.0 |
PPP1CA | -5881.0 |
TCF7L1 | -5873.0 |
SKA1 | -5866.0 |
PTPRK | -5860.0 |
MAG | -5858.0 |
WNT2B | -5857.0 |
PIP5K1C | -5851.0 |
ITPR2 | -5837.0 |
WNT5B | -5821.0 |
DAAM1 | -5816.0 |
NEFL | -5814.0 |
FCER2 | -5807.0 |
AGO1 | -5804.0 |
POLR2A | -5792.0 |
FGF6 | -5789.0 |
HGS | -5785.0 |
TJP1 | -5784.0 |
SUCNR1 | -5782.0 |
COL6A5 | -5779.0 |
FGFR2 | -5766.0 |
FES | -5763.0 |
HSPB1 | -5762.0 |
KEL | -5755.0 |
YWHAE | -5754.0 |
DLG1 | -5738.0 |
KDR | -5733.0 |
CYP26B1 | -5722.0 |
RPS6 | -5720.0 |
WNT8B | -5701.0 |
AP2A1 | -5700.0 |
GPS2 | -5694.0 |
NOTCH1 | -5689.0 |
RAMP1 | -5656.0 |
P2RY6 | -5637.0 |
JAK1 | -5621.0 |
WWP2 | -5615.0 |
ACTB | -5609.0 |
SH2B2 | -5588.0 |
CCNE1 | -5587.0 |
CHD3 | -5584.0 |
AGTR1 | -5580.0 |
KSR1 | -5570.0 |
RHOJ | -5569.0 |
PSMD3 | -5566.0 |
RHOBTB1 | -5555.0 |
PTH1R | -5552.0 |
CREBBP | -5548.0 |
ARHGEF19 | -5545.0 |
LRP2 | -5544.0 |
UHMK1 | -5539.0 |
TNRC6C | -5527.0 |
MYL9 | -5522.0 |
MIR144 | -5518.0 |
GREB1 | -5516.0 |
SPC25 | -5506.0 |
TACR2 | -5487.0 |
PIK3R5 | -5482.0 |
RANGAP1 | -5473.0 |
DUSP6 | -5469.0 |
WASL | -5468.0 |
ARHGAP32 | -5460.0 |
MET | -5458.0 |
NRP2 | -5449.0 |
TFDP1 | -5433.0 |
ARHGAP9 | -5430.0 |
TSC1 | -5416.0 |
DLL4 | -5410.0 |
OS9 | -5407.0 |
PDE7B | -5405.0 |
ADAM10 | -5402.0 |
GOLGA7 | -5400.0 |
JAK3 | -5397.0 |
PSMA8 | -5390.0 |
PSMD1 | -5382.0 |
DTX4 | -5348.0 |
BIRC2 | -5344.0 |
RPTOR | -5338.0 |
OR6K6 | -5329.0 |
FOXH1 | -5328.0 |
ATP2A3 | -5325.0 |
SQSTM1 | -5320.0 |
MAP3K11 | -5319.0 |
TSHB | -5315.0 |
PAQR3 | -5314.0 |
ARHGEF6 | -5311.0 |
FGFR4 | -5296.0 |
PSMB7 | -5278.0 |
CARM1 | -5274.0 |
FASLG | -5271.0 |
GNAT2 | -5270.0 |
NOTCH3 | -5268.0 |
SH3GL2 | -5262.0 |
AGO2 | -5246.0 |
PLCG1 | -5242.0 |
RLBP1 | -5232.0 |
IFT140 | -5228.0 |
PTGER1 | -5226.0 |
RXRA | -5221.0 |
CXCR4 | -5218.0 |
MAP2K1 | -5210.0 |
LAMA5 | -5206.0 |
CASP2 | -5200.0 |
AKAP13 | -5190.0 |
NCOA2 | -5184.0 |
TBL1XR1 | -5183.0 |
WNT16 | -5176.0 |
LAMC3 | -5168.0 |
ARHGDIB | -5167.0 |
PRKCH | -5149.5 |
GNAO1 | -5147.0 |
TNFSF10 | -5140.0 |
OR6N2 | -5135.0 |
ARHGAP11A | -5134.0 |
TLN1 | -5122.0 |
DOCK3 | -5112.0 |
RNF43 | -5105.5 |
CCL22 | -5101.0 |
RCVRN | -5100.0 |
PKN1 | -5082.0 |
CENPF | -5077.0 |
ALDH8A1 | -5065.0 |
STRN | -5063.0 |
TLE5 | -5058.0 |
MEF2D | -5054.0 |
HECW1 | -5044.0 |
SSTR4 | -5037.0 |
LRP5 | -5036.0 |
MYLIP | -5032.0 |
NMUR1 | -5014.0 |
STAT5A | -5013.0 |
TTC21B | -5004.0 |
RALB | -4998.0 |
NET1 | -4984.0 |
PRKAR1A | -4970.0 |
NR1H2 | -4967.0 |
KIF14 | -4955.0 |
RNF31 | -4944.5 |
P2RY10 | -4936.0 |
ARHGAP21 | -4926.0 |
IRS2 | -4925.0 |
SYDE2 | -4921.0 |
POLR2C | -4917.0 |
MATK | -4914.0 |
VPS35 | -4902.0 |
NSL1 | -4888.0 |
SPTBN5 | -4887.0 |
PDGFB | -4881.0 |
TRAF1 | -4878.0 |
NPHP4 | -4868.0 |
PIP5K1B | -4857.0 |
NGEF | -4851.0 |
PSMC3 | -4849.0 |
CXCL9 | -4847.0 |
BCL2L1 | -4845.0 |
ADGRE5 | -4844.0 |
GAL | -4837.0 |
POFUT1 | -4833.0 |
COL4A2 | -4819.0 |
HDAC4 | -4813.0 |
ARHGAP1 | -4806.0 |
CRHBP | -4802.0 |
DKK2 | -4799.0 |
CPT1B | -4789.0 |
RUNX3 | -4786.0 |
APLNR | -4782.0 |
ADCY10 | -4780.0 |
RSPO4 | -4776.0 |
H3-4 | -4773.0 |
PML | -4770.0 |
PYGO1 | -4769.0 |
NPW | -4751.0 |
IL6R | -4743.0 |
PIK3CD | -4740.0 |
KREMEN1 | -4725.0 |
CTNNA1 | -4715.0 |
RRAGB | -4707.0 |
GRM5 | -4699.0 |
BRAF | -4678.0 |
NCOA3 | -4671.0 |
PDE4A | -4632.0 |
RNF146 | -4630.0 |
TERT | -4625.0 |
TJP2 | -4621.5 |
TAS2R60 | -4610.0 |
HEYL | -4599.0 |
GNB4 | -4593.0 |
SREBF1 | -4592.0 |
RARB | -4591.0 |
PTK6 | -4590.0 |
XCR1 | -4583.0 |
FST | -4568.0 |
ARHGEF38 | -4562.0 |
PDE6A | -4543.0 |
SALL4 | -4534.0 |
FNTB | -4523.5 |
CDH1 | -4511.0 |
RGS3 | -4491.0 |
FPR2 | -4479.5 |
FPR3 | -4479.5 |
COL4A1 | -4472.0 |
ELMO2 | -4459.0 |
IQGAP3 | -4455.0 |
CCR6 | -4453.0 |
LRAT | -4448.0 |
DHRS3 | -4431.0 |
GNAI2 | -4425.0 |
MC5R | -4388.0 |
DTX2 | -4386.0 |
ADRA1D | -4383.0 |
SOX7 | -4376.0 |
CASP3 | -4363.0 |
PIP4K2B | -4348.0 |
MAPK6 | -4338.0 |
PDPK1 | -4325.0 |
PTCH2 | -4298.0 |
ACTR2 | -4296.0 |
SFN | -4282.0 |
PSMC4 | -4280.0 |
DVL1 | -4267.0 |
ESRP1 | -4259.0 |
SMAD5 | -4252.0 |
STARD13 | -4246.0 |
TCF7L2 | -4244.0 |
MAF1 | -4232.0 |
ANGPT1 | -4231.0 |
PROKR2 | -4225.0 |
APOD | -4213.0 |
IGF2BP1 | -4204.0 |
FBXW7 | -4203.0 |
DGKH | -4197.0 |
GPR4 | -4192.0 |
RAPGEF1 | -4177.0 |
ZWINT | -4173.0 |
GDF2 | -4169.0 |
GRPR | -4160.0 |
GZMB | -4156.0 |
TAS2R3 | -4153.0 |
LEP | -4134.0 |
NUP133 | -4126.0 |
PRKAG3 | -4120.0 |
RIPK2 | -4098.0 |
HTR1F | -4088.0 |
RPS6KB1 | -4087.0 |
KAT5 | -4080.0 |
LRIG1 | -4079.0 |
NMT2 | -4070.0 |
BDKRB2 | -4057.0 |
PLCB1 | -4053.0 |
DTX1 | -4049.0 |
ATP6V0E2 | -4048.0 |
ADCY1 | -4044.0 |
ACVRL1 | -4036.0 |
CFLAR | -4023.0 |
LPAR6 | -4022.0 |
TNFRSF1A | -4011.0 |
FMNL3 | -4009.0 |
ATP2A1 | -4002.0 |
MIR206 | -4000.0 |
VANGL2 | -3997.0 |
SSTR3 | -3984.0 |
PRC1 | -3983.0 |
RHO | -3979.0 |
PHC3 | -3939.0 |
MIR302A | -3935.0 |
GRM8 | -3921.0 |
GHRHR | -3915.0 |
F11R | -3912.0 |
MYLK | -3905.0 |
DUSP16 | -3902.0 |
CAMK2A | -3898.0 |
GNB1 | -3895.0 |
BEX3 | -3892.0 |
MCHR1 | -3891.0 |
A2M | -3884.0 |
C3AR1 | -3874.0 |
MYH11 | -3840.0 |
OR52B2 | -3822.0 |
NPB | -3820.0 |
DNAJB1 | -3819.0 |
UTS2 | -3797.0 |
PSMD7 | -3791.0 |
RAG1 | -3788.0 |
CCL4 | -3785.5 |
JAK2 | -3777.0 |
COL6A6 | -3769.0 |
PHC2 | -3767.0 |
ALDH1A1 | -3766.0 |
HSPG2 | -3764.0 |
GABRQ | -3752.0 |
TNF | -3751.0 |
TLE3 | -3738.0 |
PRDM4 | -3727.0 |
CBL | -3706.0 |
RPS6KA3 | -3698.0 |
PTPN7 | -3695.0 |
CHRM1 | -3677.0 |
APBB1IP | -3673.0 |
RANBP10 | -3667.0 |
WNT9A | -3665.0 |
CBX6 | -3654.0 |
SPPL2B | -3638.0 |
H2BC3 | -3635.0 |
PPP2CB | -3632.0 |
GNRHR | -3625.0 |
F2 | -3616.0 |
H2BC12 | -3610.0 |
IL6 | -3607.0 |
CXCL11 | -3606.0 |
RHOV | -3598.0 |
DGKK | -3596.0 |
DYNLL2 | -3587.0 |
ELK1 | -3586.0 |
PTPRJ | -3574.0 |
ROR1 | -3567.0 |
GPC2 | -3565.0 |
PTH2 | -3564.0 |
PSEN1 | -3548.0 |
H2AJ | -3539.0 |
GDI2 | -3504.0 |
MIR106B | -3491.0 |
KANK1 | -3487.0 |
PRKCQ | -3483.0 |
PPP2R1A | -3477.0 |
LAMC1 | -3476.0 |
GPR84 | -3469.0 |
RGR | -3467.0 |
MLST8 | -3465.0 |
MIR150 | -3462.0 |
RXFP1 | -3454.0 |
ZW10 | -3417.0 |
MYD88 | -3411.0 |
GPIHBP1 | -3404.0 |
ROCK2 | -3394.0 |
CCR3 | -3385.0 |
LCK | -3384.0 |
RASGRF1 | -3383.0 |
ITGB3 | -3380.5 |
ACKR4 | -3367.0 |
SOX13 | -3366.0 |
OR5B2 | -3361.0 |
PPP1R12B | -3357.0 |
VCP | -3356.0 |
GRB2 | -3336.0 |
SERPINE1 | -3327.0 |
CLASP2 | -3322.0 |
EDN1 | -3312.0 |
PTGIR | -3311.0 |
ARHGAP39 | -3310.0 |
LRP10 | -3298.0 |
OR51E2 | -3273.0 |
GSK3A | -3260.0 |
SGO1 | -3255.0 |
GPR31 | -3246.0 |
CD55 | -3223.0 |
IFT172 | -3218.0 |
HTR5A | -3216.0 |
GTF2F2 | -3213.0 |
GTF2F1 | -3198.0 |
GPR183 | -3193.0 |
JAG2 | -3181.0 |
MIR22 | -3163.0 |
FABP7 | -3155.0 |
HSP90AB1 | -3151.0 |
GUCA1B | -3130.0 |
HEBP1 | -3127.0 |
OR8H1 | -3118.0 |
OR8H2 | -3118.0 |
OR8H3 | -3118.0 |
KDM1B | -3115.0 |
SPTBN4 | -3105.0 |
PSMD4 | -3087.0 |
RHOB | -3080.0 |
ATP6V1B1 | -3077.0 |
GNG7 | -3060.0 |
COL4A5 | -3059.0 |
ACTN2 | -3058.0 |
B4GALT1 | -3055.0 |
PREX1 | -3045.0 |
MUC20 | -3040.0 |
GPR161 | -3021.0 |
PSME1 | -3015.0 |
SCD | -2989.0 |
SDC4 | -2987.0 |
ABHD17A | -2953.0 |
WNT7B | -2916.0 |
CENPO | -2904.0 |
PYGO2 | -2886.0 |
EVC2 | -2863.0 |
GNA11 | -2862.0 |
IL6ST | -2837.0 |
FAM13A | -2836.0 |
GPNMB | -2829.0 |
PTEN | -2811.0 |
HHIP | -2809.0 |
SOS1 | -2808.0 |
NRG3 | -2799.0 |
SSTR5 | -2799.0 |
GLI3 | -2791.0 |
PRKCG | -2783.0 |
KHDRBS2 | -2776.0 |
RACGAP1 | -2770.0 |
CCL17 | -2763.0 |
KDM3A | -2751.0 |
NOTCH4 | -2740.0 |
CYP4V2 | -2726.0 |
GTF2A2 | -2725.0 |
RIT1 | -2710.0 |
LYN | -2708.0 |
CUL1 | -2706.0 |
ARHGDIA | -2696.0 |
RANBP9 | -2692.0 |
TYK2 | -2663.0 |
PPP3CA | -2656.0 |
ADORA2A | -2639.0 |
YAP1 | -2635.0 |
CCL2 | -2628.0 |
ABI2 | -2625.0 |
CDK5 | -2600.0 |
DDX5 | -2584.0 |
NFKB1 | -2579.0 |
SMC1A | -2578.0 |
FLT1 | -2576.0 |
IL5RA | -2567.0 |
NAB2 | -2564.0 |
ARHGAP31 | -2557.0 |
TRIB3 | -2550.0 |
ARHGEF18 | -2547.5 |
APLN | -2542.0 |
RBBP4 | -2539.0 |
IQGAP2 | -2507.0 |
RPS6KA5 | -2499.0 |
HEY1 | -2485.0 |
PPBP | -2477.0 |
PDK1 | -2473.0 |
LPL | -2467.0 |
E2F3 | -2466.0 |
SMC3 | -2449.0 |
IQCE | -2446.0 |
ABCG5 | -2445.0 |
WNT8A | -2439.0 |
WIF1 | -2426.0 |
P4HB | -2423.0 |
P2RY2 | -2415.0 |
GGA3 | -2414.0 |
DNER | -2407.0 |
ATP6V1B2 | -2392.0 |
OR8G1 | -2378.5 |
OR8G5 | -2378.5 |
EPGN | -2373.0 |
RSPO3 | -2372.0 |
KNTC1 | -2370.0 |
VEGFB | -2366.0 |
LINGO1 | -2353.0 |
ADCY5 | -2343.0 |
CUL5 | -2339.0 |
FMNL1 | -2291.0 |
FZD7 | -2287.0 |
PENK | -2272.0 |
SPOP | -2270.0 |
REEP2 | -2261.0 |
HRAS | -2253.0 |
NOTUM | -2252.0 |
MYH10 | -2249.0 |
CX3CL1 | -2245.0 |
FLT4 | -2242.0 |
DNAL4 | -2239.0 |
SH2B3 | -2226.0 |
UCHL5 | -2219.0 |
OR10G2 | -2217.0 |
FPR1 | -2214.0 |
TFDP2 | -2213.0 |
PPP5C | -2209.0 |
LTB4R | -2187.0 |
TRAF6 | -2185.0 |
CLIP3 | -2179.0 |
AATF | -2176.0 |
PSEN2 | -2171.5 |
TBP | -2169.0 |
LAMA4 | -2168.0 |
UBA52 | -2166.0 |
PRKCI | -2165.0 |
DUSP8 | -2153.0 |
RGS1 | -2147.0 |
MBD3 | -2136.0 |
RCOR1 | -2134.0 |
S100A9 | -2129.0 |
RLN3 | -2119.0 |
ARHGAP26 | -2118.0 |
ADAM17 | -2112.0 |
RELA | -2108.0 |
GPC3 | -2107.0 |
KISS1 | -2106.0 |
USP9X | -2105.0 |
ADM2 | -2081.0 |
CCKAR | -2081.0 |
CCR4 | -2081.0 |
GNG13 | -2081.0 |
MIR34A | -2081.0 |
MIR449B | -2081.0 |
OPN1LW | -2081.0 |
OPN1MW | -2081.0 |
OR7E24 | -2063.0 |
FABP6 | -2049.0 |
LGR5 | -2042.0 |
SDC3 | -2040.0 |
DACT1 | -2031.0 |
NPFF | -2026.0 |
RHOT2 | -2024.0 |
RHOD | -2015.0 |
OR5P2 | -2010.0 |
HGFAC | -2009.0 |
PPID | -2004.0 |
PLTP | -2003.0 |
APOC4 | -1990.0 |
MAML1 | -1974.0 |
PSMB5 | -1949.0 |
H3-3A | -1923.0 |
OR6Y1 | -1916.0 |
OR8K3 | -1912.0 |
GABRG2 | -1909.5 |
PSENEN | -1907.0 |
EGR3 | -1895.0 |
PRKAG2 | -1889.0 |
RARG | -1886.0 |
YWHAG | -1883.0 |
PLPPR5 | -1872.0 |
FOSL1 | -1864.0 |
OTULIN | -1856.0 |
WNT7A | -1849.0 |
OR2F1 | -1842.5 |
OR2F2 | -1842.5 |
VRK3 | -1839.0 |
RCC2 | -1836.0 |
GPR176 | -1832.0 |
HDAC11 | -1830.0 |
USP8 | -1825.0 |
F2RL2 | -1823.0 |
OR11A1 | -1818.0 |
ADCY9 | -1812.0 |
OR10K1 | -1811.0 |
PRKCA | -1808.0 |
POLR2F | -1805.0 |
HDAC7 | -1803.0 |
EPN1 | -1801.0 |
CAV2 | -1799.0 |
DSN1 | -1798.0 |
GHSR | -1789.0 |
DAGLA | -1781.0 |
PDHA1 | -1776.0 |
GPR55 | -1771.0 |
OR5G3 | -1752.5 |
CCKBR | -1743.0 |
PSMD10 | -1732.0 |
RHOU | -1725.0 |
IL1RL1 | -1724.0 |
CAV1 | -1723.0 |
RIPK1 | -1717.0 |
MAPK13 | -1710.0 |
MAPK12 | -1705.0 |
SOCS6 | -1702.0 |
CBX2 | -1695.0 |
SIRT6 | -1692.0 |
CXCL10 | -1631.0 |
HES1 | -1625.0 |
EGFR | -1624.0 |
GATA3 | -1622.0 |
CXCL16 | -1619.0 |
MYL12B | -1606.0 |
EREG | -1562.5 |
GABRB2 | -1562.5 |
OR10V1 | -1562.5 |
OR14J1 | -1562.5 |
OR1I1 | -1562.5 |
OR1Q1 | -1562.5 |
OR4A15 | -1562.5 |
OR4P4 | -1562.5 |
OR56B4 | -1562.5 |
OR5M11 | -1562.5 |
OR5P3 | -1562.5 |
OR5T1 | -1562.5 |
OR5T3 | -1562.5 |
OR6C2 | -1562.5 |
OR6C68 | -1562.5 |
OR8B8 | -1562.5 |
PSMB11 | -1562.5 |
OR5AK2 | -1523.0 |
OR5AK3P | -1523.0 |
TAS2R14 | -1512.0 |
NF2 | -1495.0 |
ARHGAP29 | -1488.0 |
TAB2 | -1485.0 |
METAP1 | -1481.0 |
DHRS4 | -1472.5 |
STK4 | -1468.0 |
GALR1 | -1455.0 |
AP2S1 | -1453.0 |
NPSR1 | -1445.0 |
WNT3 | -1443.0 |
SP1 | -1438.0 |
TRADD | -1426.0 |
PPP1R14A | -1424.0 |
CCND1 | -1414.0 |
TRHR | -1407.0 |
WNT3A | -1406.0 |
RACK1 | -1396.0 |
KDM4B | -1378.0 |
OMG | -1376.0 |
EDNRB | -1365.0 |
RASAL3 | -1364.0 |
OR4B1 | -1361.5 |
TRAT1 | -1354.0 |
FRS2 | -1340.0 |
GPC6 | -1334.0 |
NDE1 | -1332.0 |
RHOBTB2 | -1304.0 |
PLXNB1 | -1301.0 |
KIF2A | -1295.0 |
CASR | -1291.0 |
DLL1 | -1289.0 |
C5AR1 | -1280.0 |
UBE2D1 | -1275.0 |
ARHGEF39 | -1272.0 |
RGS13 | -1258.0 |
TEK | -1251.0 |
CCR7 | -1237.0 |
MIR19A | -1229.0 |
GRM6 | -1224.0 |
OR10A3 | -1219.5 |
OR10A6 | -1219.5 |
HTR4 | -1218.0 |
GPR45 | -1179.0 |
TGFB1 | -1162.0 |
EPS15 | -1160.0 |
GPR143 | -1156.0 |
YWHAB | -1151.0 |
USF2 | -1149.0 |
MIR200B | -1147.0 |
KHDRBS1 | -1146.0 |
GPR35 | -1144.0 |
CXCL13 | -1141.0 |
AGRN | -1136.0 |
OR9G1 | -1126.0 |
PSMD8 | -1124.0 |
MIR33A | -1119.0 |
GPSM2 | -1112.0 |
JUNB | -1108.0 |
CDK5R2 | -1106.0 |
NOTCH2 | -1097.0 |
CDC42EP2 | -1096.0 |
TGFA | -1093.0 |
DRD5 | -987.0 |
GABRA1 | -987.0 |
IL2 | -987.0 |
MIR19B1 | -987.0 |
MTNR1A | -987.0 |
OR10J5 | -987.0 |
OR11G2 | -987.0 |
OR12D3 | -987.0 |
OR1A1 | -987.0 |
OR1A2 | -987.0 |
OR1J4 | -987.0 |
OR1P1 | -987.0 |
OR2A1 | -987.0 |
OR2T1 | -987.0 |
OR2W3 | -987.0 |
OR4C16 | -987.0 |
OR4C6 | -987.0 |
OR51G2 | -987.0 |
OR51Q1 | -987.0 |
OR52E4 | -987.0 |
OR5AL1 | -987.0 |
OR5R1 | -987.0 |
OR7G1 | -987.0 |
OR8B12 | -987.0 |
OR8B2 | -987.0 |
OR8B3 | -987.0 |
OR8D4 | -987.0 |
OR9K2 | -987.0 |
PROK1 | -987.0 |
RBP2 | -987.0 |
TAAR5 | -987.0 |
TAS2R1 | -987.0 |
ARHGAP40 | -907.5 |
CHRM2 | -907.5 |
FGFBP1 | -907.5 |
OR2B11 | -907.5 |
OR2H1 | -907.5 |
OR2H2 | -907.5 |
OR4D1 | -907.5 |
OR52M1 | -907.5 |
OR2T29 | -895.0 |
OR2T4 | -895.0 |
OR2T5 | -895.0 |
DUSP9 | -893.0 |
OR5B3 | -884.0 |
OR4C15 | -879.0 |
ACVR1B | -867.0 |
CDKN2B | -860.0 |
TLE2 | -858.0 |
SPTA1 | -830.0 |
ITCH | -823.0 |
KREMEN2 | -783.0 |
ARHGEF10 | -775.0 |
H2AZ1 | -773.0 |
DRAP1 | -757.0 |
PRR5 | -751.0 |
PPP3CB | -748.0 |
ADAP1 | -745.0 |
KLB | -739.0 |
CALCR | -738.0 |
OR14C36 | -733.5 |
OR52N2 | -733.5 |
OR56B2P | -733.5 |
OR7G2 | -733.5 |
OPRL1 | -730.0 |
TNS4 | -726.0 |
OR5AC1 | -686.0 |
RGS4 | -680.0 |
SMAD1 | -668.0 |
HCRTR1 | -648.0 |
FOXO6 | -645.0 |
RHOA | -640.0 |
CCR10 | -637.0 |
STAM2 | -609.0 |
RETSAT | -602.0 |
EGR4 | -567.0 |
MEN1 | -556.0 |
APOA1 | -547.0 |
GFRA3 | -543.0 |
BCL9 | -533.0 |
OR2AK2 | -519.5 |
OR5H1 | -519.5 |
OR5H14 | -519.5 |
OR5H15 | -519.5 |
OR5H6 | -519.5 |
MECOM | -508.0 |
PPP1R15A | -495.0 |
PEA15 | -488.0 |
FOXA1 | -485.0 |
WDR83 | -482.0 |
ARHGEF15 | -470.0 |
NCF4 | -467.0 |
PDE6B | -466.0 |
BRS3 | -461.0 |
ARAF | -453.0 |
ARHGEF33 | -451.0 |
KLHL12 | -450.0 |
ATP6V0D2 | -449.0 |
YWHAZ | -416.0 |
GPHB5 | -374.0 |
FZD9 | -370.0 |
FADD | -344.0 |
MIR20A | -338.5 |
OR52D1 | -338.5 |
NPY5R | -309.0 |
OR10G3 | -309.0 |
OR4A47 | -309.0 |
OR4F6 | -309.0 |
OR51F2 | -309.0 |
OR52P1P | -309.0 |
OR9A4 | -309.0 |
CGA | -282.0 |
ATP6V1G3 | -280.0 |
DGKD | -273.0 |
ARHGAP30 | -260.0 |
AREG | -256.0 |
RTKN | -253.0 |
REEP1 | -250.0 |
REEP5 | -211.0 |
CAMKK2 | -200.0 |
CXCL12 | -188.0 |
OPRD1 | -187.0 |
FER | -185.0 |
KALRN | -177.0 |
FOS | -162.0 |
EPS15L1 | -152.0 |
RHOF | -150.0 |
PRKAB2 | -149.0 |
CXXC4 | -148.0 |
OR7D4 | -133.0 |
OR5AN1 | -121.5 |
OR1N1 | -118.0 |
RGS18 | -112.0 |
GNB5 | -108.0 |
CALM1 | -83.0 |
OR10AG1 | -40.0 |
SMAD3 | -28.0 |
GPR37L1 | -27.0 |
ARRB1 | -23.0 |
PDK3 | -21.0 |
GPR65 | -16.0 |
REEP3 | -8.0 |
CYBA | -1.0 |
ERBB3 | 1.0 |
FKBP4 | 5.0 |
OR6B2 | 6.5 |
OR6B3 | 6.5 |
OR4F17 | 11.0 |
OR4F4 | 11.0 |
OR4F5 | 11.0 |
SMURF2 | 17.0 |
GRIN2B | 27.0 |
BMP10 | 36.0 |
EIF4E | 41.0 |
AVPR1A | 53.0 |
CD19 | 55.0 |
RAC3 | 84.0 |
PIK3CA | 85.0 |
GNA15 | 89.0 |
RBX1 | 95.0 |
ERLEC1 | 99.0 |
DOCK1 | 104.0 |
BCR | 111.0 |
H2AZ2 | 124.0 |
LAMB1 | 139.0 |
TAS2R4 | 142.0 |
CALCB | 231.0 |
CNGA1 | 231.0 |
FFAR1 | 231.0 |
IAPP | 231.0 |
IL5 | 231.0 |
MC3R | 231.0 |
MIR17 | 231.0 |
MIR34B | 231.0 |
NPBWR1 | 231.0 |
OR10W1 | 231.0 |
OR13F1 | 231.0 |
OR13J1 | 231.0 |
OR1B1 | 231.0 |
OR1J1 | 231.0 |
OR1M1 | 231.0 |
OR2A14 | 231.0 |
OR2A5 | 231.0 |
OR2AP1 | 231.0 |
OR2L13 | 231.0 |
OR2Y1 | 231.0 |
OR4A16 | 231.0 |
OR4C11 | 231.0 |
OR4C12 | 231.0 |
OR4C3 | 231.0 |
OR4D11 | 231.0 |
OR4D2 | 231.0 |
OR4D6 | 231.0 |
OR4F15 | 231.0 |
OR4X2 | 231.0 |
OR51F1 | 231.0 |
OR52E2 | 231.0 |
OR52H1 | 231.0 |
OR52L1 | 231.0 |
OR52R1 | 231.0 |
OR56B1 | 231.0 |
OR5A1 | 231.0 |
OR5B17 | 231.0 |
OR5L1 | 231.0 |
OR5L2 | 231.0 |
OR5M8 | 231.0 |
OR6X1 | 231.0 |
OR8K5 | 231.0 |
OR9Q2 | 231.0 |
PIK3CB | 231.0 |
PTH2R | 231.0 |
RGS21 | 231.0 |
RTP1 | 231.0 |
TAAR8 | 231.0 |
TAS2R7 | 231.0 |
FGF20 | 321.0 |
FGF8 | 321.0 |
LHCGR | 340.5 |
GIP | 344.0 |
OR5C1 | 346.0 |
NOX3 | 352.0 |
TAS2R42 | 355.0 |
DLGAP5 | 369.0 |
FGF17 | 383.0 |
COL4A3 | 385.0 |
NMT1 | 404.0 |
FGFRL1 | 407.0 |
MAPK11 | 409.0 |
OR2B2 | 420.0 |
DVL3 | 421.0 |
RAD21 | 438.0 |
FGF1 | 442.0 |
NPY4R | 446.5 |
OXT | 449.0 |
PSMC5 | 451.0 |
SHOC2 | 454.0 |
PRLHR | 457.0 |
WASF3 | 462.0 |
IL3 | 466.0 |
OR4K15 | 540.0 |
OR6C1 | 540.0 |
TAS2R19 | 549.0 |
TAS2R20 | 549.0 |
TAS2R30 | 549.0 |
TAS2R31 | 549.0 |
TAS2R43 | 549.0 |
TAS2R46 | 549.0 |
TAS2R50 | 549.0 |
DKK1 | 556.0 |
OPN4 | 560.0 |
OR8A1 | 563.0 |
APOB | 573.0 |
ADCYAP1 | 576.0 |
FLRT1 | 578.0 |
GAS8 | 584.0 |
PPP2R5D | 596.0 |
PIK3R3 | 597.5 |
BAMBI | 601.0 |
KIF18A | 607.0 |
GNRH1 | 612.0 |
F2RL1 | 616.0 |
NEURL1B | 617.0 |
NSMAF | 620.0 |
GALNT3 | 621.0 |
ARHGAP44 | 622.0 |
DISP2 | 632.0 |
CDC25C | 650.0 |
PSMD14 | 673.0 |
OR5W2 | 676.0 |
GPR17 | 677.0 |
PPEF1 | 686.0 |
GRM3 | 693.0 |
MAPRE1 | 694.0 |
OR2AG1 | 700.0 |
TAC1 | 700.0 |
RHOG | 709.0 |
ERBB2 | 722.0 |
PREX2 | 727.0 |
ATP2A2 | 736.0 |
RAF1 | 737.0 |
CBX4 | 766.0 |
SYDE1 | 773.0 |
ACTA2 | 781.0 |
IRAK1 | 791.0 |
RGS16 | 809.0 |
F2RL3 | 826.0 |
ATP6V1G1 | 828.0 |
OR52E6 | 842.0 |
OR52E8 | 842.0 |
OR8D1 | 842.0 |
FSHR | 861.5 |
INS | 861.5 |
OR4M1 | 861.5 |
OR4M2 | 861.5 |
OR4X1 | 861.5 |
OR51B6 | 861.5 |
OR51I2 | 861.5 |
PYY | 861.5 |
FFAR3 | 896.0 |
OR10C1 | 896.0 |
OR10S1 | 896.0 |
OR2V1 | 896.0 |
OR4K5 | 896.0 |
OR51A2 | 896.0 |
OR51A4 | 896.0 |
OR51V1 | 896.0 |
OR52K2 | 896.0 |
OR2V2 | 917.5 |
OR2Z1 | 917.5 |
OPN5 | 921.0 |
BAD | 928.0 |
TAS2R13 | 930.0 |
NUP107 | 935.0 |
RAP1A | 937.0 |
NLN | 943.0 |
RHOQ | 950.0 |
SPRED1 | 953.0 |
CCL3 | 960.0 |
SORCS3 | 985.0 |
GNG5 | 992.0 |
KIF2B | 996.0 |
PTBP1 | 1021.0 |
RRAGD | 1040.0 |
EEF2K | 1044.0 |
PDHA2 | 1046.0 |
RHPN2 | 1059.0 |
ADAM12 | 1062.0 |
SEC13 | 1065.0 |
MIR181C | 1066.0 |
GHRH | 1070.0 |
BIRC5 | 1082.0 |
GLI1 | 1088.0 |
OR10H1 | 1093.5 |
OR10H5 | 1093.5 |
QRFP | 1095.0 |
APH1A | 1110.0 |
SKP1 | 1129.0 |
UBE2M | 1137.0 |
MIR25 | 1148.0 |
CAMK4 | 1172.0 |
NUF2 | 1173.0 |
CCNK | 1182.0 |
GRM2 | 1192.0 |
FFAR4 | 1193.0 |
GRK2 | 1198.0 |
RGL1 | 1218.0 |
KLC2 | 1226.0 |
MOB1A | 1227.0 |
TRIP10 | 1231.0 |
SH2B1 | 1236.0 |
SH3KBP1 | 1239.0 |
TAS2R10 | 1246.0 |
SRGAP3 | 1255.0 |
PRKCZ | 1256.0 |
CENPN | 1272.0 |
CTTN | 1289.0 |
GNAT3 | 1292.0 |
RPS6KA2 | 1294.0 |
CENPU | 1295.0 |
SSTR2 | 1311.0 |
NCKAP1 | 1318.0 |
HEY2 | 1323.0 |
HGF | 1325.0 |
AP2M1 | 1347.0 |
SOX2 | 1368.0 |
STAP2 | 1378.0 |
XCL1 | 1380.5 |
XCL2 | 1380.5 |
OR52E5 | 1404.0 |
OR2AG2 | 1419.5 |
OR7C2 | 1419.5 |
OR8U1 | 1419.5 |
TAAR1 | 1419.5 |
GDI1 | 1433.0 |
KLK2 | 1449.5 |
KLK3 | 1449.5 |
DIAPH2 | 1453.0 |
ARHGAP33 | 1479.0 |
RBCK1 | 1484.0 |
AKT1 | 1488.0 |
ARHGAP27 | 1497.0 |
ATP6V1D | 1526.0 |
OR4N5 | 1533.0 |
MST1 | 1542.0 |
PRKCD | 1551.0 |
WIPF3 | 1562.0 |
GPR83 | 1568.0 |
DRD3 | 1587.0 |
EP300 | 1591.0 |
PSMD9 | 1596.5 |
TBL1X | 1601.5 |
ADCY3 | 1612.0 |
ACVR2B | 1614.0 |
GRK1 | 1615.0 |
ADM | 1625.0 |
GPR15 | 1643.0 |
TRAF2 | 1651.0 |
APOM | 1657.0 |
PDE3B | 1668.0 |
TAB3 | 1681.0 |
JUN | 1686.0 |
NRP1 | 1688.0 |
CBX8 | 1695.0 |
OR13C3 | 1717.0 |
PSMD12 | 1729.0 |
ATP6V1E1 | 1734.0 |
PSMB3 | 1735.0 |
CRHR1 | 1747.0 |
RYK | 1765.0 |
LAMTOR1 | 1769.0 |
CDC14B | 1785.0 |
NRAS | 1786.0 |
GUCY2D | 1791.0 |
ATP6V0A4 | 1802.0 |
SDR16C5 | 1807.0 |
CTNNB1 | 1809.0 |
HRH4 | 1810.0 |
SFPQ | 1818.0 |
PROK2 | 1822.0 |
DGKQ | 1845.0 |
CSN2 | 1876.0 |
FGF3 | 1876.0 |
GPRC6A | 1876.0 |
HHAT | 1886.0 |
PNLIP | 1909.0 |
VAV1 | 1912.0 |
PPP1CB | 1917.0 |
ARPC4 | 1946.0 |
GRP | 1947.0 |
CXCL6 | 1966.0 |
GALR3 | 1969.0 |
NRTN | 1970.0 |
RAB4B | 1972.5 |
FRS3 | 1979.0 |
SCTR | 1986.0 |
PSMB1 | 1994.0 |
GDNF | 2000.0 |
PSMB4 | 2009.0 |
KIF7 | 2020.0 |
DNM3 | 2027.0 |
BOC | 2047.0 |
OR6K3 | 2052.0 |
FZD4 | 2057.0 |
CSNK2A1 | 2059.5 |
MAPK1 | 2063.0 |
SUZ12 | 2083.0 |
CFTR | 2088.0 |
KITLG | 2099.0 |
LRP8 | 2101.0 |
USP13 | 2108.0 |
JUND | 2121.0 |
KTN1 | 2123.0 |
HTR2B | 2125.0 |
INHBB | 2128.0 |
MST1R | 2138.0 |
OR2T12 | 2143.0 |
OR2T33 | 2143.0 |
OR2T8 | 2143.0 |
RRAGA | 2158.0 |
DHH | 2159.0 |
FRAT1 | 2162.0 |
RTP4 | 2164.0 |
MC2R | 2177.0 |
DRD2 | 2184.0 |
CRK | 2198.0 |
TMED5 | 2200.0 |
ADCY7 | 2210.0 |
POLR2B | 2214.0 |
DYNLL1 | 2216.0 |
NOXA1 | 2226.0 |
RAC1 | 2240.0 |
OR2AT4 | 2241.0 |
ITGAV | 2243.0 |
PFN2 | 2246.0 |
ARHGAP4 | 2279.0 |
LATS2 | 2288.0 |
PSMD2 | 2314.0 |
OR6C70 | 2316.5 |
PSMA1 | 2318.0 |
CFL1 | 2322.0 |
OFD1 | 2335.0 |
P2RY12 | 2339.0 |
CENPQ | 2367.0 |
OR6C76 | 2370.0 |
MIB2 | 2372.0 |
SFRP1 | 2381.0 |
RBL1 | 2395.0 |
INPP5B | 2405.0 |
FGF4 | 2406.0 |
YY1 | 2410.0 |
TAGAP | 2414.0 |
GAB2 | 2423.0 |
SCT | 2430.0 |
RASA2 | 2440.0 |
NOS3 | 2441.0 |
ITGB1 | 2469.0 |
NGF | 2470.0 |
WNT5A | 2473.0 |
GRK5 | 2483.0 |
IL1RAP | 2513.0 |
RGS22 | 2514.0 |
PAK2 | 2520.0 |
MAPK3 | 2532.0 |
PSMF1 | 2535.0 |
BMI1 | 2614.5 |
NCK2 | 2619.0 |
RSPO1 | 2627.0 |
ARHGAP25 | 2629.0 |
PRKCB | 2630.0 |
APC | 2637.0 |
MTA2 | 2644.0 |
ERCC6L | 2649.0 |
CTSD | 2669.5 |
FGFBP3 | 2673.0 |
YWHAQ | 2683.0 |
FLNA | 2688.0 |
KSR2 | 2694.0 |
WWC1 | 2697.0 |
ATP6V1E2 | 2719.0 |
CENPH | 2724.0 |
PTPRS | 2729.0 |
GPR68 | 2735.0 |
MMP7 | 2736.0 |
GPHA2 | 2779.0 |
BCL2 | 2785.0 |
ARHGAP23 | 2812.0 |
HCRT | 2813.0 |
FGF2 | 2815.0 |
TBXA2R | 2824.0 |
MAP3K7 | 2825.0 |
ADRB2 | 2844.0 |
TIAL1 | 2849.0 |
GAB1 | 2850.0 |
RXRG | 2860.0 |
HCAR2 | 2866.5 |
HCAR3 | 2866.5 |
CRKL | 2879.0 |
WNT1 | 2881.0 |
KIDINS220 | 2893.0 |
GRAP | 2913.0 |
CAMKMT | 2915.0 |
NCKAP1L | 2932.0 |
KLC4 | 2935.0 |
LATS1 | 2938.0 |
GABRG3 | 2949.0 |
LDLR | 2957.0 |
AMOTL2 | 2960.0 |
KAT2B | 2962.0 |
MAPKAPK2 | 2978.0 |
SEPTIN7 | 2983.0 |
GUCY2F | 3001.0 |
WIPF1 | 3006.0 |
PSME4 | 3023.0 |
PDE8B | 3035.5 |
SNW1 | 3076.0 |
SPRED2 | 3077.0 |
CCR1 | 3082.0 |
ATP6AP1 | 3091.0 |
PHLPP2 | 3120.0 |
CRABP2 | 3127.0 |
FLT3 | 3128.0 |
IKBKG | 3133.0 |
NELFB | 3135.0 |
GNA12 | 3137.0 |
ASCL1 | 3141.0 |
PDYN | 3143.0 |
NOXO1 | 3155.0 |
LAMTOR3 | 3167.0 |
CDCA8 | 3177.0 |
ST3GAL6 | 3182.0 |
CCL23 | 3192.0 |
STMN1 | 3198.0 |
FGF23 | 3205.0 |
SKI | 3211.0 |
SHH | 3214.0 |
NLK | 3218.0 |
KCTD6 | 3219.0 |
HCAR1 | 3224.0 |
FLRT2 | 3256.0 |
POMC | 3261.0 |
AVP | 3271.0 |
PEBP1 | 3284.0 |
SHARPIN | 3295.0 |
GNG3 | 3307.0 |
PCSK5 | 3308.0 |
PDE1A | 3353.0 |
ID4 | 3360.0 |
F2R | 3369.0 |
LPAR1 | 3370.0 |
USP7 | 3382.0 |
CPT1A | 3390.0 |
RGS7 | 3418.0 |
DIAPH3 | 3419.0 |
GNAT1 | 3423.0 |
ERBB4 | 3432.0 |
FAM13B | 3460.0 |
PRKAA1 | 3464.0 |
HDAC10 | 3474.0 |
POLR2I | 3477.0 |
POLR2D | 3487.0 |
P2RY4 | 3493.0 |
CCRL2 | 3501.0 |
MTOR | 3550.0 |
LGR6 | 3551.0 |
HDAC2 | 3553.0 |
DLK1 | 3555.0 |
SDR9C7 | 3561.0 |
BDKRB1 | 3562.0 |
CCNT2 | 3571.0 |
TRIM27 | 3584.0 |
EGR1 | 3598.0 |
ADRB1 | 3612.0 |
GRK4 | 3623.0 |
CLTB | 3636.0 |
PIP4K2C | 3637.0 |
GPC1 | 3640.0 |
CBFB | 3647.0 |
HDAC8 | 3649.5 |
CCND3 | 3651.0 |
PSMD13 | 3656.0 |
WWTR1 | 3663.0 |
MYO7A | 3664.0 |
FABP5 | 3676.0 |
NMB | 3696.0 |
F3 | 3700.0 |
PTPN11 | 3701.0 |
MAPK14 | 3711.0 |
RHEB | 3718.0 |
ZDHHC21 | 3720.0 |
ATP6V1F | 3727.0 |
GNAI3 | 3733.0 |
ATP1B4 | 3748.0 |
COL6A1 | 3749.0 |
GNG11 | 3752.0 |
B9D2 | 3753.0 |
TPH1 | 3766.0 |
HRH1 | 3792.0 |
PDE3A | 3794.0 |
AR | 3802.0 |
NTF4 | 3813.0 |
KIT | 3843.0 |
ATP6V0B | 3850.0 |
CDK2 | 3851.0 |
PPP1R1B | 3853.0 |
PSMA5 | 3857.0 |
PTPN2 | 3859.0 |
GPR25 | 3869.0 |
PPM1A | 3872.0 |
TGFBR2 | 3873.0 |
TCIRG1 | 3878.0 |
BCO1 | 3884.0 |
DLD | 3894.0 |
IQGAP1 | 3904.0 |
MED1 | 3935.0 |
ADRA1B | 3941.0 |
PSMC1 | 3947.0 |
RNF111 | 3951.0 |
TNS3 | 3965.0 |
NCBP1 | 3976.0 |
USP34 | 3993.0 |
SOCS3 | 3999.0 |
OR5I1 | 4012.0 |
SLC24A1 | 4032.0 |
IKBKB | 4039.0 |
STK11 | 4058.0 |
DOK1 | 4062.0 |
AURKB | 4064.0 |
SH3GL1 | 4081.0 |
PRICKLE1 | 4084.0 |
JAG1 | 4086.0 |
FKBP5 | 4107.0 |
CSF2 | 4120.0 |
CCR8 | 4126.0 |
RRAGC | 4129.0 |
ECE2 | 4133.5 |
RAP1B | 4145.0 |
GABRB1 | 4149.0 |
CKAP5 | 4160.0 |
CTBP1 | 4163.0 |
FGD2 | 4170.0 |
ARAP3 | 4175.0 |
PDE8A | 4181.0 |
LYPLA1 | 4183.0 |
DUSP5 | 4190.0 |
PIK3R4 | 4193.0 |
STUB1 | 4214.0 |
ID1 | 4225.0 |
PTAFR | 4229.0 |
ZWILCH | 4234.0 |
GFRA1 | 4239.0 |
ALDH1A3 | 4259.0 |
PCSK6 | 4262.0 |
CCK | 4270.0 |
AP2B1 | 4289.0 |
NEDD8 | 4299.0 |
ARAP1 | 4310.0 |
BAG4 | 4311.0 |
MAD1L1 | 4314.0 |
PDHB | 4315.0 |
CENPT | 4316.0 |
SRGAP1 | 4317.0 |
RAG2 | 4319.0 |
RLN2 | 4323.5 |
EPO | 4329.0 |
MEF2C | 4345.0 |
CBY1 | 4363.0 |
PTGES3 | 4369.0 |
PLPPR2 | 4371.0 |
GNGT2 | 4376.0 |
RALA | 4380.0 |
SOX6 | 4403.0 |
RGS9BP | 4413.0 |
HNRNPM | 4417.0 |
NCKIPSD | 4441.0 |
ITGB3BP | 4443.0 |
RGS10 | 4447.0 |
PRKAA2 | 4452.0 |
GHRL | 4454.0 |
BUB1B | 4466.5 |
CHN1 | 4472.0 |
EBAG9 | 4476.0 |
PPP2R1B | 4513.0 |
PAG1 | 4514.0 |
GTF2A1 | 4516.0 |
KHDRBS3 | 4518.0 |
NMU | 4522.0 |
CLTC | 4525.0 |
FOXO1 | 4556.0 |
PGR | 4557.0 |
PIN1 | 4562.0 |
FZD8 | 4573.0 |
ADRA2A | 4582.0 |
IER3 | 4585.0 |
CTNNBIP1 | 4586.0 |
IGF1R | 4593.0 |
FZD1 | 4610.0 |
HBEGF | 4618.0 |
HTR1B | 4630.0 |
DGKA | 4645.0 |
PTPN6 | 4670.0 |
INTU | 4672.0 |
RAPGEF4 | 4676.0 |
WASF1 | 4683.0 |
MIR21 | 4691.0 |
OR51D1 | 4699.0 |
CAMKK1 | 4711.0 |
MAPK7 | 4725.0 |
GRB7 | 4726.0 |
LAMA1 | 4727.0 |
PDGFRA | 4729.0 |
PLPPR4 | 4737.0 |
XIAP | 4741.0 |
TRPC7 | 4748.0 |
PSMC6 | 4749.0 |
COL6A2 | 4759.0 |
STK3 | 4764.0 |
PFN1 | 4767.0 |
SOX17 | 4773.0 |
SPRY2 | 4777.0 |
HRH3 | 4786.0 |
FGF18 | 4796.0 |
DVL2 | 4800.0 |
CSK | 4803.0 |
BRK1 | 4805.0 |
LRP1 | 4809.0 |
OCRL | 4825.0 |
TAX1BP1 | 4835.0 |
CALCA | 4836.0 |
DYNC1LI2 | 4837.0 |
TIAM2 | 4841.0 |
CCL27 | 4856.0 |
RBP3 | 4858.0 |
RAB4A | 4867.0 |
CDC42EP3 | 4868.0 |
CILP | 4877.0 |
MIS12 | 4900.0 |
ABHD17C | 4922.0 |
ADRA2C | 4926.0 |
GPR37 | 4931.0 |
POGLUT1 | 4942.0 |
MTMR4 | 4944.0 |
BTC | 4946.0 |
MKS1 | 4947.0 |
ROCK1 | 4962.0 |
SH3GL3 | 4997.0 |
RDH10 | 5000.0 |
FZD6 | 5042.0 |
CAB39L | 5045.0 |
EVC | 5047.0 |
PPP3R1 | 5058.5 |
DIAPH1 | 5071.0 |
RGS9 | 5078.0 |
FGFR3 | 5086.0 |
EPOR | 5088.0 |
FGF22 | 5103.0 |
RAMP3 | 5107.0 |
ROPN1 | 5110.5 |
SUFU | 5117.0 |
BMPR2 | 5124.0 |
FZD5 | 5173.0 |
METAP2 | 5174.0 |
DUSP1 | 5190.0 |
HCRTR2 | 5199.0 |
RBBP5 | 5206.0 |
RASGRF2 | 5220.0 |
SPDL1 | 5244.0 |
CENPK | 5248.0 |
CDC42EP5 | 5251.0 |
RGSL1 | 5265.0 |
OXTR | 5278.0 |
GNA13 | 5282.0 |
OR6K2 | 5286.0 |
PSMA7 | 5305.0 |
CDC73 | 5336.0 |
ARPC1B | 5378.0 |
PIP5K1A | 5382.0 |
EFCAB7 | 5391.0 |
DYNC1I1 | 5392.0 |
GIPR | 5394.0 |
ATP6V0C | 5434.0 |
E2F5 | 5436.0 |
MRAS | 5437.0 |
PSMA6 | 5445.0 |
PRKX | 5448.5 |
ADGRE1 | 5461.0 |
UTS2B | 5468.0 |
ATP6V1H | 5475.0 |
AMH | 5478.0 |
NR2E1 | 5483.0 |
VGF | 5488.0 |
PDE10A | 5495.0 |
PIK3C3 | 5498.0 |
KNL1 | 5503.0 |
RHOC | 5509.5 |
PLCG2 | 5518.0 |
FFAR2 | 5519.0 |
NMBR | 5522.0 |
HDAC3 | 5550.0 |
KBTBD7 | 5569.5 |
AVPR1B | 5580.0 |
ROR2 | 5596.0 |
S1PR5 | 5597.0 |
RET | 5599.0 |
UCN | 5600.0 |
CYBB | 5605.0 |
DRD4 | 5612.0 |
CNOT6L | 5613.0 |
S1PR2 | 5627.0 |
PTPRU | 5633.0 |
HTR2A | 5650.0 |
H2BU1 | 5658.0 |
PTCH1 | 5659.0 |
NR5A2 | 5663.0 |
ARHGAP10 | 5666.0 |
RGS19 | 5668.0 |
PSMA2 | 5670.5 |
SPOPL | 5678.0 |
PPP1R12A | 5681.0 |
PSMD5 | 5684.0 |
TLR9 | 5692.5 |
WDR19 | 5700.0 |
ARHGAP28 | 5709.0 |
MOB1B | 5722.0 |
DUSP2 | 5724.0 |
CYP26A1 | 5725.0 |
CMKLR1 | 5729.0 |
GFRA4 | 5742.0 |
SPPL2A | 5745.0 |
SMPD2 | 5759.0 |
GPR18 | 5762.0 |
OR1F1 | 5776.0 |
EED | 5777.0 |
ARPC3 | 5792.0 |
IL33 | 5812.0 |
VAV2 | 5813.0 |
CCNC | 5816.0 |
PLAT | 5817.0 |
BUB1 | 5820.0 |
CENPE | 5825.0 |
FSTL3 | 5829.0 |
AMER1 | 5847.0 |
KRAS | 5849.0 |
PRMT1 | 5858.0 |
FGF9 | 5865.0 |
FRK | 5870.0 |
PMCH | 5889.0 |
NUP160 | 5904.0 |
BAX | 5925.0 |
XPO1 | 5929.0 |
MEMO1 | 5942.0 |
MIR26A1 | 5951.0 |
MAPK8 | 5956.0 |
ARHGEF25 | 5966.5 |
PSMD6 | 5980.0 |
ZFYVE9 | 5983.0 |
ACTG1 | 5986.0 |
RICTOR | 5991.0 |
PTGDR | 6020.0 |
SAV1 | 6025.0 |
FZD2 | 6035.0 |
ABI1 | 6048.0 |
WDR35 | 6051.0 |
MOV10 | 6056.0 |
BCO2 | 6058.0 |
RGL3 | 6085.0 |
SOX9 | 6101.0 |
ARHGEF12 | 6104.0 |
CENPA | 6108.0 |
PARD6A | 6114.0 |
SPARC | 6116.0 |
FLRT3 | 6143.0 |
TAS2R41 | 6144.0 |
DEPDC1B | 6153.0 |
PSMC2 | 6158.0 |
SPHK1 | 6185.0 |
SCUBE2 | 6192.0 |
MKRN1 | 6195.0 |
DZIP1 | 6196.0 |
DLC1 | 6197.0 |
DYNC2H1 | 6198.0 |
SOST | 6204.0 |
STAG2 | 6209.0 |
BTRC | 6215.0 |
DERL2 | 6219.0 |
CDON | 6222.0 |
ABCG8 | 6224.0 |
NAPEPLD | 6226.0 |
SRF | 6231.0 |
NCF1 | 6238.0 |
LRRK2 | 6246.0 |
RCE1 | 6248.0 |
GNAZ | 6253.0 |
FGD3 | 6255.0 |
GNB2 | 6264.0 |
OR6N1 | 6265.0 |
SMAD6 | 6270.0 |
ACKR3 | 6294.0 |
CHUK | 6304.0 |
BMP2 | 6309.0 |
CRH | 6329.0 |
VEGFC | 6335.0 |
RASA1 | 6344.0 |
DLAT | 6345.0 |
FGF7 | 6355.0 |
VIPR2 | 6379.0 |
SMURF1 | 6387.0 |
RDH12 | 6399.0 |
C5AR2 | 6406.0 |
ARHGAP18 | 6408.0 |
ARTN | 6410.0 |
CMA1 | 6414.0 |
LAMB3 | 6421.0 |
AP2A2 | 6431.0 |
ZDHHC7 | 6433.0 |
CDK4 | 6438.0 |
OR2K2 | 6446.0 |
SDC2 | 6449.0 |
ARL2 | 6454.0 |
REEP4 | 6463.0 |
ID3 | 6464.0 |
RASGRP4 | 6479.0 |
YES1 | 6489.0 |
KIF5B | 6494.0 |
GRIN1 | 6495.0 |
GRM1 | 6498.0 |
ICOS | 6504.0 |
STRA6 | 6510.0 |
ARHGAP15 | 6512.0 |
RDH5 | 6515.0 |
OR4E1 | 6518.0 |
RPS6KB2 | 6534.0 |
MIR26A2 | 6542.0 |
ADRA1A | 6572.0 |
NUP98 | 6576.0 |
ELF3 | 6579.0 |
SPTBN1 | 6584.0 |
SEL1L | 6588.0 |
PTPN18 | 6594.0 |
GNG8 | 6614.0 |
PTPN12 | 6625.0 |
SLC38A9 | 6641.0 |
THEM4 | 6654.0 |
SHB | 6666.5 |
ZRANB1 | 6677.0 |
CDC14A | 6679.0 |
FGF16 | 6692.0 |
BMPR1A | 6696.0 |
FAS | 6708.0 |
RGS12 | 6733.0 |
KISS1R | 6746.0 |
DYNC1LI1 | 6754.0 |
RAB6A | 6765.0 |
MAPKAPK3 | 6770.0 |
TULP3 | 6772.0 |
PPP2R5B | 6776.0 |
GNG2 | 6793.0 |
TGIF2 | 6794.0 |
ATP6V0E1 | 6801.0 |
H2BC11 | 6802.0 |
TAS1R1 | 6812.0 |
FLT3LG | 6822.0 |
ADCY8 | 6825.0 |
PTPN1 | 6830.0 |
PIK3CG | 6844.0 |
MTA3 | 6856.0 |
OPRK1 | 6857.0 |
CDKN1B | 6858.0 |
SPINT1 | 6862.0 |
LAT | 6872.0 |
WNT2 | 6877.0 |
CRABP1 | 6878.0 |
EGR2 | 6879.0 |
PTGFR | 6884.0 |
FGFR1 | 6888.0 |
SOCS1 | 6890.0 |
GPSM1 | 6904.0 |
RDH14 | 6911.0 |
FN1 | 6913.0 |
H4C1 | 6923.5 |
TIAM1 | 6942.0 |
RANBP2 | 6945.0 |
P2RY1 | 6949.0 |
STRADB | 6957.0 |
MAD2L1 | 6958.0 |
FMNL2 | 6964.0 |
VAPA | 6965.0 |
PDHX | 6966.0 |
LTB4R2 | 6967.0 |
CITED1 | 6991.0 |
NTRK2 | 6997.0 |
RASGRP1 | 7000.0 |
PSME2 | 7025.0 |
TNKS | 7029.0 |
LAMTOR4 | 7030.0 |
HNRNPF | 7044.0 |
LAMTOR2 | 7052.0 |
ARF6 | 7061.0 |
LPAR4 | 7063.0 |
ARHGAP42 | 7065.0 |
GUCA1A | 7066.0 |
ARPC5 | 7069.0 |
SHC3 | 7070.0 |
RPE65 | 7074.0 |
MAML2 | 7087.0 |
PTPRO | 7097.0 |
FUZ | 7105.0 |
GNG10 | 7112.0 |
S1PR3 | 7127.0 |
TGFBR1 | 7130.0 |
ANXA1 | 7137.0 |
THBS3 | 7140.0 |
GABBR2 | 7146.0 |
NMUR2 | 7148.0 |
CAB39 | 7150.0 |
ATP6V1C1 | 7159.0 |
PPP2R5E | 7165.0 |
USP15 | 7172.0 |
HDAC1 | 7175.0 |
CCL21 | 7185.0 |
ADCYAP1R1 | 7189.0 |
PLCB2 | 7190.0 |
IL2RA | 7237.0 |
LPAR3 | 7241.0 |
CYLD | 7243.0 |
SKIL | 7261.0 |
NAB1 | 7262.0 |
PDE4B | 7268.0 |
CHRDL1 | 7300.0 |
ABCA4 | 7305.0 |
INHBA | 7307.0 |
SDC1 | 7316.0 |
MYL6 | 7318.0 |
DHRS9 | 7322.0 |
CYP26C1 | 7324.0 |
NCBP2 | 7339.0 |
ARHGAP36 | 7340.0 |
GRM7 | 7349.0 |
ECT2 | 7350.0 |
ST3GAL4 | 7352.0 |
LGR4 | 7355.0 |
RPS27A | 7369.0 |
PMEPA1 | 7386.0 |
DGKI | 7390.0 |
PDE6D | 7397.0 |
CNKSR2 | 7401.0 |
GPBAR1 | 7429.0 |
AGO3 | 7448.0 |
RRAD | 7453.0 |
CLIP1 | 7468.0 |
POLR2H | 7476.0 |
CAMK2G | 7477.0 |
APP | 7480.0 |
ALDH1A2 | 7482.0 |
FNTA | 7484.0 |
ACVR2A | 7491.0 |
AGTR2 | 7492.0 |
SMAD2 | 7503.0 |
EDN2 | 7506.0 |
SPINT2 | 7507.0 |
MMP9 | 7518.0 |
ATP6V0A1 | 7535.0 |
MMP2 | 7540.0 |
MMP3 | 7551.0 |
CENPC | 7561.0 |
BTK | 7564.0 |
SCMH1 | 7581.0 |
ACKR2 | 7589.0 |
PRKG2 | 7597.0 |
TGIF1 | 7599.0 |
FSTL1 | 7606.0 |
SFRP2 | 7613.0 |
CCR5 | 7623.0 |
SCAI | 7627.0 |
ARHGEF3 | 7632.0 |
PSMB8 | 7643.0 |
SHC1 | 7644.0 |
P2RY13 | 7646.0 |
SOS2 | 7658.0 |
LRP12 | 7671.0 |
TNRC6A | 7675.0 |
FGF5 | 7684.0 |
VCL | 7696.0 |
AHCYL1 | 7728.0 |
PSMA3 | 7732.0 |
NF1 | 7743.0 |
PKN2 | 7748.0 |
PAFAH1B1 | 7753.0 |
WNT11 | 7757.0 |
PSMB6 | 7759.0 |
CENPI | 7773.0 |
CX3CR1 | 7784.0 |
THBS2 | 7788.0 |
CASP8 | 7790.0 |
RDH13 | 7793.0 |
KDM4C | 7795.0 |
VPS29 | 7834.0 |
HTR1A | 7853.5 |
HTR1D | 7853.5 |
MIB1 | 7858.0 |
ARHGAP19 | 7873.5 |
WNT10B | 7877.0 |
FRAT2 | 7883.0 |
GPER1 | 7908.0 |
BIRC3 | 7916.0 |
ATP6V1A | 7920.0 |
COL9A1 | 7923.0 |
GNB3 | 7932.0 |
CUL3 | 7933.0 |
ESR2 | 7936.0 |
PNOC | 7937.0 |
ARHGAP24 | 7944.0 |
PKN3 | 7945.0 |
DYNC1H1 | 7965.0 |
CALCRL | 7971.0 |
VPS26A | 7977.0 |
ARHGEF2 | 7980.0 |
DLG2 | 7984.0 |
RIT2 | 7986.0 |
ABHD17B | 7989.0 |
DRD1 | 8013.0 |
SMO | 8017.0 |
CYSLTR1 | 8025.0 |
PRKAR1B | 8032.0 |
UCN2 | 8033.0 |
ULK3 | 8035.0 |
AWAT2 | 8046.0 |
ITGA2 | 8050.0 |
KIF3A | 8088.0 |
PIK3R1 | 8109.0 |
IGF1 | 8112.0 |
OPN1SW | 8117.0 |
ADORA3 | 8119.0 |
AXL | 8124.0 |
SKA2 | 8139.0 |
HSD17B1 | 8140.0 |
CSNK1A1 | 8141.0 |
RSPO2 | 8142.0 |
MAPK4 | 8149.0 |
INCENP | 8159.0 |
RNF2 | 8167.0 |
NTSR2 | 8169.0 |
CCL7 | 8170.0 |
KPNA2 | 8174.0 |
HES5 | 8176.0 |
HRH2 | 8194.0 |
IRS1 | 8196.0 |
TRPC6 | 8208.0 |
PSMA4 | 8213.0 |
GAS1 | 8235.0 |
STAG1 | 8250.0 |
CXXC5 | 8253.0 |
MC4R | 8265.0 |
PDE6G | 8266.0 |
POLR2G | 8271.0 |
VEGFA | 8288.0 |
NDEL1 | 8300.0 |
ARHGEF26 | 8302.0 |
IFT57 | 8304.0 |
AHCTF1 | 8307.0 |
BDNF | 8308.0 |
SMPD3 | 8313.0 |
SPRY1 | 8321.0 |
SMAD7 | 8322.0 |
MAPKAP1 | 8323.0 |
RASA3 | 8325.0 |
ABHD6 | 8329.0 |
ARHGAP5 | 8335.0 |
CNGB1 | 8343.0 |
LPAR2 | 8362.0 |
RALBP1 | 8365.0 |
LRP6 | 8367.0 |
LAMA2 | 8370.0 |
IL17RD | 8393.0 |
NRIP1 | 8401.0 |
OPN3 | 8414.0 |
ID2 | 8421.0 |
PDGFD | 8426.0 |
CREB1 | 8434.0 |
E2F4 | 8446.0 |
CD86 | 8454.0 |
AMHR2 | 8466.0 |
GOPC | 8475.5 |
TIA1 | 8497.0 |
CTBP2 | 8503.0 |
TRIM33 | 8541.0 |
PLA2G4A | 8549.0 |
SPTAN1 | 8554.0 |
OTUD3 | 8564.0 |
GLP1R | 8565.0 |
ELMO1 | 8567.0 |
WNT9B | 8579.0 |
CLTA | 8586.0 |
NRG4 | 8589.0 |
NOX1 | 8593.0 |
MARK3 | 8594.0 |
MYB | 8599.0 |
NUP37 | 8600.0 |
EGF | 8603.0 |
RDH11 | 8604.5 |
AKT3 | 8609.0 |
ARHGAP22 | 8611.0 |
KDM1A | 8614.0 |
ATP6V1C2 | 8616.0 |
DNM1 | 8624.0 |
THBS1 | 8627.0 |
NRG2 | 8629.0 |
THBS4 | 8652.0 |
FYN | 8653.0 |
STAT1 | 8658.0 |
NCK1 | 8659.0 |
CENPL | 8678.0 |
RUNX1 | 8696.0 |
IL2RG | 8698.5 |
SRY | 8700.0 |
TRPC3 | 8707.0 |
TLE4 | 8719.0 |
RHOT1 | 8732.0 |
OPRM1 | 8749.0 |
E2F1 | 8755.0 |
RAPGEF2 | 8767.0 |
PDE7A | 8851.0 |
GABRB3 | 8852.0 |
GRIN2D | 8856.0 |
NTRK3 | 8874.0 |
ESR1 | 8895.0 |
ITPR1 | 8900.0 |
NTF3 | 8909.0 |
LAMC2 | 8913.0 |
PPP1CC | 8925.0 |
RGL2 | 8928.0 |
ARPC2 | 8939.0 |
DLG3 | 8951.0 |
Synthesis of substrates in N-glycan biosythesis
1256 | |
---|---|
set | Synthesis of substrates in N-glycan biosythesis |
setSize | 61 |
pANOVA | 0.000869 |
s.dist | 0.247 |
p.adjustANOVA | 0.0552 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NEU1 | 8761 |
ST3GAL5 | 8661 |
GNPNAT1 | 8416 |
FPGT | 8260 |
ST8SIA5 | 8129 |
GNE | 8072 |
GFPT2 | 7837 |
NUS1 | 7616 |
SLC35C1 | 7359 |
ST3GAL4 | 7352 |
ST3GAL1 | 7280 |
CTSA | 7092 |
ALG5 | 6905 |
GMDS | 6714 |
UAP1 | 6709 |
RENBP | 6496 |
DPM2 | 6375 |
PMM1 | 6321 |
GFPT1 | 6299 |
FUOM | 6173 |
GeneID | Gene Rank |
---|---|
NEU1 | 8761.0 |
ST3GAL5 | 8661.0 |
GNPNAT1 | 8416.0 |
FPGT | 8260.0 |
ST8SIA5 | 8129.0 |
GNE | 8072.0 |
GFPT2 | 7837.0 |
NUS1 | 7616.0 |
SLC35C1 | 7359.0 |
ST3GAL4 | 7352.0 |
ST3GAL1 | 7280.0 |
CTSA | 7092.0 |
ALG5 | 6905.0 |
GMDS | 6714.0 |
UAP1 | 6709.0 |
RENBP | 6496.0 |
DPM2 | 6375.0 |
PMM1 | 6321.0 |
GFPT1 | 6299.0 |
FUOM | 6173.0 |
PGM3 | 6068.0 |
ST6GALNAC6 | 5713.5 |
ST8SIA1 | 5516.0 |
ST6GALNAC5 | 5424.0 |
GMPPA | 5379.0 |
SLC17A5 | 5233.0 |
SLC35A1 | 4879.0 |
ST3GAL2 | 4615.0 |
NEU4 | 3618.0 |
NAGK | 3240.0 |
ST3GAL6 | 3182.0 |
CMAS | 2992.0 |
NEU3 | 2987.0 |
NPL | 2528.0 |
ST8SIA6 | 2385.0 |
NANP | 1740.0 |
NUDT14 | 1486.0 |
MPI | 1074.0 |
ST6GALNAC1 | 531.0 |
ST8SIA3 | 512.0 |
DPM1 | -48.0 |
GMPPB | -73.0 |
MVD | -874.0 |
NANS | -1294.0 |
ST6GALNAC4 | -2240.0 |
DPM3 | -2690.0 |
ST6GAL2 | -2799.0 |
PMM2 | -3168.0 |
DHDDS | -3360.0 |
ST8SIA4 | -3388.0 |
DOLK | -4149.0 |
AMDHD2 | -4321.5 |
ST6GALNAC3 | -4499.0 |
GLB1 | -4829.0 |
NEU2 | -5224.0 |
FCSK | -5669.0 |
ST6GALNAC2 | -5989.0 |
ST3GAL3 | -5996.0 |
DOLPP1 | -6989.0 |
SRD5A3 | -8338.0 |
ST6GAL1 | -8438.0 |
Plasma lipoprotein assembly
881 | |
---|---|
set | Plasma lipoprotein assembly |
setSize | 18 |
pANOVA | 0.000876 |
s.dist | -0.453 |
p.adjustANOVA | 0.0552 |
Top enriched genes
GeneID | Gene Rank |
---|---|
APOC1 | -8963.0 |
APOC3 | -8904.0 |
APOE | -8836.0 |
MTTP | -8003.0 |
PRKACA | -7713.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
APOA4 | -6758.0 |
PRKACB | -6707.0 |
ABCA1 | -6097.0 |
A2M | -3884.0 |
P4HB | -2423.0 |
APOC4 | -1990.0 |
APOA1 | -547.0 |
APOB | 573.0 |
SAR1B | 1055.0 |
ZDHHC8 | 2324.0 |
BMP1 | 7235.0 |
GeneID | Gene Rank |
---|---|
APOC1 | -8963.0 |
APOC3 | -8904.0 |
APOE | -8836.0 |
MTTP | -8003.0 |
PRKACA | -7713.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
APOA4 | -6758.0 |
PRKACB | -6707.0 |
ABCA1 | -6097.0 |
A2M | -3884.0 |
P4HB | -2423.0 |
APOC4 | -1990.0 |
APOA1 | -547.0 |
APOB | 573.0 |
SAR1B | 1055.0 |
ZDHHC8 | 2324.0 |
BMP1 | 7235.0 |
Death Receptor Signalling
266 | |
---|---|
set | Death Receptor Signalling |
setSize | 132 |
pANOVA | 0.00102 |
s.dist | -0.166 |
p.adjustANOVA | 0.0613 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834 |
ARHGEF1 | -8718 |
OBSCN | -8574 |
ARHGEF7 | -8534 |
PLEKHG5 | -8454 |
USP2 | -8432 |
ITSN1 | -8377 |
MAGED1 | -8312 |
ARHGEF11 | -8287 |
RTN4 | -8274 |
USP4 | -8272 |
MADD | -8225 |
NCSTN | -8213 |
NGFR | -8192 |
ARHGEF40 | -7699 |
MCF2 | -7686 |
ARHGEF16 | -7667 |
ABR | -7655 |
MCF2L | -7517 |
TNFAIP3 | -7318 |
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834.0 |
ARHGEF1 | -8718.0 |
OBSCN | -8574.0 |
ARHGEF7 | -8534.0 |
PLEKHG5 | -8454.0 |
USP2 | -8432.0 |
ITSN1 | -8377.0 |
MAGED1 | -8312.0 |
ARHGEF11 | -8287.0 |
RTN4 | -8274.0 |
USP4 | -8272.0 |
MADD | -8225.0 |
NCSTN | -8213.0 |
NGFR | -8192.0 |
ARHGEF40 | -7699.0 |
MCF2 | -7686.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
MCF2L | -7517.0 |
TNFAIP3 | -7318.0 |
ARHGEF5 | -7293.0 |
PLEKHG2 | -7206.0 |
VAV3 | -7088.0 |
ARHGEF17 | -6885.0 |
ARHGEF10L | -6624.0 |
OTUD7B | -6540.0 |
UBC | -6432.0 |
APH1B | -6387.0 |
TRIO | -6348.0 |
BCL2L11 | -6346.0 |
USP21 | -6295.0 |
FGD4 | -6196.0 |
TAB1 | -6122.0 |
FGD1 | -5982.0 |
MAG | -5858.0 |
YWHAE | -5754.0 |
ARHGEF19 | -5545.0 |
BIRC2 | -5344.0 |
SQSTM1 | -5320.0 |
ARHGEF6 | -5311.0 |
FASLG | -5271.0 |
CASP2 | -5200.0 |
AKAP13 | -5190.0 |
TNFSF10 | -5140.0 |
NET1 | -4984.0 |
RNF31 | -4944.5 |
TRAF1 | -4878.0 |
NGEF | -4851.0 |
ARHGEF38 | -4562.0 |
CASP3 | -4363.0 |
RIPK2 | -4098.0 |
CFLAR | -4023.0 |
TNFRSF1A | -4011.0 |
BEX3 | -3892.0 |
TNF | -3751.0 |
PRDM4 | -3727.0 |
SPPL2B | -3638.0 |
PSEN1 | -3548.0 |
MYD88 | -3411.0 |
PREX1 | -3045.0 |
SOS1 | -2808.0 |
ARHGDIA | -2696.0 |
NFKB1 | -2579.0 |
ARHGEF18 | -2547.5 |
LINGO1 | -2353.0 |
TRAF6 | -2185.0 |
CLIP3 | -2179.0 |
AATF | -2176.0 |
PSEN2 | -2171.5 |
UBA52 | -2166.0 |
PRKCI | -2165.0 |
ADAM17 | -2112.0 |
RELA | -2108.0 |
PSENEN | -1907.0 |
OTULIN | -1856.0 |
RIPK1 | -1717.0 |
TAB2 | -1485.0 |
TRADD | -1426.0 |
RACK1 | -1396.0 |
OMG | -1376.0 |
ARHGEF39 | -1272.0 |
ARHGEF10 | -775.0 |
RHOA | -640.0 |
ARHGEF15 | -470.0 |
ARHGEF33 | -451.0 |
FADD | -344.0 |
KALRN | -177.0 |
NSMAF | 620.0 |
IRAK1 | 791.0 |
BAD | 928.0 |
SORCS3 | 985.0 |
APH1A | 1110.0 |
RBCK1 | 1484.0 |
TRAF2 | 1651.0 |
TAB3 | 1681.0 |
VAV1 | 1912.0 |
RAC1 | 2240.0 |
NGF | 2470.0 |
MAP3K7 | 2825.0 |
IKBKG | 3133.0 |
SHARPIN | 3295.0 |
HDAC2 | 3553.0 |
IKBKB | 4039.0 |
FGD2 | 4170.0 |
BAG4 | 4311.0 |
ITGB3BP | 4443.0 |
XIAP | 4741.0 |
TAX1BP1 | 4835.0 |
TIAM2 | 4841.0 |
RASGRF2 | 5220.0 |
GNA13 | 5282.0 |
HDAC3 | 5550.0 |
SPPL2A | 5745.0 |
SMPD2 | 5759.0 |
VAV2 | 5813.0 |
MAPK8 | 5956.0 |
ARHGEF12 | 6104.0 |
FGD3 | 6255.0 |
CHUK | 6304.0 |
FAS | 6708.0 |
TIAM1 | 6942.0 |
HDAC1 | 7175.0 |
CYLD | 7243.0 |
ECT2 | 7350.0 |
RPS27A | 7369.0 |
ARHGEF3 | 7632.0 |
SOS2 | 7658.0 |
CASP8 | 7790.0 |
BIRC3 | 7916.0 |
ARHGEF2 | 7980.0 |
ARHGEF26 | 8302.0 |
SMPD3 | 8313.0 |
Keratan sulfate degradation
623 | |
---|---|
set | Keratan sulfate degradation |
setSize | 12 |
pANOVA | 0.00108 |
s.dist | 0.545 |
p.adjustANOVA | 0.0613 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PRELP | 8868.0 |
OGN | 8486.0 |
FMOD | 7779.0 |
HEXB | 7586.0 |
OMD | 7445.0 |
ACAN | 7037.0 |
KERA | 6796.0 |
HEXA | 5131.5 |
GLB1L | 3354.0 |
LUM | 941.0 |
GNS | -359.0 |
GLB1 | -4829.0 |
GeneID | Gene Rank |
---|---|
PRELP | 8868.0 |
OGN | 8486.0 |
FMOD | 7779.0 |
HEXB | 7586.0 |
OMD | 7445.0 |
ACAN | 7037.0 |
KERA | 6796.0 |
HEXA | 5131.5 |
GLB1L | 3354.0 |
LUM | 941.0 |
GNS | -359.0 |
GLB1 | -4829.0 |
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
122 | |
---|---|
set | Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
setSize | 75 |
pANOVA | 0.00115 |
s.dist | 0.217 |
p.adjustANOVA | 0.0613 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NEU1 | 8761 |
ST3GAL5 | 8661 |
GNPNAT1 | 8416 |
FPGT | 8260 |
ST8SIA5 | 8129 |
GNE | 8072 |
GFPT2 | 7837 |
NUS1 | 7616 |
SLC35C1 | 7359 |
ST3GAL4 | 7352 |
ST3GAL1 | 7280 |
ALG3 | 7136 |
CTSA | 7092 |
ALG5 | 6905 |
ALG1 | 6760 |
GMDS | 6714 |
UAP1 | 6709 |
RENBP | 6496 |
DPM2 | 6375 |
PMM1 | 6321 |
GeneID | Gene Rank |
---|---|
NEU1 | 8761.0 |
ST3GAL5 | 8661.0 |
GNPNAT1 | 8416.0 |
FPGT | 8260.0 |
ST8SIA5 | 8129.0 |
GNE | 8072.0 |
GFPT2 | 7837.0 |
NUS1 | 7616.0 |
SLC35C1 | 7359.0 |
ST3GAL4 | 7352.0 |
ST3GAL1 | 7280.0 |
ALG3 | 7136.0 |
CTSA | 7092.0 |
ALG5 | 6905.0 |
ALG1 | 6760.0 |
GMDS | 6714.0 |
UAP1 | 6709.0 |
RENBP | 6496.0 |
DPM2 | 6375.0 |
PMM1 | 6321.0 |
GFPT1 | 6299.0 |
FUOM | 6173.0 |
PGM3 | 6068.0 |
ALG2 | 6038.0 |
ALG9 | 5896.5 |
ST6GALNAC6 | 5713.5 |
ST8SIA1 | 5516.0 |
ST6GALNAC5 | 5424.0 |
ALG8 | 5423.0 |
GMPPA | 5379.0 |
SLC17A5 | 5233.0 |
SLC35A1 | 4879.0 |
ST3GAL2 | 4615.0 |
RFT1 | 4292.5 |
NEU4 | 3618.0 |
NAGK | 3240.0 |
ST3GAL6 | 3182.0 |
CMAS | 2992.0 |
NEU3 | 2987.0 |
NPL | 2528.0 |
ST8SIA6 | 2385.0 |
NANP | 1740.0 |
NUDT14 | 1486.0 |
MPI | 1074.0 |
ST6GALNAC1 | 531.0 |
ST8SIA3 | 512.0 |
ALG14 | -47.0 |
DPM1 | -48.0 |
GMPPB | -73.0 |
MVD | -874.0 |
NANS | -1294.0 |
ALG11 | -2233.0 |
ST6GALNAC4 | -2240.0 |
ALG12 | -2380.0 |
DPM3 | -2690.0 |
ST6GAL2 | -2799.0 |
ALG10 | -3026.5 |
ALG10B | -3026.5 |
PMM2 | -3168.0 |
DHDDS | -3360.0 |
ST8SIA4 | -3388.0 |
DPAGT1 | -3429.0 |
DOLK | -4149.0 |
MPDU1 | -4181.0 |
AMDHD2 | -4321.5 |
ST6GALNAC3 | -4499.0 |
GLB1 | -4829.0 |
NEU2 | -5224.0 |
FCSK | -5669.0 |
ST6GALNAC2 | -5989.0 |
ST3GAL3 | -5996.0 |
ALG6 | -6909.0 |
DOLPP1 | -6989.0 |
SRD5A3 | -8338.0 |
ST6GAL1 | -8438.0 |
GPCR downstream signalling
464 | |
---|---|
set | GPCR downstream signalling |
setSize | 829 |
pANOVA | 0.00116 |
s.dist | -0.0667 |
p.adjustANOVA | 0.0613 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GABBR1 | -9063 |
C5 | -9060 |
RDH16 | -9052 |
KNG1 | -9050 |
TAS1R2 | -9042 |
PAK1 | -9034 |
CRHR2 | -9033 |
SAG | -9009 |
EDNRA | -8998 |
PDE4D | -8956 |
PTGER3 | -8925 |
PDE2A | -8915 |
AKR1B10 | -8911 |
APOC3 | -8904 |
CAMK2B | -8898 |
PRKAR2B | -8880 |
PDE11A | -8842 |
TTR | -8839 |
APOE | -8836 |
ARHGEF37 | -8834 |
GeneID | Gene Rank |
---|---|
GABBR1 | -9063.0 |
C5 | -9060.0 |
RDH16 | -9052.0 |
KNG1 | -9050.0 |
TAS1R2 | -9042.0 |
PAK1 | -9034.0 |
CRHR2 | -9033.0 |
SAG | -9009.0 |
EDNRA | -8998.0 |
PDE4D | -8956.0 |
PTGER3 | -8925.0 |
PDE2A | -8915.0 |
AKR1B10 | -8911.0 |
APOC3 | -8904.0 |
CAMK2B | -8898.0 |
PRKAR2B | -8880.0 |
PDE11A | -8842.0 |
TTR | -8839.0 |
APOE | -8836.0 |
ARHGEF37 | -8834.0 |
CCL28 | -8774.0 |
RGS17 | -8772.0 |
RRH | -8768.0 |
TAS1R3 | -8751.0 |
DGKE | -8747.0 |
NTSR1 | -8726.0 |
ARHGEF1 | -8718.0 |
P2RY14 | -8673.0 |
ADORA1 | -8671.0 |
RPS6KA1 | -8610.0 |
CXCR1 | -8608.0 |
GNAS | -8601.0 |
RGS14 | -8576.0 |
OBSCN | -8574.0 |
ARHGEF7 | -8534.0 |
RGS5 | -8529.0 |
RGS20 | -8516.0 |
GRK6 | -8511.0 |
PPP3CC | -8476.0 |
RGS6 | -8457.0 |
PLEKHG5 | -8454.0 |
CDC42 | -8440.0 |
PDE1B | -8427.0 |
PLB1 | -8395.0 |
ITSN1 | -8377.0 |
PLCB4 | -8376.0 |
CXCR6 | -8347.0 |
CXCR3 | -8323.0 |
TRH | -8317.0 |
CHRM3 | -8311.0 |
ARHGEF11 | -8287.0 |
VIPR1 | -8263.0 |
GALR2 | -8209.0 |
RBP4 | -8178.0 |
DGKZ | -8155.0 |
GPSM3 | -8134.0 |
PRKAR2A | -8106.0 |
SRC | -8095.0 |
VIP | -8083.0 |
GLP2R | -8069.0 |
NPY | -8050.0 |
LPAR5 | -8048.0 |
NPY1R | -8014.0 |
PDE4C | -7992.5 |
ADRB3 | -7987.5 |
QRFPR | -7977.0 |
PLCB3 | -7957.0 |
NPFFR1 | -7883.0 |
OR52W1 | -7878.0 |
DAGLB | -7867.0 |
NTS | -7866.0 |
AGT | -7862.0 |
RGS2 | -7801.0 |
EDN3 | -7773.0 |
PRKACA | -7713.0 |
GPR27 | -7702.0 |
ARHGEF40 | -7699.0 |
MCF2 | -7686.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
RTP2 | -7650.0 |
GNAI1 | -7649.0 |
RXFP2 | -7630.0 |
PDE1C | -7601.0 |
MGLL | -7581.0 |
DGKB | -7547.0 |
PTGER4 | -7545.0 |
ADORA2B | -7537.0 |
APOC2 | -7531.5 |
MCF2L | -7517.0 |
ABHD12 | -7496.0 |
ADRA2B | -7489.0 |
APOA2 | -7400.0 |
GRK3 | -7362.0 |
RASGRP2 | -7350.0 |
GNG4 | -7316.0 |
DGKG | -7310.0 |
ARHGEF5 | -7293.0 |
CNR1 | -7245.0 |
PLEKHG2 | -7206.0 |
CHRM5 | -7183.0 |
GPC4 | -7160.0 |
PRKCE | -7128.0 |
GNAL | -7120.0 |
PIK3R2 | -7098.5 |
VAV3 | -7088.0 |
RTP3 | -7086.0 |
RGS8 | -7040.0 |
CCR9 | -7000.0 |
GNA14 | -6980.0 |
RBP1 | -6975.0 |
AVPR2 | -6968.0 |
ARHGEF17 | -6885.0 |
ADCY6 | -6882.0 |
PTGER2 | -6876.0 |
OR51E1 | -6846.0 |
GPR39 | -6779.0 |
CNR2 | -6771.0 |
ADCY4 | -6759.0 |
APOA4 | -6758.0 |
ARRB2 | -6754.0 |
CCL19 | -6713.0 |
PRKACB | -6707.0 |
PSAP | -6675.0 |
ARHGEF10L | -6624.0 |
HSD17B6 | -6589.0 |
S1PR4 | -6587.0 |
TSHR | -6499.0 |
HTR7 | -6482.0 |
CXCR5 | -6476.0 |
ADCY2 | -6434.0 |
TRIO | -6348.0 |
SSTR1 | -6304.0 |
C3 | -6303.0 |
CHRM4 | -6286.0 |
GPR132 | -6259.0 |
PPP2CA | -6258.0 |
PIK3R6 | -6249.0 |
REEP6 | -6204.0 |
FGD4 | -6196.0 |
TAC3 | -6187.0 |
RDH8 | -6074.0 |
RAMP2 | -6073.0 |
TACR1 | -6047.0 |
ITPR3 | -6046.0 |
PTGDR2 | -6038.0 |
OR52I1 | -6033.5 |
OR52I2 | -6033.5 |
PCP2 | -6000.0 |
FGD1 | -5982.0 |
TACR3 | -5973.0 |
OR6S1 | -5969.0 |
AKT2 | -5958.0 |
GNG12 | -5884.0 |
PPP1CA | -5881.0 |
ITPR2 | -5837.0 |
SUCNR1 | -5782.0 |
RAMP1 | -5656.0 |
P2RY6 | -5637.0 |
AGTR1 | -5580.0 |
PTH1R | -5552.0 |
ARHGEF19 | -5545.0 |
LRP2 | -5544.0 |
TACR2 | -5487.0 |
PIK3R5 | -5482.0 |
PDE7B | -5405.0 |
OR6K6 | -5329.0 |
TSHB | -5315.0 |
ARHGEF6 | -5311.0 |
GNAT2 | -5270.0 |
RLBP1 | -5232.0 |
PTGER1 | -5226.0 |
CXCR4 | -5218.0 |
AKAP13 | -5190.0 |
PRKCH | -5149.5 |
GNAO1 | -5147.0 |
OR6N2 | -5135.0 |
RCVRN | -5100.0 |
SSTR4 | -5037.0 |
NMUR1 | -5014.0 |
NET1 | -4984.0 |
PRKAR1A | -4970.0 |
P2RY10 | -4936.0 |
NGEF | -4851.0 |
CXCL9 | -4847.0 |
GAL | -4837.0 |
APLNR | -4782.0 |
NPW | -4751.0 |
GRM5 | -4699.0 |
PDE4A | -4632.0 |
TAS2R60 | -4610.0 |
GNB4 | -4593.0 |
XCR1 | -4583.0 |
ARHGEF38 | -4562.0 |
PDE6A | -4543.0 |
FNTB | -4523.5 |
RGS3 | -4491.0 |
FPR2 | -4479.5 |
FPR3 | -4479.5 |
CCR6 | -4453.0 |
LRAT | -4448.0 |
DHRS3 | -4431.0 |
GNAI2 | -4425.0 |
MC5R | -4388.0 |
ADRA1D | -4383.0 |
PDPK1 | -4325.0 |
PROKR2 | -4225.0 |
DGKH | -4197.0 |
GPR4 | -4192.0 |
GRPR | -4160.0 |
TAS2R3 | -4153.0 |
HTR1F | -4088.0 |
NMT2 | -4070.0 |
BDKRB2 | -4057.0 |
PLCB1 | -4053.0 |
ADCY1 | -4044.0 |
LPAR6 | -4022.0 |
SSTR3 | -3984.0 |
RHO | -3979.0 |
GRM8 | -3921.0 |
GHRHR | -3915.0 |
CAMK2A | -3898.0 |
GNB1 | -3895.0 |
MCHR1 | -3891.0 |
C3AR1 | -3874.0 |
OR52B2 | -3822.0 |
NPB | -3820.0 |
UTS2 | -3797.0 |
CCL4 | -3785.5 |
HSPG2 | -3764.0 |
RPS6KA3 | -3698.0 |
CHRM1 | -3677.0 |
PPP2CB | -3632.0 |
GNRHR | -3625.0 |
F2 | -3616.0 |
CXCL11 | -3606.0 |
DGKK | -3596.0 |
GPC2 | -3565.0 |
PTH2 | -3564.0 |
PRKCQ | -3483.0 |
PPP2R1A | -3477.0 |
GPR84 | -3469.0 |
RGR | -3467.0 |
RXFP1 | -3454.0 |
GPIHBP1 | -3404.0 |
ROCK2 | -3394.0 |
CCR3 | -3385.0 |
OR5B2 | -3361.0 |
GRB2 | -3336.0 |
EDN1 | -3312.0 |
PTGIR | -3311.0 |
LRP10 | -3298.0 |
OR51E2 | -3273.0 |
GPR31 | -3246.0 |
HTR5A | -3216.0 |
GPR183 | -3193.0 |
GUCA1B | -3130.0 |
HEBP1 | -3127.0 |
OR8H1 | -3118.0 |
OR8H2 | -3118.0 |
OR8H3 | -3118.0 |
RHOB | -3080.0 |
GNG7 | -3060.0 |
PREX1 | -3045.0 |
SDC4 | -2987.0 |
GNA11 | -2862.0 |
SOS1 | -2808.0 |
SSTR5 | -2799.0 |
PRKCG | -2783.0 |
CYP4V2 | -2726.0 |
PPP3CA | -2656.0 |
ADORA2A | -2639.0 |
CDK5 | -2600.0 |
ARHGEF18 | -2547.5 |
APLN | -2542.0 |
PPBP | -2477.0 |
LPL | -2467.0 |
P2RY2 | -2415.0 |
OR8G1 | -2378.5 |
OR8G5 | -2378.5 |
ADCY5 | -2343.0 |
PENK | -2272.0 |
REEP2 | -2261.0 |
HRAS | -2253.0 |
CX3CL1 | -2245.0 |
OR10G2 | -2217.0 |
FPR1 | -2214.0 |
LTB4R | -2187.0 |
RGS1 | -2147.0 |
RLN3 | -2119.0 |
GPC3 | -2107.0 |
KISS1 | -2106.0 |
ADM2 | -2081.0 |
CCKAR | -2081.0 |
CCR4 | -2081.0 |
GNG13 | -2081.0 |
OPN1LW | -2081.0 |
OPN1MW | -2081.0 |
OR7E24 | -2063.0 |
SDC3 | -2040.0 |
NPFF | -2026.0 |
OR5P2 | -2010.0 |
OR6Y1 | -1916.0 |
OR8K3 | -1912.0 |
OR2F1 | -1842.5 |
OR2F2 | -1842.5 |
GPR176 | -1832.0 |
F2RL2 | -1823.0 |
OR11A1 | -1818.0 |
ADCY9 | -1812.0 |
OR10K1 | -1811.0 |
PRKCA | -1808.0 |
GHSR | -1789.0 |
DAGLA | -1781.0 |
GPR55 | -1771.0 |
OR5G3 | -1752.5 |
CCKBR | -1743.0 |
CXCL10 | -1631.0 |
EGFR | -1624.0 |
CXCL16 | -1619.0 |
OR10V1 | -1562.5 |
OR14J1 | -1562.5 |
OR1I1 | -1562.5 |
OR1Q1 | -1562.5 |
OR4A15 | -1562.5 |
OR4P4 | -1562.5 |
OR56B4 | -1562.5 |
OR5M11 | -1562.5 |
OR5P3 | -1562.5 |
OR5T1 | -1562.5 |
OR5T3 | -1562.5 |
OR6C2 | -1562.5 |
OR6C68 | -1562.5 |
OR8B8 | -1562.5 |
OR5AK2 | -1523.0 |
OR5AK3P | -1523.0 |
TAS2R14 | -1512.0 |
METAP1 | -1481.0 |
GALR1 | -1455.0 |
NPSR1 | -1445.0 |
TRHR | -1407.0 |
EDNRB | -1365.0 |
OR4B1 | -1361.5 |
GPC6 | -1334.0 |
PLXNB1 | -1301.0 |
CASR | -1291.0 |
C5AR1 | -1280.0 |
ARHGEF39 | -1272.0 |
RGS13 | -1258.0 |
CCR7 | -1237.0 |
GRM6 | -1224.0 |
OR10A3 | -1219.5 |
OR10A6 | -1219.5 |
HTR4 | -1218.0 |
GPR45 | -1179.0 |
GPR143 | -1156.0 |
CXCL13 | -1141.0 |
AGRN | -1136.0 |
OR9G1 | -1126.0 |
GPSM2 | -1112.0 |
DRD5 | -987.0 |
MTNR1A | -987.0 |
OR10J5 | -987.0 |
OR11G2 | -987.0 |
OR12D3 | -987.0 |
OR1A1 | -987.0 |
OR1A2 | -987.0 |
OR1J4 | -987.0 |
OR1P1 | -987.0 |
OR2A1 | -987.0 |
OR2T1 | -987.0 |
OR2W3 | -987.0 |
OR4C16 | -987.0 |
OR4C6 | -987.0 |
OR51G2 | -987.0 |
OR51Q1 | -987.0 |
OR52E4 | -987.0 |
OR5AL1 | -987.0 |
OR5R1 | -987.0 |
OR7G1 | -987.0 |
OR8B12 | -987.0 |
OR8B2 | -987.0 |
OR8B3 | -987.0 |
OR8D4 | -987.0 |
OR9K2 | -987.0 |
PROK1 | -987.0 |
RBP2 | -987.0 |
TAAR5 | -987.0 |
TAS2R1 | -987.0 |
CHRM2 | -907.5 |
OR2B11 | -907.5 |
OR2H1 | -907.5 |
OR2H2 | -907.5 |
OR4D1 | -907.5 |
OR52M1 | -907.5 |
OR2T29 | -895.0 |
OR2T4 | -895.0 |
OR2T5 | -895.0 |
OR5B3 | -884.0 |
OR4C15 | -879.0 |
ARHGEF10 | -775.0 |
PPP3CB | -748.0 |
CALCR | -738.0 |
OR14C36 | -733.5 |
OR52N2 | -733.5 |
OR56B2P | -733.5 |
OR7G2 | -733.5 |
OPRL1 | -730.0 |
OR5AC1 | -686.0 |
RGS4 | -680.0 |
HCRTR1 | -648.0 |
RHOA | -640.0 |
CCR10 | -637.0 |
RETSAT | -602.0 |
APOA1 | -547.0 |
OR2AK2 | -519.5 |
OR5H1 | -519.5 |
OR5H14 | -519.5 |
OR5H15 | -519.5 |
OR5H6 | -519.5 |
ARHGEF15 | -470.0 |
PDE6B | -466.0 |
BRS3 | -461.0 |
ARHGEF33 | -451.0 |
GPHB5 | -374.0 |
OR52D1 | -338.5 |
NPY5R | -309.0 |
OR10G3 | -309.0 |
OR4A47 | -309.0 |
OR4F6 | -309.0 |
OR51F2 | -309.0 |
OR52P1P | -309.0 |
OR9A4 | -309.0 |
CGA | -282.0 |
DGKD | -273.0 |
REEP1 | -250.0 |
REEP5 | -211.0 |
CAMKK2 | -200.0 |
CXCL12 | -188.0 |
OPRD1 | -187.0 |
KALRN | -177.0 |
OR7D4 | -133.0 |
OR5AN1 | -121.5 |
OR1N1 | -118.0 |
RGS18 | -112.0 |
GNB5 | -108.0 |
CALM1 | -83.0 |
OR10AG1 | -40.0 |
GPR37L1 | -27.0 |
ARRB1 | -23.0 |
GPR65 | -16.0 |
REEP3 | -8.0 |
OR6B2 | 6.5 |
OR6B3 | 6.5 |
OR4F17 | 11.0 |
OR4F4 | 11.0 |
OR4F5 | 11.0 |
AVPR1A | 53.0 |
PIK3CA | 85.0 |
GNA15 | 89.0 |
TAS2R4 | 142.0 |
CALCB | 231.0 |
CNGA1 | 231.0 |
FFAR1 | 231.0 |
IAPP | 231.0 |
MC3R | 231.0 |
NPBWR1 | 231.0 |
OR10W1 | 231.0 |
OR13F1 | 231.0 |
OR13J1 | 231.0 |
OR1B1 | 231.0 |
OR1J1 | 231.0 |
OR1M1 | 231.0 |
OR2A14 | 231.0 |
OR2A5 | 231.0 |
OR2AP1 | 231.0 |
OR2L13 | 231.0 |
OR2Y1 | 231.0 |
OR4A16 | 231.0 |
OR4C11 | 231.0 |
OR4C12 | 231.0 |
OR4C3 | 231.0 |
OR4D11 | 231.0 |
OR4D2 | 231.0 |
OR4D6 | 231.0 |
OR4F15 | 231.0 |
OR4X2 | 231.0 |
OR51F1 | 231.0 |
OR52E2 | 231.0 |
OR52H1 | 231.0 |
OR52L1 | 231.0 |
OR52R1 | 231.0 |
OR56B1 | 231.0 |
OR5A1 | 231.0 |
OR5B17 | 231.0 |
OR5L1 | 231.0 |
OR5L2 | 231.0 |
OR5M8 | 231.0 |
OR6X1 | 231.0 |
OR8K5 | 231.0 |
OR9Q2 | 231.0 |
PTH2R | 231.0 |
RGS21 | 231.0 |
RTP1 | 231.0 |
TAAR8 | 231.0 |
TAS2R7 | 231.0 |
LHCGR | 340.5 |
GIP | 344.0 |
OR5C1 | 346.0 |
TAS2R42 | 355.0 |
NMT1 | 404.0 |
OR2B2 | 420.0 |
NPY4R | 446.5 |
OXT | 449.0 |
OR4K15 | 540.0 |
OR6C1 | 540.0 |
TAS2R19 | 549.0 |
TAS2R20 | 549.0 |
TAS2R30 | 549.0 |
TAS2R31 | 549.0 |
TAS2R43 | 549.0 |
TAS2R46 | 549.0 |
TAS2R50 | 549.0 |
OPN4 | 560.0 |
OR8A1 | 563.0 |
APOB | 573.0 |
ADCYAP1 | 576.0 |
PPP2R5D | 596.0 |
PIK3R3 | 597.5 |
GNRH1 | 612.0 |
F2RL1 | 616.0 |
OR5W2 | 676.0 |
GPR17 | 677.0 |
PPEF1 | 686.0 |
GRM3 | 693.0 |
OR2AG1 | 700.0 |
TAC1 | 700.0 |
RGS16 | 809.0 |
F2RL3 | 826.0 |
OR52E6 | 842.0 |
OR52E8 | 842.0 |
OR8D1 | 842.0 |
FSHR | 861.5 |
OR4M1 | 861.5 |
OR4M2 | 861.5 |
OR4X1 | 861.5 |
OR51B6 | 861.5 |
OR51I2 | 861.5 |
PYY | 861.5 |
FFAR3 | 896.0 |
OR10C1 | 896.0 |
OR10S1 | 896.0 |
OR2V1 | 896.0 |
OR4K5 | 896.0 |
OR51A2 | 896.0 |
OR51A4 | 896.0 |
OR51V1 | 896.0 |
OR52K2 | 896.0 |
OR2V2 | 917.5 |
OR2Z1 | 917.5 |
OPN5 | 921.0 |
TAS2R13 | 930.0 |
GNG5 | 992.0 |
GHRH | 1070.0 |
OR10H1 | 1093.5 |
OR10H5 | 1093.5 |
QRFP | 1095.0 |
CAMK4 | 1172.0 |
GRM2 | 1192.0 |
FFAR4 | 1193.0 |
GRK2 | 1198.0 |
TAS2R10 | 1246.0 |
GNAT3 | 1292.0 |
RPS6KA2 | 1294.0 |
SSTR2 | 1311.0 |
XCL1 | 1380.5 |
XCL2 | 1380.5 |
OR52E5 | 1404.0 |
OR2AG2 | 1419.5 |
OR7C2 | 1419.5 |
OR8U1 | 1419.5 |
TAAR1 | 1419.5 |
AKT1 | 1488.0 |
OR4N5 | 1533.0 |
PRKCD | 1551.0 |
GPR83 | 1568.0 |
DRD3 | 1587.0 |
ADCY3 | 1612.0 |
GRK1 | 1615.0 |
ADM | 1625.0 |
GPR15 | 1643.0 |
APOM | 1657.0 |
PDE3B | 1668.0 |
OR13C3 | 1717.0 |
CRHR1 | 1747.0 |
NRAS | 1786.0 |
GUCY2D | 1791.0 |
HRH4 | 1810.0 |
PROK2 | 1822.0 |
DGKQ | 1845.0 |
GPRC6A | 1876.0 |
PNLIP | 1909.0 |
VAV1 | 1912.0 |
GRP | 1947.0 |
CXCL6 | 1966.0 |
GALR3 | 1969.0 |
SCTR | 1986.0 |
OR6K3 | 2052.0 |
MAPK1 | 2063.0 |
LRP8 | 2101.0 |
HTR2B | 2125.0 |
OR2T12 | 2143.0 |
OR2T33 | 2143.0 |
OR2T8 | 2143.0 |
RTP4 | 2164.0 |
MC2R | 2177.0 |
ADCY7 | 2210.0 |
OR2AT4 | 2241.0 |
OR6C70 | 2316.5 |
P2RY12 | 2339.0 |
OR6C76 | 2370.0 |
SCT | 2430.0 |
GRK5 | 2483.0 |
RGS22 | 2514.0 |
MAPK3 | 2532.0 |
PRKCB | 2630.0 |
GPR68 | 2735.0 |
GPHA2 | 2779.0 |
HCRT | 2813.0 |
TBXA2R | 2824.0 |
ADRB2 | 2844.0 |
HCAR2 | 2866.5 |
HCAR3 | 2866.5 |
CAMKMT | 2915.0 |
LDLR | 2957.0 |
GUCY2F | 3001.0 |
PDE8B | 3035.5 |
CCR1 | 3082.0 |
GNA12 | 3137.0 |
PDYN | 3143.0 |
CCL23 | 3192.0 |
HCAR1 | 3224.0 |
POMC | 3261.0 |
AVP | 3271.0 |
GNG3 | 3307.0 |
PDE1A | 3353.0 |
F2R | 3369.0 |
LPAR1 | 3370.0 |
RGS7 | 3418.0 |
GNAT1 | 3423.0 |
P2RY4 | 3493.0 |
SDR9C7 | 3561.0 |
BDKRB1 | 3562.0 |
ADRB1 | 3612.0 |
GRK4 | 3623.0 |
GPC1 | 3640.0 |
MYO7A | 3664.0 |
NMB | 3696.0 |
GNAI3 | 3733.0 |
GNG11 | 3752.0 |
HRH1 | 3792.0 |
PDE3A | 3794.0 |
PPP1R1B | 3853.0 |
GPR25 | 3869.0 |
BCO1 | 3884.0 |
ADRA1B | 3941.0 |
OR5I1 | 4012.0 |
SLC24A1 | 4032.0 |
CCR8 | 4126.0 |
FGD2 | 4170.0 |
PDE8A | 4181.0 |
PTAFR | 4229.0 |
CCK | 4270.0 |
RLN2 | 4323.5 |
GNGT2 | 4376.0 |
RGS9BP | 4413.0 |
RGS10 | 4447.0 |
GHRL | 4454.0 |
PPP2R1B | 4513.0 |
NMU | 4522.0 |
ADRA2A | 4582.0 |
HBEGF | 4618.0 |
HTR1B | 4630.0 |
DGKA | 4645.0 |
OR51D1 | 4699.0 |
CAMKK1 | 4711.0 |
MAPK7 | 4725.0 |
TRPC7 | 4748.0 |
LRP1 | 4809.0 |
CALCA | 4836.0 |
TIAM2 | 4841.0 |
CCL27 | 4856.0 |
RBP3 | 4858.0 |
ADRA2C | 4926.0 |
GPR37 | 4931.0 |
ROCK1 | 4962.0 |
RDH10 | 5000.0 |
PPP3R1 | 5058.5 |
RGS9 | 5078.0 |
RAMP3 | 5107.0 |
METAP2 | 5174.0 |
HCRTR2 | 5199.0 |
RASGRF2 | 5220.0 |
RGSL1 | 5265.0 |
OXTR | 5278.0 |
GNA13 | 5282.0 |
OR6K2 | 5286.0 |
GIPR | 5394.0 |
PRKX | 5448.5 |
UTS2B | 5468.0 |
PDE10A | 5495.0 |
RHOC | 5509.5 |
FFAR2 | 5519.0 |
NMBR | 5522.0 |
AVPR1B | 5580.0 |
S1PR5 | 5597.0 |
DRD4 | 5612.0 |
S1PR2 | 5627.0 |
HTR2A | 5650.0 |
RGS19 | 5668.0 |
GPR18 | 5762.0 |
OR1F1 | 5776.0 |
VAV2 | 5813.0 |
KRAS | 5849.0 |
PMCH | 5889.0 |
ARHGEF25 | 5966.5 |
PTGDR | 6020.0 |
BCO2 | 6058.0 |
ARHGEF12 | 6104.0 |
TAS2R41 | 6144.0 |
NAPEPLD | 6226.0 |
GNAZ | 6253.0 |
FGD3 | 6255.0 |
GNB2 | 6264.0 |
OR6N1 | 6265.0 |
ACKR3 | 6294.0 |
CRH | 6329.0 |
VIPR2 | 6379.0 |
RDH12 | 6399.0 |
OR2K2 | 6446.0 |
SDC2 | 6449.0 |
REEP4 | 6463.0 |
GRM1 | 6498.0 |
STRA6 | 6510.0 |
RDH5 | 6515.0 |
OR4E1 | 6518.0 |
ADRA1A | 6572.0 |
GNG8 | 6614.0 |
RGS12 | 6733.0 |
KISS1R | 6746.0 |
GNG2 | 6793.0 |
TAS1R1 | 6812.0 |
ADCY8 | 6825.0 |
PIK3CG | 6844.0 |
OPRK1 | 6857.0 |
PTGFR | 6884.0 |
GPSM1 | 6904.0 |
TIAM1 | 6942.0 |
P2RY1 | 6949.0 |
LTB4R2 | 6967.0 |
RASGRP1 | 7000.0 |
LPAR4 | 7063.0 |
GUCA1A | 7066.0 |
RPE65 | 7074.0 |
GNG10 | 7112.0 |
S1PR3 | 7127.0 |
ANXA1 | 7137.0 |
GABBR2 | 7146.0 |
NMUR2 | 7148.0 |
CCL21 | 7185.0 |
ADCYAP1R1 | 7189.0 |
PLCB2 | 7190.0 |
LPAR3 | 7241.0 |
PDE4B | 7268.0 |
ABCA4 | 7305.0 |
SDC1 | 7316.0 |
DHRS9 | 7322.0 |
GRM7 | 7349.0 |
ECT2 | 7350.0 |
DGKI | 7390.0 |
GPBAR1 | 7429.0 |
CAMK2G | 7477.0 |
APP | 7480.0 |
FNTA | 7484.0 |
AGTR2 | 7492.0 |
EDN2 | 7506.0 |
MMP3 | 7551.0 |
BTK | 7564.0 |
CCR5 | 7623.0 |
ARHGEF3 | 7632.0 |
P2RY13 | 7646.0 |
SOS2 | 7658.0 |
LRP12 | 7671.0 |
AHCYL1 | 7728.0 |
CX3CR1 | 7784.0 |
HTR1D | 7853.5 |
GPER1 | 7908.0 |
GNB3 | 7932.0 |
PNOC | 7937.0 |
CALCRL | 7971.0 |
ARHGEF2 | 7980.0 |
DRD1 | 8013.0 |
CYSLTR1 | 8025.0 |
PRKAR1B | 8032.0 |
AWAT2 | 8046.0 |
PIK3R1 | 8109.0 |
OPN1SW | 8117.0 |
ADORA3 | 8119.0 |
HSD17B1 | 8140.0 |
NTSR2 | 8169.0 |
KPNA2 | 8174.0 |
HRH2 | 8194.0 |
TRPC6 | 8208.0 |
MC4R | 8265.0 |
PDE6G | 8266.0 |
ARHGEF26 | 8302.0 |
ABHD6 | 8329.0 |
CNGB1 | 8343.0 |
LPAR2 | 8362.0 |
OPN3 | 8414.0 |
CREB1 | 8434.0 |
PLA2G4A | 8549.0 |
GLP1R | 8565.0 |
RDH11 | 8604.5 |
AKT3 | 8609.0 |
TRPC3 | 8707.0 |
OPRM1 | 8749.0 |
PDE7A | 8851.0 |
ITPR1 | 8900.0 |
Miscellaneous substrates
700 | |
---|---|
set | Miscellaneous substrates |
setSize | 12 |
pANOVA | 0.00119 |
s.dist | -0.54 |
p.adjustANOVA | 0.0613 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYP2D6 | -9035.5 |
CYP3A43 | -8991.0 |
CYP4F2 | -8108.0 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4B1 | -6651.0 |
CYP4F3 | -4081.0 |
CYP2W1 | -3941.0 |
CYP2S1 | -1638.0 |
CYP2U1 | 2375.0 |
CYP4F22 | 4080.0 |
GeneID | Gene Rank |
---|---|
CYP2D6 | -9035.5 |
CYP3A43 | -8991.0 |
CYP4F2 | -8108.0 |
CYP4A11 | -7728.5 |
CYP4A22 | -7728.5 |
CYP4F11 | -7728.5 |
CYP4B1 | -6651.0 |
CYP4F3 | -4081.0 |
CYP2W1 | -3941.0 |
CYP2S1 | -1638.0 |
CYP2U1 | 2375.0 |
CYP4F22 | 4080.0 |
Chylomicron remodeling
194 | |
---|---|
set | Chylomicron remodeling |
setSize | 10 |
pANOVA | 0.00125 |
s.dist | -0.589 |
p.adjustANOVA | 0.0613 |
Top enriched genes
GeneID | Gene Rank |
---|---|
APOC3 | -8904.0 |
APOE | -8836.0 |
APOA5 | -8466.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
APOA4 | -6758.0 |
GPIHBP1 | -3404.0 |
LPL | -2467.0 |
APOA1 | -547.0 |
APOB | 573.0 |
GeneID | Gene Rank |
---|---|
APOC3 | -8904.0 |
APOE | -8836.0 |
APOA5 | -8466.0 |
APOC2 | -7531.5 |
APOA2 | -7400.0 |
APOA4 | -6758.0 |
GPIHBP1 | -3404.0 |
LPL | -2467.0 |
APOA1 | -547.0 |
APOB | 573.0 |
Factors involved in megakaryocyte development and platelet production
411 | |
---|---|
set | Factors involved in megakaryocyte development and platelet production |
setSize | 124 |
pANOVA | 0.00127 |
s.dist | -0.168 |
p.adjustANOVA | 0.0613 |
Top enriched genes
GeneID | Gene Rank |
---|---|
KIFC2 | -9081 |
KIF18B | -8985 |
KIF1B | -8978 |
KIF21A | -8950 |
PRKAR2B | -8880 |
EHD3 | -8828 |
KIF27 | -8612 |
KIFC1 | -8600 |
SIN3A | -8558 |
CDC42 | -8440 |
PRKAR2A | -8106 |
HMG20B | -7951 |
PRKACA | -7713 |
ITPK1 | -7660 |
NFE2 | -7514 |
KIF21B | -7488 |
KIF9 | -7297 |
MFN2 | -7233 |
ZFPM2 | -7162 |
KIF2C | -7103 |
GeneID | Gene Rank |
---|---|
KIFC2 | -9081 |
KIF18B | -8985 |
KIF1B | -8978 |
KIF21A | -8950 |
PRKAR2B | -8880 |
EHD3 | -8828 |
KIF27 | -8612 |
KIFC1 | -8600 |
SIN3A | -8558 |
CDC42 | -8440 |
PRKAR2A | -8106 |
HMG20B | -7951 |
PRKACA | -7713 |
ITPK1 | -7660 |
NFE2 | -7514 |
KIF21B | -7488 |
KIF9 | -7297 |
MFN2 | -7233 |
ZFPM2 | -7162 |
KIF2C | -7103 |
ABL1 | -7066 |
GATA6 | -6959 |
KLC3 | -6887 |
CAPZB | -6870 |
PRKACB | -6707 |
KIF5A | -6521 |
DOCK6 | -6503 |
KIF16B | -6282 |
DOCK7 | -5972 |
DOCK9 | -5908 |
KIF11 | -5608 |
SH2B2 | -5588 |
MAFK | -5510 |
CABLES1 | -5493 |
IFNA1 | -5355 |
IFNA10 | -5355 |
IFNA14 | -5355 |
IFNA16 | -5355 |
IFNA17 | -5355 |
IFNA2 | -5355 |
IFNA21 | -5355 |
IFNA4 | -5355 |
IFNA5 | -5355 |
IFNA6 | -5355 |
IFNA7 | -5355 |
IFNA8 | -5355 |
KIF26A | -5302 |
KIF1A | -5234 |
KIF19 | -5117 |
DOCK3 | -5112 |
PRKAR1A | -4970 |
IRF1 | -4752 |
EHD1 | -4733 |
KIF20B | -4693 |
EHD2 | -4660 |
KIF1C | -4619 |
ZFPM1 | -4493 |
KIF26B | -3877 |
JAK2 | -3777 |
GATA4 | -3432 |
KIF20A | -3376 |
RACGAP1 | -2770 |
CDK5 | -2600 |
HBE1 | -2432 |
KIF3C | -2283 |
SH2B3 | -2226 |
RCOR1 | -2134 |
PHF21A | -2021 |
H3-3A | -1923 |
GATA3 | -1622 |
DOCK2 | -1444 |
KIF2A | -1295 |
RAB5A | -1243 |
KIFAP3 | -1209 |
AK3 | -839 |
RAD51C | -750 |
DOCK1 | 104 |
MAFF | 112 |
KIF12 | 517 |
KIF18A | 607 |
KIF6 | 619 |
KIF2B | 996 |
VPS45 | 1048 |
KLC2 | 1226 |
SH2B1 | 1236 |
WEE1 | 1357 |
GATA2 | 1911 |
RAC1 | 2240 |
RBSN | 2306 |
KIF22 | 2377 |
AKAP1 | 2494 |
KLC4 | 2935 |
DOCK11 | 3031 |
DOCK4 | 3123 |
KIF4A | 3248 |
HDAC2 | 3553 |
MICAL1 | 3622 |
GATA1 | 3670 |
MAFG | 3707 |
CDK2 | 3851 |
AKAP10 | 3922 |
DOCK5 | 4260 |
GATA5 | 4604 |
RAD51B | 5276 |
CAPZA2 | 5364 |
CENPE | 5825 |
IRF2 | 5903 |
KIF5B | 6494 |
MFN1 | 6573 |
CBX5 | 6715 |
HDAC1 | 7175 |
JMJD1C | 7265 |
KIF15 | 7285 |
KIF23 | 7496 |
CABLES2 | 7630 |
PRKAR1B | 8032 |
KIF3B | 8041 |
KIF3A | 8088 |
KIF5C | 8217 |
KIF13B | 8290 |
DOCK8 | 8423 |
CARMIL1 | 8526 |
MYB | 8599 |
KDM1A | 8614 |
Endosomal/Vacuolar pathway
366 | |
---|---|
set | Endosomal/Vacuolar pathway |
setSize | 10 |
pANOVA | 0.00137 |
s.dist | -0.585 |
p.adjustANOVA | 0.0635 |
Top enriched genes
GeneID | Gene Rank |
---|---|
HLA-A | -8118.5 |
HLA-B | -8118.5 |
HLA-C | -8118.5 |
HLA-E | -8118.5 |
HLA-F | -8118.5 |
HLA-G | -8118.5 |
CTSV | -4546.0 |
LNPEP | -4426.0 |
B2M | 1971.0 |
CTSS | 2396.0 |
GeneID | Gene Rank |
---|---|
HLA-A | -8118.5 |
HLA-B | -8118.5 |
HLA-C | -8118.5 |
HLA-E | -8118.5 |
HLA-F | -8118.5 |
HLA-G | -8118.5 |
CTSV | -4546.0 |
LNPEP | -4426.0 |
B2M | 1971.0 |
CTSS | 2396.0 |
Platelet Aggregation (Plug Formation)
886 | |
---|---|
set | Platelet Aggregation (Plug Formation) |
setSize | 37 |
pANOVA | 0.00143 |
s.dist | -0.303 |
p.adjustANOVA | 0.0635 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FGB | -9053 |
MPL | -9041 |
FGA | -8696 |
THPO | -8655 |
PTK2 | -8355 |
GP1BA | -8136 |
SRC | -8095 |
FGG | -8035 |
BCAR1 | -7614 |
ADRA2B | -7489 |
RASGRP2 | -7350 |
VWF | -7285 |
ITGA2B | -7222 |
RAPGEF3 | -6504 |
SYK | -6379 |
GP5 | -6277 |
GP9 | -5163 |
TLN1 | -5122 |
PDPK1 | -4325 |
GP1BB | -3680 |
GeneID | Gene Rank |
---|---|
FGB | -9053.0 |
MPL | -9041.0 |
FGA | -8696.0 |
THPO | -8655.0 |
PTK2 | -8355.0 |
GP1BA | -8136.0 |
SRC | -8095.0 |
FGG | -8035.0 |
BCAR1 | -7614.0 |
ADRA2B | -7489.0 |
RASGRP2 | -7350.0 |
VWF | -7285.0 |
ITGA2B | -7222.0 |
RAPGEF3 | -6504.0 |
SYK | -6379.0 |
GP5 | -6277.0 |
GP9 | -5163.0 |
TLN1 | -5122.0 |
PDPK1 | -4325.0 |
GP1BB | -3680.0 |
APBB1IP | -3673.0 |
F2 | -3616.0 |
ITGB3 | -3380.5 |
GRB2 | -3336.0 |
SOS1 | -2808.0 |
RAP1A | 937.0 |
AKT1 | 1488.0 |
CRK | 2198.0 |
RAP1B | 4145.0 |
ADRA2A | 4582.0 |
RAPGEF4 | 4676.0 |
CSK | 4803.0 |
ADRA2C | 4926.0 |
PTPN1 | 6830.0 |
FN1 | 6913.0 |
RASGRP1 | 7000.0 |
SHC1 | 7644.0 |
Formation of the beta-catenin:TCF transactivating complex
431 | |
---|---|
set | Formation of the beta-catenin:TCF transactivating complex |
setSize | 41 |
pANOVA | 0.00145 |
s.dist | -0.288 |
p.adjustANOVA | 0.0635 |
Top enriched genes
GeneID | Gene Rank |
---|---|
TLE1 | -9016 |
KMT2D | -8177 |
MYC | -8133 |
H2BC1 | -8026 |
ASH2L | -7949 |
RUVBL1 | -7902 |
AXIN2 | -7523 |
SMARCA4 | -7503 |
LEO1 | -7393 |
LEF1 | -7053 |
TCF4 | -6313 |
TCF7 | -6192 |
BCL9L | -5979 |
TCF7L1 | -5873 |
CREBBP | -5548 |
RUNX3 | -4786 |
H3-4 | -4773 |
PYGO1 | -4769 |
TERT | -4625 |
TCF7L2 | -4244 |
GeneID | Gene Rank |
---|---|
TLE1 | -9016.0 |
KMT2D | -8177.0 |
MYC | -8133.0 |
H2BC1 | -8026.0 |
ASH2L | -7949.0 |
RUVBL1 | -7902.0 |
AXIN2 | -7523.0 |
SMARCA4 | -7503.0 |
LEO1 | -7393.0 |
LEF1 | -7053.0 |
TCF4 | -6313.0 |
TCF7 | -6192.0 |
BCL9L | -5979.0 |
TCF7L1 | -5873.0 |
CREBBP | -5548.0 |
RUNX3 | -4786.0 |
H3-4 | -4773.0 |
PYGO1 | -4769.0 |
TERT | -4625.0 |
TCF7L2 | -4244.0 |
KAT5 | -4080.0 |
TLE3 | -3738.0 |
H2BC3 | -3635.0 |
H2BC12 | -3610.0 |
H2AJ | -3539.0 |
PYGO2 | -2886.0 |
H3-3A | -1923.0 |
TLE2 | -858.0 |
H2AZ1 | -773.0 |
MEN1 | -556.0 |
BCL9 | -533.0 |
H2AZ2 | 124.0 |
EP300 | 1591.0 |
CTNNB1 | 1809.0 |
RBBP5 | 5206.0 |
CDC73 | 5336.0 |
H2BU1 | 5658.0 |
H2BC11 | 6802.0 |
H4C1 | 6923.5 |
HDAC1 | 7175.0 |
TLE4 | 8719.0 |
Regulation of lipid metabolism by PPARalpha
1051 | |
---|---|
set | Regulation of lipid metabolism by PPARalpha |
setSize | 116 |
pANOVA | 0.00158 |
s.dist | -0.17 |
p.adjustANOVA | 0.0674 |
Top enriched genes
GeneID | Gene Rank |
---|---|
SULT2A1 | -9051.0 |
ARNT | -8977.0 |
MED26 | -8830.5 |
MED13L | -8802.0 |
AHRR | -8688.0 |
PPARGC1B | -8580.0 |
SIN3A | -8558.0 |
MED16 | -8539.0 |
NCOR2 | -8506.0 |
PPARG | -8498.0 |
APOA5 | -8466.0 |
NFYB | -8282.0 |
NCOR1 | -8129.0 |
PEX11A | -8070.0 |
RXRB | -7956.0 |
AGT | -7862.0 |
CYP4A11 | -7728.5 |
GLIPR1 | -7664.0 |
CLOCK | -7607.0 |
APOA2 | -7400.0 |
GeneID | Gene Rank |
---|---|
SULT2A1 | -9051.0 |
ARNT | -8977.0 |
MED26 | -8830.5 |
MED13L | -8802.0 |
AHRR | -8688.0 |
PPARGC1B | -8580.0 |
SIN3A | -8558.0 |
MED16 | -8539.0 |
NCOR2 | -8506.0 |
PPARG | -8498.0 |
APOA5 | -8466.0 |
NFYB | -8282.0 |
NCOR1 | -8129.0 |
PEX11A | -8070.0 |
RXRB | -7956.0 |
AGT | -7862.0 |
CYP4A11 | -7728.5 |
GLIPR1 | -7664.0 |
CLOCK | -7607.0 |
APOA2 | -7400.0 |
NR1H3 | -7384.0 |
NRF1 | -7330.0 |
MED12 | -7323.0 |
CD36 | -7248.0 |
MED24 | -7004.0 |
ACOX1 | -6775.0 |
NCOA1 | -6733.0 |
MED15 | -6643.0 |
MED22 | -6572.0 |
FAM120B | -6268.0 |
ANGPTL4 | -6243.0 |
MED23 | -6215.0 |
SREBF2 | -6205.0 |
ABCA1 | -6097.0 |
NCOA6 | -5797.0 |
GPS2 | -5694.0 |
CREBBP | -5548.0 |
MED7 | -5543.0 |
THRAP3 | -5484.0 |
CARM1 | -5274.0 |
RXRA | -5221.0 |
NCOA2 | -5184.0 |
TBL1XR1 | -5183.0 |
FABP1 | -5035.0 |
NR1H2 | -4967.0 |
HELZ2 | -4722.0 |
NCOA3 | -4671.0 |
SREBF1 | -4592.0 |
NFYC | -4345.0 |
MED25 | -4175.0 |
SIN3B | -3955.0 |
MED18 | -3878.0 |
FDFT1 | -3850.0 |
HMGCS2 | -3389.0 |
FADS1 | -3316.0 |
MED27 | -3309.0 |
CPT2 | -2996.0 |
ACSL1 | -2747.0 |
TRIB3 | -2550.0 |
SLC27A1 | -2355.0 |
CDK19 | -2351.0 |
MED30 | -2156.0 |
SP1 | -1438.0 |
ACADM | -1408.0 |
SMARCD3 | -1202.0 |
PLIN2 | -877.0 |
NPAS2 | -672.0 |
APOA1 | -547.0 |
PPARA | -247.0 |
CYP1A1 | 359.0 |
ME1 | 721.0 |
HMGCR | 979.0 |
MED19 | 998.0 |
MED21 | 1133.0 |
ARNTL | 1164.0 |
RORA | 1169.0 |
RGL1 | 1218.0 |
ARNT2 | 1509.0 |
EP300 | 1591.0 |
TBL1X | 1601.5 |
FHL2 | 1605.0 |
MED17 | 1792.5 |
NFYA | 2215.0 |
MED13 | 2543.0 |
GRHL1 | 2566.0 |
AHR | 2943.5 |
CYP7A1 | 3065.0 |
PPARGC1A | 3088.0 |
NR1D1 | 3357.0 |
CPT1A | 3390.0 |
HMGCS1 | 3682.0 |
MED1 | 3935.0 |
MED11 | 4100.0 |
TNFRSF21 | 4280.0 |
NR1H4 | 4600.0 |
MED31 | 4780.0 |
TGS1 | 4793.0 |
TIAM2 | 4841.0 |
MED4 | 5496.0 |
HDAC3 | 5550.0 |
CCNC | 5816.0 |
MTF1 | 6150.0 |
TXNRD1 | 6305.0 |
G0S2 | 6523.0 |
MED6 | 6537.0 |
ALAS1 | 6567.0 |
MED29 | 6632.0 |
MED10 | 6668.0 |
MED9 | 7153.0 |
MED28 | 7354.0 |
MED20 | 7734.0 |
ESRRA | 8154.0 |
ANKRD1 | 8506.0 |
ABCB4 | 8547.0 |
CHD9 | 8687.0 |
MED14 | 8916.0 |
Keratan sulfate/keratin metabolism
624 | |
---|---|
set | Keratan sulfate/keratin metabolism |
setSize | 31 |
pANOVA | 0.00164 |
s.dist | 0.327 |
p.adjustANOVA | 0.0677 |
Top enriched genes
GeneID | Gene Rank |
---|---|
PRELP | 8868.0 |
B4GALT6 | 8861.0 |
OGN | 8486.0 |
B3GNT3 | 8351.0 |
FMOD | 7779.0 |
HEXB | 7586.0 |
OMD | 7445.0 |
ST3GAL4 | 7352.0 |
ST3GAL1 | 7280.0 |
ACAN | 7037.0 |
KERA | 6796.0 |
B4GALT2 | 5318.0 |
HEXA | 5131.5 |
ST3GAL2 | 4615.0 |
B4GALT5 | 4469.0 |
B3GNT4 | 3805.0 |
GLB1L | 3354.0 |
ST3GAL6 | 3182.0 |
B4GALT4 | 2489.0 |
CHST1 | 1992.0 |
GeneID | Gene Rank |
---|---|
PRELP | 8868.0 |
B4GALT6 | 8861.0 |
OGN | 8486.0 |
B3GNT3 | 8351.0 |
FMOD | 7779.0 |
HEXB | 7586.0 |
OMD | 7445.0 |
ST3GAL4 | 7352.0 |
ST3GAL1 | 7280.0 |
ACAN | 7037.0 |
KERA | 6796.0 |
B4GALT2 | 5318.0 |
HEXA | 5131.5 |
ST3GAL2 | 4615.0 |
B4GALT5 | 4469.0 |
B3GNT4 | 3805.0 |
GLB1L | 3354.0 |
ST3GAL6 | 3182.0 |
B4GALT4 | 2489.0 |
CHST1 | 1992.0 |
LUM | 941.0 |
GNS | -359.0 |
SLC35D2 | -885.5 |
CHST2 | -2100.0 |
B4GALT3 | -2173.0 |
B3GNT2 | -2424.0 |
B4GALT1 | -3055.0 |
B4GAT1 | -4085.0 |
GLB1 | -4829.0 |
B3GNT7 | -5845.0 |
ST3GAL3 | -5996.0 |
Intrinsic Pathway of Fibrin Clot Formation
612 | |
---|---|
set | Intrinsic Pathway of Fibrin Clot Formation |
setSize | 23 |
pANOVA | 0.00177 |
s.dist | -0.377 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
KNG1 | -9050.0 |
F10 | -8579.0 |
F12 | -8319.0 |
GP1BA | -8136.0 |
VWF | -7285.0 |
F11 | -6531.0 |
GP5 | -6277.0 |
KLKB1 | -6048.0 |
F9 | -5791.0 |
SERPIND1 | -5751.0 |
GP9 | -5163.0 |
PROC | -3962.0 |
A2M | -3884.0 |
GP1BB | -3680.0 |
F2 | -3616.0 |
SERPING1 | -3530.0 |
SERPINA5 | -1562.5 |
PRCP | -1478.0 |
F8 | -1310.0 |
SERPINC1 | 2277.0 |
GeneID | Gene Rank |
---|---|
KNG1 | -9050.0 |
F10 | -8579.0 |
F12 | -8319.0 |
GP1BA | -8136.0 |
VWF | -7285.0 |
F11 | -6531.0 |
GP5 | -6277.0 |
KLKB1 | -6048.0 |
F9 | -5791.0 |
SERPIND1 | -5751.0 |
GP9 | -5163.0 |
PROC | -3962.0 |
A2M | -3884.0 |
GP1BB | -3680.0 |
F2 | -3616.0 |
SERPING1 | -3530.0 |
SERPINA5 | -1562.5 |
PRCP | -1478.0 |
F8 | -1310.0 |
SERPINC1 | 2277.0 |
PROS1 | 4698.0 |
C1QBP | 5377.0 |
SERPINE2 | 8181.0 |
Hemostasis
534 | |
---|---|
set | Hemostasis |
setSize | 582 |
pANOVA | 0.00181 |
s.dist | -0.0759 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
KIFC2 | -9081 |
IGHM | -9080 |
FGB | -9053 |
KNG1 | -9050 |
IGKC | -9044 |
MPL | -9041 |
BRPF3 | -9028 |
ITGAM | -9020 |
ITIH4 | -9013 |
PLG | -9005 |
ITIH3 | -9001 |
KIF18B | -8985 |
KIF1B | -8978 |
IGF2 | -8965 |
HRG | -8962 |
CLU | -8960 |
KIF21A | -8950 |
PDE2A | -8915 |
PRKAR2B | -8880 |
PDE11A | -8842 |
GeneID | Gene Rank |
---|---|
KIFC2 | -9081.0 |
IGHM | -9080.0 |
FGB | -9053.0 |
KNG1 | -9050.0 |
IGKC | -9044.0 |
MPL | -9041.0 |
BRPF3 | -9028.0 |
ITGAM | -9020.0 |
ITIH4 | -9013.0 |
PLG | -9005.0 |
ITIH3 | -9001.0 |
KIF18B | -8985.0 |
KIF1B | -8978.0 |
IGF2 | -8965.0 |
HRG | -8962.0 |
CLU | -8960.0 |
KIF21A | -8950.0 |
PDE2A | -8915.0 |
PRKAR2B | -8880.0 |
PDE11A | -8842.0 |
EHD3 | -8828.0 |
DGKE | -8747.0 |
CFD | -8722.0 |
FGA | -8696.0 |
KCNMB2 | -8691.5 |
KCNMB1 | -8678.0 |
SERPINA3 | -8667.0 |
SRGN | -8663.0 |
THPO | -8655.0 |
KIF27 | -8612.0 |
GNAS | -8601.0 |
KIFC1 | -8600.0 |
F10 | -8579.0 |
PPP2R5C | -8572.0 |
CYRIB | -8567.0 |
SIN3A | -8558.0 |
ATP2B1 | -8502.0 |
APOH | -8448.0 |
CDC42 | -8440.0 |
PDE1B | -8427.0 |
F5 | -8356.0 |
PTK2 | -8355.0 |
F12 | -8319.0 |
ANGPT2 | -8277.0 |
L1CAM | -8233.0 |
CD84 | -8185.0 |
DGKZ | -8155.0 |
GP1BA | -8136.0 |
CD74 | -8112.0 |
PRKAR2A | -8106.0 |
SRC | -8095.0 |
ALDOA | -8055.0 |
FGG | -8035.0 |
CHID1 | -7975.0 |
HMG20B | -7951.0 |
F13B | -7912.0 |
DAGLB | -7867.0 |
NOS2 | -7772.0 |
ITGA5 | -7756.0 |
PRKACA | -7713.0 |
ITPK1 | -7660.0 |
GNAI1 | -7649.0 |
BCAR1 | -7614.0 |
MGLL | -7581.0 |
CD244 | -7562.0 |
SELP | -7555.0 |
DGKB | -7547.0 |
NFE2 | -7514.0 |
SLC7A10 | -7506.0 |
ABHD12 | -7496.0 |
ADRA2B | -7489.0 |
KIF21B | -7488.0 |
SERPINB8 | -7455.0 |
RAC2 | -7433.0 |
RASGRP2 | -7350.0 |
GNG4 | -7316.0 |
DGKG | -7310.0 |
APLP2 | -7302.0 |
PDGFA | -7301.0 |
IRAG1 | -7300.0 |
KIF9 | -7297.0 |
VWF | -7285.0 |
STIM1 | -7258.0 |
VEGFD | -7250.0 |
CD36 | -7248.0 |
MFN2 | -7233.0 |
ITGA2B | -7222.0 |
ZFPM2 | -7162.0 |
KCNMA1 | -7156.0 |
PRKCE | -7128.0 |
KIF2C | -7103.0 |
PIK3R2 | -7098.5 |
VAV3 | -7088.0 |
ABL1 | -7066.0 |
GNA14 | -6980.0 |
GATA6 | -6959.0 |
KLC3 | -6887.0 |
CAPZB | -6870.0 |
ITGA3 | -6852.0 |
AAMP | -6822.0 |
ARRB2 | -6754.0 |
SERPINA4 | -6752.0 |
PRKACB | -6707.0 |
PSAP | -6675.0 |
STX4 | -6665.0 |
P2RX6 | -6557.0 |
F11 | -6531.0 |
KIF5A | -6521.0 |
RAPGEF3 | -6504.0 |
DOCK6 | -6503.0 |
SYK | -6379.0 |
KIF16B | -6282.0 |
GP5 | -6277.0 |
PPP2CA | -6258.0 |
PIK3R6 | -6249.0 |
PICK1 | -6219.0 |
PPP2R5A | -6197.0 |
GYPC | -6089.0 |
KLKB1 | -6048.0 |
ITPR3 | -6046.0 |
LGALS3BP | -6021.0 |
DOCK7 | -5972.0 |
DOCK9 | -5908.0 |
ITGA6 | -5895.0 |
GNG12 | -5884.0 |
MAG | -5858.0 |
ITPR2 | -5837.0 |
F9 | -5791.0 |
SERPIND1 | -5751.0 |
SLC8A3 | -5661.0 |
ACTN4 | -5646.0 |
KIF11 | -5608.0 |
SH2B2 | -5588.0 |
MAFK | -5510.0 |
CABLES1 | -5493.0 |
PIK3R5 | -5482.0 |
IFNA1 | -5355.0 |
IFNA10 | -5355.0 |
IFNA14 | -5355.0 |
IFNA16 | -5355.0 |
IFNA17 | -5355.0 |
IFNA2 | -5355.0 |
IFNA21 | -5355.0 |
IFNA4 | -5355.0 |
IFNA5 | -5355.0 |
IFNA6 | -5355.0 |
IFNA7 | -5355.0 |
IFNA8 | -5355.0 |
ATP2A3 | -5325.0 |
F7 | -5305.0 |
KIF26A | -5302.0 |
PLCG1 | -5242.0 |
ITGAX | -5237.0 |
KIF1A | -5234.0 |
IGLC1 | -5196.5 |
IGLC2 | -5196.5 |
IGLC3 | -5196.5 |
IGLC7 | -5196.5 |
IGLL1 | -5196.5 |
GP9 | -5163.0 |
PRKCH | -5149.5 |
TLN1 | -5122.0 |
KIF19 | -5117.0 |
DOCK3 | -5112.0 |
PRKAR1A | -4970.0 |
PDGFB | -4881.0 |
IRF1 | -4752.0 |
EHD1 | -4733.0 |
KIF20B | -4693.0 |
ORAI1 | -4684.0 |
EHD2 | -4660.0 |
KIF1C | -4619.0 |
GNB4 | -4593.0 |
SLC8A1 | -4527.0 |
ZFPM1 | -4493.0 |
GNAI2 | -4425.0 |
CEACAM1 | -4406.5 |
CEACAM3 | -4406.5 |
CEACAM5 | -4406.5 |
CEACAM6 | -4406.5 |
CEACAM8 | -4406.5 |
PSG1 | -4406.5 |
PSG11 | -4406.5 |
PSG2 | -4406.5 |
PSG3 | -4406.5 |
PSG4 | -4406.5 |
PSG5 | -4406.5 |
PSG6 | -4406.5 |
PSG7 | -4406.5 |
PSG8 | -4406.5 |
PSG9 | -4406.5 |
SLC3A2 | -4375.0 |
PDPK1 | -4325.0 |
P2RX4 | -4302.0 |
ITGA4 | -4297.0 |
ANGPT1 | -4231.0 |
DGKH | -4197.0 |
CALU | -4108.0 |
ATP2A1 | -4002.0 |
PDE9A | -3993.0 |
PROC | -3962.0 |
SOD1 | -3928.0 |
GLG1 | -3927.0 |
F11R | -3912.0 |
GNB1 | -3895.0 |
GP6 | -3886.0 |
A2M | -3884.0 |
STXBP2 | -3879.0 |
KIF26B | -3877.0 |
JAK2 | -3777.0 |
P2RX5 | -3757.5 |
VTI1B | -3691.0 |
GP1BB | -3680.0 |
APBB1IP | -3673.0 |
PPP2CB | -3632.0 |
F2 | -3616.0 |
DGKK | -3596.0 |
FERMT3 | -3593.0 |
MIF | -3545.0 |
SERPING1 | -3530.0 |
A1BG | -3505.0 |
PRKCQ | -3483.0 |
PPP2R1A | -3477.0 |
GATA4 | -3432.0 |
LCK | -3384.0 |
ITGB3 | -3380.5 |
KIF20A | -3376.0 |
GRB2 | -3336.0 |
SERPINE1 | -3327.0 |
PTGIR | -3311.0 |
SLC7A5 | -3253.0 |
INPP5D | -3164.0 |
JAM3 | -3140.0 |
SPN | -3134.0 |
RHOB | -3080.0 |
ITGA1 | -3067.0 |
GNG7 | -3060.0 |
ACTN2 | -3058.0 |
OLA1 | -3042.0 |
WDR1 | -3013.0 |
SDC4 | -2987.0 |
CD177 | -2979.0 |
KCNMB4 | -2965.0 |
GNA11 | -2862.0 |
IGHV4-34 | -2819.5 |
IGHV4-39 | -2819.5 |
IGHV4-59 | -2819.5 |
SOS1 | -2808.0 |
PRKCG | -2783.0 |
RACGAP1 | -2770.0 |
LYN | -2708.0 |
TUBA4A | -2627.0 |
CDK5 | -2600.0 |
PPBP | -2477.0 |
PLAU | -2465.0 |
HBE1 | -2432.0 |
SCG3 | -2420.0 |
VEGFB | -2366.0 |
SELENOP | -2354.0 |
SPP2 | -2337.0 |
KIF3C | -2283.0 |
HRAS | -2253.0 |
OLR1 | -2229.0 |
SH2B3 | -2226.0 |
SELPLG | -2186.0 |
ESAM | -2174.0 |
RCOR1 | -2134.0 |
GNG13 | -2081.0 |
SLC7A8 | -2065.0 |
SDC3 | -2040.0 |
TOR4A | -2039.0 |
PHF21A | -2021.0 |
TTN | -1998.0 |
JAM2 | -1946.0 |
H3-3A | -1923.0 |
F2RL2 | -1823.0 |
PRKCA | -1808.0 |
DAGLA | -1781.0 |
ITGAL | -1761.0 |
CAV1 | -1723.0 |
GATA3 | -1622.0 |
SERPINA5 | -1562.5 |
ORAI2 | -1505.0 |
PRCP | -1478.0 |
ATP2B2 | -1475.0 |
HABP4 | -1469.0 |
DOCK2 | -1444.0 |
SLC7A9 | -1420.0 |
F8 | -1310.0 |
KIF2A | -1295.0 |
TIMP1 | -1254.0 |
TEK | -1251.0 |
RAB5A | -1243.0 |
KIFAP3 | -1209.0 |
ATP1B1 | -1185.0 |
SELE | -1172.0 |
TGFB1 | -1162.0 |
AK3 | -839.0 |
FGR | -824.0 |
CYB5R1 | -782.0 |
QSOX1 | -760.0 |
RAD51C | -750.0 |
RHOA | -640.0 |
APOA1 | -547.0 |
ITGB2 | -462.0 |
KCNMB3 | -435.0 |
YWHAZ | -416.0 |
SELL | -386.0 |
DGKD | -273.0 |
GNB5 | -108.0 |
CALM1 | -83.0 |
RARRES2 | -81.0 |
CTSW | -34.0 |
ARRB1 | -23.0 |
PIK3CA | 85.0 |
GNA15 | 89.0 |
DOCK1 | 104.0 |
MAFF | 112.0 |
CD2 | 119.0 |
CAP1 | 126.0 |
PIK3CB | 231.0 |
IGHV7-81 | 372.5 |
KIF12 | 517.0 |
APOB | 573.0 |
PPP2R5D | 596.0 |
PIK3R3 | 597.5 |
KIF18A | 607.0 |
ATP1B3 | 618.0 |
KIF6 | 619.0 |
RHOG | 709.0 |
TSPAN7 | 719.5 |
ATP2A2 | 736.0 |
RAF1 | 737.0 |
TGFB3 | 801.0 |
F2RL3 | 826.0 |
RAP1A | 937.0 |
IGLV6-57 | 991.0 |
GNG5 | 992.0 |
KIF2B | 996.0 |
VPS45 | 1048.0 |
ACTN1 | 1114.0 |
SRI | 1224.0 |
KLC2 | 1226.0 |
SH2B1 | 1236.0 |
CXADR | 1249.0 |
PRKCZ | 1256.0 |
JCHAIN | 1276.0 |
GNAT3 | 1292.0 |
HGF | 1325.0 |
WEE1 | 1357.0 |
LAMP2 | 1397.0 |
DOK2 | 1445.0 |
AKT1 | 1488.0 |
AHSG | 1504.0 |
PRKCD | 1551.0 |
SCCPDH | 1662.0 |
SLC16A1 | 1702.0 |
PHACTR2 | 1709.0 |
F13A1 | 1711.0 |
NRAS | 1786.0 |
STXBP3 | 1812.0 |
PPIL2 | 1825.0 |
DGKQ | 1845.0 |
GATA2 | 1911.0 |
VAV1 | 1912.0 |
ENDOD1 | 1963.0 |
MMP1 | 2049.0 |
SLC16A8 | 2061.0 |
MAPK1 | 2063.0 |
CD48 | 2067.0 |
LRP8 | 2101.0 |
CRK | 2198.0 |
TREM1 | 2209.0 |
RAC1 | 2240.0 |
ITGAV | 2243.0 |
TIMP3 | 2250.0 |
SERPINC1 | 2277.0 |
RBSN | 2306.0 |
LEFTY2 | 2311.5 |
CFL1 | 2322.0 |
ITGA10 | 2327.0 |
P2RY12 | 2339.0 |
NHLRC2 | 2355.0 |
KIF22 | 2377.0 |
SLC7A11 | 2434.0 |
NOS3 | 2441.0 |
CDC37L1 | 2449.0 |
ITGB1 | 2469.0 |
AKAP1 | 2494.0 |
TAGLN2 | 2529.0 |
MAPK3 | 2532.0 |
PRTN3 | 2547.0 |
SIRPA | 2575.5 |
SIRPG | 2575.5 |
PRKCB | 2630.0 |
FLNA | 2688.0 |
SLC16A3 | 2751.0 |
IGLV3-16 | 2760.0 |
IGLV3-22 | 2760.0 |
IGLV3-25 | 2760.0 |
IGLV3-27 | 2760.0 |
TBXA2R | 2824.0 |
ORM1 | 2834.5 |
ORM2 | 2834.5 |
P2RX7 | 2904.0 |
KLC4 | 2935.0 |
ATP1B2 | 2959.0 |
THBD | 3011.0 |
PDPN | 3026.0 |
DOCK11 | 3031.0 |
DOCK4 | 3123.0 |
MANF | 3124.0 |
GNA12 | 3137.0 |
ECM1 | 3174.0 |
EPCAM | 3220.0 |
GAS6 | 3228.0 |
KIF4A | 3248.0 |
SYTL4 | 3306.0 |
GNG3 | 3307.0 |
P2RX1 | 3344.0 |
IGKV2-30 | 3349.5 |
IGKV2D-30 | 3349.5 |
PDE1A | 3353.0 |
F2R | 3369.0 |
IGKV1-12 | 3443.5 |
IGKV1-16 | 3443.5 |
IGKV1-17 | 3443.5 |
IGKV1-39 | 3443.5 |
IGKV1-5 | 3443.5 |
IGKV1D-12 | 3443.5 |
IGKV1D-16 | 3443.5 |
IGKV1D-39 | 3443.5 |
APOOL | 3468.0 |
HDAC2 | 3553.0 |
GRB14 | 3563.0 |
IGHV2-5 | 3567.0 |
IGHV2-70 | 3567.0 |
MICAL1 | 3622.0 |
GPC1 | 3640.0 |
ANGPT4 | 3661.0 |
GATA1 | 3670.0 |
F3 | 3700.0 |
PTPN11 | 3701.0 |
MAFG | 3707.0 |
MMRN1 | 3708.0 |
MAPK14 | 3711.0 |
GNAI3 | 3733.0 |
GNG11 | 3752.0 |
FCER1G | 3777.0 |
PDE5A | 3804.0 |
CDK2 | 3851.0 |
PLAUR | 3867.0 |
AKAP10 | 3922.0 |
ANXA5 | 4104.0 |
RAP1B | 4145.0 |
CD9 | 4248.0 |
DOCK5 | 4260.0 |
ATP2B4 | 4304.0 |
CLEC3B | 4318.0 |
VPREB3 | 4334.0 |
ISLR | 4355.0 |
GNGT2 | 4376.0 |
MERTK | 4477.0 |
PPP2R1B | 4513.0 |
RAB27B | 4550.0 |
ADRA2A | 4582.0 |
GATA5 | 4604.0 |
DGKA | 4645.0 |
PTPN6 | 4670.0 |
RAPGEF4 | 4676.0 |
PROS1 | 4698.0 |
GRB7 | 4726.0 |
TRPC7 | 4748.0 |
PFN1 | 4767.0 |
CSK | 4803.0 |
ADRA2C | 4926.0 |
S100A10 | 4967.0 |
SLC7A7 | 4974.0 |
SERPINF2 | 5087.0 |
LY6G6F | 5161.5 |
RAD51B | 5276.0 |
GNA13 | 5282.0 |
CAPZA2 | 5364.0 |
C1QBP | 5377.0 |
IGKV4-1 | 5450.0 |
PDE10A | 5495.0 |
PLCG2 | 5518.0 |
CD109 | 5520.0 |
VAV2 | 5813.0 |
PLAT | 5817.0 |
CENPE | 5825.0 |
KRAS | 5849.0 |
GUCY1A2 | 5853.0 |
IRF2 | 5903.0 |
ABCC4 | 6019.0 |
FCAMR | 6076.0 |
SERPINB6 | 6087.0 |
SPARC | 6116.0 |
HSPA5 | 6121.0 |
CLEC1B | 6137.0 |
SLC7A6 | 6179.0 |
FAM3C | 6213.0 |
NOS1 | 6241.0 |
GNB2 | 6264.0 |
CD44 | 6282.0 |
LHFPL2 | 6310.0 |
VEGFC | 6335.0 |
PCDH7 | 6353.0 |
BSG | 6428.0 |
SDC2 | 6449.0 |
TMSB4X | 6485.0 |
YES1 | 6489.0 |
KIF5B | 6494.0 |
MFN1 | 6573.0 |
GNG8 | 6614.0 |
CBX5 | 6715.0 |
PPP2R5B | 6776.0 |
GNG2 | 6793.0 |
TMX3 | 6827.0 |
PTPN1 | 6830.0 |
PIK3CG | 6844.0 |
LAT | 6872.0 |
FN1 | 6913.0 |
P2RY1 | 6949.0 |
RASGRP1 | 7000.0 |
PAFAH2 | 7055.0 |
GNG10 | 7112.0 |
PPP2R5E | 7165.0 |
HDAC1 | 7175.0 |
JMJD1C | 7265.0 |
KIF15 | 7285.0 |
SDC1 | 7316.0 |
TEX264 | 7338.0 |
PROCR | 7343.0 |
DGKI | 7390.0 |
LCP2 | 7447.0 |
CD63 | 7455.0 |
APP | 7480.0 |
KIF23 | 7496.0 |
PRKG2 | 7597.0 |
CABLES2 | 7630.0 |
SHC1 | 7644.0 |
VPREB1 | 7668.0 |
ATP2B3 | 7695.0 |
VCL | 7696.0 |
PCYOX1L | 7829.0 |
PLEK | 7931.0 |
GNB3 | 7932.0 |
CD47 | 7939.0 |
ALB | 7970.0 |
PRKAR1B | 8032.0 |
KIF3B | 8041.0 |
ITGA2 | 8050.0 |
GTPBP2 | 8085.0 |
KIF3A | 8088.0 |
PIK3R1 | 8109.0 |
IGF1 | 8112.0 |
SERPINE2 | 8181.0 |
TRPC6 | 8208.0 |
KIF5C | 8217.0 |
CD99L2 | 8283.0 |
VEGFA | 8288.0 |
KIF13B | 8290.0 |
ABHD6 | 8329.0 |
DOCK8 | 8423.0 |
TFPI | 8435.0 |
SLC8A2 | 8512.0 |
P2RX3 | 8519.0 |
CARMIL1 | 8526.0 |
MAGED2 | 8532.0 |
PLA2G4A | 8549.0 |
MYB | 8599.0 |
EGF | 8603.0 |
KDM1A | 8614.0 |
CD99 | 8621.0 |
THBS1 | 8627.0 |
FYN | 8653.0 |
TRPC3 | 8707.0 |
P2RX2 | 8824.0 |
TGFB2 | 8828.0 |
PPIA | 8839.5 |
ITPR1 | 8900.0 |
Chromatin modifying enzymes
190 | |
---|---|
set | Chromatin modifying enzymes |
setSize | 208 |
pANOVA | 0.0019 |
s.dist | -0.125 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
BRPF3 | -9028.0 |
TADA2A | -8785.0 |
JADE2 | -8766.0 |
ARID1B | -8664.0 |
PRMT7 | -8656.0 |
REST | -8650.0 |
EHMT2 | -8623.0 |
DNMT3A | -8552.0 |
KMT2E | -8542.0 |
EP400 | -8532.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
SAP130 | -8463.0 |
SMARCE1 | -8284.0 |
SGF29 | -8256.0 |
WDR77 | -8231.0 |
KMT2D | -8177.0 |
SMARCC1 | -8164.0 |
KDM5A | -8149.0 |
NCOR1 | -8129.0 |
GeneID | Gene Rank |
---|---|
BRPF3 | -9028.0 |
TADA2A | -8785.0 |
JADE2 | -8766.0 |
ARID1B | -8664.0 |
PRMT7 | -8656.0 |
REST | -8650.0 |
EHMT2 | -8623.0 |
DNMT3A | -8552.0 |
KMT2E | -8542.0 |
EP400 | -8532.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
SAP130 | -8463.0 |
SMARCE1 | -8284.0 |
SGF29 | -8256.0 |
WDR77 | -8231.0 |
KMT2D | -8177.0 |
SMARCC1 | -8164.0 |
KDM5A | -8149.0 |
NCOR1 | -8129.0 |
SUPT7L | -8097.0 |
CHD4 | -8089.5 |
SETD2 | -8046.0 |
H2BC1 | -8026.0 |
DOT1L | -7989.0 |
HMG20B | -7951.0 |
ASH2L | -7949.0 |
RUVBL1 | -7902.0 |
KAT6A | -7887.0 |
PHF20 | -7796.0 |
BRPF1 | -7733.0 |
CLOCK | -7607.0 |
ATF2 | -7522.0 |
SMARCA4 | -7503.0 |
SMARCC2 | -7231.0 |
GATAD2B | -7106.0 |
SMARCD1 | -6982.0 |
USP22 | -6816.0 |
EPC1 | -6787.0 |
NCOA1 | -6733.0 |
VPS72 | -6623.0 |
HCFC1 | -6571.0 |
EZH2 | -6564.0 |
PHF8 | -6526.0 |
RBBP7 | -6428.0 |
KDM5B | -6417.0 |
KMT5B | -6334.0 |
KAT8 | -6306.0 |
SUV39H1 | -6246.0 |
ATF7IP | -6181.0 |
KAT2A | -6099.0 |
GATAD2A | -6019.0 |
ING4 | -5923.0 |
KAT6B | -5773.0 |
KDM2B | -5715.0 |
GPS2 | -5694.0 |
MRGBP | -5670.0 |
ACTB | -5609.0 |
CHD3 | -5584.0 |
CREBBP | -5548.0 |
MSL2 | -5494.0 |
KDM6B | -5479.0 |
SAP30L | -5456.0 |
ELP5 | -5428.0 |
DPY30 | -5293.0 |
KMT5C | -5275.0 |
CARM1 | -5274.0 |
SMARCD2 | -5251.0 |
NCOA2 | -5184.0 |
TBL1XR1 | -5183.0 |
ARID1A | -5143.0 |
SETD1A | -4916.0 |
ELP6 | -4910.0 |
SMARCA2 | -4640.0 |
SETD1B | -4579.0 |
BRWD1 | -4518.0 |
SUPT3H | -4222.0 |
KMT2A | -4096.5 |
ATXN7 | -4086.0 |
KAT5 | -4080.0 |
ING3 | -4047.0 |
H2AC1 | -3942.0 |
KDM7A | -3854.0 |
SMYD2 | -3811.0 |
PHF2 | -3794.0 |
JAK2 | -3777.0 |
H2BC3 | -3635.0 |
KDM4D | -3620.0 |
H2BC12 | -3610.0 |
H2AJ | -3539.0 |
ACTL6B | -3516.0 |
KDM1B | -3115.0 |
MORF4L2 | -3053.0 |
MBIP | -3036.0 |
H2AC21 | -2911.0 |
KDM3A | -2751.0 |
NFKB1 | -2579.0 |
RBBP4 | -2539.0 |
PADI4 | -2385.0 |
KDM2A | -2374.0 |
DR1 | -2225.0 |
MBD3 | -2136.0 |
RCOR1 | -2134.0 |
RELA | -2108.0 |
NFKB2 | -2096.0 |
ASH1L | -2058.0 |
PHF21A | -2021.0 |
MCRS1 | -1868.0 |
EHMT1 | -1807.0 |
TADA2B | -1722.0 |
RPS2 | -1703.0 |
NSD2 | -1676.0 |
CCND1 | -1414.0 |
KDM4B | -1378.0 |
SMARCD3 | -1202.0 |
ARID4B | -1084.0 |
H2AZ1 | -773.0 |
MECOM | -508.0 |
PADI6 | -408.0 |
KAT14 | -261.0 |
SAP18 | -24.0 |
WDR5 | 13.0 |
H2AZ2 | 124.0 |
DMAP1 | 334.0 |
AEBP2 | 505.0 |
YEATS4 | 770.0 |
ENY2 | 954.0 |
SETD3 | 1060.0 |
UTY | 1097.0 |
JADE3 | 1100.0 |
BRD1 | 1135.0 |
KAT7 | 1228.0 |
SETD7 | 1248.0 |
ARID2 | 1301.0 |
SUDS3 | 1312.0 |
PADI3 | 1352.0 |
KMT2B | 1475.0 |
KANSL3 | 1571.0 |
EP300 | 1591.0 |
TBL1X | 1601.5 |
NSD1 | 1698.0 |
JMJD6 | 1968.0 |
TADA3 | 2021.0 |
PRMT5 | 2072.0 |
SUZ12 | 2083.0 |
HAT1 | 2127.0 |
RUVBL2 | 2438.0 |
ELP3 | 2546.0 |
MTA2 | 2644.0 |
PRDM9 | 2769.5 |
PRDM16 | 2793.0 |
COPRS | 2905.0 |
KAT2B | 2962.0 |
PADI1 | 3189.0 |
SUPT20H | 3305.0 |
HDAC10 | 3474.0 |
HDAC2 | 3553.0 |
HDAC8 | 3649.5 |
MSL1 | 3703.0 |
JADE1 | 3784.0 |
KDM3B | 4291.0 |
KMT5A | 4560.0 |
SETDB1 | 4653.0 |
SMARCB1 | 4808.0 |
PAX3 | 4963.0 |
ATXN7L3 | 5041.0 |
PBRM1 | 5106.0 |
KANSL2 | 5109.0 |
RBBP5 | 5206.0 |
YEATS2 | 5221.0 |
TAF10 | 5463.0 |
HDAC3 | 5550.0 |
H2BU1 | 5658.0 |
EED | 5777.0 |
PRMT1 | 5858.0 |
TAF6L | 5958.0 |
ARID4A | 6036.0 |
SETD6 | 6208.0 |
TAF12 | 6378.0 |
CDK4 | 6438.0 |
SUV39H2 | 6444.0 |
BRMS1 | 6472.0 |
PADI2 | 6560.0 |
MEAF6 | 6662.0 |
KANSL1 | 6678.0 |
TAF5L | 6749.0 |
H2BC11 | 6802.0 |
MTA3 | 6856.0 |
H4C1 | 6923.5 |
ING5 | 6996.0 |
ELP2 | 7021.0 |
SAP30 | 7068.0 |
HDAC1 | 7175.0 |
ACTL6A | 7360.0 |
SETDB2 | 7381.0 |
MSL3 | 7411.0 |
ELP4 | 7726.0 |
KDM4C | 7795.0 |
ZZZ3 | 7850.0 |
PRMT3 | 8104.0 |
BRD8 | 8177.0 |
NSD3 | 8183.0 |
PRMT6 | 8261.0 |
KDM5D | 8478.0 |
KDM1A | 8614.0 |
OGT | 8679.0 |
TADA1 | 8752.0 |
KDM5C | 8917.0 |
Chromatin organization
191 | |
---|---|
set | Chromatin organization |
setSize | 208 |
pANOVA | 0.0019 |
s.dist | -0.125 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
BRPF3 | -9028.0 |
TADA2A | -8785.0 |
JADE2 | -8766.0 |
ARID1B | -8664.0 |
PRMT7 | -8656.0 |
REST | -8650.0 |
EHMT2 | -8623.0 |
DNMT3A | -8552.0 |
KMT2E | -8542.0 |
EP400 | -8532.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
SAP130 | -8463.0 |
SMARCE1 | -8284.0 |
SGF29 | -8256.0 |
WDR77 | -8231.0 |
KMT2D | -8177.0 |
SMARCC1 | -8164.0 |
KDM5A | -8149.0 |
NCOR1 | -8129.0 |
GeneID | Gene Rank |
---|---|
BRPF3 | -9028.0 |
TADA2A | -8785.0 |
JADE2 | -8766.0 |
ARID1B | -8664.0 |
PRMT7 | -8656.0 |
REST | -8650.0 |
EHMT2 | -8623.0 |
DNMT3A | -8552.0 |
KMT2E | -8542.0 |
EP400 | -8532.0 |
NCOR2 | -8506.0 |
KDM4A | -8470.5 |
SAP130 | -8463.0 |
SMARCE1 | -8284.0 |
SGF29 | -8256.0 |
WDR77 | -8231.0 |
KMT2D | -8177.0 |
SMARCC1 | -8164.0 |
KDM5A | -8149.0 |
NCOR1 | -8129.0 |
SUPT7L | -8097.0 |
CHD4 | -8089.5 |
SETD2 | -8046.0 |
H2BC1 | -8026.0 |
DOT1L | -7989.0 |
HMG20B | -7951.0 |
ASH2L | -7949.0 |
RUVBL1 | -7902.0 |
KAT6A | -7887.0 |
PHF20 | -7796.0 |
BRPF1 | -7733.0 |
CLOCK | -7607.0 |
ATF2 | -7522.0 |
SMARCA4 | -7503.0 |
SMARCC2 | -7231.0 |
GATAD2B | -7106.0 |
SMARCD1 | -6982.0 |
USP22 | -6816.0 |
EPC1 | -6787.0 |
NCOA1 | -6733.0 |
VPS72 | -6623.0 |
HCFC1 | -6571.0 |
EZH2 | -6564.0 |
PHF8 | -6526.0 |
RBBP7 | -6428.0 |
KDM5B | -6417.0 |
KMT5B | -6334.0 |
KAT8 | -6306.0 |
SUV39H1 | -6246.0 |
ATF7IP | -6181.0 |
KAT2A | -6099.0 |
GATAD2A | -6019.0 |
ING4 | -5923.0 |
KAT6B | -5773.0 |
KDM2B | -5715.0 |
GPS2 | -5694.0 |
MRGBP | -5670.0 |
ACTB | -5609.0 |
CHD3 | -5584.0 |
CREBBP | -5548.0 |
MSL2 | -5494.0 |
KDM6B | -5479.0 |
SAP30L | -5456.0 |
ELP5 | -5428.0 |
DPY30 | -5293.0 |
KMT5C | -5275.0 |
CARM1 | -5274.0 |
SMARCD2 | -5251.0 |
NCOA2 | -5184.0 |
TBL1XR1 | -5183.0 |
ARID1A | -5143.0 |
SETD1A | -4916.0 |
ELP6 | -4910.0 |
SMARCA2 | -4640.0 |
SETD1B | -4579.0 |
BRWD1 | -4518.0 |
SUPT3H | -4222.0 |
KMT2A | -4096.5 |
ATXN7 | -4086.0 |
KAT5 | -4080.0 |
ING3 | -4047.0 |
H2AC1 | -3942.0 |
KDM7A | -3854.0 |
SMYD2 | -3811.0 |
PHF2 | -3794.0 |
JAK2 | -3777.0 |
H2BC3 | -3635.0 |
KDM4D | -3620.0 |
H2BC12 | -3610.0 |
H2AJ | -3539.0 |
ACTL6B | -3516.0 |
KDM1B | -3115.0 |
MORF4L2 | -3053.0 |
MBIP | -3036.0 |
H2AC21 | -2911.0 |
KDM3A | -2751.0 |
NFKB1 | -2579.0 |
RBBP4 | -2539.0 |
PADI4 | -2385.0 |
KDM2A | -2374.0 |
DR1 | -2225.0 |
MBD3 | -2136.0 |
RCOR1 | -2134.0 |
RELA | -2108.0 |
NFKB2 | -2096.0 |
ASH1L | -2058.0 |
PHF21A | -2021.0 |
MCRS1 | -1868.0 |
EHMT1 | -1807.0 |
TADA2B | -1722.0 |
RPS2 | -1703.0 |
NSD2 | -1676.0 |
CCND1 | -1414.0 |
KDM4B | -1378.0 |
SMARCD3 | -1202.0 |
ARID4B | -1084.0 |
H2AZ1 | -773.0 |
MECOM | -508.0 |
PADI6 | -408.0 |
KAT14 | -261.0 |
SAP18 | -24.0 |
WDR5 | 13.0 |
H2AZ2 | 124.0 |
DMAP1 | 334.0 |
AEBP2 | 505.0 |
YEATS4 | 770.0 |
ENY2 | 954.0 |
SETD3 | 1060.0 |
UTY | 1097.0 |
JADE3 | 1100.0 |
BRD1 | 1135.0 |
KAT7 | 1228.0 |
SETD7 | 1248.0 |
ARID2 | 1301.0 |
SUDS3 | 1312.0 |
PADI3 | 1352.0 |
KMT2B | 1475.0 |
KANSL3 | 1571.0 |
EP300 | 1591.0 |
TBL1X | 1601.5 |
NSD1 | 1698.0 |
JMJD6 | 1968.0 |
TADA3 | 2021.0 |
PRMT5 | 2072.0 |
SUZ12 | 2083.0 |
HAT1 | 2127.0 |
RUVBL2 | 2438.0 |
ELP3 | 2546.0 |
MTA2 | 2644.0 |
PRDM9 | 2769.5 |
PRDM16 | 2793.0 |
COPRS | 2905.0 |
KAT2B | 2962.0 |
PADI1 | 3189.0 |
SUPT20H | 3305.0 |
HDAC10 | 3474.0 |
HDAC2 | 3553.0 |
HDAC8 | 3649.5 |
MSL1 | 3703.0 |
JADE1 | 3784.0 |
KDM3B | 4291.0 |
KMT5A | 4560.0 |
SETDB1 | 4653.0 |
SMARCB1 | 4808.0 |
PAX3 | 4963.0 |
ATXN7L3 | 5041.0 |
PBRM1 | 5106.0 |
KANSL2 | 5109.0 |
RBBP5 | 5206.0 |
YEATS2 | 5221.0 |
TAF10 | 5463.0 |
HDAC3 | 5550.0 |
H2BU1 | 5658.0 |
EED | 5777.0 |
PRMT1 | 5858.0 |
TAF6L | 5958.0 |
ARID4A | 6036.0 |
SETD6 | 6208.0 |
TAF12 | 6378.0 |
CDK4 | 6438.0 |
SUV39H2 | 6444.0 |
BRMS1 | 6472.0 |
PADI2 | 6560.0 |
MEAF6 | 6662.0 |
KANSL1 | 6678.0 |
TAF5L | 6749.0 |
H2BC11 | 6802.0 |
MTA3 | 6856.0 |
H4C1 | 6923.5 |
ING5 | 6996.0 |
ELP2 | 7021.0 |
SAP30 | 7068.0 |
HDAC1 | 7175.0 |
ACTL6A | 7360.0 |
SETDB2 | 7381.0 |
MSL3 | 7411.0 |
ELP4 | 7726.0 |
KDM4C | 7795.0 |
ZZZ3 | 7850.0 |
PRMT3 | 8104.0 |
BRD8 | 8177.0 |
NSD3 | 8183.0 |
PRMT6 | 8261.0 |
KDM5D | 8478.0 |
KDM1A | 8614.0 |
OGT | 8679.0 |
TADA1 | 8752.0 |
KDM5C | 8917.0 |
Mitochondrial translation initiation
714 | |
---|---|
set | Mitochondrial translation initiation |
setSize | 85 |
pANOVA | 0.00193 |
s.dist | 0.195 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
MRPS14 | 8926 |
MRPS24 | 8562 |
MRPL1 | 8558 |
MRPS28 | 8557 |
MRPS18B | 8556 |
MRPL36 | 8464 |
PTCD3 | 8263 |
DAP3 | 7885 |
MRPS35 | 7617 |
CHCHD1 | 7563 |
MRPL2 | 7250 |
MRPL17 | 7018 |
MRPL14 | 6867 |
MRPL24 | 6176 |
MRPL42 | 6072 |
MRPL45 | 5839 |
MRPS2 | 5800 |
MRPL50 | 5621 |
MRPL40 | 5368 |
MRPL22 | 5146 |
GeneID | Gene Rank |
---|---|
MRPS14 | 8926.0 |
MRPS24 | 8562.0 |
MRPL1 | 8558.0 |
MRPS28 | 8557.0 |
MRPS18B | 8556.0 |
MRPL36 | 8464.0 |
PTCD3 | 8263.0 |
DAP3 | 7885.0 |
MRPS35 | 7617.0 |
CHCHD1 | 7563.0 |
MRPL2 | 7250.0 |
MRPL17 | 7018.0 |
MRPL14 | 6867.0 |
MRPL24 | 6176.0 |
MRPL42 | 6072.0 |
MRPL45 | 5839.0 |
MRPS2 | 5800.0 |
MRPL50 | 5621.0 |
MRPL40 | 5368.0 |
MRPL22 | 5146.0 |
MTIF3 | 5074.0 |
MRPL46 | 4943.0 |
MRPL20 | 4603.0 |
MRPL47 | 4579.0 |
MRPS33 | 4506.0 |
MRPL12 | 4269.0 |
MRPS9 | 4258.0 |
GADD45GIP1 | 3958.0 |
MRPS6 | 3955.0 |
MRPL44 | 3931.0 |
MRPL3 | 3905.0 |
MRPL11 | 3798.0 |
MRPL13 | 3789.0 |
MRPL35 | 3604.0 |
MRPL32 | 3475.0 |
MRPL18 | 3358.0 |
MRPL10 | 3267.0 |
MRPL33 | 3221.0 |
MRPL43 | 3190.0 |
MRPL52 | 2647.0 |
MRPS18C | 2564.0 |
MRPS16 | 2548.0 |
MRPL19 | 2510.0 |
MRPL27 | 2126.0 |
MRPS23 | 1674.0 |
MTIF2 | 1252.0 |
MRPL21 | 1230.0 |
MRPL15 | 1187.0 |
MRPL55 | 741.0 |
MRPL53 | 586.0 |
MRPL49 | 582.0 |
MRPL54 | 450.0 |
MRPL39 | 395.0 |
MRPS31 | 362.0 |
MRPS30 | 45.0 |
MRPS34 | -44.0 |
MRPS5 | -53.0 |
MRPS7 | -161.0 |
MRPS15 | -371.0 |
MRPS12 | -431.0 |
MRPS11 | -799.0 |
MRPS26 | -888.0 |
MRPL48 | -1212.0 |
MRPS22 | -1452.0 |
MRPL9 | -1492.0 |
MRPS18A | -1837.0 |
MRPL16 | -2312.0 |
MRPS10 | -2682.0 |
MRPS27 | -2810.0 |
MRPL58 | -3023.0 |
MRPS25 | -3279.0 |
MTFMT | -3773.0 |
MRPL28 | -3922.0 |
MRPL38 | -4142.0 |
OXA1L | -4251.0 |
MRPL34 | -4385.0 |
MRPL41 | -4451.0 |
MRPL30 | -4489.5 |
MRPL4 | -4800.0 |
ERAL1 | -5635.0 |
MRPS21 | -6064.0 |
MRPS36 | -6427.0 |
MRPL51 | -6884.0 |
MRPL37 | -7284.0 |
MRPS17 | -7874.5 |
Rho GTPase cycle
1083 | |
---|---|
set | Rho GTPase cycle |
setSize | 134 |
pANOVA | 0.00201 |
s.dist | -0.155 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
STARD8 | -9030.0 |
MYO9B | -8944.0 |
SRGAP2 | -8939.0 |
ARHGEF37 | -8834.0 |
ARHGAP17 | -8816.0 |
ARHGEF1 | -8718.0 |
OBSCN | -8574.0 |
OPHN1 | -8557.0 |
ARHGEF7 | -8534.0 |
GMIP | -8479.0 |
PLEKHG5 | -8454.0 |
CDC42 | -8440.0 |
ITSN1 | -8377.0 |
ARAP2 | -8318.0 |
CHN2 | -8291.5 |
ARHGEF11 | -8287.0 |
DEPDC7 | -8183.0 |
ARHGAP20 | -8012.0 |
ARHGAP6 | -7915.0 |
ARHGEF40 | -7699.0 |
GeneID | Gene Rank |
---|---|
STARD8 | -9030.0 |
MYO9B | -8944.0 |
SRGAP2 | -8939.0 |
ARHGEF37 | -8834.0 |
ARHGAP17 | -8816.0 |
ARHGEF1 | -8718.0 |
OBSCN | -8574.0 |
OPHN1 | -8557.0 |
ARHGEF7 | -8534.0 |
GMIP | -8479.0 |
PLEKHG5 | -8454.0 |
CDC42 | -8440.0 |
ITSN1 | -8377.0 |
ARAP2 | -8318.0 |
CHN2 | -8291.5 |
ARHGEF11 | -8287.0 |
DEPDC7 | -8183.0 |
ARHGAP20 | -8012.0 |
ARHGAP6 | -7915.0 |
ARHGEF40 | -7699.0 |
MCF2 | -7686.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
MCF2L | -7517.0 |
RAC2 | -7433.0 |
ARHGEF5 | -7293.0 |
ARHGAP12 | -7221.0 |
PLEKHG2 | -7206.0 |
ARHGAP8 | -7192.5 |
PIK3R2 | -7098.5 |
VAV3 | -7088.0 |
ARHGAP35 | -6956.0 |
ARHGEF17 | -6885.0 |
ARHGEF10L | -6624.0 |
TRIO | -6348.0 |
MYO9A | -6231.0 |
RHOH | -6217.0 |
FGD4 | -6196.0 |
FGD1 | -5982.0 |
RHOJ | -5569.0 |
RHOBTB1 | -5555.0 |
ARHGEF19 | -5545.0 |
ARHGAP32 | -5460.0 |
ARHGAP9 | -5430.0 |
ARHGEF6 | -5311.0 |
AKAP13 | -5190.0 |
ARHGDIB | -5167.0 |
ARHGAP11A | -5134.0 |
NET1 | -4984.0 |
ARHGAP21 | -4926.0 |
SYDE2 | -4921.0 |
NGEF | -4851.0 |
ARHGAP1 | -4806.0 |
ARHGEF38 | -4562.0 |
STARD13 | -4246.0 |
A2M | -3884.0 |
RHOV | -3598.0 |
GDI2 | -3504.0 |
ARHGAP39 | -3310.0 |
RHOB | -3080.0 |
PREX1 | -3045.0 |
FAM13A | -2836.0 |
SOS1 | -2808.0 |
RACGAP1 | -2770.0 |
ARHGDIA | -2696.0 |
ARHGAP31 | -2557.0 |
ARHGEF18 | -2547.5 |
ARHGAP26 | -2118.0 |
RHOT2 | -2024.0 |
RHOD | -2015.0 |
RHOU | -1725.0 |
ARHGAP29 | -1488.0 |
RHOBTB2 | -1304.0 |
ARHGEF39 | -1272.0 |
ARHGAP40 | -907.5 |
ARHGEF10 | -775.0 |
RHOA | -640.0 |
ARHGEF15 | -470.0 |
ARHGEF33 | -451.0 |
ARHGAP30 | -260.0 |
KALRN | -177.0 |
RHOF | -150.0 |
RAC3 | 84.0 |
BCR | 111.0 |
ARHGAP44 | 622.0 |
RHOG | 709.0 |
SYDE1 | 773.0 |
RHOQ | 950.0 |
TRIP10 | 1231.0 |
SRGAP3 | 1255.0 |
GDI1 | 1433.0 |
ARHGAP33 | 1479.0 |
ARHGAP27 | 1497.0 |
VAV1 | 1912.0 |
RAC1 | 2240.0 |
ARHGAP4 | 2279.0 |
INPP5B | 2405.0 |
TAGAP | 2414.0 |
ARHGAP25 | 2629.0 |
ARHGAP23 | 2812.0 |
FAM13B | 3460.0 |
FGD2 | 4170.0 |
ARAP3 | 4175.0 |
ARAP1 | 4310.0 |
SRGAP1 | 4317.0 |
CHN1 | 4472.0 |
OCRL | 4825.0 |
TIAM2 | 4841.0 |
RASGRF2 | 5220.0 |
GNA13 | 5282.0 |
RHOC | 5509.5 |
ARHGAP10 | 5666.0 |
ARHGAP28 | 5709.0 |
VAV2 | 5813.0 |
ARHGEF12 | 6104.0 |
DEPDC1B | 6153.0 |
DLC1 | 6197.0 |
FGD3 | 6255.0 |
ARHGAP18 | 6408.0 |
ARHGAP15 | 6512.0 |
TIAM1 | 6942.0 |
ARHGAP42 | 7065.0 |
ARHGAP36 | 7340.0 |
ECT2 | 7350.0 |
ARHGEF3 | 7632.0 |
SOS2 | 7658.0 |
ARHGAP19 | 7873.5 |
ARHGAP24 | 7944.0 |
ARHGEF2 | 7980.0 |
ARHGEF26 | 8302.0 |
ARHGAP5 | 8335.0 |
RALBP1 | 8365.0 |
ARHGAP22 | 8611.0 |
RHOT1 | 8732.0 |
GRB2:SOS provides linkage to MAPK signaling for Integrins
469 | |
---|---|
set | GRB2:SOS provides linkage to MAPK signaling for Integrins |
setSize | 15 |
pANOVA | 0.00205 |
s.dist | -0.46 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FGB | -9053.0 |
FGA | -8696.0 |
PTK2 | -8355.0 |
SRC | -8095.0 |
FGG | -8035.0 |
VWF | -7285.0 |
ITGA2B | -7222.0 |
TLN1 | -5122.0 |
APBB1IP | -3673.0 |
ITGB3 | -3380.5 |
GRB2 | -3336.0 |
SOS1 | -2808.0 |
RAP1A | 937.0 |
RAP1B | 4145.0 |
FN1 | 6913.0 |
GeneID | Gene Rank |
---|---|
FGB | -9053.0 |
FGA | -8696.0 |
PTK2 | -8355.0 |
SRC | -8095.0 |
FGG | -8035.0 |
VWF | -7285.0 |
ITGA2B | -7222.0 |
TLN1 | -5122.0 |
APBB1IP | -3673.0 |
ITGB3 | -3380.5 |
GRB2 | -3336.0 |
SOS1 | -2808.0 |
RAP1A | 937.0 |
RAP1B | 4145.0 |
FN1 | 6913.0 |
Aflatoxin activation and detoxification
67 | |
---|---|
set | Aflatoxin activation and detoxification |
setSize | 18 |
pANOVA | 0.00205 |
s.dist | -0.42 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP3A4 | -8991.0 |
CYP3A5 | -8991.0 |
DPEP1 | -8348.0 |
MGST1 | -8188.0 |
GGT6 | -7974.0 |
AKR7L | -7680.0 |
AKR7A3 | -7174.0 |
CYP1A2 | -6798.0 |
GGT5 | -5861.0 |
DPEP2 | -4879.0 |
GGT7 | -3254.0 |
ACY1 | 106.5 |
GGT1 | 592.0 |
MGST2 | 2307.0 |
ACY3 | 3112.0 |
MGST3 | 4742.0 |
DPEP3 | 7176.0 |
GeneID | Gene Rank |
---|---|
CYP2A13 | -9057.0 |
CYP3A4 | -8991.0 |
CYP3A5 | -8991.0 |
DPEP1 | -8348.0 |
MGST1 | -8188.0 |
GGT6 | -7974.0 |
AKR7L | -7680.0 |
AKR7A3 | -7174.0 |
CYP1A2 | -6798.0 |
GGT5 | -5861.0 |
DPEP2 | -4879.0 |
GGT7 | -3254.0 |
ACY1 | 106.5 |
GGT1 | 592.0 |
MGST2 | 2307.0 |
ACY3 | 3112.0 |
MGST3 | 4742.0 |
DPEP3 | 7176.0 |
Formation of Fibrin Clot (Clotting Cascade)
421 | |
---|---|
set | Formation of Fibrin Clot (Clotting Cascade) |
setSize | 37 |
pANOVA | 0.00208 |
s.dist | -0.292 |
p.adjustANOVA | 0.0685 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FGB | -9053 |
KNG1 | -9050 |
FGA | -8696 |
F10 | -8579 |
F5 | -8356 |
F12 | -8319 |
GP1BA | -8136 |
FGG | -8035 |
F13B | -7912 |
VWF | -7285 |
F11 | -6531 |
GP5 | -6277 |
KLKB1 | -6048 |
F9 | -5791 |
SERPIND1 | -5751 |
F7 | -5305 |
GP9 | -5163 |
PROC | -3962 |
A2M | -3884 |
GP1BB | -3680 |
GeneID | Gene Rank |
---|---|
FGB | -9053.0 |
KNG1 | -9050.0 |
FGA | -8696.0 |
F10 | -8579.0 |
F5 | -8356.0 |
F12 | -8319.0 |
GP1BA | -8136.0 |
FGG | -8035.0 |
F13B | -7912.0 |
VWF | -7285.0 |
F11 | -6531.0 |
GP5 | -6277.0 |
KLKB1 | -6048.0 |
F9 | -5791.0 |
SERPIND1 | -5751.0 |
F7 | -5305.0 |
GP9 | -5163.0 |
PROC | -3962.0 |
A2M | -3884.0 |
GP1BB | -3680.0 |
F2 | -3616.0 |
SERPING1 | -3530.0 |
CD177 | -2979.0 |
SERPINA5 | -1562.5 |
PRCP | -1478.0 |
F8 | -1310.0 |
F13A1 | 1711.0 |
SERPINC1 | 2277.0 |
PRTN3 | 2547.0 |
THBD | 3011.0 |
F2R | 3369.0 |
F3 | 3700.0 |
PROS1 | 4698.0 |
C1QBP | 5377.0 |
PROCR | 7343.0 |
SERPINE2 | 8181.0 |
TFPI | 8435.0 |
Protein ubiquitination
929 | |
---|---|
set | Protein ubiquitination |
setSize | 65 |
pANOVA | 0.00219 |
s.dist | -0.22 |
p.adjustANOVA | 0.0697 |
Top enriched genes
GeneID | Gene Rank |
---|---|
UBE2A | -8808.0 |
SHPRH | -8299.0 |
HLA-A | -8118.5 |
HLA-B | -8118.5 |
UBE2D3 | -8068.0 |
H2BC1 | -8026.0 |
UBE2H | -7872.0 |
PEX12 | -7633.0 |
LEO1 | -7393.0 |
UBE2E1 | -6946.0 |
UBE2G2 | -6704.0 |
DERL1 | -6635.0 |
PEX13 | -6630.0 |
UBC | -6432.0 |
UBE2C | -6289.0 |
HLTF | -5920.0 |
PEX10 | -5886.0 |
UBE2W | -5708.5 |
UBE2S | -5679.0 |
RNF40 | -5625.0 |
GeneID | Gene Rank |
---|---|
UBE2A | -8808.0 |
SHPRH | -8299.0 |
HLA-A | -8118.5 |
HLA-B | -8118.5 |
UBE2D3 | -8068.0 |
H2BC1 | -8026.0 |
UBE2H | -7872.0 |
PEX12 | -7633.0 |
LEO1 | -7393.0 |
UBE2E1 | -6946.0 |
UBE2G2 | -6704.0 |
DERL1 | -6635.0 |
PEX13 | -6630.0 |
UBC | -6432.0 |
UBE2C | -6289.0 |
HLTF | -5920.0 |
PEX10 | -5886.0 |
UBE2W | -5708.5 |
UBE2S | -5679.0 |
RNF40 | -5625.0 |
UBE2R2 | -5017.0 |
PAF1 | -4974.0 |
UBA1 | -4768.0 |
TMEM129 | -4659.0 |
RTF1 | -4243.0 |
RNF20 | -4206.0 |
WDR61 | -3743.0 |
PRKDC | -3663.0 |
H2BC3 | -3635.0 |
H2BC12 | -3610.0 |
UBA6 | -3393.0 |
VCP | -3356.0 |
UBE2G1 | -3271.0 |
CDC34 | -2463.0 |
RAD18 | -2341.0 |
UBE2V2 | -2190.0 |
UBA52 | -2166.0 |
USP9X | -2105.0 |
WAC | -2027.0 |
OTULIN | -1856.0 |
UCHL3 | -1809.0 |
UBE2D1 | -1275.0 |
UBE2B | -887.0 |
UBE2Q2 | -822.0 |
UBE2J2 | -353.0 |
CTR9 | -85.0 |
BCL10 | 666.0 |
UBE2T | 1282.0 |
UBE2K | 1320.0 |
UBE2D2 | 1984.0 |
RRAGA | 2158.0 |
PCNA | 3070.0 |
PEX14 | 3074.0 |
USP7 | 3382.0 |
UBE2N | 4121.5 |
USP5 | 4331.0 |
PEX5 | 4716.0 |
RNF152 | 5085.0 |
CDC73 | 5336.0 |
PEX2 | 5543.0 |
RNF144A | 5836.0 |
UBE2Z | 6638.0 |
H2BC11 | 6802.0 |
RPS27A | 7369.0 |
SELENOS | 8727.0 |
Signaling by GPCR
1170 | |
---|---|
set | Signaling by GPCR |
setSize | 895 |
pANOVA | 0.00226 |
s.dist | -0.0605 |
p.adjustANOVA | 0.0697 |
Top enriched genes
GeneID | Gene Rank |
---|---|
GABBR1 | -9063 |
C5 | -9060 |
RDH16 | -9052 |
KNG1 | -9050 |
TAS1R2 | -9042 |
PAK1 | -9034 |
CRHR2 | -9033 |
SAG | -9009 |
EDNRA | -8998 |
PDE4D | -8956 |
PTGER3 | -8925 |
PDE2A | -8915 |
AKR1B10 | -8911 |
APOC3 | -8904 |
CAMK2B | -8898 |
PRKAR2B | -8880 |
PDE11A | -8842 |
TTR | -8839 |
APOE | -8836 |
ARHGEF37 | -8834 |
GeneID | Gene Rank |
---|---|
GABBR1 | -9063.0 |
C5 | -9060.0 |
RDH16 | -9052.0 |
KNG1 | -9050.0 |
TAS1R2 | -9042.0 |
PAK1 | -9034.0 |
CRHR2 | -9033.0 |
SAG | -9009.0 |
EDNRA | -8998.0 |
PDE4D | -8956.0 |
PTGER3 | -8925.0 |
PDE2A | -8915.0 |
AKR1B10 | -8911.0 |
APOC3 | -8904.0 |
CAMK2B | -8898.0 |
PRKAR2B | -8880.0 |
PDE11A | -8842.0 |
TTR | -8839.0 |
APOE | -8836.0 |
ARHGEF37 | -8834.0 |
PLPPR3 | -8805.0 |
CCL28 | -8774.0 |
RGS17 | -8772.0 |
RRH | -8768.0 |
WNT4 | -8755.0 |
TAS1R3 | -8751.0 |
DGKE | -8747.0 |
NTSR1 | -8726.0 |
ARHGEF1 | -8718.0 |
P2RY14 | -8673.0 |
ADORA1 | -8671.0 |
RPS6KA1 | -8610.0 |
CXCR1 | -8608.0 |
GNAS | -8601.0 |
RGS14 | -8576.0 |
OBSCN | -8574.0 |
ARHGEF7 | -8534.0 |
RGS5 | -8529.0 |
RGS20 | -8516.0 |
GRK6 | -8511.0 |
CCL11 | -8487.0 |
PPP3CC | -8476.0 |
RGS6 | -8457.0 |
PLEKHG5 | -8454.0 |
CDC42 | -8440.0 |
PDE1B | -8427.0 |
PLB1 | -8395.0 |
PLPPR1 | -8390.0 |
ITSN1 | -8377.0 |
PLCB4 | -8376.0 |
CXCR6 | -8347.0 |
CXCR3 | -8323.0 |
TRH | -8317.0 |
CHRM3 | -8311.0 |
ARHGEF11 | -8287.0 |
VIPR1 | -8263.0 |
GALR2 | -8209.0 |
RBP4 | -8178.0 |
DGKZ | -8155.0 |
GPSM3 | -8134.0 |
PRKAR2A | -8106.0 |
SRC | -8095.0 |
VIP | -8083.0 |
GLP2R | -8069.0 |
NPY | -8050.0 |
LPAR5 | -8048.0 |
NPY1R | -8014.0 |
XK | -7994.0 |
PDE4C | -7992.5 |
ADRB3 | -7987.5 |
QRFPR | -7977.0 |
PLCB3 | -7957.0 |
NPFFR1 | -7883.0 |
OR52W1 | -7878.0 |
DAGLB | -7867.0 |
NTS | -7866.0 |
AGT | -7862.0 |
RGS2 | -7801.0 |
EDN3 | -7773.0 |
PRKACA | -7713.0 |
GPR27 | -7702.0 |
ARHGEF40 | -7699.0 |
MCF2 | -7686.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
RTP2 | -7650.0 |
GNAI1 | -7649.0 |
RXFP2 | -7630.0 |
PDE1C | -7601.0 |
MGLL | -7581.0 |
DGKB | -7547.0 |
PTGER4 | -7545.0 |
ADORA2B | -7537.0 |
APOC2 | -7531.5 |
MCF2L | -7517.0 |
ABHD12 | -7496.0 |
ADRA2B | -7489.0 |
IHH | -7487.0 |
APOA2 | -7400.0 |
GRK3 | -7362.0 |
RASGRP2 | -7350.0 |
GNG4 | -7316.0 |
DGKG | -7310.0 |
ARHGEF5 | -7293.0 |
CNR1 | -7245.0 |
PLEKHG2 | -7206.0 |
WNT10A | -7189.0 |
CHRM5 | -7183.0 |
GPC4 | -7160.0 |
PRKCE | -7128.0 |
GNAL | -7120.0 |
S1PR1 | -7115.0 |
PIK3R2 | -7098.5 |
VAV3 | -7088.0 |
RTP3 | -7086.0 |
RGS8 | -7040.0 |
CCR9 | -7000.0 |
GNA14 | -6980.0 |
RBP1 | -6975.0 |
AVPR2 | -6968.0 |
ARHGEF17 | -6885.0 |
ADCY6 | -6882.0 |
PTGER2 | -6876.0 |
OR51E1 | -6846.0 |
GPR39 | -6779.0 |
CNR2 | -6771.0 |
ADCY4 | -6759.0 |
APOA4 | -6758.0 |
ARRB2 | -6754.0 |
ECE1 | -6749.0 |
CCL19 | -6713.0 |
PRKACB | -6707.0 |
PSAP | -6675.0 |
ARHGEF10L | -6624.0 |
HSD17B6 | -6589.0 |
S1PR4 | -6587.0 |
TSHR | -6499.0 |
HTR7 | -6482.0 |
CXCR5 | -6476.0 |
ADCY2 | -6434.0 |
TRIO | -6348.0 |
SSTR1 | -6304.0 |
C3 | -6303.0 |
CHRM4 | -6286.0 |
GPR132 | -6259.0 |
PPP2CA | -6258.0 |
PIK3R6 | -6249.0 |
REEP6 | -6204.0 |
FGD4 | -6196.0 |
TAC3 | -6187.0 |
WNT6 | -6186.0 |
RDH8 | -6074.0 |
RAMP2 | -6073.0 |
FZD3 | -6063.0 |
TACR1 | -6047.0 |
ITPR3 | -6046.0 |
PTGDR2 | -6038.0 |
OR52I1 | -6033.5 |
OR52I2 | -6033.5 |
PCP2 | -6000.0 |
FGD1 | -5982.0 |
TACR3 | -5973.0 |
OR6S1 | -5969.0 |
AKT2 | -5958.0 |
GNG12 | -5884.0 |
PPP1CA | -5881.0 |
WNT2B | -5857.0 |
ITPR2 | -5837.0 |
SUCNR1 | -5782.0 |
KEL | -5755.0 |
WNT8B | -5701.0 |
RAMP1 | -5656.0 |
P2RY6 | -5637.0 |
AGTR1 | -5580.0 |
PTH1R | -5552.0 |
ARHGEF19 | -5545.0 |
LRP2 | -5544.0 |
TACR2 | -5487.0 |
PIK3R5 | -5482.0 |
PDE7B | -5405.0 |
OR6K6 | -5329.0 |
TSHB | -5315.0 |
ARHGEF6 | -5311.0 |
GNAT2 | -5270.0 |
RLBP1 | -5232.0 |
PTGER1 | -5226.0 |
CXCR4 | -5218.0 |
AKAP13 | -5190.0 |
WNT16 | -5176.0 |
PRKCH | -5149.5 |
GNAO1 | -5147.0 |
OR6N2 | -5135.0 |
CCL22 | -5101.0 |
RCVRN | -5100.0 |
SSTR4 | -5037.0 |
NMUR1 | -5014.0 |
NET1 | -4984.0 |
PRKAR1A | -4970.0 |
P2RY10 | -4936.0 |
NGEF | -4851.0 |
CXCL9 | -4847.0 |
ADGRE5 | -4844.0 |
GAL | -4837.0 |
CRHBP | -4802.0 |
APLNR | -4782.0 |
NPW | -4751.0 |
GRM5 | -4699.0 |
PDE4A | -4632.0 |
TAS2R60 | -4610.0 |
GNB4 | -4593.0 |
XCR1 | -4583.0 |
ARHGEF38 | -4562.0 |
PDE6A | -4543.0 |
FNTB | -4523.5 |
RGS3 | -4491.0 |
FPR2 | -4479.5 |
FPR3 | -4479.5 |
CCR6 | -4453.0 |
LRAT | -4448.0 |
DHRS3 | -4431.0 |
GNAI2 | -4425.0 |
MC5R | -4388.0 |
ADRA1D | -4383.0 |
PDPK1 | -4325.0 |
PTCH2 | -4298.0 |
PROKR2 | -4225.0 |
DGKH | -4197.0 |
GPR4 | -4192.0 |
GRPR | -4160.0 |
TAS2R3 | -4153.0 |
HTR1F | -4088.0 |
NMT2 | -4070.0 |
BDKRB2 | -4057.0 |
PLCB1 | -4053.0 |
ADCY1 | -4044.0 |
LPAR6 | -4022.0 |
SSTR3 | -3984.0 |
RHO | -3979.0 |
GRM8 | -3921.0 |
GHRHR | -3915.0 |
CAMK2A | -3898.0 |
GNB1 | -3895.0 |
MCHR1 | -3891.0 |
C3AR1 | -3874.0 |
OR52B2 | -3822.0 |
NPB | -3820.0 |
UTS2 | -3797.0 |
CCL4 | -3785.5 |
HSPG2 | -3764.0 |
RPS6KA3 | -3698.0 |
CHRM1 | -3677.0 |
WNT9A | -3665.0 |
PPP2CB | -3632.0 |
GNRHR | -3625.0 |
F2 | -3616.0 |
CXCL11 | -3606.0 |
DGKK | -3596.0 |
GPC2 | -3565.0 |
PTH2 | -3564.0 |
PRKCQ | -3483.0 |
PPP2R1A | -3477.0 |
GPR84 | -3469.0 |
RGR | -3467.0 |
RXFP1 | -3454.0 |
GPIHBP1 | -3404.0 |
ROCK2 | -3394.0 |
CCR3 | -3385.0 |
ACKR4 | -3367.0 |
OR5B2 | -3361.0 |
GRB2 | -3336.0 |
EDN1 | -3312.0 |
PTGIR | -3311.0 |
LRP10 | -3298.0 |
OR51E2 | -3273.0 |
GPR31 | -3246.0 |
CD55 | -3223.0 |
HTR5A | -3216.0 |
GPR183 | -3193.0 |
GUCA1B | -3130.0 |
HEBP1 | -3127.0 |
OR8H1 | -3118.0 |
OR8H2 | -3118.0 |
OR8H3 | -3118.0 |
RHOB | -3080.0 |
GNG7 | -3060.0 |
PREX1 | -3045.0 |
SDC4 | -2987.0 |
WNT7B | -2916.0 |
GNA11 | -2862.0 |
SOS1 | -2808.0 |
SSTR5 | -2799.0 |
PRKCG | -2783.0 |
CCL17 | -2763.0 |
CYP4V2 | -2726.0 |
PPP3CA | -2656.0 |
ADORA2A | -2639.0 |
CCL2 | -2628.0 |
CDK5 | -2600.0 |
ARHGEF18 | -2547.5 |
APLN | -2542.0 |
PPBP | -2477.0 |
LPL | -2467.0 |
WNT8A | -2439.0 |
P2RY2 | -2415.0 |
OR8G1 | -2378.5 |
OR8G5 | -2378.5 |
ADCY5 | -2343.0 |
FZD7 | -2287.0 |
PENK | -2272.0 |
REEP2 | -2261.0 |
HRAS | -2253.0 |
CX3CL1 | -2245.0 |
OR10G2 | -2217.0 |
FPR1 | -2214.0 |
LTB4R | -2187.0 |
RGS1 | -2147.0 |
RLN3 | -2119.0 |
GPC3 | -2107.0 |
KISS1 | -2106.0 |
ADM2 | -2081.0 |
CCKAR | -2081.0 |
CCR4 | -2081.0 |
GNG13 | -2081.0 |
OPN1LW | -2081.0 |
OPN1MW | -2081.0 |
OR7E24 | -2063.0 |
SDC3 | -2040.0 |
NPFF | -2026.0 |
OR5P2 | -2010.0 |
OR6Y1 | -1916.0 |
OR8K3 | -1912.0 |
PLPPR5 | -1872.0 |
WNT7A | -1849.0 |
OR2F1 | -1842.5 |
OR2F2 | -1842.5 |
GPR176 | -1832.0 |
F2RL2 | -1823.0 |
OR11A1 | -1818.0 |
ADCY9 | -1812.0 |
OR10K1 | -1811.0 |
PRKCA | -1808.0 |
GHSR | -1789.0 |
DAGLA | -1781.0 |
GPR55 | -1771.0 |
OR5G3 | -1752.5 |
CCKBR | -1743.0 |
CXCL10 | -1631.0 |
EGFR | -1624.0 |
CXCL16 | -1619.0 |
OR10V1 | -1562.5 |
OR14J1 | -1562.5 |
OR1I1 | -1562.5 |
OR1Q1 | -1562.5 |
OR4A15 | -1562.5 |
OR4P4 | -1562.5 |
OR56B4 | -1562.5 |
OR5M11 | -1562.5 |
OR5P3 | -1562.5 |
OR5T1 | -1562.5 |
OR5T3 | -1562.5 |
OR6C2 | -1562.5 |
OR6C68 | -1562.5 |
OR8B8 | -1562.5 |
OR5AK2 | -1523.0 |
OR5AK3P | -1523.0 |
TAS2R14 | -1512.0 |
METAP1 | -1481.0 |
GALR1 | -1455.0 |
NPSR1 | -1445.0 |
WNT3 | -1443.0 |
TRHR | -1407.0 |
WNT3A | -1406.0 |
EDNRB | -1365.0 |
OR4B1 | -1361.5 |
GPC6 | -1334.0 |
PLXNB1 | -1301.0 |
CASR | -1291.0 |
C5AR1 | -1280.0 |
ARHGEF39 | -1272.0 |
RGS13 | -1258.0 |
CCR7 | -1237.0 |
GRM6 | -1224.0 |
OR10A3 | -1219.5 |
OR10A6 | -1219.5 |
HTR4 | -1218.0 |
GPR45 | -1179.0 |
GPR143 | -1156.0 |
GPR35 | -1144.0 |
CXCL13 | -1141.0 |
AGRN | -1136.0 |
OR9G1 | -1126.0 |
GPSM2 | -1112.0 |
DRD5 | -987.0 |
MTNR1A | -987.0 |
OR10J5 | -987.0 |
OR11G2 | -987.0 |
OR12D3 | -987.0 |
OR1A1 | -987.0 |
OR1A2 | -987.0 |
OR1J4 | -987.0 |
OR1P1 | -987.0 |
OR2A1 | -987.0 |
OR2T1 | -987.0 |
OR2W3 | -987.0 |
OR4C16 | -987.0 |
OR4C6 | -987.0 |
OR51G2 | -987.0 |
OR51Q1 | -987.0 |
OR52E4 | -987.0 |
OR5AL1 | -987.0 |
OR5R1 | -987.0 |
OR7G1 | -987.0 |
OR8B12 | -987.0 |
OR8B2 | -987.0 |
OR8B3 | -987.0 |
OR8D4 | -987.0 |
OR9K2 | -987.0 |
PROK1 | -987.0 |
RBP2 | -987.0 |
TAAR5 | -987.0 |
TAS2R1 | -987.0 |
CHRM2 | -907.5 |
OR2B11 | -907.5 |
OR2H1 | -907.5 |
OR2H2 | -907.5 |
OR4D1 | -907.5 |
OR52M1 | -907.5 |
OR2T29 | -895.0 |
OR2T4 | -895.0 |
OR2T5 | -895.0 |
OR5B3 | -884.0 |
OR4C15 | -879.0 |
ARHGEF10 | -775.0 |
PPP3CB | -748.0 |
CALCR | -738.0 |
OR14C36 | -733.5 |
OR52N2 | -733.5 |
OR56B2P | -733.5 |
OR7G2 | -733.5 |
OPRL1 | -730.0 |
OR5AC1 | -686.0 |
RGS4 | -680.0 |
HCRTR1 | -648.0 |
RHOA | -640.0 |
CCR10 | -637.0 |
RETSAT | -602.0 |
APOA1 | -547.0 |
OR2AK2 | -519.5 |
OR5H1 | -519.5 |
OR5H14 | -519.5 |
OR5H15 | -519.5 |
OR5H6 | -519.5 |
ARHGEF15 | -470.0 |
PDE6B | -466.0 |
BRS3 | -461.0 |
ARHGEF33 | -451.0 |
GPHB5 | -374.0 |
FZD9 | -370.0 |
OR52D1 | -338.5 |
NPY5R | -309.0 |
OR10G3 | -309.0 |
OR4A47 | -309.0 |
OR4F6 | -309.0 |
OR51F2 | -309.0 |
OR52P1P | -309.0 |
OR9A4 | -309.0 |
CGA | -282.0 |
DGKD | -273.0 |
REEP1 | -250.0 |
REEP5 | -211.0 |
CAMKK2 | -200.0 |
CXCL12 | -188.0 |
OPRD1 | -187.0 |
KALRN | -177.0 |
OR7D4 | -133.0 |
OR5AN1 | -121.5 |
OR1N1 | -118.0 |
RGS18 | -112.0 |
GNB5 | -108.0 |
CALM1 | -83.0 |
OR10AG1 | -40.0 |
GPR37L1 | -27.0 |
ARRB1 | -23.0 |
GPR65 | -16.0 |
REEP3 | -8.0 |
OR6B2 | 6.5 |
OR6B3 | 6.5 |
OR4F17 | 11.0 |
OR4F4 | 11.0 |
OR4F5 | 11.0 |
AVPR1A | 53.0 |
PIK3CA | 85.0 |
GNA15 | 89.0 |
TAS2R4 | 142.0 |
CALCB | 231.0 |
CNGA1 | 231.0 |
FFAR1 | 231.0 |
IAPP | 231.0 |
MC3R | 231.0 |
NPBWR1 | 231.0 |
OR10W1 | 231.0 |
OR13F1 | 231.0 |
OR13J1 | 231.0 |
OR1B1 | 231.0 |
OR1J1 | 231.0 |
OR1M1 | 231.0 |
OR2A14 | 231.0 |
OR2A5 | 231.0 |
OR2AP1 | 231.0 |
OR2L13 | 231.0 |
OR2Y1 | 231.0 |
OR4A16 | 231.0 |
OR4C11 | 231.0 |
OR4C12 | 231.0 |
OR4C3 | 231.0 |
OR4D11 | 231.0 |
OR4D2 | 231.0 |
OR4D6 | 231.0 |
OR4F15 | 231.0 |
OR4X2 | 231.0 |
OR51F1 | 231.0 |
OR52E2 | 231.0 |
OR52H1 | 231.0 |
OR52L1 | 231.0 |
OR52R1 | 231.0 |
OR56B1 | 231.0 |
OR5A1 | 231.0 |
OR5B17 | 231.0 |
OR5L1 | 231.0 |
OR5L2 | 231.0 |
OR5M8 | 231.0 |
OR6X1 | 231.0 |
OR8K5 | 231.0 |
OR9Q2 | 231.0 |
PTH2R | 231.0 |
RGS21 | 231.0 |
RTP1 | 231.0 |
TAAR8 | 231.0 |
TAS2R7 | 231.0 |
LHCGR | 340.5 |
GIP | 344.0 |
OR5C1 | 346.0 |
TAS2R42 | 355.0 |
NMT1 | 404.0 |
OR2B2 | 420.0 |
NPY4R | 446.5 |
OXT | 449.0 |
PRLHR | 457.0 |
OR4K15 | 540.0 |
OR6C1 | 540.0 |
TAS2R19 | 549.0 |
TAS2R20 | 549.0 |
TAS2R30 | 549.0 |
TAS2R31 | 549.0 |
TAS2R43 | 549.0 |
TAS2R46 | 549.0 |
TAS2R50 | 549.0 |
OPN4 | 560.0 |
OR8A1 | 563.0 |
APOB | 573.0 |
ADCYAP1 | 576.0 |
PPP2R5D | 596.0 |
PIK3R3 | 597.5 |
GNRH1 | 612.0 |
F2RL1 | 616.0 |
OR5W2 | 676.0 |
GPR17 | 677.0 |
PPEF1 | 686.0 |
GRM3 | 693.0 |
OR2AG1 | 700.0 |
TAC1 | 700.0 |
RGS16 | 809.0 |
F2RL3 | 826.0 |
OR52E6 | 842.0 |
OR52E8 | 842.0 |
OR8D1 | 842.0 |
FSHR | 861.5 |
OR4M1 | 861.5 |
OR4M2 | 861.5 |
OR4X1 | 861.5 |
OR51B6 | 861.5 |
OR51I2 | 861.5 |
PYY | 861.5 |
FFAR3 | 896.0 |
OR10C1 | 896.0 |
OR10S1 | 896.0 |
OR2V1 | 896.0 |
OR4K5 | 896.0 |
OR51A2 | 896.0 |
OR51A4 | 896.0 |
OR51V1 | 896.0 |
OR52K2 | 896.0 |
OR2V2 | 917.5 |
OR2Z1 | 917.5 |
OPN5 | 921.0 |
TAS2R13 | 930.0 |
NLN | 943.0 |
CCL3 | 960.0 |
GNG5 | 992.0 |
GHRH | 1070.0 |
OR10H1 | 1093.5 |
OR10H5 | 1093.5 |
QRFP | 1095.0 |
CAMK4 | 1172.0 |
GRM2 | 1192.0 |
FFAR4 | 1193.0 |
GRK2 | 1198.0 |
TAS2R10 | 1246.0 |
GNAT3 | 1292.0 |
RPS6KA2 | 1294.0 |
SSTR2 | 1311.0 |
XCL1 | 1380.5 |
XCL2 | 1380.5 |
OR52E5 | 1404.0 |
OR2AG2 | 1419.5 |
OR7C2 | 1419.5 |
OR8U1 | 1419.5 |
TAAR1 | 1419.5 |
AKT1 | 1488.0 |
OR4N5 | 1533.0 |
PRKCD | 1551.0 |
GPR83 | 1568.0 |
DRD3 | 1587.0 |
ADCY3 | 1612.0 |
GRK1 | 1615.0 |
ADM | 1625.0 |
GPR15 | 1643.0 |
APOM | 1657.0 |
PDE3B | 1668.0 |
OR13C3 | 1717.0 |
CRHR1 | 1747.0 |
NRAS | 1786.0 |
GUCY2D | 1791.0 |
HRH4 | 1810.0 |
PROK2 | 1822.0 |
DGKQ | 1845.0 |
GPRC6A | 1876.0 |
PNLIP | 1909.0 |
VAV1 | 1912.0 |
GRP | 1947.0 |
CXCL6 | 1966.0 |
GALR3 | 1969.0 |
SCTR | 1986.0 |
OR6K3 | 2052.0 |
FZD4 | 2057.0 |
MAPK1 | 2063.0 |
LRP8 | 2101.0 |
HTR2B | 2125.0 |
OR2T12 | 2143.0 |
OR2T33 | 2143.0 |
OR2T8 | 2143.0 |
DHH | 2159.0 |
RTP4 | 2164.0 |
MC2R | 2177.0 |
DRD2 | 2184.0 |
ADCY7 | 2210.0 |
OR2AT4 | 2241.0 |
OR6C70 | 2316.5 |
P2RY12 | 2339.0 |
OR6C76 | 2370.0 |
SCT | 2430.0 |
WNT5A | 2473.0 |
GRK5 | 2483.0 |
RGS22 | 2514.0 |
MAPK3 | 2532.0 |
PRKCB | 2630.0 |
GPR68 | 2735.0 |
GPHA2 | 2779.0 |
HCRT | 2813.0 |
TBXA2R | 2824.0 |
ADRB2 | 2844.0 |
HCAR2 | 2866.5 |
HCAR3 | 2866.5 |
WNT1 | 2881.0 |
CAMKMT | 2915.0 |
LDLR | 2957.0 |
GUCY2F | 3001.0 |
PDE8B | 3035.5 |
CCR1 | 3082.0 |
GNA12 | 3137.0 |
PDYN | 3143.0 |
CCL23 | 3192.0 |
SHH | 3214.0 |
HCAR1 | 3224.0 |
POMC | 3261.0 |
AVP | 3271.0 |
GNG3 | 3307.0 |
PDE1A | 3353.0 |
F2R | 3369.0 |
LPAR1 | 3370.0 |
RGS7 | 3418.0 |
GNAT1 | 3423.0 |
P2RY4 | 3493.0 |
CCRL2 | 3501.0 |
SDR9C7 | 3561.0 |
BDKRB1 | 3562.0 |
ADRB1 | 3612.0 |
GRK4 | 3623.0 |
GPC1 | 3640.0 |
MYO7A | 3664.0 |
NMB | 3696.0 |
GNAI3 | 3733.0 |
GNG11 | 3752.0 |
HRH1 | 3792.0 |
PDE3A | 3794.0 |
PPP1R1B | 3853.0 |
GPR25 | 3869.0 |
BCO1 | 3884.0 |
ADRA1B | 3941.0 |
OR5I1 | 4012.0 |
SLC24A1 | 4032.0 |
CCR8 | 4126.0 |
ECE2 | 4133.5 |
FGD2 | 4170.0 |
PDE8A | 4181.0 |
PTAFR | 4229.0 |
CCK | 4270.0 |
RLN2 | 4323.5 |
PLPPR2 | 4371.0 |
GNGT2 | 4376.0 |
RGS9BP | 4413.0 |
RGS10 | 4447.0 |
GHRL | 4454.0 |
PPP2R1B | 4513.0 |
NMU | 4522.0 |
FZD8 | 4573.0 |
ADRA2A | 4582.0 |
FZD1 | 4610.0 |
HBEGF | 4618.0 |
HTR1B | 4630.0 |
DGKA | 4645.0 |
OR51D1 | 4699.0 |
CAMKK1 | 4711.0 |
MAPK7 | 4725.0 |
PLPPR4 | 4737.0 |
TRPC7 | 4748.0 |
HRH3 | 4786.0 |
LRP1 | 4809.0 |
CALCA | 4836.0 |
TIAM2 | 4841.0 |
CCL27 | 4856.0 |
RBP3 | 4858.0 |
ADRA2C | 4926.0 |
GPR37 | 4931.0 |
ROCK1 | 4962.0 |
RDH10 | 5000.0 |
FZD6 | 5042.0 |
PPP3R1 | 5058.5 |
RGS9 | 5078.0 |
RAMP3 | 5107.0 |
FZD5 | 5173.0 |
METAP2 | 5174.0 |
HCRTR2 | 5199.0 |
RASGRF2 | 5220.0 |
RGSL1 | 5265.0 |
OXTR | 5278.0 |
GNA13 | 5282.0 |
OR6K2 | 5286.0 |
GIPR | 5394.0 |
PRKX | 5448.5 |
ADGRE1 | 5461.0 |
UTS2B | 5468.0 |
PDE10A | 5495.0 |
RHOC | 5509.5 |
FFAR2 | 5519.0 |
NMBR | 5522.0 |
AVPR1B | 5580.0 |
S1PR5 | 5597.0 |
UCN | 5600.0 |
DRD4 | 5612.0 |
S1PR2 | 5627.0 |
HTR2A | 5650.0 |
PTCH1 | 5659.0 |
RGS19 | 5668.0 |
CMKLR1 | 5729.0 |
GPR18 | 5762.0 |
OR1F1 | 5776.0 |
VAV2 | 5813.0 |
KRAS | 5849.0 |
PMCH | 5889.0 |
ARHGEF25 | 5966.5 |
PTGDR | 6020.0 |
FZD2 | 6035.0 |
BCO2 | 6058.0 |
ARHGEF12 | 6104.0 |
TAS2R41 | 6144.0 |
NAPEPLD | 6226.0 |
GNAZ | 6253.0 |
FGD3 | 6255.0 |
GNB2 | 6264.0 |
OR6N1 | 6265.0 |
ACKR3 | 6294.0 |
CRH | 6329.0 |
VIPR2 | 6379.0 |
RDH12 | 6399.0 |
C5AR2 | 6406.0 |
OR2K2 | 6446.0 |
SDC2 | 6449.0 |
REEP4 | 6463.0 |
GRM1 | 6498.0 |
STRA6 | 6510.0 |
RDH5 | 6515.0 |
OR4E1 | 6518.0 |
ADRA1A | 6572.0 |
GNG8 | 6614.0 |
RGS12 | 6733.0 |
KISS1R | 6746.0 |
GNG2 | 6793.0 |
TAS1R1 | 6812.0 |
ADCY8 | 6825.0 |
PIK3CG | 6844.0 |
OPRK1 | 6857.0 |
WNT2 | 6877.0 |
PTGFR | 6884.0 |
GPSM1 | 6904.0 |
TIAM1 | 6942.0 |
P2RY1 | 6949.0 |
LTB4R2 | 6967.0 |
RASGRP1 | 7000.0 |
LPAR4 | 7063.0 |
GUCA1A | 7066.0 |
RPE65 | 7074.0 |
GNG10 | 7112.0 |
S1PR3 | 7127.0 |
ANXA1 | 7137.0 |
GABBR2 | 7146.0 |
NMUR2 | 7148.0 |
CCL21 | 7185.0 |
ADCYAP1R1 | 7189.0 |
PLCB2 | 7190.0 |
LPAR3 | 7241.0 |
PDE4B | 7268.0 |
ABCA4 | 7305.0 |
SDC1 | 7316.0 |
DHRS9 | 7322.0 |
GRM7 | 7349.0 |
ECT2 | 7350.0 |
DGKI | 7390.0 |
GPBAR1 | 7429.0 |
CAMK2G | 7477.0 |
APP | 7480.0 |
FNTA | 7484.0 |
AGTR2 | 7492.0 |
EDN2 | 7506.0 |
MMP3 | 7551.0 |
BTK | 7564.0 |
ACKR2 | 7589.0 |
CCR5 | 7623.0 |
ARHGEF3 | 7632.0 |
P2RY13 | 7646.0 |
SOS2 | 7658.0 |
LRP12 | 7671.0 |
AHCYL1 | 7728.0 |
WNT11 | 7757.0 |
CX3CR1 | 7784.0 |
HTR1A | 7853.5 |
HTR1D | 7853.5 |
WNT10B | 7877.0 |
GPER1 | 7908.0 |
GNB3 | 7932.0 |
PNOC | 7937.0 |
CALCRL | 7971.0 |
ARHGEF2 | 7980.0 |
DRD1 | 8013.0 |
SMO | 8017.0 |
CYSLTR1 | 8025.0 |
PRKAR1B | 8032.0 |
UCN2 | 8033.0 |
AWAT2 | 8046.0 |
PIK3R1 | 8109.0 |
OPN1SW | 8117.0 |
ADORA3 | 8119.0 |
HSD17B1 | 8140.0 |
NTSR2 | 8169.0 |
CCL7 | 8170.0 |
KPNA2 | 8174.0 |
HRH2 | 8194.0 |
TRPC6 | 8208.0 |
MC4R | 8265.0 |
PDE6G | 8266.0 |
ARHGEF26 | 8302.0 |
ABHD6 | 8329.0 |
CNGB1 | 8343.0 |
LPAR2 | 8362.0 |
OPN3 | 8414.0 |
CREB1 | 8434.0 |
PLA2G4A | 8549.0 |
GLP1R | 8565.0 |
WNT9B | 8579.0 |
RDH11 | 8604.5 |
AKT3 | 8609.0 |
TRPC3 | 8707.0 |
OPRM1 | 8749.0 |
PDE7A | 8851.0 |
ITPR1 | 8900.0 |
Cytosolic tRNA aminoacylation
245 | |
---|---|
set | Cytosolic tRNA aminoacylation |
setSize | 23 |
pANOVA | 0.00226 |
s.dist | 0.368 |
p.adjustANOVA | 0.0697 |
Top enriched genes
GeneID | Gene Rank |
---|---|
NARS1 | 8198.0 |
EPRS1 | 7828.0 |
TARS1 | 7731.0 |
GARS1 | 7641.0 |
IARS1 | 7272.0 |
PPA1 | 7256.0 |
WARS1 | 6861.0 |
HARS1 | 6860.0 |
AIMP1 | 6191.0 |
EEF1E1 | 5978.5 |
CARS1 | 4806.0 |
MARS1 | 4257.0 |
DARS1 | 3988.0 |
AIMP2 | 3169.0 |
FARSA | 1906.0 |
YARS1 | 1102.0 |
LARS1 | 795.0 |
KARS1 | 648.0 |
RARS1 | -424.0 |
FARSB | -1497.0 |
GeneID | Gene Rank |
---|---|
NARS1 | 8198.0 |
EPRS1 | 7828.0 |
TARS1 | 7731.0 |
GARS1 | 7641.0 |
IARS1 | 7272.0 |
PPA1 | 7256.0 |
WARS1 | 6861.0 |
HARS1 | 6860.0 |
AIMP1 | 6191.0 |
EEF1E1 | 5978.5 |
CARS1 | 4806.0 |
MARS1 | 4257.0 |
DARS1 | 3988.0 |
AIMP2 | 3169.0 |
FARSA | 1906.0 |
YARS1 | 1102.0 |
LARS1 | 795.0 |
KARS1 | 648.0 |
RARS1 | -424.0 |
FARSB | -1497.0 |
VARS1 | -5052.0 |
AARS1 | -5067.0 |
SARS1 | -5612.0 |
p130Cas linkage to MAPK signaling for integrins
1427 | |
---|---|
set | p130Cas linkage to MAPK signaling for integrins |
setSize | 15 |
pANOVA | 0.00231 |
s.dist | -0.454 |
p.adjustANOVA | 0.0697 |
Top enriched genes
GeneID | Gene Rank |
---|---|
FGB | -9053.0 |
FGA | -8696.0 |
PTK2 | -8355.0 |
SRC | -8095.0 |
FGG | -8035.0 |
BCAR1 | -7614.0 |
VWF | -7285.0 |
ITGA2B | -7222.0 |
TLN1 | -5122.0 |
APBB1IP | -3673.0 |
ITGB3 | -3380.5 |
RAP1A | 937.0 |
CRK | 2198.0 |
RAP1B | 4145.0 |
FN1 | 6913.0 |
GeneID | Gene Rank |
---|---|
FGB | -9053.0 |
FGA | -8696.0 |
PTK2 | -8355.0 |
SRC | -8095.0 |
FGG | -8035.0 |
BCAR1 | -7614.0 |
VWF | -7285.0 |
ITGA2B | -7222.0 |
TLN1 | -5122.0 |
APBB1IP | -3673.0 |
ITGB3 | -3380.5 |
RAP1A | 937.0 |
CRK | 2198.0 |
RAP1B | 4145.0 |
FN1 | 6913.0 |
NRAGE signals death through JNK
753 | |
---|---|
set | NRAGE signals death through JNK |
setSize | 56 |
pANOVA | 0.00238 |
s.dist | -0.235 |
p.adjustANOVA | 0.0704 |
Top enriched genes
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834 |
ARHGEF1 | -8718 |
OBSCN | -8574 |
ARHGEF7 | -8534 |
PLEKHG5 | -8454 |
ITSN1 | -8377 |
MAGED1 | -8312 |
ARHGEF11 | -8287 |
NGFR | -8192 |
ARHGEF40 | -7699 |
MCF2 | -7686 |
ARHGEF16 | -7667 |
ABR | -7655 |
MCF2L | -7517 |
ARHGEF5 | -7293 |
PLEKHG2 | -7206 |
VAV3 | -7088 |
ARHGEF17 | -6885 |
ARHGEF10L | -6624 |
TRIO | -6348 |
GeneID | Gene Rank |
---|---|
ARHGEF37 | -8834.0 |
ARHGEF1 | -8718.0 |
OBSCN | -8574.0 |
ARHGEF7 | -8534.0 |
PLEKHG5 | -8454.0 |
ITSN1 | -8377.0 |
MAGED1 | -8312.0 |
ARHGEF11 | -8287.0 |
NGFR | -8192.0 |
ARHGEF40 | -7699.0 |
MCF2 | -7686.0 |
ARHGEF16 | -7667.0 |
ABR | -7655.0 |
MCF2L | -7517.0 |
ARHGEF5 | -7293.0 |
PLEKHG2 | -7206.0 |
VAV3 | -7088.0 |
ARHGEF17 | -6885.0 |
ARHGEF10L | -6624.0 |
TRIO | -6348.0 |
BCL2L11 | -6346.0 |
FGD4 | -6196.0 |
FGD1 | -5982.0 |
ARHGEF19 | -5545.0 |
ARHGEF6 | -5311.0 |
AKAP13 | -5190.0 |
NET1 | -4984.0 |
NGEF | -4851.0 |
ARHGEF38 | -4562.0 |
PREX1 | -3045.0 |
SOS1 | -2808.0 |
ARHGEF18 | -2547.5 |
AATF | -2176.0 |
ARHGEF39 | -1272.0 |
ARHGEF10 | -775.0 |
ARHGEF15 | -470.0 |
ARHGEF33 | -451.0 |
KALRN | -177.0 |
BAD | 928.0 |
VAV1 | 1912.0 |
RAC1 | 2240.0 |
NGF | 2470.0 |
FGD2 | 4170.0 |
TIAM2 | 4841.0 |
RASGRF2 | 5220.0 |
GNA13 | 5282.0 |
VAV2 | 5813.0 |
MAPK8 | 5956.0 |
ARHGEF12 | 6104.0 |
FGD3 | 6255.0 |
TIAM1 | 6942.0 |
ECT2 | 7350.0 |
ARHGEF3 | 7632.0 |
SOS2 | 7658.0 |
ARHGEF2 | 7980.0 |
ARHGEF26 | 8302.0 |
Influenza Infection
563 | |
---|---|
set | Influenza Infection |
setSize | 128 |
pANOVA | 0.00253 |
s.dist | 0.155 |
p.adjustANOVA | 0.0725 |
Top enriched genes
GeneID | Gene Rank |
---|---|
RPL13A | 8957 |
RPL3 | 8943 |
RPS15A | 8920 |
RPL29 | 8919 |
RPS16 | 8907 |
RPL6 | 8889 |
NUP58 | 8776 |
NUP37 | 8600 |
CLTA | 8586 |
POLR2G | 8271 |
KPNA2 | 8174 |
RPL37 | 8039 |
POLR2H | 7476 |
DNAJC3 | 7406 |
RPL30 | 7370 |
RPS27A | 7369 |
RPL7A | 7100 |
RPS23 | 7033 |
RANBP2 | 6945 |
EIF2AK2 | 6933 |
GeneID | Gene Rank |
---|---|
RPL13A | 8957.0 |
RPL3 | 8943.0 |
RPS15A | 8920.0 |
RPL29 | 8919.0 |
RPS16 | 8907.0 |
RPL6 | 8889.0 |
NUP58 | 8776.0 |
NUP37 | 8600.0 |
CLTA | 8586.0 |
POLR2G | 8271.0 |
KPNA2 | 8174.0 |
RPL37 | 8039.0 |
POLR2H | 7476.0 |
DNAJC3 | 7406.0 |
RPL30 | 7370.0 |
RPS27A | 7369.0 |
RPL7A | 7100.0 |
RPS23 | 7033.0 |
RANBP2 | 6945.0 |
EIF2AK2 | 6933.0 |
NUP153 | 6854.0 |
PABPN1 | 6598.5 |
NUP98 | 6576.0 |
RPS18 | 6557.0 |
RPLP2 | 6538.0 |
RPL10L | 6517.0 |
KPNA5 | 6286.0 |
RPS15 | 6242.0 |
NDC1 | 6233.0 |
RPS5 | 6228.0 |
RPL22 | 5939.0 |
XPO1 | 5929.0 |
NUP160 | 5904.0 |
RPS14 | 5784.0 |
GRSF1 | 5690.0 |
RPL31 | 5673.0 |
CALR | 5643.0 |
NUP93 | 5363.0 |
RPS26 | 5195.0 |
RPL9 | 4882.0 |
RPS3A | 4794.0 |
KPNA7 | 4735.0 |
NUP155 | 4673.0 |
CLTC | 4525.0 |
RPL19 | 4494.0 |
KPNA4 | 4361.0 |
RPL5 | 4255.0 |
RPS21 | 4017.0 |
RPS13 | 3688.0 |
POLR2D | 3487.0 |
POLR2I | 3477.0 |
RPS8 | 3383.0 |
NUP50 | 3293.0 |
RPS28 | 3175.0 |
RPL7 | 3151.0 |
NUP188 | 3150.0 |
RPL27 | 2912.0 |
RPL18 | 2790.0 |
RPS3 | 2715.0 |
NUP54 | 2641.0 |
NUP35 | 2557.0 |
RPS4X | 2555.0 |
NUP88 | 2333.0 |
RPS11 | 2321.0 |
POLR2B | 2214.0 |
RPS19 | 2111.0 |
CPSF4 | 2107.0 |
RPL37A | 2071.0 |
ISG15 | 1321.0 |
RPL36 | 1297.0 |
KPNB1 | 1280.0 |
SEC13 | 1065.0 |
NUP107 | 935.0 |
RPL10A | 667.0 |
RPL11 | 231.0 |
RPL21 | 231.0 |
NUP42 | -38.0 |
TPR | -207.0 |
RPS25 | -242.0 |
AAAS | -496.0 |
RPLP1 | -660.0 |
RAN | -987.0 |
TGFB1 | -1162.0 |
RPSA | -1493.0 |
RPS2 | -1703.0 |
POLR2F | -1805.0 |
RPS17 | -1958.0 |
RPS10 | -1984.5 |
RPL23 | -2023.0 |
RPL18A | -2151.0 |
RPS7 | -2157.0 |
UBA52 | -2166.0 |
KPNA3 | -2304.0 |
KPNA1 | -2755.0 |
RPS27L | -3093.0 |
NUP62 | -3094.0 |
GTF2F1 | -3198.0 |
RPL35 | -3206.0 |
GTF2F2 | -3213.0 |
NUP205 | -3219.0 |
RPL24 | -3268.0 |
RPL28 | -3293.0 |
POM121 | -3732.5 |
POM121C | -3732.5 |
NUP133 | -4126.0 |
RPL8 | -4167.0 |
CANX | -4217.0 |
IPO5 | -4272.0 |
NUP210 | -4336.0 |
RAE1 | -4461.0 |
POLR2C | -4917.0 |
HSPA1A | -4959.5 |
RPL38 | -5629.0 |
RPS6 | -5720.0 |
POLR2A | -5792.0 |
RPL15 | -6128.0 |
RPL23A | -6843.0 |
POLR2L | -6941.0 |
RPL3L | -7058.0 |
PARP1 | -7161.0 |
RPL13 | -7209.0 |
RPS9 | -7535.0 |
NUP85 | -8017.0 |
NUP43 | -8128.0 |
POLR2E | -8423.0 |
FAU | -8625.0 |
NUP214 | -8732.0 |
RPL35A | -8900.0 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.0.3 (2020-10-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 18.04.5 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.7.1
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.7.1
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.1.0 GGally_2.0.0
## [3] ggplot2_3.3.2 beeswarm_0.2.3
## [5] gtools_3.8.2 tibble_3.0.4
## [7] dplyr_1.0.2 echarts4r_0.3.3
## [9] gplots_3.1.0 mitch_1.2.2
## [11] DESeq2_1.30.0 SummarizedExperiment_1.20.0
## [13] Biobase_2.50.0 MatrixGenerics_1.2.0
## [15] matrixStats_0.57.0 GenomicRanges_1.42.0
## [17] GenomeInfoDb_1.26.0 IRanges_2.24.0
## [19] S4Vectors_0.28.0 BiocGenerics_0.36.0
## [21] reshape2_1.4.4
##
## loaded via a namespace (and not attached):
## [1] httr_1.4.2 jsonlite_1.7.1 bit64_4.0.5
## [4] splines_4.0.3 assertthat_0.2.1 shiny_1.5.0
## [7] highr_0.8 blob_1.2.1 GenomeInfoDbData_1.2.4
## [10] yaml_2.2.1 backports_1.2.0 pillar_1.4.6
## [13] RSQLite_2.2.1 lattice_0.20-41 glue_1.4.2
## [16] digest_0.6.27 RColorBrewer_1.1-2 promises_1.1.1
## [19] XVector_0.30.0 colorspace_2.0-0 htmltools_0.5.0
## [22] httpuv_1.5.4 Matrix_1.2-18 plyr_1.8.6
## [25] XML_3.99-0.5 pkgconfig_2.0.3 genefilter_1.72.0
## [28] zlibbioc_1.36.0 purrr_0.3.4 xtable_1.8-4
## [31] scales_1.1.1 later_1.1.0.1 BiocParallel_1.24.1
## [34] annotate_1.68.0 generics_0.1.0 ellipsis_0.3.1
## [37] withr_2.3.0 survival_3.2-7 magrittr_1.5
## [40] crayon_1.3.4 mime_0.9 evaluate_0.14
## [43] memoise_1.1.0 MASS_7.3-53 tools_4.0.3
## [46] lifecycle_0.2.0 stringr_1.4.0 munsell_0.5.0
## [49] locfit_1.5-9.4 DelayedArray_0.16.0 AnnotationDbi_1.52.0
## [52] compiler_4.0.3 caTools_1.18.0 rlang_0.4.8
## [55] grid_4.0.3 RCurl_1.98-1.2 htmlwidgets_1.5.2
## [58] rmarkdown_2.5 bitops_1.0-6 testthat_3.0.0
## [61] gtable_0.3.0 DBI_1.1.0 reshape_0.8.8
## [64] R6_2.5.0 gridExtra_2.3 knitr_1.30
## [67] fastmap_1.0.1 bit_4.0.4 rprojroot_1.3-2
## [70] desc_1.2.0 KernSmooth_2.23-18 stringi_1.5.3
## [73] Rcpp_1.0.5 vctrs_0.3.4 geneplotter_1.68.0
## [76] tidyselect_1.1.0 xfun_0.19
END of report